var title_f25_49_26384="Pharmacologic mydriasis";
var content_f25_49_26384=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F62605&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F62605&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pharmacologic mydriasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 244px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_49_26384=[""].join("\n");
var outline_f25_49_26384=null;
var title_f25_49_26385="Thoracic ultrasound transducer";
var content_f25_49_26385=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F60954&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F60954&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Thoracic ultrasound transducer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A convex array transducer is shown over the right lateral chest wall, just below the angle of the clavicle. The arrows indicate the directions the transducer may be moved during a systematic examination. Transducer movement should be in only one direction at a time until the entire area of interest has been imaged. The purpose of the examination is to outline the craniocaudal and lateral extents of the pleural effusion, determine whether the effusion is free-flowing or septated, and identify adjacent structures.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_49_26385=[""].join("\n");
var outline_f25_49_26385=null;
var title_f25_49_26386="Patient information: Poor weight gain in babies and children (The Basics)";
var content_f25_49_26386=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/15450\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/37/27231\">",
"         Diet diary",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_table\" href=\"UTD.htm?0/2/36\">",
"          Tips for parents of children who need to gain weight",
"         </a>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?16/43/17075\">",
"         Patient information: Breastfeeding (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?33/34/34338\">",
"         Patient information: Diarrhea in children (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?34/27/35250\">",
"         Patient information: Food allergy (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?8/18/8486\">",
"         Patient information: Poor weight gain in infants and children (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Poor weight gain in babies and children (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/poor-weight-gain-in-babies-and-children-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H476721256\">",
"      <span class=\"h1\">",
"       How do I know if my baby is not gaining enough weight?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Your doctor or nurse will tell you if your baby is not gaining enough weight. At each visit, he or she will weigh your baby. Then he or she will compare your baby&rsquo;s weight to the weight of other babies who are the same age and sex. Babies who weigh less than other babies of the same age and sex are not gaining enough weight.",
"     </p>",
"     <p>",
"      Some babies do not gain enough weight starting at birth. Other babies gain enough weight for a while, but then slow down or stop gaining weight.",
"     </p>",
"     <p>",
"      If your baby isn&rsquo;t gaining enough weight, your doctor or nurse will want to figure out why. He or she will treat the cause and work with you to help your baby gain more weight. Babies need to gain enough weight so that they can grow and develop normally. Babies who do not gain enough weight can have problems later in life, such as learning problems or problems with the body&rsquo;s infection-fighting system.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H476721263\">",
"      <span class=\"h1\">",
"       What are reasons that a baby might not gain enough weight?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Reasons that a baby might not gain enough weight can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Being born too early",
"       </li>",
"       <li>",
"        Not getting enough food &ndash; For example, some babies have trouble sucking at the breast or bottle. Or parents might not feed their baby often enough.",
"       </li>",
"       <li>",
"        Having a medical problem that affects the stomach, mouth, throat, or heart",
"       </li>",
"       <li>",
"        Changes or stress in the home or family",
"       </li>",
"       <li>",
"        Having things around that take attention away from eating",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H476721270\">",
"      <span class=\"h1\">",
"       How can my doctor figure out why my child isn&rsquo;t gaining weight?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Your doctor or nurse will do an exam and ask you questions about your child&rsquo;s eating habits. He or she might ask you to keep track of all the food that your child eats (",
"      <a class=\"graphic graphic_figure graphicRef58605 \" href=\"UTD.htm?26/37/27231\">",
"       figure 1",
"      </a>",
"      ). Let your doctor or nurse know if your child:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Has vomiting or diarrhea",
"       </li>",
"       <li>",
"        Does not eat certain foods",
"       </li>",
"       <li>",
"        Drinks much more than he or she eats",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Your doctor might also order a test.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H476721277\">",
"      <span class=\"h1\">",
"       Who do I work with to help my child gain weight?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Your doctor or nurse will work with you to make a plan to help your child to gain weight. He or she might recommend that you also work with other experts, such as a dietitian. A dietitian is an expert on food and eating.",
"     </p>",
"     <p>",
"      Most children can be treated at home. But some children need to stay in the hospital for a short time. In the hospital, doctors can treat children and watch them closely.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H476721284\">",
"      <span class=\"h1\">",
"       What can I do to help my child gain enough weight?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You can do different things to help your child gain enough weight (",
"      <a class=\"graphic graphic_table graphicRef52880 \" href=\"UTD.htm?0/2/36\">",
"       table 1",
"      </a>",
"      ). You can change:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        What your child eats &ndash; You can help your child gain weight by feeding him or her foods with a lot of calories. Talk with your doctor, nurse, or dietitian about the right way to do this. He or she might recommend that you add extra calories to your baby&rsquo;s feedings. Or you might need to add cheese, butter, or sour cream to foods that your older child eats. Your doctor or nurse might also recommend that your child take a vitamin every day.",
"       </li>",
"       <li>",
"        How often your child eats &ndash; Babies might need more feedings each day to gain weight. Older children might need to eat every 2 to 3 hours, and have 3 meals and 3 snacks a day.",
"       </li>",
"       <li>",
"        Where and how your child eats &ndash; Making changes to the area where your child eats might help your child eat more. For example, some children eat more when the whole family eats together or when meals are fun.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H476721291\">",
"      <span class=\"h1\">",
"       What other treatments might help my child gain enough weight?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Sometimes, other types of treatments can help. These can include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Medical treatments &ndash; Some children need to be treated for medical problems that can keep them from gaining enough weight.",
"       </li>",
"       <li>",
"        Physical or occupational therapy &ndash; Some children have problems with their body or behavior that can make it hard for them to eat enough food. People called &ldquo;physical therapists&rdquo; or &ldquo;occupational therapists&rdquo; can work with children to improve these types of problems.",
"       </li>",
"       <li>",
"        Family help &ndash; Some children do not eat enough because of problems at home. A family might not have enough food, or a parent might be too sick to take care of a child. Your doctor or nurse can work with you to find programs or people who can help with these types of problems.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H476721298\">",
"      <span class=\"h1\">",
"       When do I follow up with my doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Your doctor or nurse will follow-up with you on a regular basis. On each visit, he or she will weigh your baby and talk with you. Let your doctor or nurse know if you are having any problems with treatment.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H476721305\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?16/43/17075?source=see_link\">",
"       Patient information: Breastfeeding (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?34/27/35250?source=see_link\">",
"       Patient information: Food allergy (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?33/34/34338?source=see_link\">",
"       Patient information: Diarrhea in children (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?8/18/8486?source=see_link\">",
"       Patient information: Poor weight gain in infants and children (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?25/49/26386?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15450 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-EA571C30FB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_49_26386=[""].join("\n");
var outline_f25_49_26386=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H476721256\">",
"      How do I know if my baby is not gaining enough weight?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H476721263\">",
"      What are reasons that a baby might not gain enough weight?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H476721270\">",
"      How can my doctor figure out why my child isn&rsquo;t gaining weight?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H476721277\">",
"      Who do I work with to help my child gain weight?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H476721284\">",
"      What can I do to help my child gain enough weight?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H476721291\">",
"      What other treatments might help my child gain enough weight?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H476721298\">",
"      When do I follow up with my doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H476721305\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/15450\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/37/27231\">",
"      Diet diary",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_table\" href=\"UTD.htm?0/2/36\">",
"       Tips for parents of children who need to gain weight",
"      </a>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?16/43/17075?source=related_link\">",
"      Patient information: Breastfeeding (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?33/34/34338?source=related_link\">",
"      Patient information: Diarrhea in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?34/27/35250?source=related_link\">",
"      Patient information: Food allergy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?8/18/8486?source=related_link\">",
"      Patient information: Poor weight gain in infants and children (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f25_49_26387="Complete fracture molding";
var content_f25_49_26387=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F73696&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F73696&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Complete fracture molding",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 444px; height: 389px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Three-point molding. A) Three-point molding for dorsally angulated (apex volar) fractures, with the proximal and distal points on the dorsal aspect of the cast and the middle point on the volar aspect just proximal to the fracture site. B) For volar angulated fractures, where the periosteum is intact volarly and disrupted on the dorsal surface, three-point molding is performed with the proximal and distal points on the volar surface of the cast and the middle point just proximal to the fracture site on the dorsal aspect of the cast.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Waters PM, Mih AD. Fractures of the distal radius and ulna. In: Rockwood and Wilkins' Fractures in Children, 6th ed, Beaty JH, Kasser JR (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. Copyright &copy; 2006 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_49_26387=[""].join("\n");
var outline_f25_49_26387=null;
var title_f25_49_26388="Bleomycin: Patient drug information";
var content_f25_49_26388=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Bleomycin: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/15/39159?source=see_link\">",
"     see \"Bleomycin: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?15/33/15895?source=see_link\">",
"     see \"Bleomycin: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F141845\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Blenoxane&reg;;",
"     </li>",
"     <li>",
"      Bleomycin Injection, USP",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10024745\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700769",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause very bad lung problems. Patients with kidney problems, older adults, and people getting a large dose (greater than a total of 400 units or 400 mg for all treatments) have a greater chance of having problems. Call your doctor right away if you have trouble breathing. These effects may happen during or a few hours after your first or second dose of this drug. Lung problems may also happen months after this drug has been stopped. Tell your doctor if you are feeling dizzy, are not thinking clearly, have fever, chills, or wheezing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700213",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Unsafe allergic effects may happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10024747\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691672",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat cancer.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691449",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop fluid buildup in the lung cavity.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10024746\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to bleomycin or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10024751\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697300",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697247",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have had radiation, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697012",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are a heavy smoker, talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697613",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before getting any vaccines. Use with this drug may either raise the chance of an infection or make the vaccine not work as well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10024752\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698081",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Fever.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698243",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Mouth irritation or sores. Using a soft toothbrush or cotton swabs and rinsing the mouth may help. Do not use mouth rinses that have alcohol in them.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698393",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Weight loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698984",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not hungry.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698226",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Harm to the lungs may happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F14789818\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough that does not go away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699035",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad mouth irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10024749\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695991",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696028",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given into the lung cavity.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10024756\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12410 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-122.72.76.133-425BDFC11D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_49_26388=[""].join("\n");
var outline_f25_49_26388=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F141845\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024745\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024747\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024746\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024751\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024752\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14789818\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024749\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024756\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?38/15/39159?source=related_link\">",
"      Bleomycin: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?15/33/15895?source=related_link\">",
"      Bleomycin: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f25_49_26389="HUS Vascular II";
var content_f25_49_26389=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F69687&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F69687&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Light microscopy showing thrombotic microangiopathy with mucoid intimal thickening of a muscular renal artery",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 252px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAD8AYwDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwC74DnstGs7qW6WOK7kJEcxOGUdwPSrmuaVJ4qzDZWzFQ2/936Y64/Ctz4k2C+HLKzgsNEuNSkVgomzmND/AHcDnPFaLS61pPghtRm09NNutojXa244PA47H616iqLSUd35n2P1uEn7SC1eiuZml+FE0Ipp8Fqz3dzCJZVypG0DqxPC1u6HpbSXLJcyW8sLHIjhIbG3tnsPpXQeDfD08mnxXWuSfabmVBu3+mOAfp6V1Mmm2boI2tYyMdQuCPxrknibe6jzcRmPK3C9/NfoeT/GG8u99rZ6a7wBV+XZwzE98/SuU+Hnh7U9Smlhu5mewZvuSncFfsQ3Y5rqviNCrLLCscjPayHBPaPgDB79TXSfCRrSTRniSdGlSRsQORvUf3iPf1roc3ToJxO72iw+BVSC1/rU63wzo66HpUVlG7OqnJJOcH29q1ZGCIztnaoJNLzkdKpavqFtpGmT3t85W3iGWON3HToK8zWcu7Z8vKUq07vVs4vW7Wy8exTQ2u6G4tDhDIcbx/TpXmSJLoOry2rFVmt35KnIGPSvSvhnPcXmoX11c6dPbwz/ALy2l24j2+n16Vwvxi1W6s9YuFFhDBHbsWQheZdw++fWvToS5ajpdD6jA1XSrSwu8Er77dztbDxLpkdlFIE3Xsg2sxOMDHY1tReIbLyxBbosKhQGk29fyr5/8MavJq8JtZYl80EBSAfm/wAK6J9G1KwWW4vLa7its7UmB+UGqlhqbe5pPLKE9XK1+56xqUTazaQtFq1zBbRSDzFjGfM46cjPetG4ntf7G+zWtvM4jUEeWm3b+JrynRvEU9kPlZXeJcBgpyfTPvWxZeNrgXjPqCGdCvKoQFJPHbrWcsNLZapHJUyyqtI6pao67SZTeWy6bFbJAJCXunPOR0zz3OKl1tFh1SygtIkAmhVNp4wAawrLXor24JsoQZQCCinYxyePrUFw3ihb+G5eCAzyqyoZ5AoCjp06f/XqPZtS10MXh5Kpd2W+jfU3rO4t4Ndna4MFmjfu8bt28AdFGPXJqp4l0Sx1W/05rPT7YMN4EhjB3rjggfnyaq6j4h0rRY7e18SWlouuTZSG3tl83bnoWPbJ4rpdHtNlwjTfJevF2GSqY6A9Kl+575zuTpv2i0tp5P8AzHeGbU6S8tvLf3E0A2iMTkYBPOF9PTFbYvrdiuyTfu6beazGgE5kFx5rKvzfIQBn375qIXVxDPLbQJcS264JcoPkBH61i1zu/U5Jw9rJye5of2qhnSNYZSCcFscLVbxH4ittE0yW7kjmmCg7ViQtuYA8Z7dKJ7C6FuksEp+0DG1C2Bj61n3N9Hcabe2eqrcGV8xNB5Wcg9MEDBHvRGKb7hClCTTSuuvcseBvFdl4s0Vb21dFmQAXEIbJib39qs6vrsNlpkt5GrSxoDkrjjt3rz7wp4GsdH1s3Gi3E6I8WGtN29Q+eSw4xj39a66CW1/tERQJJJLEhW5ibO0EjBz2z9K0nCHNeOxrPD0o1G46rexzmm+PNK1XVnt7WO8uLt2TbExCZcdBnPTJPauy0zS0SdJHiKMULOHILKzEk81n6da6LHPHdaNp1nbuHKNPFEN2eeCRzgnvVuM3k7Ge5vPsluQAgQDcvqCTxniio09I6FVmnpTXKvP/AIBLNolnc6ss0rysqxkIm8gKc84I59OK4/4ga7b6R9pQAWtlCAss6L+9mkOP3aE+gIJPvXYCZLO3acGRreFwcryz54P161yPie1gvpL/AO0wR3VglwpSMsQ7yvj5QPTv26U6Pxa7FYRN1Pfd0v6+85S2v5tf8EatDplxNY6fK4RklcMynqcN3z3FWPh74H/sKC8m8RvJDZH96YjxvVRnJA5AH1zUfiXxRpOn6lFpNq9k09rIJnihjHltIOijHAA7+9dr4k0e48S+CzYyXDfbblxKVM20kf3Vz26cV1Tk4rsmejVqShFcvuqb36+v/BM7S/E+nX0d0dBuNPWwtPlBjjy6KeM4Iz26mq+teK/B2kf2hdQ6kJrqTEcligYF2OMBQAMc++K4Cbw4/gzRL9tOmuv7Wmi2S+YF2ABskxgfgMn8KqfDLQYvFmtNqepx7ntI2k2kYNy4GAAfbqfpT9lBLnvoOWGjGPPd2/M7Wa3utV0aTUrBbdXjOXhk3eYcn1/pXb6lFB4m0aDTdb06aaBESS6CEbQcfn1OePSsmS3lvNNC2Nt9mtLbiXJwrhiOh6k49a3fFGo6kfJ03w1au8s0Z3XIGEiUdAGPGeaxqvmaX9I58TJ1JRjHdN9fh23Zk+EfhvpXhKLUbrQ7iZjdBZY/MAbYV5H1HtXeKGkjBmMbRlckY4b8+1Y2hQ32m6HHDrTwNKkYUSqxJJ/ukf4VekWW+tlhVXghIAdyRlh3UD39a5Jtt6u/meVWcpy96V7Pcz9MjttSv7i8RpfklKo6EhcKPyrVa2hkmwXYSMQxK8bsDHPrWFrvimy06L7LZyrJP90lCAE/pn2rP13xBBpmjDUtQ1MQKMFI5Fw7MPQDBx+dX7OcrM29hVnaWyeiN26sLW5mVFEcrxHcY2G5Ac9TnOKJbiWLy7bTrSFo0IbC8LgHt+I/SuY8OeOIL+NZYcTm45DHgjA6H0IA/Wr1t4p89WD2slvbrGQcIQQOcEEjpTdGpF2aNHhq60krpeZoa5rFslo4vraU+WcMka7+TXIeI21bUrCCTwZrktkEkAeGRCign1JHTjpWwfEtmvlyxeaZSDlVjyrfnz+NXtM8T2Go+ZFNEqN3C85/lVKMoK6j/XoaxozpRuqbaX3fcxNATVlu1k1PyPtcNusc8yKwSZj6ep47DHNPudas1nXTLl0TWxiRYCdxOecjHatMx5EU1ncHy16rnjHvn0rk/EejrL4j07XPLiN7auCJeQHHPB54qI2nL3jKCjVnrp/Wx0cT73Aukkty/ILMcZ7gA8elIkL2l/FKkq7GQlgeAecj8aNYzefY3N55UTEFo1XJJAyMHHFXZPs6bRcXkrlMZ7fyFZ7IyvZLz6GH42iGp6MJVVs253Mu0FsdCc+n0rJ8QWduPDmkw27TGRCHVJ17HqzDpxmujmmjOz7JbTlD8oJONwHop5PT0qG6zc2RjvTOjsCMuhO3PcgggmtYScUl2Z1Uargox6J3IvAVtZxRXDWhuCxVQ5KYjPX7p7nOea6yKJETbGoVfQCuE1HTY5re3SKe6KRRCON4j905O4kDvityz8T2aQiORbpmjOwt5ec44zUVYOb5o6mGKpSqydSF3cSysNNtLq3MEGzy9ypsbfz6nuaqO3/CQ+JvIKudOscFg33Wk7DFYFhrtvd3P9n2N2j6mWJdXXadoP3VFdD4MvLe3Sa1l3Q3JcuwkGNxJ6g9+KuUHBOT3/rUudOVNOb1fT/M6xVCcLwPSlx7U0OGGVYEeoNKSQRyOvPHauQ8rU+f73UbmXxx4h0+OS4urYFpDLMm0p/sj1Hp9KztF1W50bVkurMhpo854yOeCPpXs3jmxhCW2oC1R3jlAlOOXU8YPqK8j1qF0YwOqQeVKWVUAyM9R717VCoqsdj7DLa0a9Hkt5anqPgTxTqOtXr299BE0flbxLEpXac9GFbHjWVxpQtYmSM3TiMu4yqr1Oa4f4e61a6RpM89xKZri5uUhSIN8x7Z57DNM8ZeISfHumra3IMEQ2srHMZP8XHeuV0b1nyqyR5s8E3jX7ONorXy0/4J2lt4nsLfVYNHQMxAWJJBjDHHoKu+KfDOm+JrIW2qRFlXlXU4Zfoa8DvbvxNceMob7TLZ4YLRyFlZMR85yf517HceLVh8LrN9oj/tQw52FeQfXFKrh+Rx9nv+pniMDUpThLD7/r39Cn4Z+HGl+G75ZbCA3Bz/AKy4k4XPooHPavKvilrmsXskkE9xIBbzMEijG1eDjIx/Wu3sfH+qzxxf6OXt7bC3DI3zuSODk9KbaaCviDUZrlbHyYd/mEzOWwc5zz949a2pp0m5VT0aEalCcqmM100fb/L5HmPgfTdUnhu5IAZnlxmFmyx9/r1ruf7HuGZUW2lKoAZCy/MW9Of5+1dzaWGlaJDNLNNAXkPyIqAux7KoHvVyCbUYbBrr7GnkufnjlOCg/nTliX0FPM3f93HTz0Mrw9oaTXoulhMcUMmCR98nH8ua3r4kXbyhP3duvyq+BuJ9PeqNx4hjeJYtNXyUxs4+9n2+lc5rWjatr9j9ph14xmWbyo4kTOTnkNz0yKxacnzTdjgfPVlz1nZbGba+C77WvGl/rXiuM2FuQPs9tCwy4xgZb2A5r0W3u7O2tJLe2EYMfyIq8Er1AriIrPxRZW32DxJfWtxLnFk0JwSo+9u47j1rqrmxhuXifShagyxFJC7EFGGPmA/GibUrcz08tgqtTUVN6dLbaG9IFkhRkfGceacE8f8A66ztTvF06yaaGOa6UMTKU5AIH6dqZFKdNmgWGc3ztkyLvAOegOPSl0e21U200lw1q8d3I0jxqD8oPGM9/SsUktXscago+83p91yOS1uL2G2uo57mznc+Y5MuSqEdMdBVq0iu2jkjF95zZxFK0fzKevJ796r6m9zFZW1rEGjlkbZGB2Hcnvj61niex0W8Iur+4llQjesXIUjsatJyRtGLnGy36K1zet4bmO3wYwbnGMu2NzdMk45qhbWMt7aSRbIROkmZWBwrN+HNV/tk+t6dJIYVigQl4Lhs7c9ACM9P89qq+HLfWbF2u7iSwVHZgIYyQsgz69j70KNk9bMShKMZNtKRr2OjQaTJLI0jjzcuYo8hc4wefTH86brtzoWj6NBea/drDaIAI2kckAn0xyTT52uLh3m1B47a027REPmYg+9cb8T/AAxY+KNDgugkt3LaAskMMm0AY6Uo+9JczJjCVSa5pavr/wAE67w3mW7uiZ/N8oq0UYPykH+L8Rjmue+IF7pVlq9tNPd29vO0ZlxI+DkcZx69am+GqM+nWd9NEIGNoqCFXLNhWwpJPsP5Vo+IvD+jeJYPs+uWHnq8n7qSP7ykjseo4Aqm1Cpdmil7HEOT6HhHhnwvpcXiOHU7vVbbUIPM3mBHweTn5s13vxO0zXvFdtBeaLF9jWyO2GAybWmAPJHHauq0r4feE/BsbailmhlRcBp23jP0NaMNxaXtwZLOUzvBGB5aD5Bn1Pt3xWzrqTU4rY6pYxVJKpCO3Xp/XmYFjoVzdeEtNTVLwLqMceyZVO/AGdo4H+c1q+HtBh0HUIXvEVmiiKx+WPljB65A6k81qaJM0oufOCxSxYjWOCThlLffH19faqvj3Xj4d0g6hBbxyw7jvySHYgE8fqOaydScnydzneIqzk6C2d/x8yzqM9pHpxu7qaHTdFjfzJDIdpckj06fSsrWDLrHhlr7wTq7WMTozCZlPluB3GRkHI6ivBfH/jvUviXYWWmW1i1qkU5YQwkuHGMKSfUc8e9e4/D3TrjTPBPhfQ7qNPP5lmRzkqgYtyPqQKpw9nFN7ilRnRjGcu+3l59zhvh/oGsWXiWLWfEGuefDGcmOWSR2lJ4GMjH613PjzxP9luTZWN00b7QgRMDzGY9M9uPTmu+v13WE6jH+rI+nFeFa/oV/rWpmWGS0V2Zm33kuwx47gdyf0qqUo1pc0+h0YSdPFVPazVlHp0OW8U6H4jvNbt7zSrOQLCQ8aK24qwPLEdz6k13UPgfXPG2ixXHiCZYLtmDiVu+BgYUDGOa2/AcMGnwzPqs6SQxR7SzZO5ie3qOP1FdXda4lxpMjWcksZdiqOU27QP8AP61VWrNPlj95tisVUU+WlHXa5yXhjwvpvgeExSltU1KRgz5GI4/oK6a48Q3MYXybJI1cEjcOvpWTaTyKMQyMsrYy5PzHnuTV66XDxXO8SqzAMFPOT1z3GcVlKzd56nPUipSvV1f9dNkJd+IbtkVIo4UJHOxc57d6oXLHUgkX2eCJoxvkkjQKxwfUVYkliQyqihDjoq8k+/t7U3StLOozNK0qpAhzL649KaUIq+xcVTpR5rWsJo2pPcG2trmQlGy8bEchh2b/AArJ8d67deG4bKS005b5bicRtI8PQE8KMd+wrO1zxVp9pYokUMcDteMscjfe254P04rvtKuv7U06Ke2d3jYDc5YAHj+H9KJrktNrQVaHsrVHGy7GfomqDVrUPYiaIBxmKYbgpHb6Vpw6jDZz/wCkeU4ZsBh8pDdwQagaCKKW6udIYF2wbgZyztj+eM9Kz/E2r2nh3TxqWpQAxQ4ISM7nkZunGBz7msXyyeiOVqM3ZLR/ebWqeJtL0nTzPJIASwCIQQXJPQcVbTV4mAiureRJigZolG/aD64ry7WP7X+Inh+wl0iKCNVYzC3JAAXlR83r7V1/hmabwnodtba6ksl0ylpJUJk5BwqD6DFEqUUrfa7DqYOnGkmned9r6mg6RSyzSWpJsv4oyMLnHPHaoDeXBP7oRMnb5TWn9htNUi+03FvPB5vO0ybSw9wDisq8m0uznMLJfwkfworEHnGc+9TFp6W1IpyUnazbMGx8KaHYa9caq9s8168m9GdicE/3VHfrWV481TUYLSO8jkSFYZCgtON2MZBbknn9K5iDxzr8fiC+RrJXZUeONSMCI/48ViQW+qyXTyXokIaNmYSsGwDnkdePrXoU6LUuabuetRwtTn5pnoXhr4ixnTRdCSKRY1VZojJtZXPovUj3rqtH+Ium3txsuALdeBu3buT+FfOGmaA+k211ql0xZQTHBgZ3seoHvW5oug6tFawavGJIIXYjy5EPzr/npSlhqUt1qXLLqE/jVm/M+j9Z1PT5tHaWO8iMW5cuj5K89cc15h4ut57ySbUIFEkC8iVU+UrVzwO1pq8huFHlywgqElXKyDHpXTRzPb6a0E7R/YpVYBUjJIPP9cVhBewlaJx0V9RqWhq/PzPFpJxbQfaJwAuSVGefrVS20WfxTeT6lBqCQwIwDb8+YpA7Y+leh6p4GGo2pknUrGmCJgdoyT0H51o6R4TfR9PmNvYx7Iv3js7ZZznoK65YiNtGerVx1KS0ZQ0vTLt7ezFvDLO65EgJ7ZGTjsT60pt9LsfEVhYar51xdXRZjbRHcbdAD8z+1M1u98US3Vra+HUNj5nE883CxrnoCev4Vs6ldaR4Snkv4Ym1HXLlVFxO2TuwOg9B3wKxlKV7Ld9v1ZxTrVZS5Y9e2/39DW1nRtBigWZ5I9PtgQQytjcRz3603QIm16ZJIr5n07O5087LMc9OK43U/BXiXxjJHqFxLHbQSgFYmYjYp9qsajfxeH9PHhfw7cL5qr++uFPzO56hTWag2uSMrv8AIX1dSiqcKnNPr1Ue+ppa9qVvp/iGa3s7jcYceXJw2xsH5RXON4m1aSzZ7qS9mVpM7EYhSPcjvVI2f9nWFlFMS95euzyg9VUHAArqJ5oLryI4yViCqFjiUrnH/wCrOTXQoxilpc7o0qVKMbx5vP0/zLPh2+S0vDdzMI7hhtCbd3GfmGT0PvXRz3sTPJcWwMbuvyoqA4Yd/rXnsd+w1OeZ9wgC7VTOShzzn8q9N+zaLBoAvIJU8gplJC2SWI/n7VhWiotNrc87HUo05qUk7y0/4Bz0+t3McwYRTPPJFsM3BbHfAxxzWXc6pcFraKCxW7DyEBN5jk3diSOntUsjyRMk0ZaZkXlR27n/ADiqBL391K8bRFE429GU44IPatIwXY6aVGCV7Fq1urvSnFxcIksaPlpo5N6g/wB1j6j8qv3GoXl/HCLW7aK038qjYwe1ZV/fTjRWsRbwwo7ZlmHLOw5BPp0qOa4mgs43MgbdtwcDIJHIp8l9bal+x57SaVzK+Jet3Wl3FjDFeXV3KY97SSuQitnlQB1xXSRXOoaRaxzSrFcJqNsk7SNFkpkfNkGqVjrKvcW0er2FtqNpAxaMSLl488kg9/pXR65fWGqxCVE8x8bFG/AjX6CplzRtFrQmreKhRlDTW7017en9blLStYbT7XMYdIbj5hHKgEcp4BCkdDg/pU+qZ0+7tvtlyY4FkLptcbORkLnv0xmsNLWON5LaWSTMGJ4IydyluhGO2aj1O3fxGbfTLtPKMbLIpKYCJznI/i/+vRyK9zL2KUuZba3/AENbTvGTavdajbOsccYhzEyjI6HJb34qfQ4ZYLONoYZCnWXeSjKD29+lCyQ6bpNmbeyiU3S/vbhcbgV45P4d/Wtexlt5y4SQmQpkDdsUduves5NJe6tDCo4wTdONov8ATQjtbJLN/tAedcfu4ogcE5Oeaty3F5CrSYKOFPzkn7o74HesDxPcSxxRCN/NeKPkt0LZBzn1xWva6pcLZS3rbfIkAAYnIDeg/wDr1Di2lJ6mU6cnFTetzhPjpFqz2OmxwNcXMjTfMkYICLjgn6msv4f23iDTbgn98LC5ZfMjA+fgg5/pXptrNEuiSanO8k8k0gQRydDg+neodNvB/ak7XhjjlADfL+nFaxqSUHC2xvTquNJ0+W9v62DTreGx1S5u7u3uvt12DI9xKwyi5IUBR0H+FXAba50eWz1A/wBowsA0UbKc4J6E1d0K4hulbU76eMG5byIUkYAAA4Cgep/OuJ8cSi+tLrRvDslzZGFnDeUdvnPn7oPXrWKTnKzOOCdWpy7Ndeit/VtDptLt9M0GxMun6JDaXbPtddoUdeSOen0rS0u7USS3V1d232qZcLu+TgE8c9q4zwR4N1HRtHW41XVL6S7uXCJBNMSkKn1B7nFdZfeFRqlqFvJ9sowEKqDgDpn3qZ8idr/Mir7LmanPrvv/AEjfSWS6jUbBGjD5wxye+Rx/OvD/AIpafdz2RsrFWldZy0uDznGNv09K9N07Vrm11F9Mvp7GKO1jCiTzCXlOBj5e3vVE3AvmuYJI4n8ycSL5fLZHfFVR5qcr9DTBp4ebbV0efeE3vtMs7XR9ahmhnhU+XGQQOTkk+prtZFh2p5CyAbcybhwDnt6Cug1ma6SzKXlhFK4BX7TuA2jHJAAzn6V4xdfECXStVurC5sBLapwoZykmOxzjn6EVvFutqlqdtOpLER5oq1uzPRFYeZ85DHqCWq3eXikSdNzrluw68cd64iz8b2t7JpqW9veNFcOEfHPkjux/LP4VtJcNfak2n6THc3UaP/rliIUg99x4x/jRKDT94qVLW8tLG1alb7UbSCGN3fhZtvO0d2z2FR+PrxdO0WPT9PmEHmAyXL7hnYOME5/zioLyTU/DlhLHYx5vrlwjSSAYVf8AY9evWs7wR4fsTPeHWp7vUWkLFbZlYRpn7xJzyfWs7Je+9kZJJP2z1jHZb38/keS397Y69cWdvarJFcxsQZZAQJQe/seO/rXv2l6dNY+GrXTgXImICqhAdBjqD9R1rOn0vw7Y3v224h0zT7WHKomwA/Un15q9puuWesRy3WmXRma1fC4XOQB/XtTq1HUirLQeKxDrRXKtN9e/Qy/hx8PtQ8M6zqV1eavJcWsx/wBHQHJBJ5L9sjpXS3Fj/p3laukE6z8K55VwOcFTWFqvxCs/DMRbVJQUYkRQ4AdueTgdq1NG8SW3ii0t9RsY/wB2m75XI3A4wQawmqr9+e3c4ZRrqTlNady1oUQt79YbFYLSzQFWjijCq/ccdj710Ur27uIZdjN/dPeudu9Un0+0E6QDZKS2FBZhnrXKza3bLKv2VpmLtvdzLt3tnJzn6fpUqlKo7gsJPEPmX9ep2HiPxTZ6CrJcxyPNgFEXjcD79q4u7+ImpNMTb6fCqY6Nkn86wvEupza9qcdzHGxXbsfYCynv0+lVhFY6ZFHHqOnSedIolAWYHCnpnPQ8dK6qeHhCK51dnrYfLqFGCdWN5PodFpFvoV3YNqOryyRTKSotw4Bf3wOavaJo+nXls8FlYXENpKrPJcTHkY6DPpXmuuaqdI1Hy9JSQO6jzASG4+p61t6d4w1xdU0W387z9Lu2+zJbkLudeA27HTrWs6UrXixVqNWzlCX3vY7OXwzpWqaJDdaXeKBZFi0oGVOOTx615f4j8XqJhZ200tzEjZmnlGFHavf7LT9F0fS7m2h8uG0bPmqWzya8N8aeFILg39tpd/E1t98FlIKD39frUYWopN3v5XMsBWdWUk23bVXX6mZ4c1S4u9ThTTGWYzfuwiDoCeenSvZ7PQJo5khv7lpbV1DxlG2+Ue4wRyK8M8H3P/CExRrpckc+v6jMII5njJSFOBlQepJr1/SNajnYW+rXC2zwjbIwONx7/iSaqupy1X/BNMdKrPZWtv3LGoXGoy3Mlnp00X2K0f5nkcbTjnB9c46Veka+1C2QTvFJKkmY1tiduSOrH0qSOC0n0+RIBE8JJaURt8z4HG49s15z4r+IGpWWrDQvD0MNncXG0SSqMiEY7cdcd6xjFz0itjhjF1fdpxV0dzFaqks41KaKNYj9w5JduwH5Vzthezzale36Wst3Z2yMko42hmI6H6VweveKL621OysbeV7hgh+1SStkSse+e2BXqng/WLbTPD0lvq0caJOhnBUcSIw6/pWsoOEb73O2dGdKm5Nczelvzscp411fxPBbW99Z3MiJDF5dxppkwLqLOcr2WQdugYcHsRF4V1C38R2k50izieKRgyzyLh1ZfvL6gg8EHpUEMtxfm5u5A8okJMSMM/IOOvpWbp9rfaTdSa54J3m9CldQ0/GVuunKZ4WUAnB6HGD2Itw9mrxN50lhovkXr2T7/wBf8P0FuJbjUZLiRoVmSL7OsJ5CDJG4eh611fh/wYZbRjdQEEkYaY5J55Ix0pnw+g0zVoIdUsCk0Mh3SMQQyMpxsYNyrBhgg4ORXYeIvE+n6Jo15fySpN9mBzFG43FvTFc9WtJvlpnBi8fNyVPDdbHJ6v4INqbhrFkH2lQrAjjIzyP7prJTwtfRRmNGAjXkknGT/KpdJ+Ih8awTRabava+VGzzB2DYXGOuOD6Uzwb4JvUmurk6hdR2dwSIhK+8MDnPH9auMpwj+8djWnXxFKnevJL11H3HhvUrSzjeO+kkRwd7yHgDtk9s1g3VldaRdxzSOCXO1mXOCPSu/m8RaV4csG0nWopIGRQCoBZZFJ6g96w7XxP4e1W4uVhmkC+Z+6DockY64PPXNVCpU3aui6GLra80Lx723Ryb3atqslrIrqr5IlB+Vm6qM+lXY0Vv9Yu3y8FsnLEn/AD0rrr7S9Pv4Y3tVZ4l+UMF28j+VYj6TdSRm3VTEofczuB0Hb1rRVVLyOqniacl29TEju5rTVbdzEDFN8qoUyhx149P/AK9WrF4izyrGzw89B9zBxxS6ik0H2e2uGESo5MbxguVz14P1o0e2kluRZ2jMiliEYEKC3bg9BVtpq5cmknPpYnv4Z44LS6Ry5+ZWdMEbT6irunPd6jd2Zsbgi6jQiNcgkKOo7VX0XLyT6feuYJRuVSBna47fnVPw05t9dmDBn8twdi43g/7P61DWj7omSvCXdLT0ZrIYb6d7QXS4nTcqSrtJlB+ZMDpn1qDMmmOJnVjASFljblkJP3wD9a2ZdOs7zW28hVkF7E7lguAkgOf5Hmq2rXFxLp1osFqLybLWkihlBLA8cn2/pUKV7I5YVE2orZ730/rYZcKbx4LiSZvsizGL73AyvXHvVWxjS6jn0oZVFlPlqB6DGfpxTLePU9Mt0sdZiSGRoj5Q4O4A8rkHqAc1PpmnajHqrfZkt4IYEMu53zuQNgkt3zT6PX0NNIxfvKy27FzVb0xwxQGPYkEQiXI5I7kAdD70gnhu5p5/tcGmrDb7gDGGkbjq2eBWqpd3MS7YpDljNIRlfbFcv45j1e40+8s/C0EMzk+SrYw8nZjzWUbPTY5INP3UrPuX3gtL+/0GOw1AbbNPMZYiSu3sw9ye9dZZTWtveRadaQi6nkcSyyqAfKHcseeewrzbw7Db6KF0+5eR763iRZI0U4jfvlvY446V2WkasqW08ekQSSR7ds15L+72se4GOcUq1NtaaojF0ZOKUdUvlubnjWR10y3lt3UlbhTyMg9f5Vx3xV8aX/hjQdOstIXOp6iBGkxGdhPVh+uKm0XXovE+oXcFiZF03S08lUkUkzSHgEnvzV6/lsru+lh1CITJbur+eY9zDaOdnHfpzWcafI0pK9tTnpUFDlhNXtr/AJGP4a8KX2haBHMwS8vcm7nvZny0jHtyOg61LqmmeItb0C7uNEnhg1F3R4nWXDx7f4Mgd+vXFdXqGs2txY2qxO8VvN8kuFP7tB1BH6VyVz8SVt9UmTTrGJbKN9rEjDPjjOB0+lUnVnrbU6KUcTXvyQu137djB8CTfEH+05NO8QJI0O7zHnvl4T/dI65I6V6Xqvg/SdTTde2ENw5OQ5UZHrj2p9h4ngvI5ZRbXBhRFkkc7cRrgnnJ9jXOzfFbTXWePTrSee6CnyVJVVdu3OeBWclVqS92Nmuxzyhiqkv3ULW3sacdtpehMdL0+406ISqUNu5VX6dAOp61qaJDNYyG0ikjaJV8wKw5UH09h6V5xaRzavavq+p6Us/iID98yINsH91VPrgda39MaawhuVlFxFPdnkOQ0igAY5Ixjk1U6Tta+ppPDycGpSu+vr3NvVprOS6Rr24lJRcsAgYrnoFHYn1qJ9TtrWy85bOYKq4SMEKxz0rFsbhLeyk8iwnchl3TzOCh6jIPbp05rJ8R3BsrUtbkySbN58s7goAyd30z1qo0U3Y1pYTmkqb/AK+429dt4dX8NyWE1ntS8dUZtw8xBnOc+gq1pPhmDw1ojx2LIFVfncsS2MHp7k1zeh61HqGn27wlI5+VJHRfz6Vqzl5g/wBrWWSQIdpB5I7GnKnJe7fQupQnB+zvZX1OY1O28O6vst9Ws5rq6jwA6nk+oBJrQ8F22l+G5Zl0ee6a1kOWjmUHGOAM9q5uKyu21uJVmjExAlQZyW9OOx+tao0680CeObUhLJ5xPmjYRwT29a3lBW5b79D0q2Hptcilq1t3O/a+SaBd6NOsjlSqYJ+grFi0Mx6i0dsGSOX5M5BaNT17+2M+9VrTWbFJop5Y7sIh3CZVUL6Z9/wrL8STap9pW8tLuV184umBtR1HJHqPTGKwhTknZaXPOp0KlNuMdL9zuk0KA3tqkNnHBHErjfIQZXPqcdR9T3ri/ENv4ag1eeO9nv4rhSAywoCnTtmtnQ9RuG1CS/UMtrMDueVjthPcDn17Vy+sWr6lqdxciB7jc5BlFvndjjPBp0YyU/efQrC05qo1OTtbp3/Ej1fwVb3VwYdQvZNNvYuY5FTcsi1R0/wzaadcQXkk82y0l+Vi3Mp65A7enWvY49KvYQom+zXSKSRuU7z9Tn6Vzlx4dfWRcxwSGGSORiGc8Kc9Bxz+NOGJvpJ6GdHHqV+eWhxHjDWbmxtI+m518xRnOzcf5isLwhdX2qao2lzFpp3/AHgdBjYo6gn0rodW0ndqlrYXyMSq7Syjhsnk5rd8J+Hv7H1ZpbaPy/OcQ+YvJcEdOfpXTKpGFPTc751IUqV4tXtoS2fhXde2eq+I7K3dbYg2oRtpXn5VA7n+ddLb6BFcamdZuraNmeTPkkZCDoGx/eqXxVNZwXWmSS3ChrWXc6tJwqgdSOn4mqmm3dlqttqWo2Oot5cm8rtuPl+m2uFylJcz0v8A1Y8SVWpUjz3tf/P9e5k6jryaTdXSWl0WBGTHtB3OTjGe/FZUVnBAii50+KTVZ7lZkZVHmMuB3PtVjw3aQvctctHE10WPl+Ychfen+IdUFpdy3YslkmhCqbkNnyUPTA9zXQlZ8sUeioqE/ZwWvc4vxP4WN40OopCLcNIXRz0OD9z3Nbq28uoW0cd7I8yxR+Wd6bQFzxtx6V6TZ6VayeHLS2mJkSQCbeDnGfmyD2xXJ2ukXE2pXVrYytIEZiGDcEE9/wAaI11JPyKp4+NRO+jj1Oa0hm07V4oWRnQK6gHgbTjGK6vwxo6QSLGTsM8mSQOf/wBZqK30qR9UNpJ5RliPLK2f1rp9S0C++yqNMvPKlK/vFbhSRyCCBkHNTVqp6XtczxWJhpFStzdT59/aN8HeMtI1xfEPheIf2GjRTSJYswkaeMHEs0XRmwSNyg/KvzV6HpPirQvF/gXTNcsYLaLUJvkuLZF+ZZBw6E+mensQe9bOt6jfpcRWeuTSN5IErCNVC+gJI+tVLKHT9Dvr3VLfSSs022VjHJ5ZZ+fmYepGMnqcD0FZ06Uo2le5y0MLUotVL3v22ZV8M21m9+umadarbRXRLTLC3AX3PWu/uZprO7iiiDx21sVCoi8FMdawfhrYTXM13q1wNkkspO1h688V1N9PcNqkyW1sziGIbnZtq5OSBSrSvPlXQWMqJ1+TstfX+tDM8aeGT4rWyCSQxQoGJlZSXwegA9PxqTwv4N0nw67ywhZrxwFMsgHHoAO1Q3uuz6To8XmwMHZzHuyMpxwdvpW94et0ttGtgrF2dBI8jHJZm5JJrKTnGna+hy1Z16dDkcvdvZW6/M4u9tNc0a/nlT99YTzZbCjEYJ7Lz+dSWsOp3t6xMEotU5EgXaGH49a3/G2pCz05LdMma6bYAB0UY3E+g5H51HYw3zadEslwVgl4BDfP9Bj2BrVTbjzNI6Y15SpKpJJN6X7+Zzms2IlkLyviCNs/KM8+h/OsrTbY2V5bX+qxGbTrx2tyAQ20kYGfQ5x+ddhrNri2eNJAIxjLN+g/SuRulluLKXSrVt4kPmbSeAem/Na05OUbHZQqOrS5U9P0KusQQWOs3678gTq8bIchMgHGPTg03VYBaX1pdopiVZB50iHGQfcfU81Zt7RrG9jjupWnkIyd4+8R1/TFa95CYtKnglVQERbiD6HAH5ZrXmtZG3tORRi3fS36HP317LmZ7OZI285bSN1YsisevPcY9K0PDcEdnrx0/VLuKZIoxM0+ColYgYyD0/8ArVe8V6bd6bY2SM8c0okMsTogUrKoyM9iKryapZz3Wm3XkndeQsJnK5feSOc+gwanm5o6bMxU3OC5NmmtA1uNr/U0sEQyRRu0qNJgBE65J9TVHTdSi1HUkN/AWislWJAPl8wf3vrkV2OmaLdXlw9zfxxRjCiIqd2VA549CcVHrun2mkJJfyFAI08wgn720+n9KyVWPwdTOGLpr9zu7dO/UqzXEsU0UWmWsdxeOmUtyQQqk/eY544Fc/4J8ZaRJr2o6epWK4hZiAqkhnU/MFJPTP8AKuai8a6SPEpbRRLbXt7IDPcAM7uD0A7AVR+HXgbWLfWNQvLyJ4UJbc5XDNls5H4GtfZKMWplrDpRaquyf3nosWoWaW95eSWkU2qs7PAjAEyE4xkZ5HSrN/ZazrmmJazLYWcJYNLJHndC390dgR0/Gr97pWleH9MgkmWTfLMu+UHcxOPujuR7CqWq+I7LSdORLg+SHfzCjja5Oem3k9KxT5rOmjnv7RqVGN9dL/oaX2dIUi0+yi3xR7TKIlGDjoc9+5rmb/UCrX8EEo8kS+Z5p+84HVfwArodK1calYzyaO26CaPIZs8N7E89K5TVrX/hLbBf7LtjZ6dYhjLdKoxLjqAe+OueadNWfvF4WPLNqqrLr/wfyRMt9fXVrBql5sjtZlLWzKFYZB/iHc9Ko3NzB4e0Z71beM6pdykAyqCEJ5J29h6CufsNTtrrwlJLcG6kiXUDbAnhFQrkEAdMkZ+tbOtS6TPOlvp7G4sdqHdcAsGOOW557V0cvSx6UIRUlBrS7uktLLp/W5R0Ce11P7Xb6xcXKR3a+WZYGxtb1YdMZHSte20HRvCGkahe39nBdz2+2O2aTnznYZHGO39DVNR9mk/cJGtvHjJhGA3Q9PyrU1eRW0Kykvp457Vp8fZdm7yACTuyDkDPH40p6tW2ZVduU0otqMmrpeX/AAP6uO8JXsptryaeYJ9oZBLGsfAOM/QYGaj8VX9peyx/8TBWxlUbqxA559Kw7XxBpen699svldrMyfLbtneV7MQeCPTNSeNNbivdWGm+FNPKatdqszSyr8lnF0MsgHY84T+Ij0yRMlyy5mjCpy0q/tGn+G/Yzvt+t/bT9mv5ZLUoF2mXcD7bemPcVeh1G6kdYmMILkZiJyW9ifT1FTaBNc6ZrhkZYLiS3QLIUQESkAZbA4U9TgdKhvbl11uXUtsKCRi4VRwoP8Jx9f0rbfSx2RgnJpRVmr/Mn23Fj4jty8SQxzsxFqigKox06dCO9XZtRktEmKl2t8nyyCMj2qh4fQ3fi/TWuZDHbFsxiRzkt6Z7+1bup+ZpV/rEdtpC6reI2+NfLMgVSOSR+IrKTs7PsY1WozUGru36+ZzscunWti9xaKG1edRNCQDujKnJWvTbmeTxL4Ma6tUjW5kiJRSOUcdRXnV/pN7b2dtq0tl9ijnbAhYfNC/rz2OK17fWJtOu7a3tpmlg1CPeCqlVVx1GPas6sOdJx3/rQxxdJV+WdJ3knfXXbdfgcndwXMOiRtLDK01lKWV8jYAcc47kHFdh4A8Qpf8Ah/UbTVE86eBvMBIGWDfywf51yWvalqPl3enlpVilcu8bYPGeozyAcZqr4bRZo9QSC6ktbpbZpUdSCGKjO0g9ela1Ic8HzHbiaHtcM3Na3urHZQWjxRTW8bh0L+au9cqDjniut0Owxp0TWsMMqP8AMXk+Uluh47DiuBmur/TtFgWSyFw5GTcZ+6eD6ehr0jwrOl3oNpNMY1Zk6MAMCuTEKSjfzPFxvPGkp9Gyvd+IJbOOeOVMGNf9azYUk9MHuap2E6WdvHdyTqDcyckE4LHmvN7LxLqGteLItMjt5pdGMxL+cgxjnr6c1o/FvxjN4POnWGl2UNxHsEs5KlgAOgB7VfsGmqfV6mToKFoW1e/oenLbWcX2a4mdTdSNtjklYDGf7oNYmpxS4vYJA0F8qEwyqcB8cBvrXi/xE8VXHiTwn4ev4JJoCCUkTbtCuDgEevFer+HtVm1LQLKK6JfUrAqhuCQyuccHI/Cl7KVNKTdxfV500pSd/wBP+Aec6JoGt6z4b1aW8kJmk4i81cs/PTPUV2Hw60HTdB8N3X9qxeZPJ94/3DjnB7Vv6pLrWmQQLAsV3JcKSkbJs2MT3I7daui0im0E2uqJHBcqqyTLAxZWcngAnnFaTrOa12b6HRUxDlGz2b6eX4mImq6dp9slkElkEg3LHCm9iCcnJ7DrWF4gaPUNTTUjGRp7/u0iTgSKowV9u/WtaPWBouo31xb6fG4kTyUH8agfzFc3p2pK9lPbtFGzPN9oyr5A/wBgjtmtIRafMkdVCEozc0vx77nRaLPaXFiLbTNYubGZCSLO4OUQLzwelP0W7u7UXF3bSruJ8p0c58wH+Ifj2qSxtbXUR5lhBEm1d/kB+c46bqo6XHcC5m+0LJFsbdsbuO2KWjuK0ZKa/B2ub+n6ZfJZST2MCSk5EjM3J9dvvzXb6UdlnDHICkwUbkY5IrB8ParItrbwixuBAWYyXLLhFxz9fxrM8ZX+ha7Hb2yXjSyxS53Ww3Y7EZ6elckoyqS5WjyqsKmIq+zkrK+61+8Y9vDr3jS51FYvNstPAibcfkkcZyfQ4qTxRp/2do54RJIZFLOu0kIB0PHQVx/jN9Ys9EtbLShdQWzHYFCfMV65Pv3rrfCk91baZEt5PPdXbJjJYgKOwyTW0oyilNPTax1zjOmo1Iu6WiXl/WpreBZ5p9JlmwnlbsIAOuOprmfH9zeW+hf6PLKj310ZdyudwQDjA7DgV1+n2F1otg0Vsyyo+WPmHmNj16D5hVCbw3b6jftealcyiG2KpHGWCgIACCfTJ57VlGcVNzexzUq1KNd1pfDf+keefDjT7jVtcjN7HdSwRHfLNKxKk54Hvk16zHcXc13cjTEt2tUbG6TIBfvtx15rP8Q6lHplsmm6VGRNNhSYU3GMHvx3I6VYlv20rwkJZovJnWPZHFIeS3bPv3NOrN1bStvsgxdWWJaqctk9Ev1MPxdatdX9ha3N+qSYMtxOBtVIweFA+uevWpb27vWFrPpwMttCNkRKFQuON5z1zTdAhM2oT32qPC0hwWBYHGRwvpV661GVNalSwsgRsCCRjhB69OPb8KbbVo72+4ttxappX5V5W13K13eRX1rJ9okAkX73ljAz6/SuMmcG9EtpPJHsYIJs4HXpgda3ZraQWbI8X2diSZGMmWZjz+Arn/s1w1jP9mkja3ilCsx6EnGOfwrekkr2PRwkIwTs9PwNrWIVnGnswJKsRIScEZHYD8KW7lVoLBrhgVjRkc5wApJA/HpWXrX206CDHFtuRGSS/JJH+f1qt4Avxrlldw3wzKifdY4JODkf1quX3b9h+ztT5m9I/wBfqb5152SG0uJDcqwKK20HauP881FodpJf6ksDIbY2snnpG4UMV65x+fPvWZoEYmF/bOFFujhIpZGwIsN1q5oul6daeMP7TTVZJ0Q7FkQ5VwF5GB154qZJRukTOEKanGOjt2O4u7i5htxereC3gLhCpXKovrXFeINYhv7nZfXL3drG+FVUAVxn9RS6vqUs97b2NzuW2mnwSTgDJwDjp3robW0haY6bKsbQ27jzJzGMEDnacjjNYxXs7NnFThHDpTmrv9P8zH0vSdH0u6vP9Bs1MzqyNt+eP+7z2FOudT1ON7n95DcWkS4mWJc+WO3zGtC7nC6NrTrIguZrnbGMA5UAbdopup6PbxaXa6XZTNCt06tdFmyxAHp2JJoUle8hqcb3qa3fX0V2c1HrEEBWU777U0/d2kLvmG3HqSepFYV7o9xq+qXF3qTSGxjZRJLIcGRsZ2R+gPXivQdI0jQrNWv5rQyRSJt3zx5zjuAepPNUNZ1tzAXdF+z5ZYoc4ZRjHPocVtGp73uI6oVoym1Sj83+S/rzZTkuZ9KsJGuo1htmiHkBMjC9MfXH5074b+JrOw0i4tbwSGyeR2hAj3FQeqMB+Y+tZniIXmsQ25RI54bdFSKJX2lz3JB9uKn8MaSv9hvNYXAs7u0YNIkwBJOM7j22g+3anKMXD3zarSpSw79ru2tunYoa14en1PwvqdxoytpWnQziT7EoyXkBHzEE/LwRxSaXpk5swlxOkTkYfcgz/npU1jq2r38skVxfCcSkSTEKAgwcgHHXpXUeHdGuNUuRPdor26SeaZXBG9uTwPTmm5OnF8zCVWWHg3Ua793+O5z134euovJSWWUEgsgdOD9KfbHUbKynsSlvPG44Lp9059+e3SvRNVeG+v7a1VyiRsT50bchgPuj+v4V85/tC+N9U0Xxdp/hjwXO8uqoyXFw1vHvckglISOc5B3MPdfesPrDa95HF/abcF7VedvmdT4l1/UTrNrZaPYabd+I44diyCBpFtIz/wAtZc8eu1e59smp/D+g32i2kkN3LctJdyme7mmXDTyNwXc459h0A4GK2/hh4Mnt/DFrfm7uNJ1y5jEl8JJFmkeb+JncYznjA/hGB2rqPO1SMtp9zcWWq+aCMICzpj1/+vQqq3QQxMW+aKV+2qa9Lq34nP3PhdI7dF0q6Nw/332fKq5rM1DR5F8yQCMHgOq/dPHbnrXbWWitK+25EsEUfy5YYz9OeR71LPoNnbsqqzySEcKWz+lCxNnZsuOYODtKV/kcRaz2T6RtuvtB1S0INtEU+QYP6596v22vXMWr2upW4t7ZL4rDPuGVhGQcn6881Be6eZLxpEk2GE424zkZrNSP5bu2YEqznyxxwDk4+ma2tGWp2OnTqpve/wCF/wCrnZ/EnV9Om0mO1iuo5ZmlVgsZ3Yx6kcCuVt/Kaw2XTyJ5TefakH0xvUj6YNRW1pB5T6bqMe27C7lkT+L0GD796i1uweyma0uARIvzJIOh4/8A1CppwjBcifmRhqMaUfYJ9b3/AMhPHdiX0+1vbNXeTdgkfNkYz+Vc7eRpZ3NpFbpPFdXsW51dNoG4EEL7V0enX13qFo+mpIYprZC4XbueRlOQvtj1qr4j1aU6rpV5KYzG6blVFB2sOD83pWkeaPunZh5zT+rtXtf/AIB12j6Vb3nw0aKCUxzx5mZtxJ3jkBvUY4xTvCV7d6vocF0zRREkrtUADioPDOq+cmoLbwxQ20rjbg857DH41QtXgtYRCbtI2QkMiqQFI4NYOLbkn3ueX7GXv05b3uutr7i6lcapZ2wZdNSyZiQFk6tzzz0rb0uSzvbQSSQRypKAJFmG7PbH867m9s4tQs5redA8TgjBH6ivOrCym0S5FnMCsIJCOejc8fjWcKiqx2szlpV44iDVrSRa8U6h4L0/SYtF8SrBawyjEcflkbR6ggcfWua0LwkNH1b7V4S1FdX04gu9qz5PT5TkHBrd8caTp/iTQJLbWI93loXjmx8yYH8q4/4LN4a8O6o8Ol6tJdy3AIdJAV2sOgFXG8abcb+a6BSU4wbi2323Ox0y4vIdNmnuwzTllhjEi7mU5Oce/NWV32sZluw63gyHEg429iKTVbuQaLqEm2aK4iuDNgcMAR/BnjNYdrrNjr2n5gluVYIyZufmdtvUE9O1Uk5a2N4Rc3e1l1KOl3txa6vcXyGBPkdD53GwY4I9DT/CEGl3ttNdfabaeaWRpPIJ2b2+vt/WqmoaZPANP1Cxf/QpZNpmYb056gg1mahYxaGpuYQ/nySiQbhhenYdq6WlLZ7noukqt1Tdm9Pu6HoFpaQaRcW06o0cMwcMitnaAMgZ9fatKwiQyS3VxBv3sP3IYZx0ArhdF1i41UwG6kRYo/l2D2/rXo0VnfXGnWrx7IIlG/zBxIVrlrJx3Z5+LhKi0qj1elypceODZW8iNpL5iJTiVdhx6cc/TFcXa3Fnf3BjtRJZ6jIXkWSNNqwq3fPWurF6bK+NlDNDPEMEqgDNlupY45qfQxEuqN9kAght5cTtMwDOSOg4xjJprlpptIKbhh4SlCFr67/ncmh0knRI0nvGuY7e3AVpBgyAHqO46CqT+Texi/h8lSpHycjb7H3ru1hhkuPPxudRtBzwPXFczKDcXd7e2iRR28L7TIW4Y45bHtmsIVG73OChiXNu/wDV+nzHX+v2tto7SXEqJdbCiBmO3OKr6QW1fSBskZLpEyIg/wAsn19RXP63pcd/c2zwXcYtJFIFxI27eR15qnpy/wBnMI7S9uZht28r8oIPQkfyrdUo8vu7nZDCw9n+7fvb/wDAO7sJbbRNMkvtYkSGV2JO7rjsq+vSuJGsw+NvEhed/s2k2KFlV3AMhz1Pp/8AWovYZdWu1e7uEnuVUbFdwI4x2wBWR4q8GXWm+Hb+4sXFzqDnB2KcR5649/enCEYv3n7zLpUKdOXNKX7yW3l6f5nY6bqmgahI1xcJHHbwrsjA5DDpz7+lNgn0qZJfsF1MQwO2MrhU5JwR36Vwfwl0GREnk8Quq2CKdxkO0u3oB6D1rt9UgFxpCx+G7dbW2WQ5lMbLvXHXOP50pRjGfKm/0HOnCFTkTfT0X/BE1mz/ANGVFki2lAzOvGa5gPJGrxWsjiCRMlWyA/pgd+1bd8rCzitVc3N02BlsdfWsHU7KW1vELTtJKqZl25wjE9M9vpWtJWVmdeF0XK3/AF3NhZ/tq+TMNweMPgDp7e3SsHw06aT4hkn2j7PI4Ry3bIOM+9aXhy5ZG+1lZDCDtGRkgjpx179azby0TU/EOnWttuBdi9zKpLAbcc47YFWla8Xsaxilz05fDY39N0q01GSaCN5EtbyAtIhHKzK2Dj2IrT0fR7XTbIRQyRbUYB9hJABPTcfpV9dRs7WK6lhtAlkjKiys3L59MdBUdzLHBpgv1aJoZ38v5chXxwDiuWUpPQ8upWqT01Sdvv8A+GMzxAr3t1MkXl/ZX2sxOcsRjhc+uKdby28+E1S1k0/S4l27YWyJHz1Y9WrQt7VL+CG4eGXaDhFcYBOewxWvqmlxx6cPttykFlG4kkVUyWx/Dn/Ck5qNomcq8YJU3/wfl5nEyEm7SfStPngtnTFtuzhm5G7Hr/hWilx/YdjPmIXGpEDbLjhTj17k56UeKNWnsJrIwOLd8K8UW3hI84C598ZycVc1i/stW05LGS2vLOIFZFuSo2qQQNxweQeeavVpXWhs3Kag5R91/p+fy3ON1aDVxbaTrKLOLSVWSSMuW8ggk8jtnFbOhDQ9Rtbu51RGcFUYBScMccgD16UujtLq95fR6lqjQ2GnysZACFUqcjjHXPNZ/h3S3v4IpLCzuv3KsHkLYjcZ4I98Vo9mm7W7HVKanCUJvlceq00eqQ1LqztZr6KO3nM5dTa84UKOzev/ANetm0sW17UHvNahcu6hEtbb5FIH945rd0zwjbfZFuWdhOV3AHkA1oaLJ5NvIiQsJJnJQbuOgxz6VlOsrPk3OOtjYWfsdZLS/wDl9xkNY2GgadLeXdv50sQJW2TgE/yqtpXi2XWbryJ41tLQqdyxZdmX0z/Dxnp7V1V/pcNzbk6kzXGMssZ4UH0wOtU7K+s9KtUht7EibbkpCg5+p6/zrFTUk7q7OVVoVINyi5T730Xp/wAMLbLHqTK+jzRpZ248pcR8M2QT+Hv71y03g210K+lvvDWlW19qNxI0uoTXM2JpGJLFi/HfoBhR2Aro49VsminjETWlyE811iOFA7EsK5+6ntdVuJpNKvWvXVdk3lNtXdj7qnqcd80QhLmv2CjTkql2rJd/1at99zeh0+zvLCC6ksi8zqGdRISw+o7+lS6bFdWkMUNnaW1vG7FnlV95APIBB5zTLTU7DQfCsd9qE4AI+dgOS/J249ulc9o1/Yz28t/PuaOV9yzKGSRwT90qO/qaSjJ37DVOpUUtG4p2W/8An0OrmsplP266mjkeMHy3YlQAR/dHFV4tWncRR2tosk6uVlYjA3eg/DmugjCm39UK9D9K5nQZpL/XbpirRiNSchcAZ4X8cCso+8m2tjmpvnjJyXwlTUbJ/tjqDsaTAkYdNx5we1cZq+y2vBGxLRjOCpxg+vvzivR7VILONo9QeW43Sechdcls+vuP8K8/8ZbZJriaGDYof5VU9M8fzrrw8m5WPVwFRynydO5LcRv4gu7C6jdbeYjyDJzy4HGfrj9a6XUNOi17wzDLCoW+h+dcdQR95T7cd64PQkuPJltbtisnmBojG4xkNw2T7Y6eld14D1NRd3Njd3CGeZvPQHglujqfoRkexp14uKvHoVi1KEVOn9jb0ODjM2l+LrG7tb37DZSE+c5G7K8HafcnisjU3lRr3UbVQLZLltqP/Cr8gj2NeiahoZ1Fr+2mljEv2t9sZX1G5cD36U2+0+2uoraH7IEmVWikXltw2/0xVxrLR9TopYuEainvpZ+hxXgLxHHa6p5V+uUlfcCOitWv4qdI9euseUFZtwwh5B+lcr4Z+w2utfZ722kmfeUiYMQVYHgkdxXfizMzO/llwW4JcflzV1LRnzLsdWL5KVf2iVrr7/Q9SGQMba474jQEWcFzDkyROPlH867MKAeOtUNdt/P0uYAZZBvUdASOcV5VGXLNM+Pw1X2dWMjldFcNDNJPGrxRwln3DJwRyBXDp8LrLSNam1+HUVaxdvMSAAgITyMkdq6/w812z289ikcoHyzRFvvDv+IxV3UJLea4NvKEtbFZQZBKRFjNdnNKEmkeo5ypVW4v1M251BbjR86iqb0jJJ6BuOB78Vh+HdIOieFku5yktlPM1z8uQ+xuSp/KtXxDem1e6SyhM2lbTHGRyok29R6irSiceHLW2uWSQqnyoF4XHr7cVonaKts2bpuMVy6Jv+vQwdSs7q70hRoUu3SGm8wW5wdrg5wD1x0q5eaWut26WF1p063KxeabhmCqg/rTLfX5YxHC1uBaQOT5duAoJ9Qatz30d5qsS3E8kayJsP05wa0fMjobrRsmrWu79fnbc5ey+zW8Fr9kk/exzmBwzdTnHGPzr01CbrSo7W2geS6OAZASFQZ6k/0rl9H0O0g8KawHmjM0Vy0kbjAKMMcA+hrW0vU7q1tI1toXkuLgAJHu5+p9KzrPn+HozHFzVfWGri+v3/cXnNs1xHCsq2TwN+8kiUDcM9GOOlS6xcvNcL/ZYiljiXcSoBBb69+Kl1C1uotMZpfswQJh1jXHUc5J61X07TZbjTwtsWhVvusfugdzjvWC5fiOCMoWVRvbTyKXn3t0Utlu2jMw4jUbc+o4p3irT7uHw5HbyzRpbBx5whUruHue9U2ntYvEAntYftEViCrTkYTzPwq/qHiOS7h8r7KoT7xOCwJ7Vq1K6cVodHLUU4OEdN3sV9KntEis40g8uwtwzCMYO9m7k1cxYfYpVvti29wTlYOvPbiqy6skNkFjs4WHmcfuyCa2ru9klS1t4oHE6lZXZY9yxjnnAqZXvsZ1eZSvZq/n87mJHHpWiWbR6Tp5jlm6tOhJIHXkn+XStnRLi3/s2WFlZLfkiV04JJ7+9DWYv7r7NNclyE8wnZ8wycAE9vpUcel3dsJLORw+nyNvLjgj1Ht0FTJqUbN6mVScJxtJ+9vqzEv0tobJr24kTYX8tExk7M8n/IrX1vxJZ6fpBTTWWZlQACPoq/41z2sX1rZtKY4o1SKNpMytzgEcZPU81xWoz3GsW8iaXqVo4VtzxRufnHXAreFHns5bHfTwka3K6myNVNRbU75ZmdI1gIIVSRuPvVyKykubO6l87jzVaRGyC/OOPYVkNcJGsDS26iS4CvDEgzt+uKu6HJPHcBkkMhlJDIwLHOODj0/+tW8lZaHo1IWjeGljLvLextNesLyO61I3Mrh0gIAVNv8AD3yOn4V2tnII7m/fT7eOOe9XIijTJVcAHBxwCa5G5EM+qW1skm26i3PI5X7vsK7y00q4toxeWkr2+23AbceZB169uazqtJK5hjZRUI8z1a6+uhlfYLi+aO3ML/Z1Pzwjg7881rvHBaeVYQW0Fw2TuhYcwkn16c0/Tbq8nWC5N0bdmi3ykxA4UcDAPU+9Yd1qRvvEEOlaL50k8xL3LFvuDuWPb2rJ3k7dEcEpSm+WWiX9alzUrjV4LW5s7YtHJbRMUmHzlWIOFB7Hn3615ppNn4xtWGqa5qriyjcqkE0plaVj6L049favVb65hsmjgglSWKLPzImQzkY5OcEjmsuS70uG9ibVYXk2qFgjU8Ic8sSOmT3q6baWiNaDsrqF/lqY/wBpU+J9IvpZ1mLyGOSGZio4HfI461v6fbW17omszx7rWQGRvs/I2x4yF9hnn61BrGsjXkWz/spLeZTgXHmBgMc8YA9qgvongMUSs8cjRbZQW4dM9iOo/wDr1TTaV9GavmnGKa5ZfJ6J36GLaaGWdHm2BSY9sPUtnnkdwMfma9SsbjUZBHBbxWqQqoDOONg9NvrXC6VpV8NVW6hmAjjA2oR27d+cV2sUkRkitIXNuz8SPuBZnHP9TzWWIlzeZz5lP2jSun+hYQmWzl3zP5UTGEBDjeR1Le3tVXSrhPtvm3DImyLaXHCn5vTt1FSIsZRIkaRpVk82R9u3oMZx3BrKvr+1uUttPVn+0TKZMspCvg8gHpWEY30OGFPmvFdfwLOoeKIW1U6fFcG2yCI5jEWVmxnJboAOnesO41zzrcW1gy+YflaZvlXPfGfX3rA1a4vL+/isIFeViwURqd2CT/Fgdq9C1bS5YvBn9moUDsqxvIFyEBPLAe1buMKXL5/1c7J06OF5FbV+f47fgecrcW+pwmOSSb7SvUE7fM7fitXPAV4kF9qFrZeH50e3QNI0c+UYk8nGK09I+GsmmaRqklxe/btXnUiGQghUx93j8q4bQYPF8b3VreWF/Gw+SSSD5A49Ce4rbmhUTjFnSqlLExlCEtvkj0TUBC0EsElvBdW87ieOBjuxk9h2PesnULDxJHrVnDYw+TpgZJJZ/lCtn+EDtjpU2kGSG2jjuEkN8W4WTOQv1/pXRRPJNC1pIziHOB8wJyBnH0rFtw2MnOVB2STXn+aGalqlxHp00MrBWVyoMfWUcfl6Vk/25cWEC6bpUDf2zevvkBBKwA4Cj8sVaDR31xMoTyDGuwSEbSWzzz9TWjocU+mK3lFbqVgDcSTEqzHoAtRaMVqjF+zpwtKN3vb/AD8i/cWsqaPBBLKJL4fOzE4JPc/SuE8QhWgwWKhmG+uw10SIwkuYlMkq5IU7vLA6AH3zXLtbxatqdtpzhwSdzbTgkYyaKGnvMrA+6vaN6bmVcaFcaLb2ct2Vke6O/fnOxQBx+uay72xS41W4utMuX+2o3mREHb5g7qOnP862/ErXdlK9q8jzwaeP3Ujt0U46/QcVnWrz3iRXNraqotjhmUgAZ9a6otuPM3/XQ9Wg5+zU21r92u25heItQv114y2U88cnyTKTlWbAGODz26GvT0t459O07VtQ83zL1R5qb9uwlTyoHTp0rh/EMUc2p2N5A/kzKv7xmXA4PBHPb1rrNIuvtcNnJHc+YkDYyfmAPPOPSs6ibhF9jPG+9Rpyjpbf/IXw34Zh0+Oe7guPmck+Y8YJA9ATyCTVHW5DBftFptywgQAHnq3c1uXGpWYsiyXImuQ5YxngE9OB6VJ/ZweKJsWysUBb5MZPc1iptPmmef7aXO6lXW/c7QHjnnPvTuMYOCMdM1CRgfpT8HgD+Vefc8Fo89glk0PW7iycbEMnmxY6EE5/Ssn4o2l74l8Laiul25upVYBcHDcYJ47muh+JiER2UkCKtx5mxWJ5IPUYqPSbq4s9O+zWsX2hpLgZLDG1SeTn25r0Iz0VVbntRfNCNdL3tjifDsmrax4bsLS6tzB9kC7zKChHTg+tej/2aIbC4uJmdopIcELz5eBnNYfihNSa7kvre3E1tOVi8tckjHG7iuiVpbfRZbaUEoIicuMHn+dFSbaTRVeo5Ri42V3t+ZyU9ssPh+6ms1RvsxUu+/nOOePxrltQuZIdL80uwO4szHOVzjA+lbl0z2Gl3FjsIiu/mCg9+h/Gp7TSTq2ik+ZuuU4ZGGTge3f/AOtXVGXJrLa5305+zu5vS+5yul3bySM0juAxB4JyPr616p4KkDq07+X0wrZxx/SvKgJrOS5t7kNLMrHyiPlOM5OT9BxWxpmvrpxjNy7GN1wpzjA/lTr03UjZF4uhKvTcUrM9J8Q30tzE1tEESJj8zFuSB2xVbR9Pl1W1MdzczRJAR5axnGcjqfUVjQa7ZtGkttIHZ+VVfmxT4tauI7jzhIBMRgA8qR71yKElGy0PLWGqQp8kFY6HR/DtvY3jI489I1DAuOrHuR09fzrdnlFtbPKwQBATywUfnXOaDrObiUX1wshmIIcDAHHTHatfV72zWBra4zIJ1KlVGePf0rCam5+9qcFeNWVVKpr/AFqX49rqshCMxH3l5H4Gszz7TR0vZJrhCWkLiMEbhnooFcrui0izmt9NurmEz8klg233X0NYdvcWlnMs1u32i9lJzLMc+xrWNC99dDqpZe5Xs3b0/qx6N4ctJIYJbm6H+l3TeZJznHoB7Cs3x1q82mwRrEdsbjMhx1GcYzXJWN/fPFeSzarHA0ZBEe/lx2K1ZkXUPFcMP2jK26c+Y4CjH/6qtUbT5pPQ1jguSt7Sq04rf7tDMntYta065OpR7PNDeRLldrFSMr7HGOKbqnh/RoIrGTSYGgkPM/lnGR/j1q1pcAZ7W3uHku4reQmNWPyhe+PyH5VqX9jCLtZbCcIpUv5LjIj/APrmt3PllY7vauE0r239DM8FC0026+3TgyEB44YxhnJz159uPxq+lteN4hXU7OyCQI2GWNsAZwAp9T9O9cstzc2nijRtPksUa3uZSuwPklB1PqM16ndrPHExCQx2cb5wByB69ayrS5ZX7mGLqezqcy1clb5djHnsNJiMdzcQebfbhsiByEJPHOOfoc07VLx9UdLWBmhS3+8D96Ru+P8AZH61x/irW9+t6fZ2Vtci3Yh5JEy20Zw20CoPE3i1PD+tW2ntp9y4nwVnmUh2U9BimqUnZ9SVh5Plk7t62v0OwZ7i4bynkYrjBCJkcdge9NVb54VdRFZ2zAo80KAtyeeRgmr63iXMcKSQC0sVThJGxnI9sVzt3rd1HFa6TZW6vIGIRVU7iuevP86iKk9EiKcJ1HZRX+X6DrOG31PxbDZRORBCvzRgYBVfX3OetRapfabY+I9bnngEwt40t7eBAM5Y4Yj6VFBdSaVqNhqFwQWmWRW2j5lIOOfWqgtpLjXWkt2OZpS0qnknGCuD6+tbqOt3tb9dTqlSbd7+7a346/kWLC3+zaAbK8UNKkybnU8MfY/jUWZJbm0ed/MhgTC5OQfTP4VoXsRNw63P35cNtVcj3BPb+tdHb2tnZ6dDKUWSSQj59pYR/gOtTKpy69xSrqkr2u3/AJEemzzXavHHAFzjLsvAH/6u1XxPaabG9y1oZZy/+sCjcffJ6VW1HWUkuIYbdGFuBmWQRkAn0H+NTzXNusZuLEO+FydwI29MYGOa5nd9NzzZJyteNk+n+bC4u2ntrVIZDHK/y424dweMj0+tZ2qpJDGbWLfHbW/Ku7Dk4+nHPart1NbXdrFf28dwjxMAHClSx6dfSsrVjO7NHMxaPOXl8snCnscVUFqXQjqla3+Z0Hg6whstK3RyNNLMxkkkYckntnHIFW31qy+2LbJIZGKliyDKAD1bpXlHinxdql8ItE0CxnhtT+7knQfPL2wvoD3NeheDtDbTPDdnBrOyW5Ul2EhDCMnsCaVWnyrnqPV9DLEYfkvVrvWT0XUn0nXI5rp4XmUwgkRyYwOvC57mtC8vZftaWljGJZesr/wwjsT7nsPaklhsrqN4QbdkC4KxkZU/h6VX0KE2gu5HUJEzbiSMYwP5Vi3F62OeSpu80rW6GN4svxFJBbKEEkiFlOOVbIzn9ahgglUxSzTGOVVDMD1yemRVG6uH1zWhe2yAQpIIoSeDjPLfjR4jkh02WOC4KJuyZCHJ3nr+VdMVZKHU9OFPljGmt+poXUtzFbwTNB+8ZgkKxAZbk9FPfvmi9jnuNQjimae3l3qw3NjI9eOv4Vm2IvNSuptQl2W10Lc+VtPYAjIXtgHIrWWTMWnM1z9q+x2+JZgf9Y5x3P06Un7opLkelrlHxRrIV1SyVP3bjLN/y0c8dO9PvdEOi2drrETNcXFt+8kVzjII5GR9a5m4AvtVlVY/NIQkIoJOfoO9dvo+op4g8IXEKnFyLdonQ9c7SAeac06UVbbqaVoPDU4cu32vR/0zi9RiuNZ028n8x3mkbk4BUk9sdQAAK5jT7m4sr94rqIorna0TdGA9a3Nt7bQRLY2jySXahIGU8OwP5etLP4f1S2gVtWt0EkyZLGTftweefWumMlHR7HqUqsad6cmrPYytZvmhsBviXynypCyZUjJ4zj0IrX8HyRyWcQWZ47ZsrECoZiR24qrr/ibwzp8Nrpep27FoAA6oo5JIzz7EVtajLatpMN34ej8tba385srt2jGcAfSplK8bW3MqlZSpqnytNvfoM8Z3ttomgXaW8ge9jUF0hwzIc9zjPNcVpeqeLdftf7QSYRI52qmwHAAArqPBOhpHa33iabc8l7NiOJ1JABPDYb6967l9GuBt/wBLFvwMRRYVV9gMVl7WNLR6v+rnD7aFF8r1fdnUl0UjcVUnpnqTQHLE5XHPHPWmeUm/fj5umf8APSn8A8jvXlngHC+PZYZfEOlQGZTLGrSeWTz9cVqaPGJUOVB2Rk/KAMY7H3rzLx3DcwfFyG5dXEe1BEeoYHg/zrv7a3k+2RFbiWKNAx8tBgMcdSa9CcOWEVfoexKnbDwV+hqWl+kFis8Lo5AJkTPA+vvmsiPVp72W4xALmArtfbwyAkkkfnW9pdtA+kPDNGnkOT8xGN3vXG6+f+EWu98M3mW0pBaMnnHTIPt6VNJRk3FLUzw8YTlKCXvdBmoBlukki3i3K7UMgyVI9/8AGm6XqUVldpdKCsTna+Bgf5yK1tWihv4raSzO8hN0hA+X2/GovDKQRajNb3YiAlIJVhwfpW6knDVHaqkZUm5LVdCLxBoMWqoLvT9rLIP3gU56jsa4G70yW1L210PNhDbW3D5l9Pw966nWZbzw5fTQ6bLJcvJLu8pR8sUdV/tlrqOpl1mIuFOeOGHvz+PNbUnKK7o7MN7SML3vHp/wTi7TSdR06R7rRJfNXOWjkP6fSu88HS6X4gtjHqElxZXytiSLdtB+hq1aeHprqf7TBc+eoGTG4wXznofWq+o2UEEmEiMckangjBBHY+n16U5zVTRPUKlWNX3Iys/LoVtWgGg3Dizvglu7EKkzZx9e9T2kkl14cur9b1lu4XAID5DD2HT/APVWSTaeMVhtF8q01ODOJGyRKPc1zGp2l3pNzLaXW+KTP8B4yOhHrVKN/de50wo88eST99b+a/4J1+nXIcPFdN5wnIJY/wAPPTn+lavjK3Nv4WMmh6TM5J+WUDjrzkVxXh6/vl1RbHUYYSso3RuRjHsfSvQraWSOxk037TcWs0Th4ihJV1PYHoaiqnFpo5sUpRmpR9bf8Mc14W0qS+0hJtRULdIA5Q9RzxxXc+GI4t0kF+kaxD7u48AenpVaTSrSS8+1RTCCQjO1lwCR344q5p2jx6os0d1cMGHB8gjBHrmsalRSTbZxYnEKpF80rL8ipcQ2819eQWbJ5XmAxOuThu4UjtWmNNi021lmv7+G3DkBpJiF2j0GayfiPPbaHoMGmaVKthqF+wt7eRR8y9Mse9Z/irSrfW/COl6d4i1WLbZsst3eEFR8vGBnuazTckn0Zy88qkYtO0X83p1/rqddbabp9xeW91LHFLdxLmOYdAvtjinXV/E1pLaxOPnYwKWbgn2Peub8LeOvCc2nTQ6NHLHHbMI40aIgv6EHmotS0TVNbM11EyfZt+9bdTtP/AfRvepVN83v6LzJjRbn++biltcNJksLO6uXkCyiE7YlYZPBwenSp70WPih01WC2ybeT5HY8/L39qlsdOSz0i/XSZPtdzKhLNIMSRkjG3A71xPw2nv7Dws9lqfmJJcXZkLSc7EBxwPrW1uZuUd0daiqknUhurL5ddDqvF+pfZ7C3mmhdkLZPzc/U1maTrMkOvW1y6x3DyKSjEbW78H8qv+KWibTIobvc3zY3le3Xt7Yqjd2lrIZpYCpijWJldW4U9Tgehq4JclmjpoKn7Llkt7kLwNcJamd13xTFiynqGOT+tTX1x/ZepWVzbSISpDtjkHsT+RNXNRs4f+EZtdTYFmDnC8dP/wBdc/YFZY/Pb/UENGy7SCnPH5Hmri+b0NqdqicuiurG5qN/FPfi6VVRTk5BwM8cfpXXaVeQyW0aN8zHooGMH1+tcMkEF5HeCdyqlh5bIQMNgYz7e/vWho7yWYWGNvmhIUsecHisqkFJWXQ5cRQjOCit0drpiRgzR3BjMauVXjgg885rMuUtjqUyyQR+UXQW+xsFsjkg+mavRXBntjEsYdC28OX5PPOBip0lSFwkqriNSu4jIQdSSPU1yJtNs8lOUJNlLUbHy0jLwb0U5HlttAPbjvUV0k0EJbTwA+QhJILSHPRifr0qSaOUlWlhuJIEDEiTjJPQ4Pb2piWrPMrTP9ojDAoh+Uk46YP8jTT7lxlZLmdypPYQ3AkWAxf2hERhUOSPauH8VaXrGqITNf3ZtA4CiTcI1b69M16XHpV5OJ5JHt7eVpN0bIm4oMYxnI/lVR3vIbE6fdxRvAQymSNC56+nIH41rTq8r01OijieV6WbX4ehynhXVLTwloUtqpnutSlyWwgwrY45zkiqV94s1i80z7F50cSFdryY+dh712cHh6C1LT3JLIqjuFYZ9sfpRN4dS4gE9pHHAR/C8W5mB6554FX7WnzczVzZYjCqbnKN23u+5m6LqFs+madOpRJUfYxX+Lb/ABN71yWq3s/i3UhY6FFNNfMx824kGyOFQeevWu80Hw+4t5bu4t4i0rZSJPlKrjGR7n3q94V+wJdXsVrbvBdKAXEgG4dc/hnmp9rGDco6tGbxEKTnOmrtEeh+G7Lwvp13M0rSyPGTLLJznjkCsfxJM2nae0crQofIWRhGuO2Pz4rT1u8lvb5YLiEW+lW8qmZnOGm4zjb1Az371wvjPVTqr3kmFjQ/ughPJGKVGM5y5pDwdGrWqKdR3vq/0K/hnXY4PEVre26l4driby16gjj9cVe8B2s3iDUdUdndLfDbSODz9Pqa4zT1ubeYGFzERGqAgZZxu5JPpjtXrUdpJ4Rupbm0hSa1u2Uu7A5U4yenQGumvaN7btaHfjfcVoaTkrL5P/gnL2l7JZrYadbQlJrG5do1LFix3Z249ODWz468a6Jb6WJL0zLscMRt6kdVX1OetVby8e0ubbUbZ0idna5mjeMgY+vpj+debeNUi8SFr7T3icLP5pEkqhWJOSACf/11CpqpJN/0yPYRrSU2rWv99/8AMqeIfDi+I4IvEkiT6fDITI58skSLn7wGev6Vs+BvEtt4n1218Ox2NxbWoTaZBKd8oUdHxjAOM4r0zwjocurabFca5E6oUCpGMKCOoAHYVo3HhTTdEkGp6JZpDdQndIE6yL3FTLERi3D7jnrYuHM6fXy2MD4janp3hTR4EvrucWjOo8mPG5gOw/TmuY8P/GSwWwKzb8hyB5oBbb2ya6nxVoegeJ7KF7uJ57bzBK/3g688gnqa5HVPht4burxm8P6RPPZqApdZWAL9TjP1FTR5GuWormdNQcFGa9b6anvIBJwMYqG/n+zxbv4jxgVOMhcmiSGKQgyKGwcjNeardTw00nqeZ+O9W03+2NNs5rlVunG7coBPtz2q1rGomy0qAtcC2E7LF52M4ya82+MCLp3xJjubvbFayBGRjyBjritnWnn8YeCtugq8tyjgxKerFfavWjSjywfQ+ghTXsacuh6mL9INAKWpM4iURiRsdexNcuPteorc3ckDSpAAdzAEfQVZ8Jve3Ph97bWtNRL7y1SZeFwcYyTTJ9Iu3gWG01I28Y+Ro0JO8dhWEEotrqc1JRpykut9/wDhh1nctJczRwhbcXBAG3DFfX6VD40T+yru3vbeTz1ICMMZII7mtI6ZZw2hWBjHPbxhpZHPJbHSsxtUZ7YwXFvFJKfmG4gdOauGsuaOxtT1qKdNXS3Xc5q/vLnV9SjkS2iKKPnO7aWqpb6Gbe8bVJ3mjkY4WNPf+Y9q66wjgnumuoLZtOeI/fX5kkY+oPFGp6Td6kyATKr5DiNTw49OldHtEvd2R3xxag+Re6jO0TbHqRZ7uWC3jGSgyQv09TWnretw3N8scUZWF1CRv/EfcinX+lyJYGOytJPtaryGH6CqVjp12YVVUUTZ5VxlkP8AKovGT5mc0uSpL2t9v6uTWHhsyStcQJFGx5MYO3d75HQ1m+KmudMtkkNrDMQQI3kQMoHX8TXVrGo+yK8sc0qt86L/AB+xq3qN35UhiitUnYYKxyLuRfwrNVZc2upnHFzVROS5l9xyfhRbnWHaeSFEuSOInUAMuOg7j8a6BYLbUrhoFjmgigxhD0Vv4vxp+lWl9a3Nzf3zZV2ATy4gj4IxtGa1b20ntbG4msrZHmc7gpc5H+etTOpeWhjXxKdT3dO2uxm3WkQRz24824VXJ3ENk8e3fnFOvvEOg+CrWVtWvxG0jbhlfnfjsBUL2t3HBFJd38USODI4j5KLwSAen6VwupfD4eOvEP8AbN1qrQaMrCKFH+Z3x7ngZNCipfHLQhxVSP7yfuo7W+jtPE9nYeIY4vKEZ327zYzjPDAdvpXm3x+s9YeTTwJhcW7Al1hXHzdRuA/GvTdU+zNcQ6Tb3aTRWseJYcjepHTA/Kh9GvmtLxreCKWQwlo2uF+82OB7Y9adOag02VQqqk4yk9FsvL1OE+EGk6dp+lOmruItSlH7qIjBb6eprr7Sx1a6ltFWKfTbUSF5naUE5z6fhSeFL3V7a0SPXtNsLTUgfLjMKbjgdyRV7VorjUFeVrubyouSkQMasfUdyac5tzf/AA/3F1asp1W+j76/cP1J9M8JW9xetO0gIyYFk3SPIfQemM1yWmahF4hstQuzE8aKPKgjbAK5OSePp1rW8P6Ppt14nlmuzJI/kjyxNncGJ9fWtm1jsbO5dLa0h3iRo8zOFEgP3iODSuoabvuCnCjdaynprt8jhpNcu7nULCNkga2iYIofBL8YJra0yK3tNQOmz4S2mfLZALK2OgP93pUc2m200rQ28aTTKzNHIpHA7YI6/Ws26aS51U2sbyzzyQ5KhsMjDHzfn/KujSSstDvSjUXLHRW/4ZnU+FJYp7K60i8dBuB8veAB+GfQ9q5W6jn0Ez29y6/ad+EWQ/KpPQj1zT9L1M6hpLQXCP8A2nZXGfMBx5ielamvkavopinCSXarmJyvOPTnk9qlJxk77MhRlRqu60b1X6+jOYW4ubaRlYbXYfOB0dfcelb2mXBWdUd4nhlTLDHUjt6jrXJabcm7tWinObq0+VwTyy5GMU+2ulGuR28rNCkmRGwOCG7r9a3lC53Tgpp3PVrMI0fnJKkY8sjbjlec+vSr0N1FfyNHa3MaswG0EYPHf865C4WTTURLvDQyDAmBzg9s+lSaevlXyTCUjBzu68H26VwypJq9zxZ4ZSTlf0O1d7wosbtE8rELlf4fXiq6wSMVhOFlRi3nk88HPr74punC6WPzXtw6OSTL5nJB74qN45o49roFXbu8yPnjPAPfOa57W0OBKzsrf1/Wwj24mmcyTTRZyzrEzfMO3HvS232m3LeXshiVQGbGcD0Y+tWJNSsreOWW5uo18ocknk/QHvWJb+Lnug6rZGG1XP72YZJHqV4xVRjKS0WhpCFWonyxukaMO+G+lnusTmYBfkYjaR65xjGRRfyRmOOQXJngifaQxCs2e27vToBNakeVKl95vzMEAyFPIIHf6VCUgmvPlhWZ5pSsaYx5YXBLH+VHW4K3Nf8Ar/gGrpOpx3IFvMvk3CjARiMOPVT3o1SI/bbKWBWE4YrvVR93HRv9mpNWgtDp7/asIiDKuOCp7EH1rj28Wz2eYy0cihBhmXDj9eamEHN3gZ0aEqzc6K+RP40uYlvUlkA3RrsKPg+/HvXnsQhku2a6RXRl2t2KtnPFbNzO2p3g1S8b9yh2kN/Fn0Heq51GH7BLaS29ssUsgmiQKSyHv8w6dOhr0KUXCPKfQ4aH1emodevkZzW5FosGnRM1+zsjMDzGuOw/rXYaCLvRNLtdF1EnUi0gkJQ5YAjJXnrzmneA7OO4ktWhtArW8zyy3OeTkEBc966HxN5Wlq16F8tVGAYhhtx/CsK1S8uQ5MXiuep7C1/zv09Di/EkWoa5NdWswFlG8ZtzlcFIxznHPX1ry+y+DGtalr8L285OhsdwuXbDbR229c9hX0Lpfh+0vLKO7uxK9zPiR3Y4J9selad7Pa2Fp5KqEOP3caDB/Ko+scvuw3OSeNslSpLVGZ4Q32ugWkUauLaBTFh23su046962Jr+3jUB2JduAgU5rmNG8X6Vb3ElleTQwTNKcsDhST61N4q8SWNlZGa0vbSSTmPAkBbJ/wAmsZ05SnqtzlnhqkqtpRepEml3vnTyabMhil+Y28/UfRh/LH41itf32kMbZRLb87yhXPJ75HUUlpqiortc63bW11gSfZh988ZAYnr9BXQ6Z4nt5bUG5YLIDgg81taUelzsaqQvePMv6+86lFZUUMQzAc47mn5Jx2pi+YWYNgAH5SD2qTAGST+Oa4DxWeIfHnwy+p7L+BG81HERz6etTfB42NhnT/tsX2mGJnZNwBJx2HtXV+O7xLu7/sgFSsyhmdesYHWvC5vCl7pvjCDUNGuBJbo3mGTf93HVT+VetTTqUVFn0VG9TCqm9L/kd/8AFweJJNPtbzQJJJLSYg3HlHD57ZPpXYeF4NYl+HYFi6f255WCZzu5xWd8K/GcniWOWwuLDfBFlXlCYRR0A5q1f213pcAl0ya43EsGj3cKmTiolf8AhOyaZz2b/cuyaat2ZxFn4o12xl/svxXpVxBMXLGYLtWQfWtDw7fvr+ptDNp9wLWM5MgU4+mareLNc1doc3ulvdQIesrE/UCtjTPGN5eeBmj8HaWI9TBKGPcDs9xnrW8k1G6Wr89Ed83OnS92Or6p6I6S7s4dQnFjbKybMMAr5yR25/lVQ6xLY6l9mkCxSQZ5IyXHYfrXE/DC5kt7u/sPFUl1/ajuZAOSxb1r0u80rT31CO6vdxMUYYIWJMn+NYzSpvllqcknGm+SpqrfiXItZjlh8yaRI73AChjj9K5+edtU8SQabbXUfkoN88w+XJ/ug+tS+JLG51DTydOsxHMp/dh4+SPfNZ3hqJbyxaDWrRrSWI44P7tyOh4qYRjFOS/4YilThGDqR+7sdMdS0iwt5Hs7ZnkglKLtUtuP19Kjt73UDcJfPZETXPyRIxx+lW57O/fS4U0yOxhhjwzKCckjnjFVbufVlhi1CWCMPCOhfAH0FZqz2/Mwhyy21b7vUu3S6um24uvIk2DcIVYjH09TUujXOq6p5r3KJaW/RVC5f9a8v1fXtY8TeKYtI8PTSQLN/rpJYyFXHXB/SvY7cjTdKgW6kTfGiqzZ4Zse/qaKsHTik0rsjEQdKCi0uZ/gcN43F3YXttHPdJJZyjA3LtI55BPSrE62Nhp8MFuXNqcSFUbcRz/TNcd8V9bmD/vEDOzhFQHhB3zVD4cT3VxrBtJirAqWG7lU9M+tdUaT9mpN7Hqwwz+rxnN7avzPSdL0uyvr2LUoZUhCOdmUG9zjnNN8Va7LBfJbJLt3JkhcjHX2z0rk/Fk97Yma7tmliuY0+YRMQpI43DHrXBnUNQla2vJ7uY3UrYYljkD+lEMPzvmbugo4H2klUm7roj0681S8tdMhvoNQWa6fcq7RkRj0bIznrVrw/r9xcSM8wQOMK+85HXg1wuoeda6DDDDKzPcgyRFjk/SjQ5XhtHjuiVuI2V8P1Y+n0q3Ri4m8sLTlBxsrnrNwzXc0EsMiRSO2MowJx1waq+J9Ludd0v8AsrT5o4beVhvlB/ebc/OV96yzJDJcWNxZh47K6BBjiyWVx7/WtJdTNtbKbhShjfBcc7Pc/WuTklGzieTKjKLTiWv+ESsrDTbe209pIjAmxX3dR6E+neuF1K4i0S88UXUaubp7UxwzA8JgZx+PFdjJevNPcXI1IC3dCrRMCFPGARXOyaTJf6c7tEotZgIpPMbaqjGN/wBDV0rq/OzfC80U1Wlo/wDhzlvhas3ijTZ5lQJqcJ4uM43E+o6GuwuLSSzWE32Y3z+8brg+3rVb4aWEGj6rcaTY3WwNFuWQYO4hudtdB41JsbaBHU3sT5RhwGQnvxVzm/acqN6teTxKpdHt32PONd0G9tPE9nfWX+quRv35wPx9ulYWt3EtzqIm8sLPBcZkVSCMqetd2q3aaY9q6GW3gcNBMxzsB5wf6VDqVnBLpMN9YRNcXoUrKqx/MSfUCuiFS1rnbGpyq0tel/8AP+tzpNL1qbVtNlmgs7U2MabZhIu48D+I8YrnINRNnKi2zEw3PChjkpz90nHbArO8NNcl544ZTbxzOElgmBAz23D39a2PFFlHpjwTajcW6szeYkduuETAAx7kj6VkoRhLl7nLGkqNZ0t1Lodj4d14rbizuI97rwhBHK+nNaAvLoQKLcR5b5hvGcc/5/KuYvLSy/s+11XTbiQwzoGVZDgLj19PSs6LW72C3MsR3KvDYOcDvmud0lPWJxvCQqtzprfo+51V7puom6EkdxYCZjmSZoAGUcdyTz6VzMk0l5eyedJDfG3cbyV2q6g8gdqgvtft7mBRemJ4SRguOWxniiynhl2m2kG0uEUKpOSen4VpCDitToo0Z043nv6HW2WupDdlntWitzGATuDNkdOnbFVr7XLeDVWvIozhU2/MdgJPc/4VzHiKO8trNnQO14AT5D5TnnpjrWV4bhGoxtLqxlt5I495By4Jz90emfekqEbcwoYKjZ1Hta2hP4m8Ty3D7RLGW5bfIxKJ7VX03z59M+3vaCRXwpkJ4FTeVpOpavDbXh+yWb/u2lZNm4/3Sen41a1zw3qlho99Z6fMJNMSRGDJJgBcc5HryOlb3jFKK0OtyhStTjpfv/mU9IlkYTiWS3igjwRJKcBQevNZ2qeHrnIk08vM0z7YGj4AY+/pXdaloun6bpNlZwrFNcvGCzMSQcfxf59K0LO5vTpVulxBbW8dr+8RlblgvQhazde3vRMZY3/l5BaN7P8AP7yPTbyfwxo8Vv8A2a17elPMuFt3HBwOcH+lcve+NJ/Gzpoemadd2d+rhpRJyqAf7Q7Vc8Z6tPa+Dr6+szLJeXB+z+XCn3CeDk9qofD3wlrOk6Q8FxevaalqCecxBDbBk/Ln17msoxik6kt/6/I5YxpxbrVLc9/Pfrp5HVaZeSTz3MPnssljAqtJ1H+79eK4jWdVv9U8+6jmSGwmLW6u6klSOwx61oTaa/hHTtdknuJrnU75Arbc4A6Lim+H9LOq3elabBNLDapafaZnQhh5h4I59auCjG8+n/A1OigqdO9Z2t3+Wv47GNaaZFCIZX0t5rPGPOlGAr4zlQev40mmaPpUNxPJfyTC4QeZHhkKqTyPl7/nXplppl5d332PVbVBY2gxAy/dbjHIqvL4X+x3W22tLaa2bLMZG+ZWx1Ht7ZpfWU9GxvMotuMnr6nmNt4auNY12K/GoQNBGgHmSDoRgBfetq5mTT5Ps6wIQuTu+bLZJ5PNTasdHtvE0NhZBYpASss1sCx3n2PTH1pb7w/PbXLCeYSNJ+8Dbckg9M+h9q2U07cz06HV7SLac3ZNXS2/I9lGRxTZE3oyuAVPY0/09KzdcnuIIoPs6qVZ8SZODt9q8eKu7I+OhFykkjy3Xb2103xfJHcuoS4XaoJBXj0NSX+iJcXmnSWVpGziYFsDqpHP6VmfHHTreU2K6eqedvGCOoJPeut0IGC2t2z+8RVyc8ZxzXq81oRkux9Jz/uY1I9jq9G8P2emWX2ewjENu53sijGW9a5vxXY3MySWUcjxzyDagRtodP8A61XdU8R38eiXTaDYm91CJ9hgJxtz0bPpVLwxrWsa9pLpr2jvY3cUu1pSMLnsy5rlgpxfOzy6aqwk6kjndQ8I6ifAmo6XpFw09+pyFY7cHHIFch8I/hxr1jriavqxltRaHLRFsb+O/rXr11f3WmXs0102+WNdpKJtEi44Yj2qn4h8UTaH4abXLuGSWzmIYxwnkenPbNbe0qNcq6nT7aty6W1Ls+s6XpQudRmtkOosOTgbyOwz2Fc1pPjCzv726mZp3CZLywKdqHsuela+mXOk+PPBcmoW8f2dZEKvvGSrD1rkPh/ZqIbvS9Pu4VjklKyxNj5jzTpwhyyb3RpQp0nTnKSfMtH5Io3Hia6bxPH5QuLrTh+8kUycv14rk7XVNTl8SyR27z/PIdtu7EgKT0r3UeANJZWaOSVZj95kYYyPauD8YabH4funFjc4dRmSVgCy59K6KVanN2judmGxVCq+Wnv6HW6bqV3b2qaVfWLWctwo8poZsbj059K3dft5EtUj8x3CbdxbByvQj/69eW+DPEU/iHXlEhM62KDy93JcD1r1u/uYrZ7VriaNRcMAwJA2DHb26VyVYOnNHnYqHsqsbLV6v1Ne3jiSJTDGiKQCNq4rl/FwnnufJR0UKodSx4U+9bq6zppDiK9t5DGOVjkDEe2BXnXjH9ys148hW5uXGUVs4XsM9qzoQbnqc+X0ZTrXehm3r22oHy7uOKRVbEqn5SR3/GpNKtIY902jXdvbWijIik5mb1BPp9K5qCC7uLhUjKM7jAy/TinjS9c02eCa5Xy0Vz+8RgQRn2r0XBbXPpp0Ir3ea3kdzcOZYVudTjjtYVh2h5D8zg9sfWuHsdHE0zW6ajE1uMyM23qR0963dZ8P63rDCW1nh1GPafLUSZMYPPINUtH8ManZ28kupubVg2FUj5iQeoxUwkorcxounCPxq/bt8tzXt9CGuWtvby3UMNpaIvlB/lyCehI710fhDRNIljvbZV8/yXCs7HO4Edj1xXGNqXkWk1nBLEIHVfMklByxB6D863vAT6dN5jJctZ3xX5Ap4I/Hr9KyqqXI3fQ5cXSqqlKV2l0sjXvNFOieF7gvcOXin82EIdu3LAAD1+lUbia4a5j3b4muY9k4LDe5HQ+1cr4v1Oa3dp9Q1lriBXPlxq20lu3A4FZug+N57mV1mj+0qvyne2Co9j1qoUZNcz1KpYSo4c7ak3d/1+Z6RbmGzaOO+lhcXPymMEEIOvWr2tzXUWizWOn2v25pFITcwAZSenHf3rzvx9rVhHpWiQWRme8V/MmAB5DetdrodybzRIma/SylGAsUvcDHfOfasZ02kps46tBqMar77fk9DitP+HmsXSSXqobSRv8AVRtJh0PfkdR6VrxeHPEli1ut2wuov4tpDHA/Wu0ivZLK3a58xpIImKPGORj1Ge9ZGp+KNbnkkbRdOLQRkYLISW+vtTVWpJ9LGqxuLqytaLXnoTaPKdNsL03MDzxTEMiBRnGP1/Cs2xAWxE9qGiaQsXjJwGx/Wr+n6dr7A6jeuoZJAyWarwEP3gD2Na91cWd6gTICccn5WrNys+5zuqoydtb722OSuLS3exuruSJjcKo2L1H5+tcBfPcazrmm2N1dERuwjDtkbT3r2OS1a3WWBI/MtphhTL82Prjr9awbvTbfzP8ATIIhKQHjnUbjG4PBOK3p1Vqd+ExqhdtX7eRPc+Hm0zSMW8u23iX54JH3A4/xrnfDGlz67G9832fTbeJ3jjQEhZAeeSetbOqwxTai+pvZzvKsaqZskJ74XuDWP5euWmjz3VrZTy2kr4jhAwTnocelEHLl31FSUpU9ZLmbWr/Fb6/M1kstJu/CMsWprbrPBI0YbhZAR0x61y3hpJdPS3lM6OttKHEZbjOc/wAhWzpWh3d7p5m1XTkjnRgy73Cn67T1q7c6Lf39m/2TToUVefMWVclh3YZ/zmqUoxum9y1OnTcoyle77qy9NS/4g8SaRqtrZtw08MyvJA4wwUg57c9c1tnT4dSs7m4FkY2CbbdVIGRjgj/A+lc9ZQWN49mlxYLFqNunlmSJgQwx3Hf6Vu6ZptwsDwxTyQ2yff2kr5mc5x6YrlmowVoux51ZQpRUabat39eljzNo7iO2vLW4kjeMASENggtngE+vsK2tL1Sa3hh028Q4nUIbeNgyuOx9h0rsdL+zkMYtG3WUZOyQ7WO4dTzzUGi+HPs3irV9WuEEYfb5G1uNuOeO3StZV4tNSR01cfCakpx21+ehPp+jW0MTNe4juFTjAyUH8qyNd17RNHUXV5cMbZ18sAAkuQcAV1OoSiVIvtCMImyuVfAb2P1rFudNsr69jl1CJZYIsRpFJhgoI4x7/WueEru8zhp1Od81Vv5FKS0MmhXN6saxIZVeNC24vg8dKtk3TmS61HbBLLGFt7ZTl1A6H2yafZyWi6n595IlrDbLgRA7UkOSFO31ABplvrEOqy6he2y7kimjgB6sADk/Squ30Lbk3t8/W2hga55VxLpqXLT5WbM+RjgdPpzWz4OaN9d1q6tbdo7dNkKR7cMFUHJA9c1iatqtxqM90I2meOIOkUToCZWHrjr0rnvhz8QNUfxRFpEtoptWLb1SM7lOeT+FbOnKVNpb2/4J2VaM3h2ktbbX+Z7RqVtcXQgFvcm3RWDSfLkuv93npmszxPotzqlqViuzGByI9uATjua6HI6jvTHdVI8xguexPWvOjJxaa6HgU606bTj08jlLPTZdG0FTpFrbTXUfzz78bmbGSAfWq1k9m0Hm6ys4vJj5hADYAPTGO3FVtZ8USpe3VlZW/kh32i4jIYnAwWx+Q56Vhanqdw80Ya/AKRhfnjy3412RpzlrLr957NPDVaivPS+t+v6nrblw6bACpPze1Q3OyLzJ5guxE781SfxFpajP2pCPauf13WzcpLDZkXGQeQuAq+hrnhSlJ7HlUcNUlKzVkcN4w1YXl+zCMAM4AQD9a6XSHL2cbYCr0AHesWy0eSe+8+fO0dOMbfpXVm3W1tVQIAeoOa9Co4pKKPfxE4RhGlHoc/qn2nTr1Lm0keKR22tt46e1SePbfxNceDGaz84XvmrMqxnO4f57Vyvj671XQ5tOv7torizuZhthU4JA9xXR/E3xvrNn4H0/WfCcY2Fh54ZN2wen096JJ3g0kzmruXuSik9d/wBAtdV1GGx0seMZoba+u/3bwMuWKjo31NdIE0+30lYTB9rstxLR55f1yvTFeQ6Hfap4712wu/EsBt5Yo99uADhgR1r09LCO105oL+Qh42LFg+3jrgnvSnBKyf3BUhaMVLTrZC6jcQ6V4Xnt9JtYtOgdztiwAOepJrzGHw/Y2F89xJqUks0q+Z+5kCqT9frXfePEj1jwwiwQ/wBnhwAzSj5cepxXIHQNJ0fSra3/ALYhvr4sXkMLZRV7KK1oNKPmzqwb5UlbVt+f4nX6d4quDo0drYARtD8pIPJ+pPeuM8SWlzrFzItzI0Yk6hyVKgfXrXUXlrJolrBcC23WsxV3ZOV29jmp5L63114ZYNkFxJu8uLOAVA6gngmiDjF80Vp3NaThSbnTjo76mH4Bt7LSLjFtIZJiQJJ+gWut8deH18S2DS2E3lzqhXeGyox1/rWJoWjS/bWa1iRVn+Ys/bBre0a6ltZp4bjZPArkPtI+XPtU1X73PF6owxPx+0g9UYXgjwmnhcx3TQm+nnHMm3JUDrgZ4q54osri58y4u4GitY1yiBf511OtCY+WLVZo44yA4Vfl2nknFaK3MM9i1rcFAkqHY7D5fofQ1i60rqbORYuUZKra7/Q8buY7+80GO9tba2gikOURf9ZtXqzHtU91rsely/YsSvkKS0o+6CM4xmreqeGLi3uxbrKfsX2lJmgPfn7oP932pniTwVd3fiqa5vLxds2GdcZ4x0FdfPF6N6HqRrQbtJ6atG34auYB4ht5tPNy8bwM8hiGA3sB9auXNzq0ut/b7ffHaxIQ6s4f5e+fTNU5LG9mju7LS5hp+2IRCUjGFHUZ+tcXcz614Dsrq4uZVaO4DRsjnO8+orLlUndbmPs1Uk5K17Ws+xJ44v4rW4murFQ6Sfd3LwhPUD2qHwLqzXautzCplTG2ZOoHpgVzGk+Ip/EazaXeW6Y2mSN042Edq7v4d+E5LdsFXJmJ2lxwR/kVu2ow1O6Uowpe89ELP4fl8RbYyoVXJYsv48f1q/p/wzk09HkDoWU7iuck16MkVj4fs2W6ZQ3OzavJ46CvKptC8aa5qMt0t9cQxByyRtnCDPQdq54VpTbs7I86OOqVW3BqMV1fU6rVrm/SCCO0tY9ObjzJwquTjjAbtTYLC91a4a5lvo+MtsddpHbk1L4e0W5gtLkXNnPdXMg+aXfj8MHvWxA0EPkq1tc2sqrtfzU4+oqJSUdImMqyheNPfvv/AJslMIayi0xo5IkZPN809GK44zQs+pQXclzYGL7IEANtMdpYgdQe1QXN5BcyNbabKIZ9+XkuHIjQDqV+tY934jXS75LO8ubW7eVcAWYL/hj1rOMXLSxzxpynpbfo/wAzoZ/GEdjYNLqkaQSJxJhsqnoSOtec+L9Quf8ARx4VubO+jlJkeSMgsGOBtHPSrvjzX5dNt7q3t9Gu7iyu1CSM0e1lVhwcfyNZsvwp06LSrafTNVvIZgVdw6BiM84GO4ralGFO0paX+ZvQhToNSel/n/wx0Pg2+8VQaVL/AG8txZpGcK7oCNvfr0rN8S/Eaz0udLfTXS/mAzLPwo+nTrXVaRpSbVL6zc3tiV/fGV8A44ArGbwt4UfVPLh06K63tu6kbeec4PIpJ03JuS+4cJUpTcpK/orL5h4W+IsPiEzqyNPcRr/qhFldvclh071l678QdShu/KOkkRK/lrLJISqjswx7c812+l6fFYT3FnoVrbWyAAtPDH+7U9cbs9fwqC7XSpZ1tNRjWcOTtZU5nxjPHr/hUp01K6iRCdDnvyaHNS2HjPxBfj7DdW8elFAY7piHDD0A6iulk0/UdJt0h8+GctGBMUJGOfvEelbVs9qqWNppcwW2kyoAbDRYBPAPOe2Kkmfy3EH7oxk7HJI3SY7Gs3Ve1tDnliZOVrJLtb8znpLHU9M06a6mvF+17GaCGC3G4455OeapeDtW1/VLAy3OmRWt6pIVpm2gr3LDPPWupSzsra1aTYV87PzO+7b7Lzx+FVLgQyWpt7e3+0ODuEvCMBn+dJTUk9Bqrzppq/nb+vzJNIlvdN0pv7Wu9PRwxZfKb5cenNWo9Wtbrabm+tFjAzhJPvZ9Qa55/CdkJPO1LzQpAMaBt+5v6fStFdLsIEktLrydrpmPfFghfr39KUowbvcmcKEnzJ3fkvy3Ita1Bv7O8nSZEvZJZslCMjZ3x3yKt6baSXE7IkL21r8rMjYJ3AevcVSijs0unitd0blfkcE/Nj+HHU8VFNrl9p6GSR0ldUwB0B9AB3p8rtaJfs248lNa+f8AVjlNeZbjxXqou42uWsbGSSIbdoZ8YXH51d+EHhK+0Twtqc+tlke9InWLfkx4BIJ9+nFdJpKXeppHqupRfY4vSUAPjJ5x71yPjDWr26mltNNmuLW3JIMknClSccn0rRc017OPlf5HRGE8Q/YRdrWu/Q0vC9zDdeJ7SZcz+YpkVgOVyMcjtyCa9CtNKsra+uLuG0hjuJjlpAg3H8a4X4e+H72wspxDsgllVc3JBJIzwFB/H869HiVliRXfewABbGMn1rHEyXNaL8jizSova8sHotBffmq2oyrFas0kTSIeCBjvVquZ+IVwbbw5IVLhmdUDIOhJ6n0rlhHmko9zhw8PaVYw7s88ugWeWRV8hDuKKg4IzyAe3Faa6TdzRxubKQAqCu4buO3NUvCNtHJ4iWG9Jlh3gKpPBPqR/nNd3rPia1029NruC7FHGcYr0qtSUGoxVz6LFVpwmqVJXdrlK60i3lYMkOzGM478elLBZxxwtFFDhSck4BNTxT3xlWO2tlkZuQSwx75NaN3YX8xQRvAgHJ65BrncmtGzzJVZRtGUvxMqGARMXZkXaeQe9M1S/wBKtrUm4kL7hwhHU+mBWlPp0djKrbXumdSAG6BvWktdCRpre9mhR7pWztcfKg9qOaO7ZPtYN80mzzvX7GTxDpSq9pLBb27EwjYefTGa0fh/4KvX0V4fEd15tswO2FDjaDzgmup1nxabGaW2itS0yHaDnKg1zzaxe22g31xayR/MxDRbT17kVvzVJQslY7VOvVp8sVypvT5mrfnQNP8AKWe5dhbDy08vAx9SP88VpQXeg32nCG4uYpkGHPmkFs189+N7wpZwkXEz3Ltl4geF/L61d+GXh/XNfglkt3ZIi+0u4+771csMkrykdFXLoRhedRq3U9p8W2K+INEuYNJnDyLFnCqMcdPxrxLRvCupQS+dOSi52nB6n0r6B8J6D/wjtisBla4cjMsp7n/Cue1Xw5eTaxcjT2zbOnm/MeMn+EVFCsoXgnp3OfA4yNKUqafu9Gy34e1fR49Ag0zUW2hU2uJl+Un60mqeINC0iIR2drDIqRkK4UBQD6GuH1D+0IHSMWbMpHLKM5/Crb6VDfiFZIppFVPnTYRn8Kv2Eb8zejNXg6Slzybs9bX0KuneLYheTR6TBK6vy5Veg74Pan6NPZJPd3kAuBzudn+6vsa6Pw94cvY4zJZvbWdrygLqCWHStvR7e10myls1tluJZGOd6ArJ757051YRvyhVxNKN1BXf9bnneoa94w1vXUTRYHXT1wpnSMhWUep7iuoi8W6Uwm0y2kjk1OY7hGOURsAHn9a3IvFum3tvLZWUpt7lP3bKE4Q98YrE0LwlY6VNPfPp5klJLtNLwR3/AK1DcWveja2xg5RatUhy22Xc1XvLfVUljmBN1AuXfGF45HNUJWso4vt2pSPbWgP+t3cs2MdTW/BFbX2l3K2WyKYvgFP8/Wo9Q0i41jwtPo9/bxozrsDAggAdCPeslNLyMFWjDRaa29EZFkllNDDd2FwXtGYq0q/OgI6/zFZ/jrwmPENoI55jcrJ8yqgAdAO6j0qLwt4RvPDmn6hA/mzNLKpTaMKpAxwPf1rptLtW0kzahJCZru4H7wlsFQPetHJRleLubyqezlzwld9PM4fwZ4F0jSLqY+XK77PlVxy2R9K3r3X4fC1ozSQbLlfuxbCzbfp2qfUPEDT3LzWoS2gGN8vcKOuB0z1rlviDq2nRpp0Fvbz6hfXLMY2jkOGB46j2xVpSqSSmtGavnrSSqrR9Ox3ngi3k1bTYda1ZC9xdDzI45Bny1zxgdq6x5EjwGYL6CuN8OXGuzwpBqNummwrb5jijHzOR2BNRSanNbJL5DNvkjG2ViSd3fBP41yypucmebUw861R3a+Wx0V9q/kXi2sEavK2AAxxk+lO1ADUrGeyZkgvSvyBzna3ZhjrXnutJfafGZpAS0nziRzyD61hN4phgULdz75wQWRlyfpmtY4W6TizthlfNFTpvb8yHWIfiPpd1PJeQLqlux2uiRq6hR0IPUV3dvoNtp9tFqLWNsZJthc8+ZExHA/A1Rg1P7b5clg4QSKGGWPA9T+tathGuq6Xc3TSyFYmwobo2B1HpVzbSV9PQuq5xS5rRXW3/AA5uapL5lgbK2Y3N4QA20Z787j2FK1vCghjlIgWHk5bABI/U1S09ILbTnk0+dY5YjslPTLfj1qRdRKMFvWXZcLjfIvyt6DHrXLy9EedyNaQ2X3kfiE6TptvFHe3sdpbMQWB/iA681V0pLfWIXutMsGe3kJVJZpTGCBxkADNYera/4Zg1mDTrxlubrcAIJELYB7Cukk8Qw2x8rTkhNsgACgj5fXgdPxrTkkkrJ3ZtyVIxShdt99EUYNLl0q2uoWmaFZHyIoW+QcdeefSnweHrPUNMkM1zOGZif3Mu1kGeelFw73yzSzs53KGAZf5D8azPNFtMq2zbF28urFTn0q0pS66myjOa3tItzWWkeF/DF7ejzbi3jbIZG8xwM9ST3qhonii3WK5urSwubpvIaaCU8g+iH0NPnVL6CWKUs0L8SRKMoT6GnqiwWSRxssKRg7LeIEnPuB/M1XImmpatlqmrNVNWzhvCeneKfEOtXmu6tdpYQlJFiimYjk9Nqe1dv4Mg/wCEZSK0eb7XJK2XllJJJx274rl/Ger61Agis7SO1nA+bYp3sp6Gsnwcut/2wdVvPtQiiT7xHLZ7DNbum5wd7JdjrnQc6b5mlHov+CetWsl1FqCXF9Lm3SRirBOEUg4HrXSYtb+AH91PEeh4YVxOj+OLa6uY7HUIi87AsjwHd07N6HpV+IWeoSTOqyhlPEcYXdn1OK4Z0nf3lY8etQm3ea5bdjSutKs5tVVorkxXyLuVeuF6cA1ZtdPskDSt5dw6EktwdpH8jXPs4juBumlEbKMlmIdSO2KLuCN5JyuoXQWMb2V2+T6cdc1PK9rjdKbSi5kurXb3umXt20qrbwKQUBwV9yD7ciua0DRJ/EcxW/kZrGNShdDjnPGB61sabqN9favczS28MWjCA/aAVG5zjqBWp8PZLZtFkW1UhEmcFj3571rd0oOy1/I6HUnhqMuVa6fK/wCp0lvCtvBFFGPljUIM9cAYqnrmpR6Ppst7KhdI8ZVeCcnFXLmZLeCSWVgsaKWYnsK5TW7+113wRPNvbbIdoIBBDBuP6VywhzNN7XR5lCm6k05L3bpP5nTWVyL2zSdEZA4yocc15p481W7u9ej0yQiHT0kV2cjBb2rvtFuGTQ4zKAWgjwdp6gD/AAFeQW2saJ4qGrSJf3EGrJIzRRuceYoPRa6MPBKo21oj0MupxhWlKS0Wi62udP4bhN1Lql/KwgmR1EaL8wIxx9TSro+oT5nEUV2ZTvMkzgnPoPYV03hF7a10gtKEhcHcxccnI/P1rkNU8SpZ6hPHaXojty5ZFx2Pp+Oa0TlKbUUbqdSrVmqa2Oo07UFtbmOzW8+0zop+UoFB49a2LXWbeSVYXBhlfOFbk5rzj9oDV7rw74btf7IKW7Sy4ZlQZ/Oqvwo12813w5azakUlnSXYJdvzYx61m6alBT7nL7GNen7U7y1luLvXbqGbUVa1ReF24Ib2NJqWpSwX/l2+qRlo0+aIqCWPtWNF/oereZH85yeH5B/zmtGezgvYzdyIFmLDlOOp5puKUrPsU6cYzV9rdkcHrc15HHdSCIzyOTtXHek+GtnqM9hqy6ulwtiB5oQ8cjqK6HUl+wSmWFizryN/OKqaTqV3cpcpPO7LIu49ufwrrlJuFkj1Jyc6dopLY6fwp4Z0QaLFc3WmxLPMmXM4yf1rTv5rTRdNVdJFrGHkC7FIAOeuMUy/tku7KxtpWfYYhyD8351z3j21h0e30ySxQJtYgqejYwQSPWuOP7yS5nueXCLxFRc8m7t6dNDk28ZazYahdWLpPeWcEh+cIScE9M/jXp1lfqnh6K5sIGSSVfkVzuwfevM/Huo3OnCO+sJDb3EqqzmPjORzVCbxRqo8FmX7QfNjc7X6HmumdJVIxklY76mEjXhGUUldnrmkXCCRba5WB2bLCRQOD1waL+wurieSSxu4t5BCgAA/TNeXeAZpr3wSt7PNIbhpWy2e3p9K7jQtTmNjbBliY7+pXmsZ0nB3RxVsM6Lc4vyIri2msbBt0he5lDOJJf8AVCRemRXmmh2XjK/1O51HVbi4ForFfMVvkGf7oHavSdZ127kvY7UrCISSCAn+1W3DN9rks7CWNBbddq5GcdB16VcargrtbmkMRKklNpNszvC2lw6L/Z++Nbm4uSWMy9ckd65n4neNtV0TxF9gtoLdbZ4QzFvmLjuPau61C2SJ7iaEmPyRlEXG0Y56YrmfHOgafqOnxXs8JFzKFyynGPXANFJxlUUp63Cg41a8Z1Ve5lav4itrW10/UdHDxLcRgmFQflk9854qSXx7f3GniR4wrwuAWUYJb0rO121i+ww2gXbHDhVI+9j61kx20dpeSQpl49oJDnOTXSqUGrtHp08NSmlzK9u+53fhrxO+sP8AZLh5UZmy2Tzg10S2hu7ue2gvpHhMeQxOSO2BXAeE7KDe7Bdrbm5B54Fdn/aE8dnayRFUaN1X5RwwPrXNWglL3DzsZRVOpalp/mcVqfgfUW8Pah9mnGJ3HmFic7Aegqz4f0q30SxLsq3zW67o5ym0xZ9K7G+1W5tZJoYSgQNxkZxkVga5PLd6aDM5+RWxt46etVCpOas9maUq9Wu7VOrK2p/EIW1rCjwJLcDmMkY7Vipr8l1ppuDFEt0j7wpJxgn/APXxXNaoFfUIkZBjt149qvrthlYIq7QvAP0zXTGlCK0R6kMHSp6xRJ8RL3UZZ4kaQvZqgyQOv+PauZ0nTo7wNdTqxjBwOxNW5tevp5Ak7o8ecbSvFJe3k6bYY5CkT4BVeBjjj9a0iuVWN6MOSCijvvBZjjhlRyqiIZBaPI57H9a9E07bf2J8t4WgZdpjUALn2xyK8vsUFnJAsGVWVAWGeOBWjBGkN9HJGu0sfmAJweRXHWp87vc8jG4dVZOSdjd1PVoLCWGLUpbc26HlYTycccmqOueLLA6vY2Oi6fFfqWV5XZfkRc+vrW1rGj2V3p58+EMYoAVPQjPJrF8OWkGlIyWkSAc8sMk5NZxUHHm7HPTVJx9o02102RxnjO2vdWj1q5sdLt4b5GX7PJHBtk2+zfSovhDpN3YacLrUtPkkvJJziOTO6Qdfyr13R5RPdRxSRReWFIA2989frVKDTYZLuWbfKjhTja2AOT/hVqvdONivrSleKjay/wCAc34sv9U1Oxnh0Ox8h4zkwRJudsdckdB7VR8K+HfEFzM8uowJDE65CM2WU/T/ABrsxfT29jdeQwj+znapVRkjPf1qvaSvcPcPKzFtplzuP3ulJVHGLUUEa0oQcYJJfezKma40N544baC6KgM0GMBjjjn1rD8QW2tanc28hU26zAM0CZHJ7flXQ2d0biQiWOLg8ELz+dbU0825lMrkRYRcnsQaaqcrvbUr2rhLmtd9SnHocumWqXUlxHJdyKq7X5bGMADPWpjoeoSCMShJN3A81sKg+n9KnOnwyywNM0sjvHncznI6dPzrGR5buRZp55mkhbCNvIwAahOT6mKdSWt9fT7rHN/EmaTwfqVkugaZbJNLCfMuWXIJ7jHTNdF8O/El34i0VZPsSQzbijNFFlf97/61aeqTm5fyryKK5gdFYxTIGXPrVzSrZdHg32RKRzHd5OBsT2UAZH50pTTp2a1JqVE6KjJXl3LbKzgfaYf3pOFUR5JXpk56VR+1WttcIgLzXMTAKAuCV54P51yXjjxVqOkiWa18kyk4DOpO0ZxxzWj4eu31Wxi1adUS6BbiMHacAnoc1MYaXZMKNo3ls/6+4reJXuZ9RR3DW4TLOkS5ABPIJ7k11Vs1tpvhIG0AgWZSQSADlupxXNFM3cO4s3nKkz7jn5iM132o2EGoaaYLhTs2cbTgjinWaSjHoVi5qKp03sc3pmp6vd6XLF9it7qHygFmdyocEYwc1j6jod7Z2IuNDsVkmDKTCspZRyOdvel13Ur7SJbeC3u5ZIHdV2S4IAA7YArq7a4kXVoeRiVQjDHGMZok3Td0lZhNyw75opWettfxNezUtZxmWJY5HUeYoGBuxzXg2teDrTw94huLuwDyYn3RkvkKCeRj869+jYs0gP8AC2B+Q/xrj/iHplpH4fmuIYUjmRlwygDIz0NZ4Wry1PU58txHs61ntIzhLLfaekaMUZju2A/xAdKwNfsIlvUAhDfulOcjr3rW1+CK0fTktk8oS2rM20kcgcVm+FLuW60aKS5xLJuYbnGTjPSuqDsuaJ6dOXIvaR2Z/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Mucoid intimal thickening of muscular renal arteries (arrows) as an early healing response to previous fibrinoid injury in any of the forms of the hemolytic-uremic syndrome, including scleroderma and malignant hypertension.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_49_26389=[""].join("\n");
var outline_f25_49_26389=null;
var title_f25_49_26390="Old World CL due to L major";
var content_f25_49_26390=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F87207&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F87207&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 595px\">",
"   <div class=\"ttl\">",
"    Old World CL ulcers covered with typical eschar",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 575px; height: 425px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A previously healthy, 23-year-old soldier noted lesions on his neck two months after deployment near the Iraq-Iran border. He did not have fever, chills, or any systemic symptoms. A physical examination revealed five painless, mildly pruritic, indurated lesions on his neck that had raised borders and a central scale. There were two similar lesions on his right lower extremity. He had mildly tender posterior auricular adenopathy, but there were no other abnormal findings on physical examination.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From: Polhemus ME, Aronson N, Weina P, et al. A US soldier who returned from Iraq with nonhealing sores. Clin Infect Dis 2004; 39:1008.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_49_26390=[""].join("\n");
var outline_f25_49_26390=null;
var title_f25_49_26391="Primary cutaneous large B cell lymphoma, leg type";
var content_f25_49_26391=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Primary cutaneous large B cell lymphoma, leg type",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/49/26391/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/49/26391/contributors\">",
"     Eric Jacobsen, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/49/26391/contributors\">",
"     Arnold S Freedman, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/49/26391/contributors\">",
"     Rein Willemze, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/49/26391/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/49/26391/contributors\">",
"     Timothy M Kuzel, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/49/26391/contributors\">",
"     John A Zic, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/49/26391/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/49/26391/contributors\">",
"     Rebecca F Connor, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?25/49/26391/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 25, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary cutaneous B cell lymphoma (PCBCL) refers to those cases of B cell lymphoma that present in the skin when there is no evidence of extracutaneous disease at the time of diagnosis and after the completion of an initial staging evaluation. There are three main subtypes of PCBCL:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Primary cutaneous follicle center lymphoma (PCFCL)",
"     </li>",
"     <li>",
"      Primary cutaneous large B cell lymphoma (PCLBCL), leg type",
"     </li>",
"     <li>",
"      Primary cutaneous marginal zone lymphoma (PCMZL), included in the broader category of extranodal marginal zone B cell lymphoma",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These appear to be unique entities with differing clinical presentation, pathologic features, prognosis, and treatment approach. This topic review will discuss primary cutaneous large B cell lymphoma; leg type.",
"   </p>",
"   <p>",
"    Initially, patients with this type of lymphoma were classified as PCFCL. Because of their characteristic clinical features (presentation on the legs, older age at diagnosis, intermediate prognosis), that were different from those of PCFCL (presentation on head or trunk, excellent prognosis), they were included as a separate group, designated PCLBCL of the leg, in the EORTC classification for primary cutaneous lymphomas [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26391/abstract/1\">",
"     1",
"    </a>",
"    ]. In the 2001 WHO classification, both PCLBCL of the leg and PCFCL with a diffuse growth pattern were included in the general diffuse large B cell lymphoma category. In the WHO-EORTC classification 2005 it was recognized that these PCLBCL presenting on the legs were a distinct disease entity. Since cases with similar morphology (predominance or cohesive sheets of centroblasts and immunoblasts), immunophenotype (strong expression of bcl-2 and Mum-1) and prognosis, may arise at other sites than the legs, in the WHO-EORTC classification, and subsequently in the 2008 WHO classification, the term PCLBCL, leg type was preferred for both lesions on the legs and similar lesions at other skin sites.",
"   </p>",
"   <p>",
"    The other PCBCL subtypes and other forms of cutaneous lymphoma (ie, T cell lymphoma) are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/9/26776?source=see_link\">",
"     \"Primary cutaneous marginal zone lymphoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/6/15464?source=see_link\">",
"     \"Primary cutaneous follicle center lymphoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/32/4618?source=see_link\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of mycosis fungoides\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 25 percent of all NHL cases will present at an extranodal site without systemic involvement. The skin is the second most common primary extranodal site, second in frequency only to the gastrointestinal tract [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26391/abstract/2\">",
"     2",
"    </a>",
"    ]. The overall incidence of primary cutaneous lymphomas in Western countries is estimated to be 0.5 to 1 case per 100,000 people annually, of which approximately 20 percent represent primary cutaneous B cell lymphoma (PCBCL) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26391/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Primary cutaneous large B cell lymphoma (PCLBCL), leg type comprises approximately 4 percent of all cutaneous lymphomas and 20 percent of all primary cutaneous B cell lymphomas [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26391/abstract/3,5,6\">",
"     3,5,6",
"    </a>",
"    ]. The median age at presentation is in the mid to late seventies and is more common in females than in males with a male:female ratio of 1:3 to 4 [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26391/abstract/5,7-10\">",
"     5,7-10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no clearly defined risk factors for developing this disease and there is no identifiable hereditary tendency.",
"   </p>",
"   <p>",
"    Primary cutaneous large B cell lymphoma (PCLBCL), leg type shows many genetic similarities with diffuse large B cell lymphomas arising at other sites, but marked differences with primary cutaneous follicle center lymphoma (PCFCL). Interphase FISH analysis frequently shows translocations involving c-MYC, bcl-6 and IgH genes in PCLBCL, leg type, but not in patients with a PCFCL [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26391/abstract/11\">",
"     11",
"    </a>",
"    ].",
"    <sup>",
"    </sup>",
"    Using array-based CGH and FISH analyses, high-level DNA amplifications of 18q21.31 to 18q21.33, including the BCL2 and MALT1 genes, were detected in 67 percent of the cases [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26391/abstract/12\">",
"     12",
"    </a>",
"    ]. Amplification of the BCL2 gene may well explain the strong bcl-2 expression in these cases, particularly because the t(14;18) is not found in these lymphomas. Deletion of a small region on chromosome 9p21.3 containing the CDKN2A and CDKN2B gene loci has been reported in 67 percent of PCLBCL, leg type, and is associated with an inferior prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26391/abstract/13\">",
"     13",
"    </a>",
"    ]. PCLBCL, leg type have the gene expression profile of activated B cell-like diffuse large B cell lymphomas, while diffuse PCFCL have the gene expression profile of germinal center-like diffuse large B cell lymphomas [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26391/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients present with red or bluish nodules or tumors on one or both legs, preferentially the lower legs (",
"    <a class=\"graphic graphic_picture graphicRef68920 graphicRef79655 \" href=\"UTD.htm?29/42/30375\">",
"     picture 1A-B",
"    </a>",
"    ). Ten to 15 percent will develop outside of the lower extremities [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26391/abstract/5\">",
"     5",
"    </a>",
"    ]. Unlike other cutaneous B cell lymphomas, these tumors frequently disseminate to extracutaneous sites.",
"   </p>",
"   <p>",
"    The presence of \"B\" symptoms, abnormal blood counts, or an elevated lactate dehydrogenase (LDH) should raise suspicion of a systemic lymphoma [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26391/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PATHOLOGIC FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of primary cutaneous large B cell lymphoma, leg type is made based upon a pathologic evaluation of a skin biopsy in a patient who has no evidence of systemic lymphoma upon staging studies. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Staging'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Morphology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Skin biopsy specimens are characterized by a diffuse non-epidermotropic infiltrate, which often extends into the subcutaneous tissue. These infiltrates generally show a monotonous population or large confluent sheets of centroblasts (large follicle center cells with round nuclei and prominent nucleoli) and immunoblasts that spare the epidermis (",
"    <a class=\"graphic graphic_picture graphicRef58187 \" href=\"UTD.htm?42/36/43593\">",
"     picture 2",
"    </a>",
"    ). Frequent mitotic figures can be seen. Reactive T cells, which are few in number, are confined to the perivascular areas.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Immunophenotype",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evaluation of the biopsy material with immunohistochemical stains is a key component of the diagnostic evaluation of cutaneous lymphoma. At this time flow cytometry cannot be routinely recommended as a replacement for immunohistochemical studies. This is principally because of the difficulty associated with making a single-cell suspension with this tumor type.",
"   </p>",
"   <p>",
"    The normal counterpart of PCLBCL, leg type is unclear, although it has a gene expression profile similar to an activated (post-germinal center) B cell [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26391/abstract/14\">",
"     14",
"    </a>",
"    ]. The neoplastic cells express B cell markers (eg, CD19, CD20, CD22, and CD79a) and may express surface or cytoplasmic monotypic immunoglobulin (Ig). One study has demonstrated cytoplasmic IgM expression by the tumor cells in all 40 cases of PCLBCL, leg type, but in only 5 of 53 PCFCL [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26391/abstract/16\">",
"     16",
"    </a>",
"    ]. Clonal rearrangement of Ig genes has been demonstrated.",
"   </p>",
"   <p>",
"    In contrast to (diffuse) PCFCL, bcl-2 protein and Mum1 expression are common (",
"    <a class=\"graphic graphic_picture graphicRef78894 \" href=\"UTD.htm?16/28/16841\">",
"     picture 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26391/abstract/17,18\">",
"     17,18",
"    </a>",
"    ], although the t(14;18) which often leads to bcl-2 overexpression is not commonly seen [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26391/abstract/17,19\">",
"     17,19",
"    </a>",
"    ]. However, up to 10 percent of cases may not express either bcl-2 or MUM1. Bcl-6 is frequently positive [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26391/abstract/18\">",
"     18",
"    </a>",
"    ]. CD10 staining is usually negative.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of PCLBCL, leg type requires a representative biopsy. Excisional biopsies are preferred to punch biopsies, but if a punch biopsy is taken, the diameter should be at least 4 millimeters. The biopsy specimen is evaluated for morphology, growth pattern, and immunohistochemical studies.",
"   </p>",
"   <p>",
"    Importantly, lesions with a diffuse pattern or a monotonous proliferation of centroblasts and immunoblasts are classified as PCLBCL, leg type regardless of their anatomic location.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12556659\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Systemic lymphoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;An estimated 6 to 10 percent of patients with systemic B cell NHL will develop cutaneous disease at some point in their illness [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26391/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. They key to differentiating systemic diffuse large B cell lymphoma from PCLBCL is a thorough staging evaluation. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Staging'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/45/24282?source=see_link&amp;anchor=H12#H12\">",
"     \"Epidemiology, clinical manifestations, pathologic features, and diagnosis of diffuse large B cell lymphoma\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Primary cutaneous follicle center lymphoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;PCFCL may show a follicular (less than 5 percent), follicular and diffuse (30 percent), or diffuse growth pattern (65 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26391/abstract/9\">",
"     9",
"    </a>",
"    ]. In particular, differentiation between diffuse PCFCL and PCLBCL, leg type may sometimes be difficult, but is extremely important because of the therapeutic and prognostic consequences. Differentiation should always be based on a combination of histological, immunophenotypical, and clinical criteria. In contrast to PCLBCL, leg type, PCFCL characteristically show a proliferation of large cleaved cells (large centrocytes), which generally do not express bcl-2, Mum-1 and cytoplasmic IgM, and in 85 percent of patients present with localized skin lesions on the head (in particular the scalp) or trunk. Additional histological criteria favoring a diagnosis of PCFCL include a considerable proportion of admixed T cells, the presence of a stromal reaction and demonstration of (remnants) of follicular dendritic cell networks. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/6/15464?source=see_link\">",
"     \"Primary cutaneous follicle center lymphoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Primary cutaneous marginal zone lymphoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary cutaneous marginal zone lymphoma (PCMZL) can be distinguished from PCLBCL, leg type histologically. While PCMZL consists primarily of small cells with irregular nuclei, PCLBCL, leg type has a large component of centroblasts or large cells. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/9/26776?source=see_link\">",
"     \"Primary cutaneous marginal zone lymphoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Cutaneous T cell lymphoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cutaneous T cell lymphomas can be distinguished from cutaneous B cell lymphomas through their expression of T cell markers such as CD2, CD3, and CD5. Aberrant expression of B cell markers (CD20, CD79a) can occasionally be found in advanced stages of mycosis fungoides and may raise confusion. In such cases, lineage analysis by immunoglobulin or T cell receptor (TCR) gene rearrangement studies may facilitate a correct diagnosis. This is discussed in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/32/4618?source=see_link&amp;anchor=H19#H19\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of mycosis fungoides\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Intravascular lymphoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intravascular large B cell lymphoma, formerly also known as malignant angioendotheliomatosis, is a distinctly uncommon non-Hodgkin lymphoma variant that typically presents as multiple, erythematous tender nodules, tumors, or telangiectasias in older patients. Isolated involvement of the skin does occur, but the disease more frequently affects multiple organ systems, including the central nervous system (CNS), producing a wide variety of symptoms, ranging from generalized confusion or dementia to focal motor and sensory deficits. This is discussed in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/12/13511?source=see_link\">",
"     \"Intravascular large cell lymphoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1793124\">",
"    <span class=\"h2\">",
"     Iatrogenic immunodeficiency-associated lymphoproliferative disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;The 2008 WHO classification system includes the diagnosis, &ldquo;other iatrogenic immunodeficiency-associated lymphoproliferative disorders,&rdquo; which includes lymphoid proliferations of lymphomas that develop in patients treated with immunosuppressive drugs (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    ) for the management of autoimmune diseases or conditions other than transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26391/abstract/5\">",
"     5",
"    </a>",
"    ]. These lymphoproliferative disorders commonly involve extranodal sites, including the skin. Diffuse large B cell lymphoma is the most common histology in this setting. Primary cutaneous large B cell lymphomas that develop in this setting often express CD20 and CD30 (but not CD15) and variably demonstrate positivity for Epstein-Barr virus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     STAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;At the time of diagnosis, patients with suspected primary cutaneous lymphoma should undergo a complete history, physical examination, and staging evaluation. This evaluation confirms the diagnosis of primary cutaneous lymphoma by excluding involvement of other sites, and provides information to guide treatment. This staging evaluation is described in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/6/15464?source=see_link&amp;anchor=H18#H18\">",
"     \"Primary cutaneous follicle center lymphoma\", section on 'Staging'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    While optional in patients with indolent B cell cutaneous lymphomas, a bone marrow aspiration and biopsy should be performed as part of the initial staging evaluation for all patients with PCLBCL, leg type.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary cutaneous large B cell lymphoma (PCLBCL), leg type is a rare disorder; accordingly, large trials regarding therapy are lacking. The published data regarding treatment consist entirely of retrospective reviews and anecdotal reports.",
"   </p>",
"   <p>",
"    PCLBCL, leg type is widely reported to have a more aggressive clinical course than other categories of PCBCL. In contrast to PCFCL and PCMZL, which have estimated five-year survival rates of over 95 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26391/abstract/1,9,22\">",
"     1,9,22",
"    </a>",
"    ], PCLBCL, leg type has an estimated five-year survival rate of between 41 and 58 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26391/abstract/7,9,10,23,24\">",
"     7,9,10,23,24",
"    </a>",
"    ]. While a watch and wait approach or treatment with localized therapy is often appropriate for other types of primary cutaneous B cell lymphoma, patients with PCLBCL, leg type require a more aggressive approach with combination chemotherapy.",
"   </p>",
"   <p>",
"    Our treatment approach is largely based upon observations from the largest literature review that reported outcomes of 164 patients with PCLBCL, leg type treated with different modalities as described below [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26391/abstract/25\">",
"     25",
"    </a>",
"    ]. In addition, we integrate high-quality evidence from the treatment of systemic diffuse large B cell lymphoma discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/45/26330?source=see_link\">",
"     \"Initial treatment of advanced stage diffuse large B cell lymphoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Multiagent chemotherapy &mdash; Twenty-six of 32 patients with PCLBCL reported in the literature treated with CHOP (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/37/36440?source=see_link\">",
"       doxorubicin",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/29/1498?source=see_link\">",
"       vincristine",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      ), CHOP-like, or COP (cyclophosphamide, vincristine, and prednisone) regimens achieved a complete response. Of those, a little over half have relapsed at an undefined length of follow-up.",
"      <br/>",
"      <br/>",
"      Another series of 12 patients treated with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"       rituximab",
"      </a>",
"      plus anthracycline-containing chemotherapy (eg, CHOP) reported a complete response in all but one patient (92 percent) with only one reported relapse.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"       Rituximab",
"      </a>",
"      &mdash; Cumulative data on 13 patients treated with systemic single agent rituximab, mostly in the setting of relapsed disease, demonstrates complete response rates of 40 to 50 percent. Long-term follow-up on relapse rates is not available.",
"     </li>",
"     <li>",
"      Radiation therapy &mdash; Compilation of data on 101 patients treated with radiation revealed an 88 percent complete response rate. Relapses were seen in 52 patients (58 percent); extracutaneous progression was seen in approximately 30 percent.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    We treat patients with PCLBCL in a similar fashion to patients with limited stage systemic diffuse large B cell lymphoma (DLBCL). For patients with PCLBCL, we suggest treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"     rituximab",
"    </a>",
"    plus an anthracycline-based combination chemotherapy regimen (eg, CHOP (",
"    <a class=\"graphic graphic_table graphicRef63586 \" href=\"UTD.htm?22/2/22574\">",
"     table 1",
"    </a>",
"    )) followed by involved field radiation therapy rather than either of these modalities alone. The data supporting this approach in DLBCL is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/45/26330?source=see_link\">",
"     \"Initial treatment of advanced stage diffuse large B cell lymphoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     ASSESSING DISEASE RESPONSE",
"    </span>",
"    &nbsp;&mdash;&nbsp;We evaluate and restage patients 8 to 12 weeks after the completion of therapy. Restaging should consist of repeating all laboratory, clinical, and radiographic examinations used to stage the disease at presentation though we typically do not repeat a bone marrow biopsy unless there is suspicion of new bone marrow involvement such as an abnormal complete blood count.",
"   </p>",
"   <p>",
"    Following the completion of therapy, restaging, and documentation of complete remission, patients are seen at periodic intervals to monitor for treatment complications and assess for possible relapse. The frequency and extent of these visits depends upon the comfort of both the patient and physician. When planning the post-treatment surveillance strategy, care should be taken to limit the number of CT scans, particularly in younger individuals, given concerns about radiation exposure and the risk for second malignancies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/17/21785?source=see_link\">",
"     \"Radiation-related risks of imaging studies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For patients who are in complete remission, we typically re-evaluate with a physical examination, complete blood count, lactate dehydrogenase, and comprehensive metabolic profile every three months for the first two years following therapy. The frequency of clinic visits is then decreased thereafter. We do not pursue routine radiographic restaging after a patient has attained a complete remission in order to limit the number of CT scans, particularly in younger individuals, given concerns about radiation exposure and the risk for second malignancies. Unlike systemic DLBCL, relapse of PCLBCL, leg type almost invariably occurs in the leg of initial involvement with or without regional lymph node involvement. More widespread nodal involvement without skin lesions is exceptional.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     TREATMENT AT RELAPSE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Greater than half of patients will relapse. The median length of remission is largely unknown. In one large series of PCLBCL, leg type 27 of 58 patients had developed extracutaneous disease and 26 of 58 patients had died as a result of lymphoma after a median follow-up of 26 months [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26391/abstract/9\">",
"     9",
"    </a>",
"    ]. The overall and disease-specific five-year survival rates were 37 and 50 percent, respectively. Relapsed disease should be approached in much the same way as relapsed diffuse large B cell lymphoma. This is discussed in length separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/25/33178?source=see_link\">",
"     \"Treatment of relapsed or refractory diffuse large B cell lymphoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21004635\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;PCLBCL, leg type is widely reported to have a more aggressive clinical course than other categories of primary cutaneous B cell lymphoma. Unlike other cutaneous B cell lymphomas, these tumors frequently disseminate to extracutaneous sites. Retrospective analyses have reported estimated five-year survival rates of between 41 and 58 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26391/abstract/7,9,10,23,24\">",
"     7,9,10,23,24",
"    </a>",
"    ]. No difference in survival is found between PCLBCL, leg type presenting on the leg(s) and PCLBCL, leg type arising at other sites, nor between cases with or without expression of bcl2",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    <span class=\"nowrap\">",
"     MUM-1/IRF4",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26391/abstract/9,26\">",
"     9,26",
"    </a>",
"    ]. The presence of multiple skin lesions at diagnosis is, however, a significant adverse risk factor [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26391/abstract/7,9\">",
"     7,9",
"    </a>",
"    ]. In analyses that included 58 patients with a PCLBCL, leg type, patients presenting with solitary, localized, or generalized skin lesions had estimated rates of five-year disease-specific survival of 75, 49, and 0 percent, respectively, and five-year overall survival of 70, 27, and 0 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26391/abstract/9,27\">",
"     9,27",
"    </a>",
"    ]. Inactivation of CDKN2A either by deletion or hypermethylation has been found to be an unfavorable prognostic factor [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26391/abstract/13\">",
"     13",
"    </a>",
"    ].",
"    <sup>",
"    </sup>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Primary cutaneous B cell lymphoma (PCBCL) refers to those cases of B cell lymphoma that present in the skin when there is no evidence of extracutaneous disease at the time of diagnosis and after the completion of an initial staging evaluation. Primary cutaneous large B cell lymphoma, leg type is the most aggressive form of PCBCL. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most patients with PCBCL, leg type present with red or bluish nodules on one or both legs (",
"      <a class=\"graphic graphic_picture graphicRef79655 graphicRef68920 \" href=\"UTD.htm?29/43/30391\">",
"       picture 1A-B",
"      </a>",
"      ). Ten to 15 percent will develop outside of the lower extremities. This terminology could understandably be confusing, since a patient can sometimes be diagnosed with PCLBCL, leg type without having any lesions on the leg. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of PCLBCL, leg type requires a representative biopsy of involved skin and the exclusion of non-cutaneous disease in the appropriate clinical setting. Lesions with a diffuse pattern or a monotonous proliferation of large cells with round nuclei (centroblasts and immunoblasts) (",
"      <a class=\"graphic graphic_picture graphicRef58187 \" href=\"UTD.htm?42/36/43593\">",
"       picture 2",
"      </a>",
"      )and expression of bcl-2 (",
"      <a class=\"graphic graphic_picture graphicRef78894 \" href=\"UTD.htm?16/28/16841\">",
"       picture 3",
"      </a>",
"      )and Mum1 are classified as PCLBCL, leg type regardless of their anatomic location. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Pathologic features'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Diagnosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H12556659\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The staging evaluation confirms the diagnosis by excluding involvement of other sites, and provides information to guide treatment. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/6/15464?source=see_link&amp;anchor=H18#H18\">",
"       \"Primary cutaneous follicle center lymphoma\", section on 'Staging'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      PCLBCL, leg type is a rare disorder; accordingly, large trials are lacking. The published data regarding treatment consist entirely of retrospective reviews and anecdotal reports.",
"     </li>",
"     <li>",
"      We treat patients with PCLBCL, leg type in a similar fashion to patients with limited stage systemic diffuse large B cell lymphoma (DLBCL). For patients with PCLBCL, leg type, we suggest treatment with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"       rituximab",
"      </a>",
"      plus an anthracycline-based combination chemotherapy regimen (eg, R-CHOP (",
"      <a class=\"graphic graphic_table graphicRef63586 \" href=\"UTD.htm?22/2/22574\">",
"       table 1",
"      </a>",
"      )) followed by involved field radiation therapy rather than any of these modalities alone (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). Given the aggressive nature of this disease, neither surgical excision nor observation is appropriate treatment modalities. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      More than half of patients will relapse and extracutaneous relapses are not uncommon. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/25/33178?source=see_link\">",
"       \"Treatment of relapsed or refractory diffuse large B cell lymphoma\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26391/abstract/1\">",
"      Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997; 90:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26391/abstract/2\">",
"      Burg G, Kerl H, Przybilla B, Braun-Falco O. Some statistical data, diagnosis, and staging of cutaneous B-cell lymphomas. J Dermatol Surg Oncol 1984; 10:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26391/abstract/3\">",
"      Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105:3768.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26391/abstract/4\">",
"      Dores GM, Anderson WF, Devesa SS. Cutaneous lymphomas reported to the National Cancer Institute's surveillance, epidemiology, and end results program: applying the new WHO-European Organisation for Research and Treatment of Cancer classification system. J Clin Oncol 2005; 23:7246.",
"     </a>",
"    </li>",
"    <li>",
"     World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, Swerdlow SH, Campo E, Harris NL, et al. (Eds), IARC Press, Lyon 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26391/abstract/6\">",
"      Bradford PT, Devesa SS, Anderson WF, Toro JR. Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood 2009; 113:5064.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26391/abstract/7\">",
"      Grange F, Beylot-Barry M, Courville P, et al. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases. Arch Dermatol 2007; 143:1144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26391/abstract/8\">",
"      Paulli M, Viglio A, Vivenza D, et al. Primary cutaneous large B-cell lymphoma of the leg: histogenetic analysis of a controversial clinicopathologic entity. Hum Pathol 2002; 33:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26391/abstract/9\">",
"      Senff NJ, Hoefnagel JJ, Jansen PM, et al. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers. J Clin Oncol 2007; 25:1581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26391/abstract/10\">",
"      Vermeer MH, Geelen FA, van Haselen CW, et al. Primary cutaneous large B-cell lymphomas of the legs. A distinct type of cutaneous B-cell lymphoma with an intermediate prognosis. Dutch Cutaneous Lymphoma Working Group. Arch Dermatol 1996; 132:1304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26391/abstract/11\">",
"      Hallermann C, Kaune KM, Gesk S, et al. Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6, and MALT1 gene loci in primary cutaneous B-cell lymphomas. J Invest Dermatol 2004; 123:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26391/abstract/12\">",
"      Dijkman R, Tensen CP, Jordanova ES, et al. Array-based comparative genomic hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma. J Clin Oncol 2006; 24:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26391/abstract/13\">",
"      Senff NJ, Zoutman WH, Vermeer MH, et al. Fine-mapping chromosomal loss at 9p21: correlation with prognosis in primary cutaneous diffuse large B-cell lymphoma, leg type. J Invest Dermatol 2009; 129:1149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26391/abstract/14\">",
"      Hoefnagel JJ, Dijkman R, Basso K, et al. Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling. Blood 2005; 105:3671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26391/abstract/15\">",
"      Grange F, Hedelin G, Joly P, et al. Prognostic factors in primary cutaneous lymphomas other than mycosis fungoides and the S&eacute;zary syndrome. The French Study Group on Cutaneous Lymphomas. Blood 1999; 93:3637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26391/abstract/16\">",
"      Koens L, Vermeer MH, Willemze R, Jansen PM. IgM expression on paraffin sections distinguishes primary cutaneous large B-cell lymphoma, leg type from primary cutaneous follicle center lymphoma. Am J Surg Pathol 2010; 34:1043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26391/abstract/17\">",
"      Grange F, Petrella T, Beylot-Barry M, et al. Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas. Blood 2004; 103:3662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26391/abstract/18\">",
"      Hallermann C, Niermann C, Fischer RJ, Schulze HJ. New prognostic relevant factors in primary cutaneous diffuse large B-cell lymphomas. J Am Acad Dermatol 2007; 56:588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26391/abstract/19\">",
"      Geelen FA, Vermeer MH, Meijer CJ, et al. bcl-2 protein expression in primary cutaneous large B-cell lymphoma is site-related. J Clin Oncol 1998; 16:2080.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26391/abstract/20\">",
"      Sterry W, Kr&uuml;ger GR, Steigleder GK. Skin involvement of malignant B-cell lymphomas. J Dermatol Surg Oncol 1984; 10:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26391/abstract/21\">",
"      Muniesa C, Pujol RM, Estrach MT, et al. Primary cutaneous diffuse large B-cell lymphoma, leg type and secondary cutaneous involvement by testicular B-cell lymphoma share identical clinicopathological and immunophenotypical features. J Am Acad Dermatol 2012; 66:650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26391/abstract/22\">",
"      Fink-Puches R, Zenahlik P, B&auml;ck B, et al. Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a large group of patients. Blood 2002; 99:800.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26391/abstract/23\">",
"      Pandolfino TL, Siegel RS, Kuzel TM, et al. Primary cutaneous B-cell lymphoma: review and current concepts. J Clin Oncol 2000; 18:2152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26391/abstract/24\">",
"      Rijlaarsdam JU, Toonstra J, Meijer OW, et al. Treatment of primary cutaneous B-cell lymphomas of follicle center cell origin: a clinical follow-up study of 55 patients treated with radiotherapy or polychemotherapy. J Clin Oncol 1996; 14:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26391/abstract/25\">",
"      Senff NJ, Noordijk EM, Kim YH, et al. European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas. Blood 2008; 112:1600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26391/abstract/26\">",
"      Kodama K, Massone C, Chott A, et al. Primary cutaneous large B-cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients. Blood 2005; 106:2491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26391/abstract/27\">",
"      Senff NJ, Willemze R. The applicability and prognostic value of the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and S&eacute;zary syndrome: results on a large cohort of primary cutaneous B-cell lymphomas and comparison with the system used by the Dutch Cutaneous Lymphoma Group. Br J Dermatol 2007; 157:1205.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4715 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-199.231.185.123-23AA9155C3-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_49_26391=[""].join("\n");
var outline_f25_49_26391=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PATHOLOGIC FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Morphology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Immunophenotype",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12556659\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Systemic lymphoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Primary cutaneous follicle center lymphoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Primary cutaneous marginal zone lymphoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Cutaneous T cell lymphoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Intravascular lymphoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1793124\">",
"      Iatrogenic immunodeficiency-associated lymphoproliferative disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      STAGING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      ASSESSING DISEASE RESPONSE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      TREATMENT AT RELAPSE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21004635\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/4715\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/4715|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?41/35/42545\" title=\"picture 1A\">",
"      PCLBCL-LT clinical presentation I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?41/16/42242\" title=\"picture 1B\">",
"      PCLBCL-LT clinical presentation II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/36/43593\" title=\"picture 2\">",
"      PCLBCL-LT histology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?16/28/16841\" title=\"picture 3\">",
"      PCLBCL- LT Bcl-2 staining",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/4715|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?22/2/22574\" title=\"table 1\">",
"      R-CHOP21 regimen for non-Hodgkin lymphoma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/32/4618?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of mycosis fungoides",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/45/24282?source=related_link\">",
"      Epidemiology, clinical manifestations, pathologic features, and diagnosis of diffuse large B cell lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/45/26330?source=related_link\">",
"      Initial treatment of advanced stage diffuse large B cell lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/12/13511?source=related_link\">",
"      Intravascular large cell lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/6/15464?source=related_link\">",
"      Primary cutaneous follicle center lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/9/26776?source=related_link\">",
"      Primary cutaneous marginal zone lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/17/21785?source=related_link\">",
"      Radiation-related risks of imaging studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/25/33178?source=related_link\">",
"      Treatment of relapsed or refractory diffuse large B cell lymphoma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f25_49_26392="Connected Roux-en-O misconstruction";
var content_f25_49_26392=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F57903&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F57903&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Connected Roux-en-O misconstruction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 443px; height: 653px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAKNAbsDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD3n4ofEDSvhxoFvq+uW99PbTXS2irZojOHZHYEhmUYwh7+leYf8NV+B/8AoFeJP/AeD/49R+2t/wAks0r/ALDUX/oievKfgN8HvC3jr4f6p4h8TajqtmbK8lhY2ssaRrEkUbliGjY5+du/QDigD1b/AIar8D/9ArxJ/wCA8H/x6j/hqvwP/wBArxJ/4Dwf/Hq4r4XfBz4W/EnTLy80HUfGEItJhDLDdy2ySDK5VsLGw2nnHP8ACeK+X6APtX/hqvwP/wBArxJ/4Dwf/HqP+Gq/A/8A0CvEn/gPB/8AHq+KqKAPtX/hqvwP/wBArxJ/4Dwf/HqP+Gq/A/8A0CvEn/gPB/8AHq+KqKAPtX/hqvwP/wBArxJ/4Dwf/HqP+Gq/A/8A0CvEn/gPB/8AHq+KqKAPtX/hqvwP/wBArxJ/4Dwf/HqP+Gq/A/8A0CvEn/gPB/8AHq+KqKAPtX/hqvwP/wBArxJ/4Dwf/HqP+Gq/A/8A0CvEn/gPB/8AHq+MrW0mucmIDavVmYACnx2MjuF3xgnOMt1oA+yv+Gq/A/8A0CvEn/gPB/8AHqP+Gq/A/wD0CvEn/gPB/wDHq+OTpVyE3N5a5OFBcAt7j2qs9tMmcoePTmgD7P8A+Gq/A/8A0CvEn/gPB/8AHqv6H+0n4X13U4dO0nQvE91ezZ8uFILcM+ATgZm5PHTqegr4brc8D6x/wj/jHRdXy+LK8inITqQrAkfQ4xQB9p2n7QGj3mqy6ZaeEPGs+oxY8y1j0+NpUz6qJcjr36Vk3P7Ungy1uZYJ9I8SLLExR18iA4IODyJq6b9ovx8vgr4dTvY3AXVdTBtrIo3zAEfPIP8AdU8EdCy18Ak5JJ6mgD7U/wCGq/A//QK8Sf8AgPB/8eo/4ar8D/8AQK8Sf+A8H/x6viqigD7V/wCGq/A//QK8Sf8AgPB/8eo/4ar8D/8AQK8Sf+A8H/x6viqigD7V/wCGq/A//QK8Sf8AgPB/8eo/4ar8D/8AQK8Sf+A8H/x6viqigD7V/wCGq/A//QK8Sf8AgPB/8eo/4ar8D/8AQK8Sf+A8H/x6viqigD7V/wCGq/A//QK8Sf8AgPB/8eo/4ar8D/8AQK8Sf+A8H/x6viqigD7V/wCGq/A//QK8Sf8AgPB/8eo/4ar8D/8AQK8Sf+A8H/x6viqigD7V/wCGq/A//QK8Sf8AgPB/8eo/4ar8D/8AQK8Sf+A8H/x6viqigD7l8PftK+Dte1/TNIs9N8QJc6hdRWkTSwQhA8jhQWIlJxkjOAa7P4ofFDR/hzNo8Or2Oq3kuqtIlumnwpIxZNgIIZ15PmLjGe9fCXwn/wCSp+Df+w1Zf+j0r7k8fPFF8RfC08kUTSRaZqTQyOgYxP5tkNy+jbSwyOzGgCxcfEWa3iWS48GeJowyCTDvYhgCM8r9pyD7EAj0qmfivCE3Hwn4j24zndY//JNcJqc0SeDofEGva/4qkGoazc6VBZ6XHY4BF1NHEo82LONsQyS55NV5NKsr/wAFeNb/AEvXvF1rqXhuG48601COw+WeKJnAJiiZWXj+FvyoA7mX4z2ERAfwv4kBPT/jzP8A7cVW/wCF6aTnH/CNeJf++bT/AOSK8w1lmCO42jaAcnjn09qqWtqpt4yflK8ZJ5JP8qAPXl+N+mMCV8MeJTxn7tp/8kVch+LttNGrxeFPEbKe+6y/+Sa8k021a6LqQRGgzx1PP/1q6CC38l42jDANjI9eKAPQ0+KAdSy+EPEhAGc7rH/5Jq8PHV4duPBXiTDDIPm2H/yVXFRsfLIjwB1wRjNdXoV01zaxwtkyRYBJP8PagC0PHV4SQPBXiQkekth/8lVBN8RZoB+98G+JB1/5aWB6f9vNaUkTKG4+7zn1+tZk0PmyBig3AEZI7UAV5/iksBiEvg7xOplOFH+hcnGcf8fPHHrTJvivFDvMvhLxKoQZYlrLAHrn7TVDUESV47dk3uh81cdRgZzjuO340mqwpNoswVwpKFWK9TmgCez+Mllearc6bb+FfErXltzKjfY1C+nzG4CnOeMHmtk+P7nIH/CF+JM4z/rbD/5Kr5UubvUvDV097ZSl7ZXZXik5CAnsfrXpnw/8cM0fk6wBFDckCCZX3CNicFW74JxyOlAHsCePbpwCvgvxJg9My2A/9uqmfxpqKR7z4F8TsME/I9gxOBk4Ausn+vas60feNsgxg7dpOf1rotLu3VN3VB1weBQB5LcftSeDLaeSC40bxRFNExR43tYVZGBwQQZuCD2qP/hqvwP/ANArxJ/4Dwf/AB6tP44fBe2+IdlNq2mC2s/E8Wdkijal0gHypL/tej9uhyMY+I9W0280jUrnT9TtpbW9tnMcsMowyMOxoA+6fAX7QHhXxv4ssfD2lWGtw3t55nlvcwxLGNkbOclZCeinsea9fr4A/Zc/5Lt4Z/7ev/SWWvv+gDwD9tb/AJJZpX/Yai/9ET1x/wABNB1nxR+zf4n0Pw7cWlrd3+sPBJNcsyqsJht/MxtUkkrkY9zzXYftrf8AJLNK/wCw1F/6Inr4qoA+/wDwJ8MtQ8D/ABCl1LStUW78P3emRWd1FdbEnEsICxMqxRqhUIAvPPJJzXwBRRQAUUUUAFFFWrWzedgGZIlIzukOAfp60AVant7aac/u0JXoWPAH1NacVnDCOY5Hk7M68H6L/jW/pfh/UtSjVkykJ58x+EHYkCgDno9LijYedL53tCeB+J6/hX2J+xuqp8NdXWNdqjWZMD/t3t68KtPDGm2Etu1+J726eVYEitoHkDO33QFQEkk8Y9xX0x+zvp0+neGtcWfTLvTY5dVMkMN1ayW7FfstupIVwDjcrDOMZBoA+fPj/o0t58ZPFV4s9pFEstsjee2AMWkByR1I5HTpXIaRpelFt9/dowQEghCVbHfP8Q/wrqv2mtJ8TRfFDxNqdvpWqLoW63f7cto/kZ+zwof3uNv3ht69eKTwJ4ai1fwZol+8YmuZJJVdpDhXwxATI6cdj1oAwIT4SvAkaalCkw65Uxqw7feHH0q6/gUXlrHcpIqWjZIkjX5T9DXK+P8AwTeaXr9yuk6VqTaeoUhzAxQMRkhT3UVjWKeKmslt7BdaNoeRHCJdn5DigDprXwC2p6x9lutV06xDnalxPMAc9t4/r2rG8QfD/wAQ6HqL2xtkvgpG2406UXEb+hDL/UA1NbL4r0Z0N/o91c20W3dDeWrOu09BnGRn2NeveHZ/Ds1pbXkmmXunSzxbjBFCRufn5Fb1JHy+vfFAHmHxP1vxL4tk0mXVNNv4rXTLCCwj3wuAWRAHc8Y3M2T64wO1cItldO21bact6CMk19D6MP7Q0y81Bra70mSO7MJs3kfeoHI3A4ye5rlPGmseI9FaS9tZ55LTIWRmONjHpnHY/wD1qAPJv7OvPMCG1mDnoGQg1GbS4AJMEmB/smu70DxWuq33ka0LGPchCyzLtQn0Zuoz69K2bvTdGhuUgv7S50m4eNWhdW8yKUH+JWHBHvQB5KylThgQfQ0leoyeEVnYtBOtxEOVBUOAPTPb8a5vVdAMDtHc2jW8gP3ojkY9wfX60AclRWzfaMIoo5LW5SUt1iYbXU/yP51kyxvDIUlRkcdVYYIoAZS4OM44qewtJ7++t7Oziaa5nkWKKNBlnYnAAHqTX3VoPwX8I6T8KItG8WWdrK0ETXl7fkhHik25dlk6hVCgehCgkdaAPg2irusrYpq14uktM+nrK4t2nx5jR5O0tjjOMZ96pUAFFFFABRRRQB1fwn/5Kn4N/wCw1Zf+j0r7R+L0oi8b+FGP/QP1EZ/7aWdfF3wn/wCSp+Df+wzZf+j0r7E+OUixeMPCLOcD7HqHP/bS0oAyx4OvvHPwc0ey0xdPd7bxJd30kV87LFLGl9c7kJCP13Y5XGM1dm8F3/hbwB8V727GnWNpqmmXElto+mOz2tmEtpFJUlE5cnJwqjjv28o1rR9Hlv5ZpNKsHlYszubdCWY8kk45PPU1UTQNGVCf7I07HQk2yHn0HFAG/qWJbWRxk5kz65xWrpVmZgHKkDuAfQD5f8axpW3W205+8CQB15rp9AcfZdmTlCc8knntmgCZYPs9yWZd0bZVgFzgY46VoaGFu2dsMskJ29vlbHWnTsUQt7fd6ZqjZTeS0UkG3cwIcMBgnOeR+NAHT28L72aTawXqRjn8O1TecdPuI7iArxkFQp5H+FN025+0IxCsrD+HGce/0qzIEkljDMFkxySMA+1AGjb6/p96uDKIpeP3b55qo96C5BIYZPAGAPxqnPbQtAcLv+bhQACGrJuU8hgCxQH5ipPI+n+e9AG1MYbjLloRJtK4YcAe47jIqnqMLzWLJBcxrcKAU5wmR0De319appcbF+R1wOvHHvVS6uvNjaJhypyu5eo7fl3oA89isvPu9Vt5LSN5vMKuHXJR/Uduf5Vk2mjiK6ktR3OOBwR3+ldZru6HU11FFkiiuVRZCOQ2BjJHbpj8qsz6VLEYL22AdkG7aV4dc880Adz4VkuJ9PgbVY47bYApkL/K8fTcVJyDjHB69q+cvEPxy8Vx+I7h9Gv2trW2nmW3SSJT8pO351IxwAMA8g969o1uOLxnYLphmnsB5nmXKNHkSLtIAUg8EE5B6HvXnHxh+Fizwwat4YuLnUb0Qg6hHLhpJMcCUFQATgYZR6A0Ae1fAr4qxeOvDzi9Ea69ZqpuoYhtWRScCVR256gdD9azf2h/hJF4/wBIfW9CgCeJrOP5dvyi9Qf8sz/tD+E/geMEec/staZPotzqNzc27LJqw+zWU6qWz5LbpUPYZyvXrjjvX07pGoBlEbkZoA+Hf2YY3i+PXhyOVGSRDdKysMFSLabII7GvvyvFdc+HVno/7QPhDxppW2FNSuLm3vYBwDObOdhIv+8Ebd7jPUmvaqAPAP21v+SWaV/2Gov/AERPXxVX2r+2t/ySzSv+w1F/6Inr4sCkgkA4HX2oAbRRVm1tHnIJOyPux/oO9AFarsGnzSFS6mJG6FhyfoO9a9jpimX9xyykcyL8309B+tdrpPgi6mXz7qT7JEDkpncz9+M9ePXFAHFWmkkShLeMtOMEbhlm+g6YrrtE8DXV4Vl1ErbocZzyxXuP9kj0NdJ9p03wxYuzRxFVXcQ6E554O7qCfQVztj401jVb29j0SLzFhgaUIQPMk6DnPUDP1xQB2Fp4d0XRlxGAXX/lrcDcyEdwD1FZWreLNLtC32dHvH3AnkIg7Ae/Nc3r/gf4mpCbzUdG1ZobgA5hIkBHUDCE4FcPcaFq9vdi1n0u/juT0ie3cOfwxmgD0LVvFd9qVtLCLaG1gxwVYl4yO4x3HUelfWHwE+Ig8ceF/s+oyp/wkGnBYrtQR++XHyzD2YdfQ54AIr4x8QTrpksCSwmC4+zxG4t2PzK+MEc/TOO2az9F8Zap4f1OS+0GeSxuZIHtnkjOGaNuCP8AA9jg9VBAB9geNtdbxX4kRLd/+JBpcrCGTG5Lm7XhpPQqhyi9i+8/wqa56Kzigt7rydkREv2lzGR94nlumP0614TpHxf1W1gSyltraPT1QRrHAu0ooxhevKgDoefepfEPxZvLyGMWjSFixMiOiooA6Yxyfx6UAe/+fFfW+5ZFkuhGXVRIcMfTvyeM1zPiCzuzd2VrYfaYraeFlumgP+jJIOVRmHzLg5PArw7TPiXqdjepMsMZjBJZFYjP417DoXj/AEPW4rbzplt7pujA4XceNrDqrf7XSgBNPvtdm+w/Y7mzvnLs0Dws+DGowySFvvHP8Q9K697yeSGGFoyLuZT+8VRtib+8fUdsj+dc9czLodhNfoPslo67maQB8YOSFYcHIxyKtWOuWXiDRhd2kzmEsGjGTvDdiT9e1AFnUVnm0+wgn+a6Lk4U/Lgev19a5H4r6ZqJ8CXQ0qyDwNIv2hFO75QchgOuQf61s63qlzHNarMcXDY2CLheR2/Lt+tdCb+WLT45ihtmaElQgDEerA/xfUUAfI2haLf67qKWOl27z3DdhwFHqT2Fetaf4RuLLSl0vXbtb9bZjJFHBKdqsQf3KuegJ5JHANepXNxb6fpFxeRw28Ea23mPPDHycgnacY5/Xmvl7WvE2o6nLMDcSR2zknylbAx70AdlazTpeqLnT4dJsgCoa1uxujYdC+WO734qeHXIp714NV8rYDxPtIWQ++efxryurtlqDwzRmctNCp5Rj29qAPX9U8PR6paGSCEpIo+WEAF2OeoPQiuA1OzeBZlvY2bZywIyQB6Z7/pXQeGvGMtpCFkjE+mkgdfng9vXFdd4mhsNW8KXd7aCOWB4H8ucnLlyOpx0HI60AeyfDD9n2w8D/EKbXXv/AO0bKCP/AIl8UqYkikOQWfHB2joR3OcDaK539r/4i/2fpkXgzSpsXV2BNfsp+5F1WPPqx5PsB1DV7X4l+IHhvwzaQS6zqMcNxMgeOzjBluHyMjEa5b8cY96+Rvjf4x0bxxrX2rTfDI02cnMt3cMfOulAwN6L8qkcfNktgYyBQB4hSVsXOk7j/o52SH/llIcZPop71lSI8bskilXXgqRgigBlFFFABRRRQB1fwn/5Kn4N/wCw1Zf+j0r62/aLJXxH4TK5z9k1DGOv37Svkn4T/wDJU/Bv/Yasv/R6V9cftEAt4i8KhW2k2Woc/wDbS0oA8ihuWeaY5DDv+XBrVij+RdxBXupIyDj0rEsN8erXeV3AEYx3HNa1zOwJ4LN3+XOM9OaAJriRFjKybgMYOR1/zin2GtralZnVgGHzR5OfbNZmfPnWPABLAYB4rpbLTowhmnRfNGdjkZ/z/wDWoA1rO/S+idjJlSdpAUknHfp0qSNFhUPEJFcnhX6fn6YzWh4etrfZFF5WyRvmPzcOOOfcV1S2UbKM4CgYxjIAoAxbGWSII3AOenoP/wBVdKbmOaFW8sAuPl29alsNOgLEshOcgbeP/wBVWLq2VWATG3kgEf5xQBk3EYaEkxmIj3BFZV1GHOwSoo68jPP+e9XvGF82naI8tiiyalM621pCV4knc7Uz7AnJPZQayh8O5dMsIE8O6zcxTxoFmjvi1xDctj5mOTuRicn5GCgn7prx8yz3CZZUhTxLtzX6Xtbq+ppClKabRAyyIkilsAsRtz/L1FV3ijcM8sqrKBtV41Jwcdeaz9ZvrrRbab+2tH1CC+x5dv8AZz9ogupDwiJKB8pYkABwpqx4dt78G50nW50bWrDb55T5VnRuUlUf3SMgj+8rCu2jj8NXcVSqKXMm1Z30Vr/miXFrdGfLH/pdysmzayoQCMlOvT0J/So9Gv7iylWCKUyQhiCs65IA9+7d6o6tLeWOszRXYaKSRlEEjDCNg8HP5j2rF1DxJJDc2lpIqqYZCrOCQcHI/A811knpFuvmXP2m1C+YPkM275CfT/e9qy/CI8rxh4usvPYulysqIGwwyAx/U/SrGh6lYNo9qYvnEXDfOBgjjkevXJNcPomsGP4uyTwsolv/ADISxGc5wVGPwoA9O8UaUl/4Wu0EKXUlu0d1DCwBRpI2DL9MjKEjoHJHOKq6X4kgXW7H+xNZuZdHnCGT7cTPtZx+7RXbDruJKh2Z13I0Yw2BVx3vZQ4knJjP8KptyfT25rNl0MXun+XsS3mh3ojPGHVlf7yunRkYDDJ345BCsODFYWpOrGvSk0430vpL19NbPo312KjJWszvtZuxca54EAbcBrMnP/cOvK7yvCPCMutDxN4UtdbgaKODW5VtTJMJZGT+z7vO5h94AkhXbDsuCwDZJ93rthLmipWtck8Q/a20bUPEPgXQdK0a1ku9QudbiWKGMcsfs9wT+GATnsBXE6Z+z9d6f8EfENrqkUEniid1voFhO8x+Up2x56FmDSDg4yV64zXVftmzS2/wz0aa3do5o9bhZHQ4KsIZ8EGvPfhV+0D4h0hYrDxfbya5ZIozcRH/AEuFf9rOBL2/2uuW7VQHz1YWIlBd2QkcbScAfU11em6DPeBWaMmJjw7jBBA42sOGFdT4is/DcnjjV7jQ5xe6VcSC8tIYhtYCTJMbqQCgRwwKkZwVPcGu58HeEdV1eX/R7KO5KLu8pMxRj0Gew/X1oA4Nxp/hG1try+mSSRgfLQrmb3CjsO2TxXQaEl/8QND83wvPNpWoeYY2eYeYsmO24fc7c4rodS/Zj13Wrhr7UvFdimoznLQrbuyRj+4rZBIA46Cuxi+HOs+GR4fsdFaGDTNNkSS/milCy3hUchRj5VY5JBoA8usfhdqOn6deWvjm7jvGvCvlJDdMzW5yf3hJGMZI6Z9+tP8ADXw8t/CWryalDPcXEkMLKbaQL+8U/wAQYcY4r1jx3Dd6lYm1VjC7M024pggn3B+nTgY6V5DrnizWNB0+Sw1nTf8ASETyxerIRknpIVHt6UAfR9k0E2hperP5UZhBUocHB6Db+mPyrl9U1ux0u3vNZvrp2hhiKKZuoPQYYdPoa8S+HviHxRd2ZtWube6hQny5XXfIVAztUjqa1/Fema5qUTDUp2bCKyRquAF7Z9SPcUAbHhv4L6P8SLSfX9SvtTtLiaQtsjC5ZfbIIP4VcuP2U9IkXdZ+JdQiJH+rmtkdgSeM4Ix716X8Gr22fw19ghCI1v8ALIrHaVJHOAD831GK9CC7YEKvJH0ADycMM/3j3oA+bB+yzo7RCNfFF99pB2mQ2qbGb2G7P61jXX7LkiOyweJhk/6tZLM/NntkNg/hX1a/lyg+YpDY24YbWIHXFTAcZbIU9QpyG/CgD5Tsv2VmMwF94pEcYxv8uzyfoMt+tdXB+zL4RQrNba14hikVRtcPGMP652ete/yIrEqI9vTBQYIGe5/pVW6cwo4WKRBn5pAQoAA6sT2+lAHzX8a/hnDovg77XYXN88lgUWZ5JMC4U8EhRwGz1xxzXjng3xSdBaZWTfbMM+SpwYz/ALLd69h/aC+INj/YU3h3RdQjuL0zK1zJHKWZQDwob9QBXzzbSSX4kgMQmbI8sohU7j15HQH3oA9h8H+JG8T65qF7JZuttZQbY7dhuI3cM2fX0rrtLhtbbUDAyYLR+ZCSxIAU9ME9TnJA6cV4Zp7674H1K31BY4FSZM48zMciZ5RvcenUV6PZ/E3QpLaP7RZ3lq8ecRuwkO4jnDf3frzQBueMEmu9I1TSrQSG5nVtskxCiUleCuO3YmvE4PhZ41uLeSaHw/dyIjBcKVLMf9lc5P1FdHrPjE6r4mtpzE8enxEKIS25gueTkdvpzX1Z4TB1G2sruOZZoVhXymjiCrjHOcdB7tQB8h2fwU8dXFv576OLeL1nmROewxnOa0IfgD48YH7RZWVoQCxWe7QED3wTX2i0A8wiKIySbSGxyCO/Ocf1/Cqv2GBgI/MjfOMAA4XHc54UDoM5NAHxDq/wn8Z6LqtvZQaa+oXcsfnAaaTcbB6PtHyn2Naml2nibSNIvb7UdCv7XRpC1vcWz27oPu8lQcFfdu3FfbGnxpYXbCGJY2blwMl2GOuMZ/PFZHjnT7vxJ4evtM0zUXsL67i8n7RGBK8Y/u4zhQe5znB4oA+XfCuraNcRSDSgI7iZsTCT755ydzHlv1qzq+i2l1Ezoihvuh8/6z8T/Suj8Yfs/XGkaDDe6RqZvNVtId10AuzzO5brwewHtk1wGieIJbW4Wx1wEMMKikb3A9z0wcdRQBzupaRJZs2IWCn5UXqR9GPasq6tRKNlxGZcDrnLp9CP616+8On3cTCVDL5ozvJ3IP8AdNcfqemBEZ7ck2wzmRcA/lQB5nd2LRAyQnzIf/HlHuO1Uq7z+z4VZHt4U84ceZIxO36KOM/WsnU9Mt7h9sJSG97qOEf/AOJP6H2oA5minyxvFI0cqlHU4KkYIplAHV/Cf/kqfg3/ALDVl/6PSvrv9oSSOPxL4UMrKq/YtQwW6Z32lfInwn/5Kn4N/wCw1Zf+j0r6z/aQj87xL4Oi4/eW1+OTj+O1J/lQB5BHJGNUYxspWZTghsZIPFbEZHlncC/Xnjn3/wDrVQ1eOKFrSSJVMccu3jB+9xzV63t7cqG4U5bjcRyP85oAfptsGvYc7QrNtA9M9fxrr/syxJGF3bh0LHkD+tcgl79ndWKo5U5+YYz9a6K21WO5uY2EaKJBkA/w0AbWjbmvIhCw8lDuLgdD6L/Wuyt2LAk5bkHB6fT61y+luVuZNu1jhW44+XoBXTRSNtVmAyW7f40AbNpIMKD2PXvnPNWp8bQVOWI9OuaxxOE8td+Rn8ce9WPtW4YUhVIyM9/rQBT1rTNO1ewFrqdrDcwFg2yQbtrDoQeoI7EYI9axo7bX9BYDRtQGpWS8fYNVlJkX2S4ALZ9pA/8AvCt8yp/d5PYnr6UqHAGCCTng81x43L8NjoezxMFJef6PdfIqM3HVMZ4X8SQa+LyIWt1ZX1k6x3VrcKMxMV3DDKSrAjkEHoRnGayfiJp7wraeJbOJpLnS8/aI0GWmtT/rFAHVlwHUeqkD71Y2m+G76zN2F8TaoFubp7qWO3jhiDu57tsL4Awo+bgKBVpfCWl3WRffbtSJGNt5fT3Ck+yuxX8hXxWF4PxGEx6xWGqKMYu6Wrduqe2/9M6ZYhSjyyRc1Kzttb8M3UUbRzQy25uIZM5CkDcrg+4x065r568WN9q1NniYkugZtvYgetez+Ptf0rwZ4RksLeW3hv7mMW1rZwADaDwW2j/VqF45/CvnqHU47nUXeSUbM87R1A46e9foJyGxNrcdvpmInKsR9xcqxOPX+tcvFf3NtqEVys+J43WUSoeQw71t3tt54kmhUrApwN3QE9vrWNJZRzR7rRlDrwQcjdQB7V4c+KenT25h1iJra9VGZZesbnHT1B712Gg301xaRSvH5kEp2x3I+6R/te49a+bdMs2SQPcqNgbgKeteteBPHtxoFtLZGCK6gb5o0lJGwjrjHTIoA9VNvFB4u8ElVPmNqsuXx1/4l93Xq9eK6V4gtNe8X+CXtY5YGXU5d0Mgzj/QLvkHuOa9qoA8O/a6hefwBoccRw7a1Hg4zj/R7jn8OteB+HNMjtbVLhRLJ837pDGMSv6/7ua+i/2nYopvCvh1Lh5kiOtKWMLbX4tbk4B/DFeI6cpMv2qWR0dCVjSRNhRR0GB39x1oASx0d9Q1TmA/2lKPMnZUDDaMcZUdsDrXufhBrXR7aG1t5JHjBDM8RKuWPcjqCOnORxWB+z+IY7LxDqTN9ou5HEUalfmXg5yPc4H4VJpNjLfX98bneMbisEch8/aeDtU8kj2oA9D1bXnSeNbEk7ZNkksjgKF2/eX0PY/jVrTpBdXXno84tWCkA7gAx46gkjPvXm8S69Y2jzahc2kukRp9nj/0UpPMegO4H5yOMnHrXaeANZTUA6m6IkTbvVowN4AxnIHOffsKAOZ+IGkX9lrAvYDc+Qc+UokH7snsTjof7vXFfKnxC1+61LXpTJvhMBMQz+8XPoD6V9YfHLWraw0WRmuNjnOCZGQqccADrn+Wa+NLOOW61hWWKeeSWUboQwJkOe7Dp9aAO1+H1nr0EYvNPdbJHPy73O2Qf7vf69q9d0PVrq7by9e8uy1ALuSYDasqnrhuSRjsRx7VhDUbHTIUttYhS3jQDlUw0Z9WYcEfzriPil4g0a8tbG2024FxOsv2jzUJG3Ixjg/pQB6zf+JtG8GXttq9rctPETsmtojsDIeAwLD7wP6V6R4b+KfhXUbf59VhiSTJxdEB1I5wR3z618NyXUzK7mRJFJwZA2/GfY9/apIbi1ki/wBIjYFAdkh+Vj9X9PagD7vuviT4V01QL7XdNWMZIVJCxA7Y45P8q4PxH+0L4Xsrljpn9oXx6B0QLGPwPOPevlWxlgj/AHsVkJZCpRAyqQM/xhex9Dz9Ks6VdJZ3Dteact8sqFQrHDKfUY9O470Aey6z+0TrMqONL05IY+GidTkp9V/iX05rhPFPxR8ea9ZyR3+rTw2cnyGOGPyw49GA5xVXTrC0GhatcXOnmC6hgSWCSQleGPDAds+1ZOk6Jqevpbw3CzpZ8t5qoWiz3I/xoA5skxTCSUozEfLn5x15HPB/pWxaaQZtHl1Npo44ITsdEmCSjPcA9R+prV0TwzZ3BldriGa2jJBKyhZWIPXB6DtW1pHijSdC0ue0g0GKe43swLNgA9Pn3DJP0wKAOU0jTL6/lRZLXUbuzPzAZL7P9rA6496oarp1xY3nk3Vu6s6iRPMQqGXs3Sui1/xhJe6bDYacrWxbLXCwjyoi393I5J988+lZNhF9tvA9/eCJUAE000j7guMAKh6//XoAxXiARwmAmMsCp3Ifb6+3Br1v4TfFeTwnax6PrJWXR2fcLiGLfLB65Bxx7c157c6pFabbeyt45bdE2OSOX55yfTpxVKIxy7VhC2rE4I8z5ZPqT0oA+7PDWs6ZrujR32l3gvbE5ZSMZOO5BOVA7HqKs2V09/DI627wwj7suAzT+g45B98c9q+FdL1C80i7861Jt5Ad7BHYg4P8YGd3+eK+jvA/jHxfrenQT6jaxXFtMPlaAGJmB/2RgLn1OfagD2hIA+8OyMmQz5LbR6MzdWPoKlmuAV2W6hFYYEYIXPbOR2/GuNTXY7OKKOHT5rSGMnessu5Fb3weSfQ5+lb1vqtnOHhtbtbncBuRNzDJHYY3MfyAoAnvbaKa1aGaOPYw2sMkKe/J7H25NeWfFTwDa+IbWa70u1Ed1arsjmiQojgD7mOpx07V6yybRuWMxDP3wEaVh7KM4/HmuM8deILew028DTrvClAHk8x2PfHoaAPlTw7Nd2V3Lp07sMtjCEARt35PAx0NbsF+kk7wzoi3IPODtSXjqrHoaIbNIb26u5PIjnvGB2S4OwZ6AfeqnDqqXF1cWcqwRvnYjzN8zfQckH2oAW8sVYZUMZMYZUU7Sf7oJ71iz2RkUCU+XH0VnbkH0c/1xXc6bJHGMX1w08TALIVXJPuPVunuar6ro8k12dsJE4XKyylT5ydsqPuntmgDzrUbSCZBBfK8M8fCT4JJz0BHcfrXN6hYXGnzCO5QqSMqezD1Br0i9sEvYwtxKsc0RKxBOo9VJ/rWS1oJY5LO6gbys4JbAZD6qcnHv60AZvwm/wCSp+Df+w1Zf+j0r6z/AGj5kh8TeDvMUsr22oJ9Pmtef0r5a+H2mzaX8X/B0E2GB1myZJF5Dr56YIr6k/aShM3iDwkB1W2vmHf/AJaWg/rmgDxrWprd4SiBFYsGA6EYNWCqlBNHkgsenAJrf/sS3e0EWY2dedzLg7v71Z2p2BgjUY25bH+97+lAFOf93tCzsC3zYatGzMwMYRxJtGQx42nrXPmNrufOAwHA/lWxol3HJqi2yxs6RriV8DZ6cH1oA9Q0AxpaLJJjccbWHG4kdfpXTR58oAjke/B9fwrDtUj2qgO4twM8rj2rXtHcW2GP3GKq3XIoAlaRo3Dlsgk54zgVn+IPEmnaGtu19JIpmZgqxRNI2FGXYgDIVV5ZuwqS8mnWzufsYjkn2N5KynCl8cAnqBnGT2ridH1E6tFHpXicbb4TAxXEY+zvHOBu2jlvLlUcqQSrp8w3KWAyq1OS0U9Xtfa40j0C0nW5WN4WV43+ZXVtysPUGrUshLHnAHpXn+mrregasulWdrFOlwG+zIB5cTH/AJ6Jz8mCR5kI+6DvjyvA6vTdSOoaZbXDRGGVhtkiPJjkUlXT3KsGBPtWdHFQqydPaa3XVf8AA7Mbi1qW2UqpJPPZup/KuX8b6+lpaPpttcSpK4P2mWEZMaDqoYdGJIziupgQsWYMAuScueB7/wA68t8bwRPLeSwytHNFOzBc7fMikXeox+f5iukk8b8TXO+6dRgPGQMHk4z1Ldz71naeVgmBlICPgZIq/eW7MtwpQExkLvx39qyGjLMQoIZBu60AdzJZsLRbNS8AdfM/e/3Tx0/qKyRbiCVLdi0U23DZ7n1/GtDT9dS4n2XEBfzoo0SQnmNl7D29RUVzMl1aeRMf9MtidkndloA1X0C/1Pw9Y6jokEt1eyEpcQRLuxg4U4HTsK63wB8NdauC58SRSaR5ZwRMuWkPsAegrzvw9q2uWlzPp+lXctt5oI2IduS/GQ3bJxz0r6l8GaNf6P4ZsLLWpRLqcaA3DL8yh8Y2g98AYLdzmgDlNB8Jz+H/AIkeDJluI57Nr6ZFYMd2TY3R+6enQ177XmN62fGHgj0Gqy4/8F93Xp1AHj/7TMccvhfw4k3l+WdaXd5gyuPstz1FeE3LQTW7wqCqBRI3ksx2L/CBnIPHOOte8ftLCM+GfDgmcJH/AGyCSRn/AJdLnj+leGwtCdHubpgUkmyztG2DsHABHc0Ael/szyaK+k6lDPf28l9HKwMTSlW2HpkHH9a9DutHtH1c3+m6nCJE3HYreYenHPVa+MNa/tDT7iHUIDcxCRQrvCDjcBwSV6ZHOKt6L421jTrlbiLU7qKZeUmSQh/x9j75oA+qdXi1mK2b/SILy1Z8mLzAGDDsuBlSec9q881bUJfC+pNfQKk0c3+sWUvGD9PQ+9cVJ8Z9dMaLfwRzSD7zlVDvjoDjggcVzureNdb8QNIJUIilYB8BWGT3JPyr6Z4AoA2viJ40/wCEjt0glZ0t1X5bdzvCAdWBPJP41zvwba3l8ayuPOMqQO0QiHzA9ztP3sDNei+HPgF4s161jlvdQ0vSNOnAfKlbqYg9CNnyEY9GH9a4vxh4FTQfHsmmeB7i81e90WJZL+6ndFUSn+BF9BxkZPO4dqAPTA6XEc0d5ah7YA+W7w4Z1PVhxyOvHWvnPVIrOK/vIrcBUErKij52AzwMEdcV2OrfEDW7uzmsZoksmJxNJGmH44wFJwP/ANVdv8PNA0x9GjuIPL1Bpl/eElXZV75wCV9yRQB4xBa280YaOY+cow0bo2Px4yPbFIYGRVcIxRj8pdd0Zx3x1rc8a6ZDD4ru10GTdajBHlkGNT3GewHpVNrXy4opNSj2eSpYhG3O69gWHB7YzQBRkijSNZW3BpBx5ilS2OpUdh7nmtfTtOtbnT72a51GxCWkKyLFMXV5R6Lnqw9+Kq/NdSedebZI5SvmeZIR5Sf7nOMfiPauu1O28K2d3cx6ZdanHCLTfHI6LKk83dc4H9BigCHW74SeDNLtLOQ3E95mW7ljYM4ROFXYT8oUenHtU+jeF9RutDbVYWUaPApxErEqQPvFsHhc1xc5mSNPPhSDc2JOxAxwM9cfhmu48JeJrSO3g0zWMzaZDuM0cbrE5OQQvuD/ALVAFq+1rS7XSUuE0u0vXnGd0Y8tAegKjHJrzmb7Vq95JsgLSn5xAqFgQO5A9PU12Xi/SAmpibUYrnN0pktrQuoUHjapdenHXFcei31reGW2ZY7hScpFkFVIwVwR+GWoAbarbyW3lebFBciQrukYiMg/wjAx19K0LTR57qQW1ha3N5fDIZICGjT/AGhnmtz4aWEninxRDpmoStbgRbGYw8Ig/wBkYP1wOa+p/DXhvTtBgW10qKCItyLmFAzEAdQcAKfqMjpQB8nX3g/xZZxW6XtlKsc77EVVQIrHpuLHvVzX/hZ4k0Owtr/UFgNvKVV1hzKy56ZVR+uMZr6G8aKseoaebiS7aT7UrlIwJpxgd2cBF+pzXTTW8GoW5jt4JG3rh5SwV1PqXxjPsv6UAeNaL8FdPk8NW0p1i507UZRu3Rhn3E9Ayn5vwAo8L22sfD7Wf7E8SxpLZ3Tbba6kcsH9m5wPYE/WvV/CLz263FjPdiCWFyHe2RvnHqWb5uR6Vs3lrZanZyWbWv2zeu5pHUcJ0DdePYZB70AVNMt45IFmnKRxyHKyPANwHQDyxnPT6+lR6tp+mwJvixYTgHaYpSsmeuW/+JA+tc1c6heeE7o2v2WS5tbhC0L+cUdQP4mI6D8cmuE1+LxNrmopLNrDaZpwBxb2TASP/tBjz+JxQB0fizx1rGgajJp6rLfOw3ecoAUqRxuJwAee1eO+IPEuq6xMslwxVsHAiUt0PQYGMCvRINGs7OEqJHuQPmNzNulJJ65PQH8q53xHpUi23nm2ljhPUzP5a56jIA+6e2D9aAOW0NGuXnuJizuMhUQMze5JHpVC9t1fxFhVMLbSS2MN+Z6fzqx9vu1fBkkjiU/MISoXjp35/Os2Jxa6j9vu5JTNIdyiLLsPTJPA+lAF+TU59I1SKS4ZpbSUDBmI2p7KAOn0r0C3hS9sYyLndG/KCKLaqt1ySf0rzvU5Y9U01pQyW8yKXjluDvkOOuAOBn2rW+G+pPNGdNubh+RujM1xtQD6Dk/QUAa+oqGR2niC3Ef7uRpgG5/vDFYF7Zi8RmmDGROOW2hvfHeuovraOK5W5EhCY8uT90cD/D0rMa3aOViHkKdUfYPmH496AM/wM1vJ418KRuGdodbsWgOABGTcxhvqCM19C/tCB/8AhJvCboobZZ35OTjA8y0BP614J4esTD8RfC0u6NQdZsCEUg8G5j9Ole9ftC3cVn4k8KPOVCNZagnzd/ntDj9KAPPmnZom3EEjB78n0qLVrj7QhTAIVeRjOD1NVZ9Qtwd1rbzOwHB27APXk8/pWVLqMxl8x2toFYj7zFyPwGKAJLO1ZIPNbcwG5iM8D0qPwPaW914pureR4rdYWaa4d22l8kYQHuCeT7CszUriSfTY1kluZEbjbHGVXHtgda0tHlt57tIDYTNfsiqsbvjeuOCqjknrQB6de6rp1vA6PqluSfmwH5U9sYFTQ+N9JitI0upmZhyXiQnPqcHvXFnRNSlYmPRSqBsYZOB9cmrCeHNYmRWSzskBPBLKP60AdPJ420QLlZLp+cA+Tj+vFc94o13R9QjikhtrtbrKxPIyHyzHu3bZNmXwp+ZWQF0Y7l/iDOt/CmtvJxPYRjtzn+QrVTwdqbxkPq1qoUDpG359Kzq041YOEtmNO2pCh0fQ9RGo6fq2oX/2y3BN/Y3K+aJUIVlkXGw4VoyEZONrnA5qHRfGUOny6hNfyyaglzciWOSG2EDKdoVg67mXJKg/KQMljgE1n634XvbLTbrULi+tUmhiZbeXycyDdlSgcjIBBPAOOa85srLWL2F3s7xprXTf30zKMYJIGFPc1yYPAxw6UpvmqarmatJq97PvbT7hylfbY9f1P4iaFcxrZqNRVWnTz41iBLxggsDz07YHX8647xHrOnah4lmMF0Lh7vLP5YI2kj7pz0Cg449Kzl8MavNpSyJeoJL2UQrFcxsjDLfKC/69c1x+u2V3o2pvBqFsLa5jcQPLE+6IEd8jjmu8k03tnnttTbyypQ7yBwoTPGPWubnhkhAbghhjIHFdToDN/aF3pt0ztcmAlXBIEnGfof8APpUuvaR9n02BjGQrN8ueuMUAcK07xwovTaetary/arZbiEnevDDv9Kqa7ZS2KWzSRlUuI/NUnuOxz6VufD/w1quuNd3GjQwzC2jEsscj7SyE4+X1waAJ7CeKfTLW5gXNxCpSUEfePOR/Kvb/AIVeOL/WZYtL1NDcOsZEVzj5gFHR/Xjv1rwqfZHOz2KGGZWIlhzkZ6cete9fCXSIbXw9DqgWYXF4DtUgBUTPUeu7Gc0Adle4HjPwQqsT/wATWUnP/YPu69Pryy6+bxn4IYdtVlH/AJT7uvU6APHP2niw8J+HdisxOtKMK4U4Nrcg8njpXzz4+ntobFLGORYmWISSFwrDA/iwDyewr6L/AGlYVn8N+GY3DFTraZ29f+PW5NfK3jNJLu8uJkufLcMFVB90gdzkce1AFPStQ0/Uy2mzWzW1vPGFDRMWy6/dcgnis8aRcR3csbSwy+UxBCYBJH9Ks29hcaJdNdT28beQN6vFkBnPQDscVj5eV/tMoYyM52ZXls+h4OR6UAb/ANiuI7d42zbwlSTh1K8cnLZruPhn8L7jxbZnXPEF0+heC7UF5byUiJ7lR12Z4Cf7ZHU4APIF74deC/DmmeFLf4hfFHUIH0dstYaTC/mfaXUkAOoPzNkH5Ogx85ADCsP4k/EPUviJcql8/wDZ2gQkC00iBuFA6PLjG446dgPTnIB6pY/G7RtAsb7S/BuhpaeH7WyaPR2b5Wu7ouApKn7qcsxLcnaT1OK8I0j+2bDWJNViufMv5ZGlnkM43Mznndz39e9UJtIR4ZDbwGR1GXVRkfU0/T9F+0xG5e3byohgkZPmH2xzx/nFAHQahHp99IBqFuNNnc7nEkTSjPfaynP9KZaeD7R97x+ILexDfL5cUcu8+hBGSxHpmqKWF09sFMKmDlv9dsY8dOTj8gKx4rW9jnMMKzRuvSLzWVj/ALW5RgD69c0AdD4v0zT9Nu7KOynVpjGqyswdRKR/Ex/vH0/lWStvftJM9h52yIjcoUA/Qjv39eKqyPfFHeaa9VR8sn2mZmQ+mMcj6Vatbm5ugsZuXWTb8gNuzrIOxjGOvXrigCzaeHr+WQL5UNs5AJO9TnPIyOQD61sReCrtVV7m8tUMjbcDcW3emOV/LFa/g69t0Uw3c0FtKvyiSHbb9eobJOT7H0rantNIilUtqd27BiSJMFcf3gB0BoAwE8AwrIhl1NVckKFkcowOOmTnt6ms7XfB8umW/nRwC6gTJElsyjaB1LcHcPp+de8+E9V8Dx6YsV5oKNkZkuygCu3T5SWyW57YrpZH+HMlmsFwfsavGFDSs6soz3JJGfrQB4PokcnifwDDpd3eILiO68yKGIhZlGcEKxG5gRk5BAFcZrOnQaTBew32iqUiuGt47xbuQSsw5BKg4OR3xXqPjbwL4Z0e+h1Pwt4nuV1AsXjEDrGVPGCMYB/KvP8AxF4VkuLi5umnuzey5ed5mMhkH+1j25wcCgDH8F6fr0uqxXmk3It/JIIuFXzAB75wQPrzXsi+NfFnhi1H9t6TBq1owxNMmIiM92jDbpP0r58QzadcvHBNcRLLgOBLsEgHZgCRj9K6+xa98QXMtvolwYLFY1X7GZFYk99uB69c8+lAHsB+ImheIZ9LT+0raK5SdcwzxfZmVfYEkD05616hDqsf2dHubmIQsuBGAJAwI/v/AMRPp0r4r1W3u7DVTp9/pcSXyc7TGzSleu7PT8asWGozxxhbObWFB6iObaoPTmQj+VAH1D408Q6N4ev7G+v5bF5Jh5MsDyhozt+6fLXHzD17VDJ8TNKu40t7G6s5Z2JMSPbjAPqQOB9TnIr5khe1W4Z3e3Uj/WB5S7A/7zferYs/GsOkybNM0+Fmxgvt838cdP0oA9iuZ7i6uZrp7jLSnbv8wkA+gA6cdgagsdPD6taxaiDDp8sqi5nkYmTZ1OAB8o9vxryi5+JWsxkNbXBgLZwMoAB7KRx+dQ6f42v0nE02pmJSBul8kzMp79eAfwxQB9GfEjxLpuo6ZbeHvCaP5VrKkhmhTCZUcIufvHByfp3rx74i3M66LkQS/amb77EyMw7knoB6CsNvH758uOVbuToCVOGB9sfzrC8Sa5eajahtSQIBJ8qbfLzxx8o6j3xzQBj+c0ILSxyg8bpJBkD6DvTVlglbcomC9nlJG76Aetafhm6uXnuXtbXMccbyMxkYRk9M7GPz/TtUNgI/PFzrF1HZxx/MFEgDMP8AYXBYD9aANe38PO0Ecq2xjef7ks8nIOOgAGBVO7tr7SbyG6MUCvCwPmIQAuOuSev4V6NB4j8P6TdabazMWl1KFZYprgGONYznYzE55JB5/OtDV9F8zS9RgnW3kd2MimV1QIcfwlR82fWgCpDJ9thXM0pSdA4WFABuxzz+uTWNLtOmkveozROckPvcYPIOe3sKPCl9Fd6LGXjEk9vIYitvE7L/AMCY81NPbNBdXr/ZoAAPM3yyjYuRySOi0AM8NlJfFvhdolYoutWGHEQA/wCPmLv1Fer/ALUal9d8GhXKEwX/ACAD/Fa+teUeFJJpvEPhe4jjnns/7esITdRwnyFcXKHZ5hABPyngZ6dq9V/anONe8FZGV8u+DH0G+1oA85OnxMgNy003HR3OPrtGM9KPJhgdhbRxoBjGwd614lRoVVSwbupJ4Pf86ybxSjOFwUOcYOCaAIPPeXdCCxTzMqBk5IPb/PWjTtQn/wCEnTVlD/aop1ggiA+dRtKiPB/vAnP1z2rT8PwoY0LINygqM+/Wutt4IyVcRRPKo+WQqN2APXr0oA05pLmRwZEBQ46HCj1zUlvckxo0CDZ0BjYMDXLm71D7Y9tqt/FpGi3C5i1MwGUruGDuO5RCw6h2DL6+h2dG0+DRb/UtDsgqWVncb7VFbI8iUCRTnuNzSKP9yuP69T+tfVNeazeztZW2ez36X8yuV8vMdFahmjDeWy+3Wk1CdrWGJwY182QQqHOMEgke/v8AgaktNhJ2jP8ASuF+KmpadaX+niCTbq8b7LjaxIERUhVb/aGc+oFdhJynxF8YTave/wBlW0kkemR7XZggV3YZz/Q1mxWT6rFBFpTxtYqFSaKIfvBjqT+PaudvmSa7aUfKVboedw96l0qaL7VLJKiwQKu3KkqzZ+nUjrQB7dDbR2UFo0E8iwQyJ9kkVQ0dxKeAhbnHzE49D7VPqHhGPxPosNhqFmIIFtZAuGAZrjcduRj+Fu5zmqPw/wBUuI4YFu5vL0qOPzZIkjBHYAHuBntXqSGKeFJ7YrLG371WQ5VvQj8qAPlbQ2ns9S0q4vFE4hnFvLGPlPBxgH8a9B8U6bHqCT2cMAhZEL7GGCuD6etY3i7TxZa74ktkiwsN19ojU9MNzyPxrutQEUMVnrSW0htorR/tIQcbXRcHPT7xIFAHL/E210G9+H/h+4mt40vrSApLJG33WGF2H8gce9aHwG0iObwFqN9pIC30119nlR34aNVyMH+Hr+NeWatpPiLxVpNpLYWF7crJdi3WSNCY5JsYVSegJ7npxzX0n8LvCTeCPBlno88iTX7lrm9kT5lMzY+Vf9lQAufqaAPM9A+Ceq/2y11rl3bW9kspcx20nmyTAknA7KPc17FFA7HgBEQBQq9FAGABW+pUYBjIY5zjv7Y/CoJgJSPLDKNvbvQBhX0KR+LPA535f+1pRjsB/Z93XplecapEE8V+BiDn/ibSjgY/5h95Xo9AHj/7TMyW/hXQJpXRETVtxL9P+PO64r460y58/XPtMwklZmJLJNnr3I9q+r/2xJGi+G2ksmzJ1dU+YZGDbXAP6Gvj+xEi3EflCBRn7pwSOfU0Ab+qRuiqI5I1eVsABzHuH+11BqnOZVIhKFliOXIjBCk99w7VuX+pRRWD2s9wkckr/fW3+ZcDlcd8/lXP2yWe13MRCL8p8iflz+Bz79KAHQyLHdK8ZXyeQhLGRd5+8Vz91j39fWug03Sbu7hYSXFgY15Lj5GC/wB7jp6ZxWZpOktql4oSGEW6j95JBGcgdTkZBJrvvDnh46/PFC00dvoSlch4cPMwONqN+uScUAW/C3hdL61MlgtwLYAmS7dw4LDjCE4z/Ku707wlZiNfs3nJJHyN83IXHXavyjnIxnNbltYm0WJIrY/Z4VCK3m+XGvoSOjH2qbWGihsZJ74wogXeuxI1aVgPurtILY9MUAULawhit18nT4m3dnhAOf7xPOR2zn8Kr6loa3sRhkjgXcc74I1byz3fA+8M8AEVV0bxvFeX4jgL5cgNcKArqPQIwwG7fdrqIkh1C2hubaOS/MgLK8UYVw2ccyMOPx4HagDwvxvo93pomH2aNpol80Sod/nR95FHAA6544964KHUZeBbFo5HGA8UhQnPVe5bPocV7n8SbWC3tLYSwzRzRsTslmyUB7lwACfYflXhL24e/mS1t3kiJJBkJOM56gAgnr1oA1tP0KXVleKBjB5jJC5ljG0A8ttHrV+fR47TVtQ0qDX/AC4rWISxBQZpJn6bQB8oP/1qyZL3+yrb7NHbwFi2JZjMwZieiKw/hxXvngvwVpPgKx0kXstxFq0hWfU7diOU2llhQgHIBxnkEgGgDxO60/UbSctq8F3FFKq/PBHx09AcE57AZpdL0G61Ofbo0F9MU4YXZbbn0JBDJ+I5r6T8YRk2A1qKGxs9IuVBkSQAIueRvBAKMR0AOK4D4TyaObTU5LaTfcS3LZeJykrKTwWblenQdPegCLS/hBbw+EbvUNXt7C9unjadVsJ38y3UKTt2ZBLDqcHNeQTwXVlFHE155Zf5okaZ2iOD1wP5np3r6medmkSH5Gl3YSK6kLFs9gIup9CffNeGfGHRdO0zxTfWyXFkyyxJcypA2D5o4ZRlsn6YxxQBxmvWV5BexWuvD7ReTAFIrZkZGDdCZB09DjP4Va8JaPOniKZrW5j0a70pxI0lzcLuj9dqfxfnzXNhzezMEe1Qon35Z2QHHbJHHHY4q9Hp1xdWuITFKqN5xCQiRwMddxGNv4+9AGv4l1DULvxDLeXV7FcyOPKS8jjGyUAnnZnoPf8AI1R0TTJtf1QWNg7TO5wxnUop9SAMdK2vh74Yh1vVTdmC2lt4nKzrNPufgZz5eF3f8B4GK7K4i0nQNVTXdD1BJdOwUmtY1CqBnnacllOefmz0oAfpnwhWOFP7Rv74oFyscMRQNx1yR8o/3qsw/C+Ncpb6ktxb4ysDW2zY3qW6HjuDzXQWPjewkeQwwyvjB828uUEkmeSyN/j69q0LTxdod/eC1vbxXlb5jDNblvLB+7+8X7v4cUAcRqfgGO2DW1jYxS3A5NmGj3Yx95cg5/76/CvL9Y0+8sbh4bqzVcOQ2XHyjtlRlvwr6ob7Xc2RTS57uGxUZVLYeWq89S7DeQe/ANcd428M6bqdjNcXM0dtcRKT5804QP7EgbmH1oA+d9WR0nFttg2L8w8l8DOOc45JqzaXFxZ2UEmoR29xZXIaKKYyjfa+zcfoe1dNrejWN5Yqs09vHdQKQksIKBQOfm/vfnXEPPGiMsTREygowRmkVvovf+dAFy70+WylVJxC+GGySB8oB6gnof8AGu78H+GfDHi2K1stbkkt7i3kCJcxThdyE5KPkYB69Oea5KbV7u7trNHMOEXasbQiIMBxjOM+neuh8HXEmna4hjlWyLLtbzArMf8AaDYIBHY8GgD3S+8E/D6ayGnTaBHdQW0RFtI08g2YXgGQYIX3JxXNyadawWVnGllJHEFMCtJIrKiJ/wBNcksOwJ9K6+yn0O70KWLX1WeCaIlpp5BtKfxZRTn3OcetM8UeJUbT47TStSt7XSIo/mdLTahGPlIdj8xx6UAeFpZX2lSa1BpcMc7STrIkaq3EfO5sfxsOOO9elfDi2+FEl1DN4q1C5udeKqxj8RQ/ZYUI4wsY/c9exZjXFzXFxq899PcTWZR0yqyuUyoOFxkg9s8Cm629pJb2Fk8lpKu4ho1XzEzjOBnI+poA9m+OwuP7e+E39mrEdCHiK23mLGxZPMj8nbjjG3zelUP2nUR9V8MF2VSllqDpnuwe0OP51474XhFt4w8NW9pLdW8A1ywmltopWEEjG5jAZkJ688HAr2X9pVd/iHwepUtm21AYH+9a0AedaXdLPtMLj5wGX/aqtdnc+0nkngjo3uKyPDc9gbkaezj7WFdvLHDcHAOe2Mg461si3gSMTO7YHUq3T8aANjR1ZLEIoTzOSTjJrobO0lA/0g7Vx9xDk49Ca5fTNRSEsYpGfgFc9yOcE11+n6havbtcSZjt/KMkgHPAGePft9aANGMLNbFXUHnA54xVHw/4YtdN1Oa6sTJGJYljNurfulVC5BVT90De3AwOScZJJ43TPilpyW98+s28g/egW1vaKo2IB0dm6k8ZNcL4y+Kl/wCIYJ7C2hGmaU4KyQwSEvOv/TRup+gwPrSaT1A9f8ceOLLwrZFbSWK61ViBEkZDIg/vO3T6Ada+fL/VpbxnklkZ5ncyMxPJYnOfzrEfUXkWNZHZljARQcYCjsKkQqxyrjac5J9PpTA3LOd5+joshIzkc1uQ2CySq99cQQQEjcB39eTXJQPltsStwvBIzn39qsqUkYeY4JXsxJAoA6+XxFLNOtnoJuFBIj+0ZyrHPXnqfQ9q+kvAWnXmleErCx1LaJoUKkg5KAnKqSOCQP518taRuaWLZFKy8kCKPJ2ryWA6fjXu/wANNX1jXvFF9qOpXc7IlqQYBJlIx0QEDgknP5UAZXxWthF45uduFFxpsbDtkgYP8q1dF8ETeJ/BekSr4lv7K1ni2z2qxoyEqxHyng5+tR/F6HPiLQJwDh7aSJgfZj/jXVfCGXzfAdvH/HFczITjnBII5/GgDqtL0y38PaRaadpSeVZ2kXlRr1wP4ifUk5JNJPtcoVXaxHTOelW2BEZ+bJHrnn/CoFBCoGZQCSMnnJ9vegCWHDRqf0JwcdxVqLyxGCy7S3AyeeKprMsR+RdwHUEdfx7VJ5pkhyFAUH+JskZFAGV4gZD4s8DBD/zF5SR/3D7yu9rzvWAf+Es8DFjljq0nA/7B95XolAHgn7ZhC/DLSSylh/bMY2jv/o89fH9rcQq4OIY1U5wV5b2//WK+xf2xVZvhvpARirDWEYEEDpb3B6n6V8gRiZGYzSMGGcfdYAd/m65+goA3dRkle2jeF7151bLOoAVV/wBn0HtTdMgW6lhhkgsVgfhWaT58/gck/XFS3E4fSkmRyWMeQguA5yPYCs+xlndoXeK3ETOPnAALHpycjAoA9L8P+Exc3YtUWeLflpZeUVUHcn07cV6/ZwSWttHa6Xby/Z/LEZEUhjDjH8SkE/ietcB8NfJaW/ktvNZ1CRs0MW8IO5GD93PavRUjumE297toFGG8yMqpb/aCk54/I0AEdrGGkcrbW80YPEwKY7YBJA/ka4Dx+sWq6dd2kP2VXgA23Udyu7zByVyxwfX5eld7E1tHKka2FzfkH/UNIqID2OG5J68Guc8deGptUs717GwhmuJ02vaSxxKB7iQYBcdcAHigDzvSLvXdJ0ywvrmCa+sJSB51pFHOwPQh5AeD7d69C0DV/Dt7YbzcDToS2Ps6lgzMe5BbGT/erxV7rVvDt3Npt2bi1YLte3klwhU9yMAc+o5rVtgJgjJcTCFuXWAhoM9gSc7iB2ANAG/8RNVxfJb2TxxwAbYlRHuBIe4APc9+fxrnY7eex0mXM9ta31y211AaOONc91Chf1/Ota2n0qzdVea2iuMEmRJH8056DbggdjuqvqGo7rtLS/v3DyjO+4jNwg9AVHOPfrQB59qNwbh7a3JWRoco7o6xiUlsj5hkdhya9+0v4qRrpcFz4x8MJc68Nscl5HMIo7mILwzEAncOnAwfUdK8O1x4IJLeKzfT7pDukU21uyLu3dWQ4z7da6bwVp97deIrS4dbe4upJ1jVbuVrcZOMFUVsk8454FAHV6sPEHi64uLg2cmh+E7iQPb2sOGmkyQFBHJY5HAK4549ai0fTNd+H/8AaN9q1rqWkWcyYgV7V5Yrhz0DgEBG4PevpPwx4etvDIgu763il1iQESTRSkxxA/wJuIJGPUE9a1Z9e027H2a5ksrqNsgoRlWIPvwAPfrQB8uX/wARNbsrO2j/ALDOmRyoWjuHR1hnHqGxhQf515ze6mZtduJvEEY3y/OXjIjkQ/w+WVzgD8Qa+8LrUNH1If2ZcW0V9C6gPF5QliX2bPAriPjh4EtNa8Hvdafarb3WnxsyC1t1EjJjG0YGcDrigD4wvFk898zLMT+8EisruQe7t05Hbn6V2EWs2VhpthG17POJVDeTLEn3xxk9zjtmuf1Xw1q1jKG8qKeDoJMeU4H+0OCDUMNt9lVJTBEJCmG+YOQvpjHU96APTdCtrHxFloITcaiy7N0MZiIT/voBienGK0D8L7mH5mmmQ9ViiRcgj0Zm4/DJrymy1qW2IkiEXmIQDGiSDZnsH6LXar4n1aaSHTba6vbN+AdkW9c4988UAXPEPgnWfCelC+m0rT7qxMhxPcOJGHHIAByR6kgVa8EQf2lqCy2NokFiVVpbsOVaQjooD8hR6Lk1lXngrVdQull1a7upLaaPd5ysXVZOygLgD8ea9D8L6XdaJpNjBdGKeKJCvkw2TMwHoVGQ7H1yKAOqtzZExpKl5dyxZDzTTJIyc8Agtgkdgcmi5dChC3MhToRd3SgntsKpzg+nWtaK0sru2jlFhcTbh+7S6UQ7SO2BhQfY4qmtrcPI/wBkgkjdW4jZk2j1K7ece4zQB4V43SG01nUbKC2eMJB5oig34bjBxuwOPQ5+przWRzbNHJC2xjtKHeinjpwBkn6V6v44spE8f3L3LRorwIY0l3FjjsAxz+NcX4h0lba0Z4bdFDsQWSLcR3+8xyPpQBiXlw91Daz+U000haKQnJdjnP3fuir2t3t1DcQxC1dUZFPzwhBnHXj09ar20KPpkAjvmOycswEZPbpu/wDrGovEzNJLaosd44EA+WSQsAPoRQB1Phr4h6jo0TWs0kU1hINjxldxXPXsc/jV3xD4+1LWZLW3spjHpAGyRYbdYw2OAMkcH8K85S5eIheLfaeVWQIR7gdq2/DX2y4vdtvfPcRSDBCHknp8xagDvNBs3uNPe8urO3VJ3Aj+0OS5Ve4B/pVnVQ4kRJdghReQq4O5vVh1qaGIyS5unuDFbL5fyLvDH04GM/jWUJGDyT3BKQbhLvmjJ2joCP8APegCTR44IfiB4ZRVcyjVNOy7TA5/0qLnbivV/wBqRrtNX8JNYgbxbX5chdzBN9pkqpIBb2JA9xXj3hK6a48baBI1x5iya5YFV+7tH2qLtX0P8YbUXnjrwhCUL5stQ4AB/wCWlmM/rSauB5PfeGfD/wDwgNpqfhi+a+vBqiNfXEy7Zg0uYxG69UAdoyB9SCQc1hazYXlpay3M0qFI0Ltj+PH9e1dd4q8DW9zrF69lczWTzqD51sdu8Bs4YdD/AAnB7gdwKp+JraOXTJ4ruSKG3aJleRztVOOufr2HWuDL8JUwkZwqVHO8m03vZ9H8+33FzkpbKx4pp/ia+j1h9RnlV5IkMcULLmNQ3XC+uO/etbUfiXe+Q1pBY2sRlUrK7Fm4I6AZADe9eey3H76TZ0J256Zx7VExLMCeeMCvQIL8upzS3DM6xjPZRgU0yhju5yf1qmcdRTlbHI60AWhhl3DOachYdMgVEjA8E4OatKuACSCD2oAswTkL15Hap4pfmHXHTpyaqQlFPHfgmtSxFnGQWaUS5znGFHuBQB2vhme8jt57KyfE9xFieQKD5eOQin0OOQOv519GfDrw6PDHhuC2kfdf3mLq8kx/GR8q8/3VP5k1zXwO0/QIfC9veadBFcao2XmumUsy5OAgLccAduma9DbzN5Ztrew5x+PrQBwnxldQmgyLy8Vwykj0IBH8jU/wWvlGjarZ8bhellH975Of6Gsb4tSvPp7sf+WNzGfxziqHw1kkt7nUmjzmO8VwpPX5eg/+vQB7E8rktvOW6kp29MUhncKNigk9SwzULzR7cqMuRnBwCPbHrVdrkZKbMEchfb3NAF0lpEKnJU8/PyeafEG80Ddk44YDkVBHP5bgLycFmyeAfpV22mjZlJXjrg9en6UAUtZiI8ReBJCxJ/tiUHP/AGD7yu+rhfEEkI8R+A4g6CRtZmYLkbmA067yce25c/UV3VAHj/7TcSzeE9Bik2BX1Yr84BH/AB53XYg18V3Sy2VzJDPCInVirFkIJ+uPbtX2x+0lOLbw74alPbWlXuOtpcjtz3r5d8e6FFbaibqC6M85++kYDE475PJI75IoA5+0vWazETyt8mVQtHjBPr3/AMKd4cuPJ1NWke3kHmbfmj8zJ7AZx+eKqpeyWiFJPJBI+6wy5z/I+/So5Qb9VZPswkVTlAnmPj1PYCgD0vwnrr6P4qZ74IsE3y53ndGD34BJPtkV7Zavp7KgS+8oHBRNpgDE88uSQT3BIr5WsBHHGVuXmUA8OWKBT2Bx/LrXd+FPHl9oPl2l3FHqMAyVkLN07g4XcR6LQB7B4y1waRoxNteRh5H2Fgm8Z9WcdT3GOK8sJuLyWSX+05JpCPvKHiOf9o56e4ArpL/xt4d1zTmtbm9+zfLvUC3fdGw7sccf4dq4e41DT9xVbma4C8CTzi8ee5KkZNAGldWzXNvcMk6NMifO1mXaVwB91ixycdcdK4bTpnWWfzPPuEiDMFYrvA9Fxyp9q0dW1iKS1NlpOWeQEGbzBFEid+DyPqT+tc6i/a1SHy4vITq0ZYGXHTcev40AaYjmn1JIbeK5PmAGO1iha4BY8/MAcg/Tim2Vn5k8jwmewIPzMLZgzeqx4yR9TWp4fOoWV8s9hbR2/moYjci7YELjoN3T6V1ejzQzpKylGuUGHliuzlR2whyGz6DFAGDdNdTQxQxvcp5UYWMzOm/A75I3EV3vwD0I6r8RVurvy7iOwQzNK0Me4PjAAyMjrk4rn5Z9Ksbi4jmLQTkjzJlUO6Ej5ScsWI9AAK6T4HalpOg/EqOFr5kTUkaJGnj8tg+3IDFj/FzjHfigD6FvLc3MfltLcSENktcRbhxnBVPQj0qNbKa0hjZm5cYEaQqrMB/D17Dpg107RARFFXK4+7nGaypGUXRQLAkzgfK8vzPjnaBnjHf1oArW8LncEW6s4g2diyhc+uRzjn0PNaC225JY4WiaC4UiTKliWIwTycY9qvRRlEVWO7A5Oe/+FOd0ghZ5XCogyzuQAAO5PSgD5X8Z6E2l67e2OoWtuYVfIkuI2kVgeQ37s5HrtxXlGs22jw30sx1S1a2ZHYr5LqPMHRVyckH9K9j8e63p+v6/fanptq8UJKx+eTy5HG8xHIbpgeuB2rnr23URMfNt5WdcYmUO2D2KgfK3fPGPegDy3Ro5Lm3ldLsskWJGg5JcdzsPIXtk16b8MPC1rezXeqMbWzRZBFGIpjEQSOWIDEnPtXCavoN/Z3S3cVrLc2xbcv2eZpPL+u4cj2HSvRfhzqlnakRMt3CJTgNdK0YikHBAdlwR/wDqoA9BXSLdZZNtm7tjBcSGNhj+8iFj1796sxWTrvkt12pxv/fvCT/s/Oep+h/CrlpeyRRYTUre4jGPkgcwg49Nv8zwfSprieO4RVkv+OogJaNgfQuTj39KANG1vb2OwjiuIY0twOVkvRLwOm75S351i6vI91/rlgEKggBkVgPoSRgfUYqpdNbacHbyZ7ZlXcZTs5932L0+pNcF4t8cfaElsNNuYrpXHzO7EhR/s5AIyfXmgDA8S3CX2r3DQyy3VuvyfuiqhgP0H1rmNahh+zFL6S2s0JHMrb3PsC2fwI6VblvwkpjmjEjZ/wCWOxGX8WP9DXP+ILxvs5S1kmWFiRLGZlIOOOcc5/KgCpBObhmaPfy/loxXCgAewwTUXiourWCqQ+yIJghlx3IJNMimtV0ZR51usqL92SIhWz35PXHcCsVWjZVBRMc7THKSOe2D/KgCRLl48Mz+UvcryR6deK6z4frJJLPcpIWDHYhmmVFJPU7R6Vz9lYyXt1Fb2qiItjmRWKgeueRXrmkWdvpGlxRC3t5RjaHYbRIe53Y4oAluFjj0yWGWTykK7cbXIK+xB7+ormr4lrCaZIXiQ7Y/LmlwzdgwzWrebIZJLiOF7WUjJkMhZTxgfMD2+lYV7eG6u4xsiMEZUgkggtjnk880AavhGR/+Eq8LxeZDtTWNPzHkbl/0qL2r6H+Ldx9l8e+D5d4QCzvwTjJ5lsxwO5r568MTo3jLw0jZR21qwIVox/z9R9DXqn7WGqz6RqXhKa0cpcSW1/Cjdl3Na5P5A/jigCt438fnR760kt7eOeyxLF9slAID9gFXkg4IJPfpXgHjDxVqfiW9ZtRMSRW6nyreMYRAR1479PyqHxBqL3MtujOxgT7pIxnjGcemOMVzlzMEvGC54UhsnNAGdIP3rfXNA6cdetOlwXBHA/pTeh44oAUHIxSjjjtSE+lKrYNAEinnvVy3ZWwCQD796rRqJGA3BfcnitKHSLqaINbqJt3I2nGfpmgDU0Lw5qWu6jb2ek2klxdynCRKOo7k+gHrXpWk/BnxQJIhdw2iqT8xW5QiP/ePb9a5v4cWXjiw1N08NmW0nmTZIzMgCpnJ3M2Qor6A8DWniDTy0nijxJLqdxIpxAMGGLnk7sAs30wKAOl8JaJF4c0G10u3KSiIFpJU+VWbvgdcduea0jJEnLSCQ46Dpmq7Xyfc3jBHAPGfpUEbSqZCQHViOQeQKAOU8VJ9qsdT8xCSyFx2HHIIPrxWb4WjSOXUCioWknQszd8oCM/rXSeIY2ls79kjfYIJC644B2nnPbtWT4RtFm+2syldrQHDdzs5zigDprgr+7BZtqjDNjP4UyyLeTmRj1yDu5xT2iVV3n5ic8dgPSnRqXbOBnHGOaAL1nG8UP7uOTDH7zNk98c9qtyXNrpmn3Gp6tdLb2FpGZZ55OAij+Z7AdScCkgl8u2klv5I7ezhUy3EsjbERAM5YnooA618k/Hv4syeNr86PoUkkXhe0fKZBVrxx/y0cf3f7qnp1PJ4AOt+HfxAu/iF+1B4cv5FaDTbcXUNhak/6qL7NNyf9turH146AV9jV8Afsuf8l28M/wDb1/6Sy19/0AeNftRXUNn4R8PT3SLJCutKHVgSCDa3I7fWvD7aeDVNDFv5MzwEfJO0ixKnPQqOa+sPHkvhtdPsofF2nRalbT3QjtrZ9Ne/LTCN2+WJEc5CLIc44APNcf8AZPhh/wBCD/5ZF1/8jUAfIXi3Rvski3FtGgiYYeK3wMn+906fU1zsd0YsSKkibTwdwBHoAOua+3/snww/6EH/AMsi6/8Akag2vwwHXwF/5ZF1/wDI1AHxW92tzaBJLVvMzuWWUlzz9Tj9PpUP22VJAroJgg+SNV4H4CvtaWP4Vxf63wNGn+94KuR/7bVE0nwlQ4fwZbqfQ+DLgf8AttQB8fQaghib7XZxNI3IEgYAY/Hk1WcTXBaNIYlAAcATgKv0HT86+xjd/B8dfCNoP+5OuP8A5Gphv/g4ASfClkAOv/FHz8f+S9AHxzHEUlyxSRDjKM4fd7Bl4Aq/ZXFikzJqJVUcGNtsQdlPtk5/+tX1odV+C4znwxp4x1/4pGf/AOR6adY+CqjJ8NaaB7+Epv8A5HoA+drG8s5bSSSxWMR2uMxNKpXbjj5OvOP8as23iK3gjY6VYQLM3zBEh2PKD2boo/3vyr31te+CKj5vD2lD6+E5v/keoT4o+BIznRdFH/crS/8AyPQB4BLfS60iXGnaOItRIAkkt4gHjVTy25jj2DEU7ybGXWrWCOC/Zbhg+bu8jIVh6uBjOehxXvh8U/AgddF0X/wlpf8A5Ho/4Sn4Ef8AQG0T/wAJaX/5HoAwdJ+JnjTRbmbSpjaausSjbNdROhhA4Ku+Rvbpg45qtefFTW7mZGuNN0fzl6yXFmSZB2+YMdo4+orp/wDhKvgR/wBAbRP/AAlpf/kekPiv4Dgc6PoY+vheT/4xQBXuf2gYtGtbeK68OySSt8u6GYxxKR23MvP1HFch8R/Gev8Ai7To7fV57PT9DeTElpbb98jfwAyEZ7+gXvXa/wDCX/AQddK0H/wmJP8A4xSf8Jh8Av8AoF6D/wCExJ/8YoA8cs9Na2uLOGJ7SyuLVOBJdiSXHXC7eDz71ux3XmxBTqS+WBki1tv3gbPcnp+QNei/8Jj8Af8AoGaB/wCEzJ/8Yo/4TH4A/wDQM0D/AMJmT/4xQB5RqiQTSeQl6zOvPlzW4j2/7TZxn681zl8txYSy3MhtZwikyCR8CRu35e2K95/4TP4Af9A3w/8A+EzJ/wDGKP8AhM/gB/0DfD//AITMn/xigD5/sPGlxZoPJWFOf7jiNPYkDI/HrXQ/8J1rA0xLiUWk1vuwsloqIUHpliGHpjmvX/8AhNPgBjP9neH8f9izJ/8AGKD4z+AA66b4f/8ACZk/+MUAeC6l4za9RbbfIGJ+YeY+VB6knO39K5648Rzq7iGd4gDyxTerAdCfWvpr/hNP2f8A/oHeH/8AwmZP/jFL/wAJp+z/AP8AQO8P/wDhMyf/ABigD5Ha5SecNNJ82TnylY5/AnOKvKJtScACTyI1CvIgbapHds9TX1UPGfwAOcab4f4/6lmT/wCMVF/wnf7PX/Pn4b/8Jx//AIxQB8r32JLklTlI/lXzcZP0bGKjtdMF9OlvG1ysrcEOqsPc5HavszwVd/Bfxtqsum+GNF8N3t7FCbh4/wCwRFiMMqk5eIDqy8ZzzVTxTrfwN8K67daNr2leG7XUrbb5sP8Awj/mbdyh1+ZYSD8rA8HvQB4f4W8L2+g2ZkEolZwGkBUYcj0JP6VNf3Li5QXRkjiwd4jQIUXHC98k16r/AMJ5+zz/AM+fhv8A8Jx//jFH/Cefs8/8+fhv/wAJx/8A4xQB8/anrVxeHZvnhtVYjy2VeQOxIAP4VRiurBF5keNADs6MM+mccfjX0rbeMfgFdBjbaXoEwX73l+GJGx9cQVI/iv4DIAX0fQ1B6Z8LyDP/AJAoA8U8FBm8S+GJWmkCNrGn4jdQMn7VFnFehftpXUdpdeCXmQvGy3ykKcEf8e/I/Kuss/G/wLtLqG6s7DRoLmB1kili8NSq8bqchlYQZBBAIIrQ1z4o/CDxAIP7ee01TyN3lfbdCuJ/L3Y3bd0JxnAzj0FAHyNcmC400SI4cnmNkOQDjkn0+nrXOX8YRy6H5G/P8a+xv+Ev+Af/AECtB/8ACYk/+MUp8X/ANcZ0rQRnp/xTEnP/AJAoA+Ks+ooyMV9q/wDCXfAT/oE6F/4TEn/xil/4S34C4/5BOhf+EvJ/8YoA+KgrM2FBY+grT0vRL6+lAS0umXazfJCz5A69BX2D/wAJb8BP+gToX/hMSf8AxilXxZ8BmJ26RoZx6eF5P/jFAHingL4MzakyXfiNLrT7JcOInUrJKOo47A16jb/DrRLdcC9vPLb+CNUXAHQAnNbv/CUfAn/oC6L/AOEtL/8AI9A8T/Ak9NF0U9+PC0v/AMj0AauiaRaQQiDT7SOKDAXYoyCR3ZupP171sW+mIruyxAleNxHeuS/4Sf4Ff9AXRf8Awlpf/kemt4q+A643aPogz6+F5f8A4xQB18tkZSFIIUY4PT8qrLYSpcBFdlzztbkYrmf+Er+A2M/2PoeP+xXl/wDjFN/4S34CZx/ZOhZ9P+EYk/8AjFAHbeJJJbXw5qCXCGLdD5S4HdiBjP41ieCbdWl1FyAFkuiin/dQD+prG/4Sv4D4z/Y+iY/7FeX/AOR6UeKvgQemjaIf+5Wl/wDjFAHY3FuXuWVMdunr6VX1K6sfDukzavrl5FY6bAPnnk9ewCjlmPZRzXLjxP8AAo9NE0b/AMJaX/5HpR4m+BR6aJox/wC5Vl/+R6APnb40/GC98eTHTdLWWx8NROGWBiPMuWHR5SP0UcD3PNeTV9yjxD8DiD/xINI4GT/xSkvA/wDAes//AITz9nn/AJ8/Df8A4Tj/APxigD5//Zc/5Lt4Z/7ev/SWWvv+vIPAXi34N6n4ssbPwZbaImvyeZ9ma20VreQYjYviQxLt+QN3GRkd69foA5Xxl/yMfgT/ALDUn/puvKydS17Xhe+LLlNa0DSNF0K5WFnvNMluH2/ZYJ2dmW4QdZiAAvYdSa1vGX/Ix+BP+w1J/wCm68rj/FXhi68ZeGvivoOnzLDd3eqQ+UznCllsbFwpPYHbj8aANDw/4i17X7v7NpvifRDMYRcItx4UvrbzYsgb4zJcqJF5HK5HI9RXXeCtWm13wVoGsXqxJcX+n293KkQIQPJGrEKCScZPGSap+DdQ1qe3tbPVfDM+kJb2qrJLLdQujSDA2xLG7ErgE5bYRxwcnGX8OLwx/CrwgFHI0Wz59/ISgDa1m4BjcfLgt/EM9K5C8myzcHOME1oX8o4JJY9Tk1g3T7QepPrQBm3mWDBW6ng1nTjO4LnpjnqT61buJAWOOpbH14rOlkJMmOg9sGgChMM888k8Cs26A25IyMcDPU1pSkNkEDnp/Q1Sugu3LDnHT29KAMK+OLVjzuA6+hrkbhSJGwe+eldfqQ/cEgnORyK5S4HzOMY5oApOpCn5ccetRsPcipnOQQM49aiJOc9BQA08Dnr6UxydhzyO9PJzmomz3yTjOKAM+QAMy55BqFgD/T6VPNxMTng8/wD16gYkDkfX1oAhYenHuaY/Pfnp61K3Pc/hUZHt1oAiYcZ/Cozx/jUzKCT7dzTCOetADMDI/lSFRnpzSnPXmmFuMelADWGM9zim555pxP8AjTDQBNG5HPOaz9Vsxg3EC8dZFHb3FXFPoKnibGMd6APVv2LP+Sp6p/2Bpf8A0fBXJftR/wDJdvE3/br/AOksVd1+yDaC2+LGpNH/AKqTRZio9D58GRXC/tR/8l28Tf8Abr/6SxUAdZ4h+Avh3w/rf9j6n8QboakLX7cYLfw1cXBWDJUyExuwCgqck9O9Zfjf4Kab4Y8LaL4isfFya5pmpXa26G3sxECpilfcG8xucxbcY4J9sV9G+JNJ8RWHxzj8WaZ4dutX01fD508fZ7m3jPn+czgESyKQuMZYA9eAa8y+JvhS98F/Avw5p2qPCb6TxC11LHAcxxGSC5bYp7gDA+uaAPIVkitLcW9lEsUK9FX19T6n3qhO7SOS5J7VIxz15z1qOOF5WwgyPWgBUOT8xxSnMjFVQ4PpV22s1QjPzN39KtkCGJm2gADp6n+tAGDny2bK4GQPpSyushUg5A6/Wr0kUe4bsE4+uTVS6RM5QKvtnFADkRiPl5NEjPFG5GSMcjFLBJsPJB+pq1dBZLduARj19aAKyKXAbotWbWZI7gliAp+b8qgt3zbov3W4BGe4qxZQCaVtwzg5xjigDTDLKP3e4segAqW1iIztHGeK0NOw0IVlIx83uD9avRqS4DY4/OgDJkQvn5VU9RxVSW1duBHnHQ9K35ogOQOT0qFoiFOc9P6UAc29rKDwoBPUFuntTGgOeVIOcZA5roZLcMB69eKr3cYtbJ7i5xHBEMszHGfYZ9/xoAxgB82SBjrx3osXS4+0BfmWOUoCO3cVh3N99pdpl7kgKemOwqfR7i8t5WPko6S4DbuAPyoA6JS+45A2gcex9/ep4eZNzYCLnNKpBjXztkT7dzKT938aVlOVVMFe+OpoAsWskjSKwwq8855B9qoeJ/B1nr0Uk9mUtdVHO48JP7N6H/a/P1rTsk2MeMlvTkVfi3qyhU3PuGB9TQBy/wCzZZXOnftA+HbW+gkguIzdB43GCP8ARZf096+9q+Z/AsELfE7wVO8MZu0uriITY+cIbK4JXPpkA47fjX0xQByvjL/kY/An/Yak/wDTdeVLfeCdHvNTvNQZ9Xgubx1kn+x6xeWySOqLGGKRSqudqIM4/hFReMv+Rj8Cf9hqT/03XldQ7bVJ7d6AOPu/BOkxRki88SA+p8Sajx/5HqqYbbStJtdO09PKsrSJLeGMMW2RoAqgEnJwABzk+tbWr3RwB7ZGfzrkdSuTv2q3Uevb3oAr3ty3PPTt0+lY88hBI35bkkntTrqY9vlIJOc9PX61myTDOTjHPb9fegAmfPHRR1x2rMupgp2jkAHjrn60tzdbiQq7R9OprOuJJGx5bDIP4e9AEzMh3dvUis6aXczdemMVYeVViKgc/TtWbK3y88c9u1AFS8zJbupXj7wz7dRXMXIO8n16V1Eu5hg4weBXN3aHeuevqO9AGeSASBnANRPxxjH0qd1OSOPyqFwCOSTQBExxj88gVEeOAamZMAk5OahdcdvpQBUuR84buRjFVWxnJ5q5OAUBxjH4VWYnJJ6+1AEe0d+mcUhUg8g5PXjinqMnHOB0702aUBR5h2tnHpQBWuCQPvADnnGTUZb5AcEkjp60XcylAEU9fvPwBVCe6dePMjABxtHJoAuZ3DOCPb0pjc1TgvZHdFeNfLZsBlGDmrpX8ce9ADW+mAPakwcZp2xjgAcUu3tjJ7UAMAx1z+NOB+Xk/KPwqrc3SQ5TBeT0B4H1qpNdNIEHICjLc9WoA+hP2SGB+Kl6vcaLOTx6z29c78fNGjv/AI7eKbm75tka2QIDgu32WHjjkAZFan7Gjl/ilqRY/wDMGmP/AJHt6k+Nqhvi/wCLMnH7+3/9I4KAOZfxR4lHTxT4kB9tYuf/AI5VHU9T1nV4oo9T1fVr6GJ/NSO9v5p0VsFd212IzhmGevJpm1V6DJNJnn/GgCCK2QEGT526Y7f/AF6tovPB49O1Njz9KmRMHnGO9AEkagDgZ+lJdwGVUVW4B5z0+lSBhyFOPU96dJlY8qMgdhQBV+zg4OFP071nXgjXeERcYGeKuTeckRI2qSONrdKyHXLOAeMDHJ6ZoAtJGCM7RwuelThMiGIqQOXwcUljZSTIxV+fbnNWrrTLmOHzFcEooYAL70AUIoR9qkVgoU4cdD1FaNiqQykMcbhjAOKqSadMrszPnKhicYxTFYiQYbBOc8HFAHU2CgOHIyQuODx68Vpx4IHIGP0Nc1a3clpaCdxuZiIwu7aD3/AV0QkDRROMfOAwAFAEjHPYkAd+9RYALEnkAtk9FAHOT7DNSRgkDAJ59DXM+INTa53W9uQtoCdw6Gcjn5v9gdl79TQAmu+JIrO1mNkpkmKkRyN/ex94D265rzO4ubm6ZTczzTMDkGRi3PrWxdO0rMxxkrngdqyZIsMfQ9KANHQf3suxdu48Lu5575/StqG4iETtC6xbVCvLIf4s8/UYrlrclJgQSoPykjjg8Guh8N7GvDIwU7AodZFyoYHhiOwPTI6GgDqdHtXmQ3M4lMbHdF5gwzH++QecelaccJXhvm9xwKswSLdIZQsihjnLMGye+CD0qQowz0yPwoAjhizjGPxq7aIRICCQucj3qujKrEEgEfrV6yTzS7AE9Ac0AdT8P8n4jeDN3X7ZPn3/ANCua+mK+ZvAII+Jvg8HnF5Pgnr/AMeVzmvpmgDlfGf/ACMXgT/sMyf+m68rb1CfaQnHPUVgeOW2a74GbnjWZen/AGDryk1a8+aQqckg9/50AZ+qXYZmwQc8fQVyeoXOXOM9xmrN9dF8Drn26fQVjFmuJTBaoZWT77ZwqnPr6/SgCtNKOdxxkmqcsigsNyhsc56Y9q6kaPdfZY2L2yAHhduQB9TWbcRvaljPDFIucB0XGT75oA5uQAEdhkn2z71UkOc5yWJ5BNaeowhWWS2/1fdH7nuR6Y/WsiaZXUDOeM0AQSyc7ckrjOD6j/PWq8rMylmwFPOeuBT7ngDdkEccjAFVRIM7TgEdMfyoAZMWIJ4+7nrWDd9VxjqelbcxwjkA9DyeKwLh/wB5wPxBxQBWk9/y9aibgc5P9ac7An3qNjgjA6d/WgCJwRnqajZe4qQjLEcZqJiPxoArSgBW44xkVTJAGeBxnOeMVoPhcHr7ViarKBcGFFBYYyueNx9foKACS4yPkJVezEcn6D+pqt5gDEoMt3bPP4mmorSt8uHbuScAVYW0TA81vMI7dFH4UAUH3SsVUbjnG1BR9jbIEgRAQRnG6tqNFwAFUDoMcVA6jJxjFAFGCziidZCC0nXJ4APsKmxjoPpmpSMdRz6VDJLGgkLMMRrlsc0AMd1RCz9unvVOW8xcgKcRryMHkn3qLUJC5iGfm8sFgOmTVIgk+/qaAByMnH1pO460pGF7CigD3v8AYw/5Knqf/YFm/wDR8FWPjYT/AMLf8WAf897f/wBI4Kh/Yz4+KWpD/qCzf+j4Kk+Npx8YfFeP+e9v/wCkcFAHE/n+VA+9yDSkZ5zTkXnB6mgB0SBj0z6ZqZV/nTIe3v6VMv16UACE7iP4R+pp4k2kYGT25psSnJ7AVLEoLA4JPfAoAztQjeQxHJSMt91egqrcWewHYDjaRnP41sagFeIJt5PUVWBElu5ZhuUYYd/T8qALmjgRQkEDcf8ACtZ1VoGEgOMdfTisOAiHAJC8dO/4CpJ9RkWNvJRmIHO7nH4dPzNAFmUqgLkhvl5JHFYbqgkcpl8thewz6AmrW17hFkmYn5QRg5/+sPwFLAUhmUquG3hs9yOnWgA1ISyaS1vJGRZIAzkRk599xxj8KsGbWLpI5Cbra6KVO5F4xx+lbF9AlxbLEYvNUFWxnHAI4/Hp+NVZZ5CqW4wZUG2RwQQnXCA9yBwSPpQBi3b3+1oXml5+STFyDxjlRj8ifwrN1eG8ht1eTzPLj4UhwwG4YI/lXQRQmK2Quqs7ck44Htis/wARnbpdzg5UgHg9PmHb3oA4wysCoYZ4wM8duxqKXayEnjn8RUhcnIbp0A7Go1wsmSFUZx+NADBGSenOeTmuk8OaVPttNUQSmzMjQSGFvmVx6gcgHjtWAoLZQ/NgnntXbfDm3nOsCWKURQKjiREfl+OMr/WgDrYbdoVwQQdxbJq2It4PynHtzV+O3CkbFJbGcEdKbJC6AGT/AFn92gDPlhaNg6BflPK/0FS2atKWAG187uD8oFTmFmB4HuCeas6ZaxNK+7bnaMdu9AGt4ADf8LQ8HlydxvJ+M5/5crn9a+m6+bPBUKxfFDweAwZheTjJOTj7Fc9a+k6AOJ+JL7NR8FN6azJ/6b7ysTWLnAfHJIwT0/KtL4tP5cvg9znjWH6f9eF3XKXUrT3AHHz9hzxQBWjt5dTvUsoJfJD8zT8nYvoO26uytLPT9MgjttPi3EcBU+c/Unp+JrmvCl1DbTR3M6F7djIm0ZbMm7gnHbHArsrjWLZodqgqx6hflz+FAGLfyzJGoMfQ9d2TnGMkVzV9eBI5opk2nBJHoPUetaF/qEZdmO8ZY/d5x7fhXBeJdahuVkMTnbG33wOS3oPWgCvd3rcANlicJ35PepNL8meK4SIBlRsg46+v61yz30l5L8qFVHGG6j/69dT4caKy0+4up1LRBMADlm57e+aANCWyELbZwrx9pOw9jVObTkdiJogQ3c9f/wBVV7fxON2x4YTHINojLneef73Qt7YFWpdWs2twUmxEx44JIH1/r7UAc3qOmshl8n5VVfXgf/WrlXjkZm4HB6V6FezxtaSyL91kxyuMH3HrXKvbpuDDOfvfn2oA56QeXgMu04zg1Fnd0PPqOa6Ce2HykjA9ao3VgCoZeDjjjrQBkkEgYxTTkrjHJq5JZvtzuIUdcj+VYmoTuGeGNj5Q4dl6n/ZoAhvLsAMkDYA4aQfyFZrWzLcK0iuifK2P4iDxW1b6Y6xrcSBSf4I/7o9/eo76CRinykFgVJJ/EGgCssQABVQAOAKUrtB4z7e1V7y9aP5Y0Bf+Jn5wfpVWO/lMNyZHJlIHln0NAGmOwx09e1UGu7bcwEu4qM/KCfwBpk9wgspIfNZ38rByM7mJ7n2rKBwT7jH4UAX57z/RA0fyysf4f4R/jWc7v5WzJCddvYmnD07H3pG4oAikJO0nnAx0phB/H6U8jK/Q0IAVJPXPFADWXnGaekRwpPfJH0oOVIPp61ftIS8Jc4AYYHtQB7P+xmP+Lq6p6f2NNj/v/BUvxuP/ABeDxZ6+db9v+nSCn/sewmH4pahuAGdGm6f9d7eo/jcAfjD4r9fPtv8A0kgoA4sEnvgZqVeQBx17Gm7MHj1708YCEu21QMlj0oAWPoCO/wCtTqDgdj6GqsUjyBHjiBiJ+8Dg59D6VcGyIqGJ34ztHUD37D6mgCaNRtJPPpj/AD0qyZPIiMkojjQAn5jiq0bXNwFW2URqf4//ALI/0FTrpkIANzceY33tqA/zOT/KgCrPewsQcNJu6cbQfz6j6Cqk9vctmVYDCOrY4De/r/KtU28ak/ZY1TCkgdz+NVIHaOHgZw2M98UAULSNV++S+eoPAPt71cvJAbVkC4UjbgdhT0hZWAIPI46fnTbgkoI+PmYKenrnNAFewk22/ksfmiypPrj/AOtVmwiRrknhtnzfT3qnGxjvmLcCRc5B6Ecf4VcjkER5+UNxx1oAv3lzKsD28IK/KPnXqqk44z069feqtupQLuG5RwAOw6VNH5U7PGny715BPJGOP5VWgfdbROMDIBYZ9un5igCwW2wl0PyoRn1x0/Guf8TSAW/kgFQSCy/r/hWncTqisxODIOR3Nc7qc32lZJepULknvxjNAGAw5x2I/OmEc+me3rUpHX2qNuuO9AEkQ5A/h616f8MrEiyu79xgO3kRA9SBy5/PC/nXn2kWE2o3kdta4WSQhDIw4QEj5j/h3r3G2s4dMs7ewsVZba3Ty0zjLdyze7HJP1oAuwuFLKw3A/dOOhqEo7B8DLY24x0+lQsrZynr6cir1vFh1yNzfXp9KAKLxMI8YJIIxilguEt7lWmJGD8wAzmth7YSglVXcvVdvX1IqpPbMU3Z+Yjg56UAXfA17Dd/E7wmIkYFNQuF3N3Asrkce1fSlfNvgZAnxG8GYJJ+2z5Ldf8AjxuetfSVAHnPxobbF4RIOD/bLf8ApDd1ytvA99exWUauDMu6TZwwj9Ae2fXsK6r40Y8rwjuIVf7ZOSegH2G7qr8PbaO8t9Sv7yY2yXD+XEoOJDCBwxPUZ60ATXtsNNsxFDst3K8xlcqe3T+tcZc6yy2QWVZGZS2GDYVuecn2zW34xWC2LxW8rTAfKo++T9T2ryrVb2Ql40k2HPMZ6L/jn0oA6nVNSlkbyVKxwDI+Tq2O1cJrc2br90wAHJAHc1H/AGncbRGvLAEAljxzWdO8slw3IIY/M/8AeP8AnvQB0nhm2iudyMAMt1HU+wrob2aJbSWzjjVVkBTJOR6CuT0W6WzWNOgDcnNaF3cGZgVAXBz1/lQBwWo2dxaQqzS+XcBipj/uEE5Oe+exrVsdUeCO1W8Yp9nURRI4xufbnqPTOea0fFEKXOnRXWVEkZEbE/xAjg/mMZrktTljbw1awqrG4juDMznrjG0g/XP6UAaF3rNxLC8bzESo5G5Pl3ADgnHUmr2n6pBPYxS3MqrNjYypzkj6etceHd4wgORtPTqPrTbFXRv4gmMgHvj0oA7YX9tJO0IEnGMMRwSe3tRJNAbkWwnRpz/DkHPfr0zXKidkkbZ97rx9Ky2m2yq+eQc/U0AdbrE4SIwxnaD1PTj1/Dt6msfT9M3y+a7IIYf9odf8f5Vgsxmn8yUnK9Ceasi9ZCEEaMqAkKy8D6+tAHTvLDEQjzRAsCQgbnA9uwrG1PVbQRKIFaVi+8NjaoC+nqO1c8J2LyyNzIwOTUMjkqgJ4CbetAEM0xkdnbqWLce5qIMeeeaVqae/86ABj83YAioiMfhUjetMbrQA08e1Nc+3BpW601jx70AN9jT4Y/NLxjJcg7Pc0w9PWtOzs1klt7gMTEBuIzzvHb+tAE81jHJGoBKlVCkjv+FS4AUBRhRxgVYG00xhk8ZoA9j/AGSB/wAXUvvT+xp//R9vVb41jPxg8WHsJ7f/ANJIKt/slZ/4Wpe5P/MGn/8AR9vUPxkGfjD4sz0E1vk+n+hwUAcS5WNMueD29aYZiyECDepGDuHGKlVDId4GQeDVa9mECED7zcAgdB3P1oAmW6UbLeBPLI+XK9vYZ6e7HpWhbWccWPM2ytnJHVAfb1+prP0pFij8yUDe3XI+6Oyj2/ma3Tc27W6RZVZDk5IFADtzORlgD2PpQOrBFJIGcAVAXIYfMVycZ9M11mmWiwxABI27DOf8mgDlHtrj7O0sisiAEHaMd+x71kywbFBKMf3nzbq7nW4GlSIKqJEFYqE5AYEY578ZrBnsFUzI0u/DA7m7gjrQAmmwho9vlAgj5j1xUy+Hzd5ITaBlgfujcB1q74fjV5oEdgFddpJ6A9vxzW3qE8cSqsQyEwjfXPH4UAeeXGkgLFKQqP8AMSQc4x14qquRMGX7xKkq3UVt6lOTbynBXG5mx2bPIrJmQOCcjjkE8YFAE1vOEn3TABo+SR2FQCdY45rfeN6OVBBBzk5U/SoZXHlICWbepzns393HrjpWbMGnjCwqfMXAZQeo+lAEd7el3JPBzyPT2qorbnZScB1281fFgZVy5IPqOo+tA092TYP9cOVP976UAc+f16YpmMnHbucc1sTWCu/zFoZScMCvf6etbll4eFvYyXLK52yookddoHPOAeSeenSgDX8AaHOki6heDy0UBolBG6STHX2Cgj8cV3pGcCQE4Gfc1m+GCj6LZIg2KkezB9QT/P1rS2E7jkbQOQeaAGjBJAI3E8cY/CrtmxLBXJBzx/8ArqmEAO488c5p2+UQsbUI0mMor8Kx96AOjto9rHGSQD26+2KLmArHGyrjcecjnPWs7Q9RnmtRJLbzW0ithopBzkHqD3B7flW/EBdxMAoIccYHegCn4Wj2/EXwaw6G/n/9IrqvoSvn/wAOKy/ETwaH+9/aE/4f6DdV9AUAeZfHSB7q08IwRqzPLrgQKuckm0uhjitS4h0/Q0uH1BbeO3htlBOBn3Uep6Gsz45XsmnWnhO7hOJItaJBzjH+hXVeX65rM+p6czSSNNK4IZnOcA/196AJ/EOo20lwJ9NbCKuFVGwrA9c+1cFrUxCS3Ez7gvJ28k9sAdz0AFWlWcQhFJx0Cg5FaX9llWtLhJvKmgnS4hcBWCuvI3AggjPOP1BwRM3JRbjuByMqSQ3z2WoW9xZ36fetrlCjgdiB0I9CMg1ehjxE+UAXHGeOen5V6pNrug+LbWLTvHdlDbXA/wBRqCZRFY4wQ/JhYnHDEoTgbm6VzHivwLrXhmGWa3WTWNLHIuI1/fxDH8ajqP8AaXjqSFAr5/CZ+vaLC5hD2VXz+GX+GW3y+WprKlpzQ1RyFu+2QBiN2OnbitNZl8jlgQKw4RPPFNe2kfm2VsqtcSIf9UrHarEdwT3/AB6ZItqWYbV5JwK+gjOMm1F6rfy6/kZWL9+ryaTPIoLhZIy2OcjmuK1ErNBtTBCk5XI+X612smofYLNUI3LMxVgem3BGf8+leZXVxtuXZG3ZXax6Z9zVAaemxqbeBiAWbcDxySKlMJGw5Iwxx7cdam8O7pre1BYBXYrnHUda3ZtI2BXDeau7dtGMhe5xQBxwH72TLA5bPP06VmXGRKF6N1+ldJqti9tqRjKhQ6iReOGUnqKwLlf9MZsdT1H5CgCtkBiBxxgZqJmznk4x0z1p8y+XPgk8cHNNaNg5XjI5x3IoAqk/Nj16VEx447GpZ1KP/npUUqlXKkYyMj3oAjfGaRuuB1pSDg+1LKhXYTgqwyCOh9RQBEeRTWqWJPMlVAQNxwCelMkRkkZWBDKcH2oAhOe351JFC0w+THy9R6CnywGOQLgsCAVIHUVp6XZNATNLxIy7Qufuj3oArabZi4t5fNTMDEBHBwcg849q1NgT5UUKBxtHan8BQFUADgADpSAHOAM46kUAR/xetDtx09qc30z71E3pyKAPZf2STn4p3vBz/Ys/P/be3qh8cHx8ZPFY5P763OO3/HpBWj+yZ/yVK8Hpos//AKPt6q/Gbn4y+LBxzNbfj/okFAHBrIyfdBP90ioCHuL394AAox9Mc/zq+sAg4c5AORjp16VWtZUmupixO7DdOh+agCaO4jTcgOD/AJzj3rV0pUkkd5wo28L6VhXTI1wiRkbVAzV2CUh1Vevc0Abtrbxy34jAGwLvC+pzXe6Mm4IrjKEcEHGB6GuD8NqX1qLJBIQkcdhXpNskcA8yQ/uSc9P85oAj1XS4n0x1LlZXcbPbByTntxXA3m+yY20+XKZVTj7y/wD1q7a71L7RIysGRANsYzgY689+axdTdZoVIRQUJDADBU+n8jQBiQkxxFQQQox9Tj5SKydQ1l2idXJClPujoxrRkmSGXYpUgjcpzxjuPwNc54l8qGPzADtkyyAdQf4gce/P0NADre6862USO3zqG3sc7GHBI/T86ic5t5rdGKyR/Mh6CVDwfoc9aoWFz80sblRFnKAjG0Y/wp8Uh+0xfOgbOY2IztPp9DQBclRQMrGwbhSp7/4fWi0tlE5m3ZUA4bHTjoferD3UVyqqQouWHPofXb2I+tQ2thcXUoQHcOg3ZYD6HigCyEQP+5aMk4/iGD7UrJC4Ebc5OSAclT61Nb6CZ5VhABkJyW3Y2oOpxj8vWrVxpFtppUtJLLuO0FsLkf7oHSgB+nWE1xJHO1w4gjzsd0O44/ujPQep71o6uI2sDBCzABSctyc5ByT71SsrMT8xzsrH5fuYz6dCKnuba8SGTBWZQp5zvJGPfB/nQBa0GRobFEBBIU59PvHFbAmMgHO0DjrnFc/o00ZgQS7kbkEgZA5/MfWt6EAwhkKtGfulTx+dAE0IUE7xkZx61YVMPkYI61XjJBHyjOcZHX6VftV3NhgfxoAsxHOAWyB/eOKv2M3lzbefLYZBzjA/z0qmEEcgUnC+p/pWjbQsUQuNyrk4Hf0zQBY0hdvxL8GnbgNfzH6f6DdcV7xXiGlxAePPBEoxzqEyn3Isbqvb6APJ/wBovb/YHhvd93+2Mev/AC53VeUxOIrHYEDSEFFBbknsa9N/abl8jwr4ek/u6yD/AOSlzXj8WouRvULIQmVx79vagDbe1WBRHuVnQAN83c+lUr3U4YbkKxyiDaeO/ce9ZNx4jaBHjZSHI+b5hz/hXN6lqjXQARFgAGBtP60Abt7rrGMqdoB5PGcdvr0q14N8e674XuoraxVtS0piFXT3zlMnpERkqeeFAI7BcnNcdZrlC+MnGc0/zp7WZLi1uJ7eeM5SWCVo3UkY4ZSCODiuTHYKjjaLpVoKS8+/ruvValRk4u6Pq/RdG0t4bu/TRhYy6vEv223lUAtw3DoCV3fO2SOT3zjjw3xZ4afwnrradydPmzLYynnKDrGSerJwPcEGsDTvHvi6ycCLxFfFD/DMI5v1dSf1rW17xn4g8Q6R/Z+ptpk2GWWGf7KwkjkByCCHA6ZB+XoTXyGT5JmuVYv2jlGdOVlJXd7LZ6r7PTXbQ3qVIVI26nOeK5ClnbYyHMhx+A4FcROhmjbbx83LHjrXReMbkS3MUcJZ8JkEHAAxg/iTXNyXEihQPnXd9w8du1fdHMdho8ElrpyID8iOjhkAIz/jXTxzo6h0OVbn1rldJuIRp/yo5jkAUjvnHOKntLg2w2gbowcgHjFAGvqhgW1LtFG5hRvL3DO3PHFZEml2t9p21l2SBiIpR1UDgAjuDzxVbV766liURxiJWbOSfmOOfyqK0u7i3RIywJVRlH/nQAt94cS7WOWF3SSMgTKf41B5ZfTH61V8Q2lrH5Z0yBtvODkkKfr71qxyyXFsgbAXkEDvz3p0kixKQp+fGM+lAHOLoo+yRm5UyySjOOFaLPeom0Kd08nqqcxzEYBB/hPcH9K3jcrggFt5xuJ5Zj7monn5zn7vOc0Acdf6ReW0hzBIVHRl+YH8qvWNgJdOkju4jEwYMp7jj+tbk1z8w4zkcgVlFmWQoy9cp1/KgCkNFHDfaCBjIwvIp15ZQtK87BiWIBXtnH51rMGK8Y9qhkT5fvc9R9aAKaAogAwABgYpec5oztY56dz6U7IYEg8UAMH3hjH41YEf7lgRktz9KdaQ7ySSMA1adAF6fTigDIbgdsjrUeMnB+tWZEPmNtGR1pqxsBnGe5zQB7B+ycMfFO89P7Fn/wDR9vWR8d5kj+MPisbC0hmtiCD0/wBEgrb/AGUl2/FG69f7FuM/9/7euc+PjbfjR4r9fMtvr/x6QUAce169xGUYYCDnnvUVkfLuuTgPz6dRn+YNV0mjTaRj6CrTxkIhAwR39iev4H+dAEkrKl0zdwecd6tWKvcOzYJHTiq0kkZHmOOf4lPr6UQXcrsViXEZBU46n/CgDrvCWZ9bhlQ/KkbL7N2/KvTxMsEO9iAqcsTghc964DwBbeTI5miOw7EJUds9B71s6NqOuTandx68ulf2VPvW3itP9ZGVbgMQPmyOuT1oAm1W1jkUxw7o5CC8QT7sg64we/cVyzXwW4GU3MBtmBPMijsM9x+vStHXb+7t4DaW7QIVbMbtnOM8DnA49utcnNcTyIZGaJixw5SPkY/HrQBtvbmeMxxbBwJI2XGPb8D+lZOqxrdLAjZjkLhJE46qMg/UAdfSrOk3ssqLG0e5c/Lj5dp9h3p+ox7IhNcxkOWLIQME8dfp7mgDiZY3iv3TAjOM5zkcdD+NXHiaYKRGFUcFSOM/4+1WryNLjfIy7WLDZt6g9wv4Z69adPOCxjSP5Rxt68e4NAEZLlBbQwpJDIMuhAPPqSea6PQtGkv2EVrA6xqMSOJiY192YfyHJqn4XsbOS+/fQhXZVxLJGDsPYDqBmvUX1GJLeJbaIIir90cAHvQBkixg0yzKxAbQMs/djj35rjdTdprldxO/lsDsMV2eozF7VYyQCDklh09Px9q5O5tfLuJGDbguASe/f+tADLORo4Aqth179T9avPfRm1lRhg+WRjsO1ZZJDDANNu3xbkAkszBeKAOn0+KCXTIA6rKQoOOSRkn05pxs5UdpLByc8Mp4b6ejfQ/nVXSiYplVSV42nHU8da6bT0EvyswyvTj360AUbGQyttlxFMp2/NwpPoc8qfY/nWwI5IdoYFe/StWbS4LqLMnyy4wsgGSB6EfxD2/lWTfzTWUsFnd/cJ2pJuLBQeMg9Soz35XvxQBr6PYtdHzHH7lBx/tEn+VdQunK5RlAwBtIA9f5UywaK1jREjHlgAf/AF/fPWta0kiJwcYOeM4BOPSgDJaNY/GXgYL0Gpy845/48LuvWa8rnfzPGPghsYH9qzAZ6/8AHhd16pQB49+02qt4V8PBxlf7ZBP/AICXNeFNMzWXlliAo27Rxx2z6171+0j/AMi74a/7DQ/9JLmvDZ7NkZj+PP8AX/CgDlLlPLuJFIyTgjPpUDJvdlLHjgnGK0dVgdJdzH/Z+UVBDAI1zIcsccD/AD1oAsWR8mIANtXHT0+oqreOjMQuf8TUN9fRW5ZFYO56qp6fWs4amc4KLt9DkGgDdto1kIyT9D3q5JI0FuzNgFhtGec//XrCTW4I1yIzvxjaTSwa4k1wr3iExrwAvUfTNAEd62HYyg/N0PovpWRcIjyDZjA/nWxeyx3KtIrFgeTntWGoZZS0fJ9KAOj0J8Wkik4VDuIPUe9aMEiySorDhv1qGwtIbiwWdeZJBgbTgDHUGos4nQ9jz9O1AE+sjfPHGvoBnHQk/wCAqrKFcn+8MkH0qfzPPvWXOCo4P+6v/wBeq5YYI7DvQBNZT7kcHOQcsOmKS8bnjof0qkH2XbFerAZxyM1MSZEBHBH60AVpGIboRk5FMebOF4IPXApZwQCFbp1x3piR5X5cnvQA6Ny0hzzxUV0hZgex+Un0I6GrGAmWJ4PXinIgk3K2QCvUfzoAbGd8SOM8jBHcEdaZL6fhRv8AKlZZOOiv6Bux+hFEv8Q5+lAFSRcgn1qtKDG24HjPSrj8Z/KqlwckYPHpQBdtJlVee/P0qeSRNp3Ec9veqFurbWPY8c8U5unpmgCVU3HK/wAqnEWT0/M5qG3f5cHr3qyrYAP6CgD1n9l5dnxUuQOv9i3H/o+2rkf2g1z8ZfFBzj99b4P/AG6QV137Lxz8VLk5/wCYNcf+j7auO/aFjZ/jN4pwxx5tvx/26QUAefALIcrndnGQa2bS4cHA2YxgBhnt2FZdrFjO3v36Y+launja24/cHXPGB3OaAM2aNoptxLNG5weefp7e1X7S9t4nRcB1U/NjjaPSnazJCLXzLW5jWBiUM2CUz/dYjlT9RXMGR4nBAI/2uoI9j/jQB6paa7FaWMcU5JsrjdLFcp1TttYenH1FXNOu3ltlWaby7ko0m/PDZwdw/wBnpx9T1ry+z1Vo08mbL2rtlx0Kj1+lbek332Z0tHUMisGjZ2ygB/gb1QjqOx5oA9A1NjLAs8UQeGPDMh+b3Yc9MHpXH3F3Gt3cqqCGFiWLEYx6/St2We8bTZHtbcCORXjTKk4furE4HTkHHaublU3VzuuQY3VQrMDuJP8AIfhQBa0y7G9Y4Bul65/lx/jxWrdiFLZpbyffIOWUHcCfUnv/ACFZFtbonEKqM/3u59zUN4qvH5S4Gfv4PP1oAaWW6k82NQUPzAjk1UcfM4IIJcrn0FMsbh0UxoMBfvfh0q5eMBn5Cd5GMD9aANDSCogk+Y8twvQBh3/lXTrKxjWMs7HA5Y81geGVie1WFgFmxuQP3yfXua6O48uCINI43NyPfFADLy4VAFQYx19zWX5qyxyfNlurZ4/Gql7cO7kHHU8YNP023d5Q7cBeST0FAEag7u+0+3X6VYjtnuL+2gRdwX524/Hn8B+taVqY5xJJHbYSN8bn43DGSR7D3rP0/UZL/UZvsrqiytsE23jA6hB64AGaAOgtzBZNGJpB5shwvp781d+1pE+WwMY2kHDfUD0981mJYxyhX8uS5TdsAUBVBxnB/wA9akMKRp5bPIFBA8qLnB9CaAN2x8TwHZE88i8lV82Dhj6Bs81cldL8gvKGKnKOuPkPqP8API4rznUbe4llkdImeK3ywRGHy56lj0BNXNC8QRQ3ENs4uJrhiBKysvlJnoFHU49fWgD0PSNWNlILG9YRr/yzk/hXJ4x/sH/x08dDXVx3SJkqyjA2884+tcNcwLcw7SRvGTGW6c/wn2PT/wDVUmjXP2mIwSj95GvO77zKDj5vcHg/gaAOyh1CO58ceCoY23H+0pXJA4/48Lsdfxr2KvC9DA/4TrwX6jUZhx0/48LqvdKAPKf2hporfRvC0twpaJdbG4Drj7JcivJbhIZDlGD55BA6V6r+0giyeHfDayHCnWR/6SXVeC72iACO/wAx4CNjJoAh1pI4fM3Mw2DceO/YVy8+sRrJzAWT1z1PvT/EF9I1w0WcRoSMep7k1ztywLdTQA2dyzluMEk8e/pUYORg/wD66arHOOfenbRwR355oAUccUu7HB6elIvTPekfGRg8duKALNvOwIB6du2RUsSYYSLyD7d/SqUQw3XitbRoXuJWgzjAyTnt2FAHU2Mfk21uigKAvOB1yOao38RScKDlGyR2IHpWpOXigDDay8DKnGPrWdK2LlHkIOCM+lAFXTt7XU7bTlQx/UDNSThS3Ri/TB6VHbSqbmbaeSDjn/apbw5cHJxjoO9AEMMW+c7z+A71aYZxgcDiqBchzjirkEgdfmwSP1oAjWPcWDLgseT6D1pAFVcKMduaknQ4HRWz19PrVVxNx8qke3NACTMNjA0tq2FBfg4KH29KjETty5/+tUqx/KQgGB69aAEvI943KMsBjH94en+FU0l4CsTjopPH4H3qyQDnsAOmarzW4kyyqCx7N0b/AANAEbtvJC8n9KRbcscv+WOv1qRHKrtkzheCccr9f8atKF2hgcr1z2oAqleOOAOntTdoxgdankAz0A+naojx260AREfMGB5pfNYeh447UrDPPWmNgAliFUdyeBQB7H+yoxf4pXWcA/2LP/6Pt6z/AI02C3nxf8WF324nt8Y/684KufsoMW+Kd58u0f2LPjPX/X2/JpnxfIHxc8WnoftFv/6R29AHn5sHTI27EAyWPQD1rmdbv7iI+UIRHbEdGKuJPcspwPpWv42nuFs4ooXRICC8uWwWOcAe/wBK4ISMpbYdoPUDoaALsF7Nbs5t5GRXG10PKuPRh3FOEqsT5IEW7rETlT9M/wAqoB89ePelB9frmgDRhkHmbkO09CM10WlXcSQmO63CBRyy8tEexH95f5VyiSbuG+903f41btriWCUFGKsO/Uf/AKqAPQLbXXhQ211MoOxRDMCCrAdAT6c8Hr2NSXEkRXcrpu5JyRya4iSZZYDsT9xnLxf882/vL6ZrZ0qECNcgNEyko6nj0IPofagC/DOduQ4yeBzRdMxQsXBJGARzxVZ44k5UkgZycd6tXGnOmnCZ22uozs/z9aAMiC5/0rnGDw3NdCFLeUw+8MZ9MVzRtFhvz3Gc4/CtzEWEMbyBhg/6zpQB08McSKoKjcV3lc4wfb3qhel2m/eSSJnorPwaisGghd7u9djDEAxklbIGeBx9cYqhqF9bmUf65ACSgMaE/wC9uOQf/r0Aa9nHCUeZ5QkCDc0hyFwPc1DBr6NOwEMj2EgMYx8j5I4Ye31rnby5EgQs00jK2W8yTcD6YHQfStrRLEz6c0tswdPM+5I3KnHOD3/pQBqSNJFoH2a9kZbp8KiZ2kI2SB7sBwfqKNFsXtJhbXMcq5XbHIo4Rwc8/wAqSAPd3ENvcQFTACzZOc9+vX+7W9ESyEHJyOpGM0AXYvMDOkj+UHILAYw/1Hp9Kc4VV2KgAz0J4x9arLIyoFlUEEcEmm3E4hDEsOmdhPJ9h9aAKmuLJNbSRiYR2UYJdIgFLkD+WccUvhbTYYfLkcwCYfehUjKDHHPr34rDvbZbnUSb6V4WKruiRwCgxkDDHn9K6bQ/scaxwwiaToNxVSB9CKAOl/hAAxxniql0Ta3sN6inJYh1zjLY55/2lyPqoq+qsgGDnPOKS6iMthOo5KKZR7MvP9KAOh0VMeN/BDBtyNqEpU46j7BdEH9a9yr5/wDBsvneK/A3ORHqdxEPcCxusfoRX0BQB5L+0cofQPDSt0OtD/0kua8s0fSPtE+9eTGG2jb99gDhR+OK9Y/aECnRvC+/lf7Zyf8AwDuq4DTVeWd1h3BdoIA4APrx3oA8C1WZpbiV5SRLuw2Rgg9xjtg8VjvkEgdK7z4lPEfG+tR+SVZbg/MVwW4HzfQ1x5RXf60AVUjLDIBx605UIyCMY9auBQkDuqlioLbTxuxzXp114C0SDTrdpbrU/tTRI7yIUALMobCpjoM4yTQB5HICm0MCM9M96cY3Me7Y2wnbuI+XPpn1r17SvDWlxQlG0/7SpGGku1Dls+3b8MYpt3pFvZ6alnbx7rFQUWJz5gI5Jznvz17UAeRDgHg5Xtit+zhkguvmzGu0OWx6dP51buNHggf92srxqejOSP8A69PhimuTsVCSDxx0oAuxSh1KDJ39VzWbduS5x6/nXRadpJVkMw+b+GPPNTaj4am+1uJIyhIGPLO4E+mfWgDhrcsLuQDOTkD860rlGKI3QEd60I/D8iaxLERn7wy54+6D2rUm0Z41G1xIVOXG3C49qAOQZDnJ/PvVmzU7uQOn4VuyaQhXeIwD7HkfhWaR5bYwOBxQA4gAcjPsfWonjAORgKTggjOPpTgdpGRzjn3puTxyfxNABkAcAZ+lMfG7nv8ApRna2CePTNMkYYyMYHegBkqbgc4HHNNYLsHTPSnuePTios8AYI/GgBskayA7hyBwy9RVR45IiGQ5J5ynBP1FWhkE+9MY5680AUvPYcMFP1yppvnA4+Qn/gQq4445GcdvSofLT+4n5UAQPcHoAg7cncf0pqxu53NnrwzD+S1ZI29ML9OKMgng5PWgD139lJFT4pXeMknRrjLHqf39tUPxhRj8W/Fr7SVFxbjP/bnb1Y/ZVx/wtO7Gc/8AEmuP/R9tUfxmvotN+IXjq8lUN5MsDKp5DubO3Cr+ZoA8U8dXqvqggVQxgXaSex9K5bOc4/SpLy4a5uJJpmd5JGLOx7sahH40AOpyt+VNUe1SpGWDYByoyRQAAkdehqeMkjn/APVTYE3sIyD833eO9TpA6MVdGBBwwI6GgCS0lkhlDqMgfeBPBHcGt+3AgwI32xO25UJOR7H6VnW1k8kHmjAVGAP49K01kDSKgXp1570AaUNyAgMsa4BxkHgc1YubzFrJzhj05HFVUkjWNV8ss2eMiqdxua4kAB24Xn39KAEMh8zfIrb/AE29RT7WeR5lLxlhnt1NW1sojbblLbSMgHuKLOFXxwMKOMjoR3NADdUvU8z7JIj/ALvbgpJgk49OQRVQxS+WjLbyhW5TewGffFOF95ZkNvFFgHBaRcmQZyR7CoZLp7qdmAdWI6nDEegyR0FAGhZ39t92fTo7koCV8uIEkjoCxwFHuM11+nX9teW6m0WNApw6RjCqx5/EZ7+1cVFbrNCftV+yKGGYpRw3uP8AE1dtLuy0uKVIXmkeRcOVbhSOn86AOjsrwie6mkbBdgoOOo64H6VblvhGqSgFoc85P6YrlLTUhHbrEZHZXBZGCEkn0qezkla3lU5I5Kk8Hn1/woA6Zr2PzFMOOdvK9GU9CKlv5LgQFra7itWj5JP3vqOxxWLpW1zGGfdFEoUyY+8xPQewq5rDJ5kcgQSqcblbgDBOCD2NAFLT4LCeTMiySs7km4uGOXOeS3pXYQXttpcUCXZhtzISkSoC5kIHQBQSTWbogtpCEkgaJzj5TyH98/0rpJ9LtLm3WKQOApDo0Z2PG4OVdGHKuDyGH8qAHJ4k0gfLNd+S4/hljdD9cMopZPEugi2mU63pSOInBV7yNSflOBtJz9K9T+G/j2S4ng8P+Kp4xqxGLO9wETUFHt0WYD7yd/vLxkC/8XfGV74V02yt9JgQ6jqTSRxXE3MdsETczlertj7q9Cep7EA8s+G99aXfizwgtpd21yV1ackwzLJgf2fcgHg9Mg/ka+ka+e/Btgth428HCWR59QuNTmnvLmQ5kuJjYXW5m9McKAOABgV9CUAeUftEf8gPwx1/5DQ6f9el1XBeH7qGC1USLMGdiWaPkge1d3+0Y0SaB4aacZjGs8jOP+XO6ry7R590aqpYbcsT7elAGf8AGi3tLu007U4/JacbrdpEBBdQuU3cdcZANeMyYODjnPUda968RpDq2kXdqQTKybo8DAEi8rj9R+NeCXca8kBhntnv/SgCRLlUHzdvQZrox4w1mezjshPthTgED5yOwJ9K48bVzmrENyUxtxntkUAeweHHkt9At576+8xrli481i3l442jvn17Vcu7mNlHlOjqSfmXkZryH+0ZmG155yh/gVsKPwrT0nVJUnBVjtc7WVjkEUAdXe28cxBVyvPRQBVjStOj89R9owD8uQveqZkIk2lhnoOcE1fsJNtwpdxj0DUAdTYWJsJdxkVwVwwKfMKL9yXZiQvAHrRcXYYYwSOOT39KzJpt0rsG5HFAGTPcqmtqwj+Xcg/NCMmr85UQMA2d3Q1iTxq3nZdiXYk561d8zfDEuRkYUEevvQA64UsgQAcAAn+dc/q0RWRGUYHX8K6CQ4XA4XoOKydQQyxuSMEjuOgFAGQMZO4DjtSOMDGMewpR06mnbQeB2oArMo701hgn1FWGX1qB2CgjqR1AoAjIySaawHQ9PepGYkY6VXdsEc8+uaAFdhzznmo2frnikJIzmmFSwywOf7ooAjaTnrxTGJOc5qbb1yp45puwAnOcfrQBHz7ZpMcZOOalfGRgH61GACP8aAPX/wBlP/kqd4f+oNcf+j7as/483VvB4/8AHQu7MXsQmtmMBcoG/wBFtucjkY68Vo/sqf8AJU7vjpo1x/6PtqrfGDLfGDxagwGeaBUYjO1jZQYOD1FAHzreukk7PFClup/5ZqSQD+NQqORzj8KW4ikhnkjmUrIjFWB9e9MBx0NAGjDNDEv+rDOcjeDz9MdKjinKuSnDEdc4AFVAfelzxQBo/alQgbVkx36ZrobHUrLVLuFbuEW9wUCEoSyyMOh9iRXHU4McEZ4PagDtdSEMccrIpRBxtXq2Oufx4rMt7qMqCxALE7lzwARgD657VUtpzcab5Ukrb4ySp3csO6n6darQlxOSmCEYZPp2zQB1FrcxuVVIADtwuev1PbNPlJkim3ZGeN2e/UU7SoYodPeZivzsxHHUDv7Cq9vPFPclJGIZySEHUgdAeyjHJoA2oZRJBG6cZUcDtVSRpgJVgQEODkN9KQTiCQpvVWCliMcH2qK5eMWMzBgzbdpIJ7mgCvJZvDbJK4iQH7qBiWPv6VCI5OCxiQE9d1UVlK/ddAD1xwPyq5bwCXl5MIeQccH3xQBYtIYmkAlmAJ67MHA9fpVqOGJt0bjah5EgGR7VRFwsZ/0YFYxnJK53/UelXoJ55lDL5TJ1EbIePagC9pbyadhpCTHINpwN2PcHsa0Jm81F+Y7SSB2LDsQaoW8cVzJLHAJRayW+cMvFvL359AemfWtnT9GW4tI5HHkzhgEKZ2bR6j1NAFuyihFpvDoI4vnZEHf0HtWhbws6LtyFVg4V8EFSOg/WrMkCCNoo41CHhkxxj3qeLAxkjOOOOlAEltbRhUIYJsJKn1J9a27B96bGBWRRx/8AXrMgGTkcDv8A/Xo1a9W0gjXlZZDhQvDAdz7D3NAFvXJLKWykguU85AVLFGKsrg5Uow5Dg8jHIqSfxbea9J4V0/xDG811ZXUxi1LZmO4TyHwJMDAkVgmezYyO4GHaW8l+yPN8sA4AHGR6J9e7nk9q6SIiOHJHlxxjG1BjaB0AoA6HQ+fHfgo8/wDIRn6+v2G6r3WvBtBm87x/4JOAB9ulwM5wPsN11r3mgDyH9pYZ8NeG/wDsNKf/ACUua8n0iYWsiF2O12K8eh4/wr179oqPzdC8MpjOdZH/AKSXVeTqiPcgYGwEjpyMfSgC0tu0sykSldrEqygkZHauK8Z+GFvJbm9spUhuCSzQlcLJ6kY+7/Ku/fMBQMrJvUspOOfWuR1e5kEpbcFYHJIHTNAHkc9tLE5DYBHGM1GAynGcEf5zXT6ppYmuJJIXCq3JVux9jWS2j3WQq+Ux9N4/OgCmuAmCSPUVZt5ir5Tr2NSLpN5u+ZVXH+0KtQ6X5bZncY6nZQBsQTO1rG8hy2CA3rirdvOVZiCc8cZ61ASDGFACqqgADsKRAVbnpj14oA7GxuneEK+TtXqT09qazHHOck9RVSBjDaplRubt04FMknyGJJx1yTQBXuLjy7mQKAN34dKsW8hdRIwxgYxjGa5y4vDIwxux3J/i+lamkO0kW5sjoSG6UAajcoPc4H+NZ90ww/UgDoTVqUgbgucDjNZl+4SI49u9AFLGcHt3xSMygYJ5HbuarzXRQbVIyfQdKhDswORj1PrQBO8mWJA4qszZyRkUEZz6ds88UeWMfN2oAZuLA8EcZpjE43YIHT6VPsGAMYzT4174GQe9AFVEJIJU04K/9whc1d2jkDOQaj5Gcj26UAQNwQxyB9e9VZT8zEHr6VamAKkjg9RzWe3X3oAfz6800+w46Uo6d/8AGkOd/U7qAPYP2VRj4qXef+gNcf8Ao+3rL+Nk3l/GPxYvrPbH/wAlIK0/2VHV/ipdlST/AMSa4yex/f2/SsT47OF+MXivgZEtsc+32SCgDgPHFol5pxvEi33cG0NIpwTFz1HfBxz6V57n6V6jHMdg6ZX5cEAj8a4zxHo7W00l1ax/6GxyVXnyj3B9vQ0AYYNKKYKdQA6lBplOFAF/TEaWbYjEEDcOPQ10NhpURuLieSURwA+WASMOccjOfXFZHh+Ft0sxX5cbFJ9epqzq1+4m8kJsSMHacAk+/sD60AdJqVwBaeUGimLDaERwpGPT1+nFc1ZNb2lwGSPzZFG0xsAUPryDng1m/aiYmTJLMRuYnnj0ogk2noBigDRu7mSaYzpIc5wQBgL9KmNy09sVPDhePes2Mgvt4BPHWpYmZSM9RyD6UASQhmy5AwD9OTV7zRtC53FgBxwPzqm2EkG0Db2PY5q0pBIESjBXBJoAeuXjd2IigUhQFXcSfp/M1qaVDNdSJElwpkcAZccKO/HsOay3O392CWc+hwB7D29q6DRLZo7aSUr5hRCTHxk+wI55oA6nTrSKGEIJCylt7jaP3hPT8MdKbeX8lrKtpYjYCOZGA+Tnt61Wke9s9P0661CymsBexLPaPKcxThhnCSDgtjqpwQeMVUsdU1JXzLzFnIEij9GIz+WaAOotAxt13OzO2TlvT0xVppI4MCV1VmxhOrE/TrWNC99cYIxCh57xg/8Asx/SrttYwqf3pMjE8j7qn+p/E0AWP7QmmcxWUbDHVuC3/wASv45PtUo0wyW+93E0obzNnVTj1J5Y/Xj0FS28tqJFhZ8RLyVjT/AVBf6kIppAqSbQcKfuj6gUAaNreoGxyH9H6g+1Wkm+0SbOWJHC96wNSv8AzrNbkWwEygHO8AntWtpOoyRFZI7ePPRsnJIoA6LwdFcw/ETwck5GwX8231/48bqvoqvnzwrqYvPiD4MhKJuXUJ2DL3H2G57V9B0AeX/HpS+m+FQOv9s/+2V1XmtpYN5nnf3TgY65/wAK9j+JdkNQ1DwXaswUSay+SfawvD/SuU8UaN/ZlpKxQjy8lWbgsaAOGnzKJ4ncNEM+Xv6qx759K4rXRMMmQhOSOgOa2tVnCkqvPAPTq1c5qDvKwRySw4B9P8mgDElGMDv7c01UKqXIGW7e1bKadcMrO0eAvcdfx9qimtSCSwGPbkmgDFckMwAJz6cZqPBznB+uMVdnUBsEZIPWoGX5wDytADFc7VIGDirtg5aUbhlAM7cZqqMDPOffFS2knlhjyDnAoA3hKH5XBOMA1TlfzAcgjBwM1FbTEk84J6cVI5IQDqM+mKAMQlmnYcNjOB2FbGlynZKXO7Azx6VlTYSdlXpnGKntrpYY2LcsRhV65we9AGpc3KW0QMzfM33Qp5Nc1fXst1IMkJGP4V70+SR7p3aRjknv1P0qMptGTx6c0ARIWz0P1NWEX5RnJA6YFMUd2Jz61KGzwR07mgB4C9QPz70ucNxn0puTnBI/DpTd34UASE9T0PrikG1eScfrTd3HqTUsX0yT0z3oAEfcueePaopQq56g9gBVoBWJzxz361XuGUAg4wf19qAKshAGSVxn1qrgl8/j0p8gO7gH6VWlm5O3aSDgseg/xoAlLquMkDPYck1BMzTEoFI/2M8D3Y/0pUiYncxYZ7nhiP6CoNUv006AbAPOb/VoOg/2j/nmgD2j9lAxr8V72IOWmTRJi/oMz2+AKxfjyAfjD4sBOP3tv+X2SCnfsYMz/FbVnclmbRpiSe58+Co/j3Hv+L/i54nBlSS2Lx99v2SDBH45/KgDhQ+5RtGQOpxwccVPbyEMNpAOCOvaqVtINpRcgZ4FR3AIlBUkNnIYHvQBcm0jT75QJoiuAQDE2wIfXGME1T/4RKz+UpeXCj+IFFJJ9vSr1pfLs8uYhZT1PZqbdajHbwu4OXVeB6noPzNAGHe6DZx3DJBdTtt+8CFJz6fWoV06yikxtllPo5x/KvVPiz8N5fAWi+Dr9lcy3toYdQZudt3nzPmPc4YoPaOvOC4Ylh24xQBJAMKg2qqdAFGAPoKNQsVu1STDGVeCQPvL6fh2pYn3lTzjqa0YInYBmO3I6n/CgDhriE29w0bMDjoR3HakQ8fWuo1PSvtUm0MPM2ghsY5J5/CsC7067tHdJoHG0bsgZBGcZBoAh3f3T9DVrzc7Txg81RQFw+3naNx+lT2yvNJ5aZJ68DOPX8KANi2KGFd3yj7px3HUVr6bpRu43cTRIC+MFD/MVSsNJdFBvW2gnARW5I9z2rprd47eJYolKqhHyxKTj2oAzPsMULOA2ZFO0n+ozW9pkixW5lJVEHO7pgdKyGG5i4/i5IBBGO59RV+GNrqSONMrDGN2cdM9/wDePb0HNAH0H+zvPpvif4ear4W1e0gvLXTrtlFtOokUQS5kj69CGMg9towfTP8AF3wUutFaS98D/wCnWvVtMupMTRgDgQTN1HT5X9PvVyvwZ1+28J+OIpLyVbbS7uzlt5z0RDGDMjn8FlGfV6yNb1q78Y31zqOty3UkF5MZobGWdzDBEeI0EYbZnaASccknNAFawuobrzxHvWSFzHNHIu143HVWHYipbi4yDFGCBxuPoPT3NVLiWO3j8i1gEaDk+XGFVfwHeqxkZUBMbKMcZ7UAXFuVtpHCoQOvHpirtk51QhI9oRR8zSc4Ht61gtMJCMngdcelW9NnMU7AZByGAX9OaAOu/sG38lmaSYkKSu9gQfr9PasXT38m6ktpZSu4ZUdOR2B+lbEV59ot+rAjG8Yzj2rF1UJLcxqmcnoV4KkdxQB1PgSVW+Kfg9Dt8z7XOcDsPsVx/wDWr6ar5c+GiqnxO8IgA7jeTkk9T/oVz1PevqOgDlfGX/Ix+BP+w1J/6brysn4pyK9pHb5wWGQcdPWqvxv8U2fgqDwfr+pxyyWVrrgEoiALBXs7qPIHfG/OPasnxrq9lr8FvqmkXcV5ps8amK4ifKv1yPY9iDyO4oA8tudPZZw8jqUzxt5qrd/ZrdwqRfM+TlxnI9cUmr3D3Nw3zbVXhQOgFZLufMf5iFAAz1xQBYfUnDZBC9sFeorEur9Z533AbT6VDeXH2gSKBhVPbsKojAQqCcn0oAklbgiMuVHPP+NVZHkDsrAjFTgOMgAde/ehIXJ3+vUGgCFZAehB+lSIwKgEDg561K9vkbj8p9SKiGSME8e1AFuCT5gMY5z9KtzKQw9e5/lVK24lTjjNX5m3cjGaAMa7XFy5Y47nPpjmqEL+ZKzdMggD0q3rZCybAc5AJx6VStD+9CkdRg0AWACqhQCzeg4GKYWxnzFIbt6Va+6pI+/+lMkVwCLgDae4/hoAYp6HIx6UrHB57+tV1YoxBPHuKex6f40APBOBzzTc0wknGOBTNwzyeKAJwTtI7YqaJsZOf/rVUB9OKerZycHGeSOAKALUjAoTwDjgms8thWYsAAMkt0qaY5xg4J6VmySNcSBYyCoOVz0x3c/0FABLM0rbEB2/3c4JHqT2FPijC43YZvXHT2Ht709I1RcZODyWPVj61T1XUo7BdvElwRkJ2Hu3+FAD9RvorGDc43SN9yP1PqfauQuJpLid5pm3O5yTRcTSXEzSzMWdjkmo6APfv2LP+Sp6p/2BZf8A0fBXN/tJ3k1j8f8AxLNA2GH2YEHow+yxcGuk/Ys/5Knqn/YFl/8AR8Fcl+1H/wAl28Tf9uv/AKSxUAc7YXiXUfmx+nIPVTU5fjtk9u9cZaXMlrMJIWwR1HYj0NdPZXkd7HujOJByyE8j6eooAW5wFy2dwPyjOcmu6/Z98MS+Lfijp0V3Hmy04/2jcjnB2EbF9CC5XIPUZriZAMhiCc8A+n0qbS/Eut6Ba6haaBqc2nx6gUFy1v8AJI4QEKPMHzAfMeBjOec0AfbPx38NDxb8L9ZtLcB720X7ZbFQGYSxfNgD+8V3L/wKvg6K4Jj/AKGtrwZ438R+DNSe78P6pPbSSP5k0TkvFcHuXQ8E+/UZ4IrnrqUTXk06QxQrLI0ghhBCRgnO1cknAzjk0AbGmElFZmKuckDHatRJW7g4HQ4zxWLZMoVR29D/AErViwR0/WgC0smfmC5bG3P9KDJMJVYADHvioUkC8fMCOOtBm+VsDd2HagB1v4fvtbt9e1DT7OJoNGt1u7tkUZKM4XaB243Pz2Rqy7YLHGRGqoM8bAORX17+zf4UhtvhhPd6jAHbxEzzSpIOTb42RocdQVy3/A6+VPG2izeEPFmq6Bc7mexmMaMeskR5jfoOqEGgBwmJyx78gVoWjSqimFk2v853A8fTFc/azfueNp7AfX0rSimuVt0zuTAwueo9SfpQBauflZYGjRmz8+3BYnGQDjt3NaNtcx7RHAW3DLEMMMxPUn/CqWn2zxR+a0ZBdc+px159z1NXBISEJP45oAmuDDf27QXCeYgZWbJOBg5FbMEgjgkmumMjFSdvT8K5kXCoS2cszZOD78CtjVbyFLW0jhy3mMHJ7EAc5oAtWzh5PNnxk/MF6KD/APWFTfal2TJKVdVHy5HassXG5MjHK5x/QVWuZxGgBP3ztPPagCzcKkWwxAgSDcRnp6fjT4MjEvUqckEYyPT61WluFmmATnCjJz+Qq1EQRwOcZx6UAaMOoRocqxOeMLzn8PWp4cAl2wXc7ic4/AntWdEvQMDkdqt5VUMkjKqIMlmO1VHcknigDq/hxx8UfCA5/wCPy46/9eVzX1HXxt8HPFUOr/HLwtp1gvmWsMtzIZ2GC7C0nGFHZeT15NfZNAHiH7XOi6rrvw30y20PTL7UrlNWjkaKzgeZ1QQzAsVUE4yQM+4r5s8HaX8SvC0zCz8I+JZbGRt01nJplx5ch6ZHy/K2ONw5+vSvsP41/EX/AIVl4VtdZ/sv+0/PvUs/J+0eTt3JI+7dtbP3MYx3614sn7WzSOqJ4HLOxwANVySf+/NAGXFbarNCkz+FvFEDsMmCTRrpmQ+hKx4P1/lWXPo2uN9zwz4kyep/sa7H/tOvRR+0ffhFZ/BlujEZKNrByvscQYzTD+0neA/8idb/APg3b/5HoA8tk8PeINpCeF/Env8A8Se65/8AIdNg8N+IVOX8M+JQT/1B7rj/AMh9a9S/4aVu/wDoTrf/AMG5/wDkekb9pe7VdzeDoMf9hc//ABigDzX/AIR3Xcf8iz4k/wDBNdf/ABunx6Dro+94Z8SDH/UGuv8A43XoY/aduScf8IZD/wCDc/8Axihv2nLpevgyH/wbn/4xQBwE+ia40WxPDPiXH/YGuh+f7us4eGvESOdnhjxIR76Pdc/+Q69Ml/ajnjOD4MiJ68asT/7QpI/2pJ3GV8FJ+Oqn/wCMUAeexeHtfQn/AIprxLjp/wAga6/+N05tB8QZ/wCRZ8RkAdtGuhn2/wBXXow/abuj08Fxev8AyFm/+MU7/hpi8xn/AIQqPHr/AGs3/wAYoA8evvC3imW6Dr4V8SN05/si5AHt9yltvCfiRJAzeFvEo55/4k9z/wDEV7Af2mL3YG/4QpMH/qKt/wDI9Rt+09cqefBcf/g2b/4xQB5hB4a8QiQb/DHiQKvI/wCJNc8n/v3Trrw1r7xME8MeJC3Uf8Se65/8h16lH+0xdyFQvg2Dn/qLt/8AI9WR+0ZfEceD7U8Z/wCQw3/yPQB4sPCniYoAfC3iTI/6hFz/APEU0+E/E3T/AIRbxJj/ALA9z/8AEV7l/wANB6jjP/CIWZBGeNZbp/4D0H9oLUgM/wDCIWeP+ww3/wAj0AeGDwn4n6/8Ir4kz0/5BFz/APEU0+E/FB6+FfEh/wC4Rc//ABFe4N+0TqCnB8HWufT+2G/+R6Y37Rt8vXwdben/ACGG/wDkegDxIeEvE/I/4RTxJj/sEXP/AMRUn/CLeJ8c+FfEhx0/4lFz0/74r2f/AIaQvskf8Ibb5Azj+12/+R6F/aRuzgt4RtEXuz6ywA+p+z0AeJXXhTxU8Mgi8K+JSxGFzpFz/wDEVFaeDfFEQfPhTxKCWwP+JRc9B0/gr1mH9rISXKRHwdGgZtvmPqxCj3P7jOPwroP+GhtRzgeD7QnOONZb/wCR6APANS8L+NFBSw8HeJGYjmU6TPgfQFP1Nc63w78cMxZvB/iVmJySdLnJJ/75r6mT4/6mxx/wiFmOe+sN/wDI9Y2t/tQXmjXIhvfAoAYZSRdWyjj1B8j/AOvQB84/8K68b/8AQm+JP/BXP/8AE0f8K68b/wDQm+JP/BXP/wDE175/w1z/ANST/wCVb/7TR/w1z/1JP/lW/wDtNAFH9kbwn4i0L4k6lda3oGr6bbPpMsay3llJCjOZoSFBZQM4BOPY1zH7R/grxVq/xn8Q32leGtbvrKX7P5dxbWEssb4togcMqkHBBH1Br3X4KfHP/hZviq60b/hHf7M8iye8877d527a8abdvlrj/WZznt0r2qgD81v+FceOP+hN8Sf+Cuf/AOJp0fw88dROHj8H+JVYdCNLn/8Aia/SeigD884PB/jSWIrc+DvEkb/3hpU5Dfhs4ofwN4uYjPhLxIR6f2Tcf/EV+hlFAH52SeAvFzcjwf4kz/2Crjj/AMcqIeAPGO4/8Uh4kA/7BVx/8RX6MUUAfnhF4F8Xr18JeJf/AAU3H/xFWB4M8Yr93wr4k46Y0m4/+Ir9B6KAPz7Xwf4w53+EvEZz1/4lFx/8RU9t4I8UXN3b2934b8SwW0sipNMdHuW8pCQGbAjJOBk4APTpX37RQB4Vqnxb17SXtNP8J/CzxTNpVoixB7mwnhJjUYCoojbHAGCT+FeefHqyuvH02i+IdC8KeLLbVRG1rfWU+i3KuFB3I+4IUOCWGc7sFeBivriigD4A0nwZ4ntkfzPCPiQHJwP7IuScdgPkrVtfC/iPe8lz4X8RZ4wo0a5P0H+r6D9TX3VRQB8SR6D4gQFR4Y8SBR0/4k11/wDG6rzeHvEZf5PC/iXGOf8AiT3P/wAbr7jooA+Dp/C/ickmPwr4l3eo0i5/L7lRS+G/F/2lP+KT8TPApJ2nSbgDnqR8nWvvaigD4bHh/wASBfl8LeJQcd9Huf8A4ioZPDniZpAT4U8S7V4AGkXP/wARX3VRQB8PWnhzxDG25/DXiTd6/wBjXX/xur8eia4uc+GvEmfX+xbr/wCN19pUUAfGqaVrKI7Hwz4mYhc4XRbrLH05jA/PFcJ4q0T4ha4Wgj8GeJbbTw25YF0yclvQsdvP06Cv0FooA+IP2cPBXirSPjP4dvtV8Na3Y2UX2jzLi5sJYo0zbSgZZlAGSQPqRX2/RRQB4J+2bDJcfDLR4YELyPrcQVR3PkT15v8ACTwN4VtvhF4p8U+JNFOr6no11KFMV/PbbkW3hfYGRgBy7c4PWvWP2ryV8D6ER/0GU/8ASa4rh/hDfeHb34Q+MvDWu+KNI0O61O+lRTeXMaOqtbQAOEZ1LDII6joeaAN/4Z+B/h/42tFuP7E0hFa2juDBYeLLy9uIS4zsmj+TyyOh5PIIr5tsHZ7C2ZmLMYlLE8knHrX2L4E8V6B4d0iy0rUviP4Kv7KxtIrW3+zyR28mEUKC7G5cNwOwXn8q+OdMH/EutT/0yX+QoAsgZ656VBdEbwO+BxVrAUbnPyjk5NUmcTTFlBx2zQA1FOcEg/WplUfKMjrjjtThGNuBySe1K4KKQuAx4HfFAFUx+ZKcHCjK8UtogXjHf9KuRIFIUD5c4ANMChZHAAGMEe4oAsQqdwy1W5UBVePlIxz61WjbGCCMdDVmRwIFIxu3DrQAw/6nGCFXPFZ/lAyNuz1GBVxmBA5JznrUkCBp3yM5I6/SgCOxgCglsYB6/wCe1XPK2hVBxnk8etKI85BBAIx6ZFWdysSjqC6nG/FAElqwQiJ2AAPysf5VPceVjOQfTHNQPCTjeBsIwAec0141jJCtjA6DoKAI5lGcgnaMdqglIKk5II746VKWUjGT79qhfdjB4z60AU1zFOc8hxuz9O/0qG809rsxJJLtgRt5CrneT0HPH51oOhO3IOVHBzzzTVbacEHjH5f1oA4rW9AngviLGJ5IJGwoUZ2E9j7e9d7btlUZQyjAAUrjGBjGKgD7boRZJYx54PQA9DU4l2AlhkHGT2+poAvxt3zj3qaaztdVtvsN9F5sDn6FT/eB7Gq6nIyOvXr0qxE/2eMyEgEjAA60AeU+LPDdxoF2AW86zkJ8mcDg+x9GHpWDXvsMVrqdlJbajEs9rOMYJ/UejDrmvIfGPhq48N6iIpCZbWYb4JwMB19D6MO4/wAaAPYf2Kf+Sp6r/wBgWX/0fBX2pXxX+xT/AMlT1X/sCy/+j4K+1KACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDxL9rM48CaF/2Gk/9Jrivl48cCvp/wDa2JXwFoZHP/E5T/0muK+WNzEjJx7CgCYsB94/rTWmAAxjFRc9KEHqT9TQAPukI3c+2elOjAGOf/10qpvbCrn+lXbayH3pOufWgCEAkYRSW6fWllt5EiZ2XGeAM1qRqAPlGKZcSAy7McL8xxzk0AZKv5b7WAyOBgcUblZz2J5Aq6w2RsAmB6DmqDq3mZ2nnpzQBbjQlMqQR0zSyl4ymehcUlrIVPIODx/+qpL5SY1wuSGyO/SgB7xFcFz06DNQ+d5Um45OOuBUkpY4BB29c0/Tow7s5BOD9PpQBbtWaZTiJj3wenNXY4JQwBRgQBjBBz9DRYbYuHIIZuGzyT/nvWij4H90e/TP+NAEXlyCIEgqQTyB2qGW2kJBKnJ5Oa1nztBQ89T7+1Vn4OSx3dAehxQBnNaSEHPljj8ahks3R8/e47GtYqCRjpjjFVbl0gi824lihizjfIcD/wCv+FAFB4ucMPmIHFUNYk+xxDZtNw/3V/ujux9qz9W8ZQBJotLtnaUnaLqU7QP9pV6/TNc5Z3jzzMZ3ZpJRliSckCgDXGqwxX0UqgFQCjsQcn1P410VldQXgDWvmsh7tEUU/iep+lc1ZW0cqpMIw0TuFDMwwM9CR/jWqGkkuQIUnjKZiQFs+Y+eGHsOeaAN+NMvlscDoRTwvmuM8qeBxwKpQwXdo6RzyPNHJy7H5ip+ta8URBVSMHtigCxbn5cFsZ44q7faRba9pb6bqYPkPho5FGWjbHDj3HcdxxVaLCZxyT6+lX9OdDdeZlsgYGCeAe36UAJ+yZo13oHxr13TtQTbNFo8vI+66meAhlPcEc19hV4L8JGV/ijaPtXzf7EvFLgclRcWhA+gJY/ia96oAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAPD/wBrj/kQdE/7DKf+k1xXyzg9enavqj9rQbvAmhjpnWU/9JrivmJY1UcjJ6e1AFUIxb5Rx71PDa93OfYdqnGOnbt2qRMHnv60APUbVCqMAdh3qRMDJx07UgUEY5I6VKAMYIzQA6IEtk+tMMSxuSXOXORnnt+lSL1+lRziQOwBAXk+5oAJzHFHudxj+dZMkyvKuCp7/wCTUuoMVODtCqMAAfrVQ5J4OQV44xQBdjwRxlskAEA1ZjYSTtuPyqNnGe9JbWjlV2O27A4zxSvazRTrhm3S8Enpkdz+FADLUr5IEjBSvynI4ODirljNDDOwLDkcn+VUBbyRpIWbODnPqc9faolcCcAFvrjvQB1NuFlMTKwPBPPYjrUtrPb3QL28yzRnjcucfr/OsW0mWK3b7TK2GUqEXljkYxijStQexs8T2waZpC255NgC4wox1/xoA6OR8sQM54xznimbQ0oUKMCsF9cmbO02i5PIw0lLDqOoO4MbMWOANlqeKAN3UJ4ILWWaeRlgjTfLgcgDt9e1eS63q8+qXcs026NQcRx5JEa9lFaviHxDf3drc2n2iT7M5Cn5ApYA98dq5gHkFiM9j6UAMwORkljVnT7yWxulmiZkJBQlTg7T1FMAzgH8h3pDGNwznnoaANe1k+13MkSqqG5YJ8owAchhwOgJBHHTNejaLZPLbxX0syszApHGg+SBc8qB3bjkmvKYJRFcxvIW8vI3FOuPY9jXo3he5Nzc3bLKrFEDPtBjLMTgM6dM+9AG6FIIKAgA8ZNG1h0ORnOKktj5gyRiQHHpn6VZ8og4bauevzcigCqHcxkLgEHGHyKt2qlvu8fNknvVGXcJ5Nkm5Bjr0+ma0bJd6ICMY6kmgD0H4LHPxRhJz/yBrzr/ANd7SvoSvnn4Jjb8UY1JBI0e8zjoP39pX0NQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAeJ/tYf8iPoX/YaT/0muK+Ziue1fTP7WH/Ij6F/2GU/9JrivmcDIPHHtQA3GO/ftUqAg55Ge9N5PNPHp3zmgCVeP8afuwRjknp6UwEc+9DcucH/AOsBQBKGCk5/Sh5C0bKq4J6Mex+lRkDPp9aswqNm7AKjqTQBjLbmRpDIzFwx61CsJLxjn7uCPoetXpWIuGJxh2II6c9qRoz5oBGD2xzQBr2pVVUL0HenypkK6LnJPH19KzUuVhGCdzAdAc/megomvJLgJGeEB+g/xNAE9zNHHG8TfOTjdg8D6ntWMIZnyQPlLEA8gH09z+laQjVWJxvI6MQMfgO1MZvnXn5hIDj2oAu22mxpbrHI7tjj5fkyfw5pml26R3U4uLVdzZMSN82xVOOM9j61qqUEaHOQRkHpTiYlEkrskYwGkkbgY96AJIlw4WNEXJ6ACud8S+JGW2ktNOZwGPlyT5PI7hPQds1FqmvktJFZO0UQOGkxh3/wFchNMSuOcA55oArzE9BnGMVWqeTBzn1qLv7GgBuMYwKtJH9oAQYyRlfr6Gqre1WtPLGaONXRNxC7n+7+NAHS+F9JlluWscuyXMRNwvlHaoXlea7uysIbG1WG1jAQcsQvLse5/wA8VY8Fag9xoUf7hrVYSbd0PIcr1PPNa4hUYOMYoAzPsvy5fIz0x1IpXtE3AgMT0+9Vwxc7icf407aC316etAFLygoB2qoB/rWvYW8UsAbaQwGAy9f/AK9UpIvl+UDPQc1c0eYLDjIDAksO5oA7L4OReX8U4cHIOjXmMf8AXe0r6ArwH4QOr/FWEpj/AJA15nH/AF3tK9+oAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAPE/wBrHjwNoXX/AJDKf+k1xXzOvToK+mP2sP8AkRtC/wCwyn/pNcV8zcjP9KAHEY60oPTp680dhxyOgFKoGcYoAcCRx+lSR89Oee1UkeS6eQQs0aocZYYz7ex9q0rSMFcFw56lhgAf59TQA+KMydgBUkuBhSFCrjr0FD3iJ8lvGXYnhmHB/wB1ep/QVCLB5HMly+xickH5if8A2Vf1oArXhhdCACwJ4KnA/A1nslzwHXaDxg5AI/mf0rZm2RToI0K+rMcsT25qCYq2G5VhnIagCK3SMAbhnHTPQ0y/JWSEr1Dbj7CrMIYgYRm98cZpJY2eZ18vjYc8dM8f0oAlfHl5UHkgfjTba382f5gWAPQfp/Wks/Mltw2wtjg/X3rSiikhgmfCgbc5Xkk9PyoAka7gsFAuGxu4RE+Zh+dcz4h1aS8kCKSsKN8qk9x3PvU9/Gqgs0jyyA8lqw7xRhivfnigCnPJk/eyCMgVVc/rSuyqo3HBzx6n2q3q+japo4s21XTriyF2hlgFwvltIgON20/MF9CQM9qAM1j2pvNOPUUhFAEbVPaIWbkZXJz6AAZNNjgZ8gD612ngHw4l9fltQBjt0QS+SflafnG32X17npQB1Phe/XT/AANb3uo+ZHDGXO7blihYBTjqeoro7K+guUd7WZJNjbHUcFCDghlPKng9QKdqQhv7eeC4XMc0ZjYBeApGOO3HUfQV6f4D8O6F8SPAdpJ4htfK8SaUTp1zqNo/lXKvGAFfzABuDRlG+YFfmPFAHmbkSZBLBh02+lRRhsnAYntVjxLbW/hvXUstP12y8URtJtK2Q/0m256y7AYsDoTlD7Gr8kKtHvC/L7dzQBmtEzr/AHVA6Y6/jUFsvlzyKw+VujMec+taG1k3DHJ6A1WuEJUbTySB+HegDrPgZL53xNhcZIOjXn/o+0r6Kr58+C8axfFKEIML/Yt5gDp/r7SvoOgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA8T/AGsM/wDCD6Fj/oMp/wCk1xXzOB3HA68V9MftYf8AIjaF/wBhpP8A0muK+ZpZdnAxnr7UAS+3GRUUs3zEJ8x9qqySMVyCTUtunP8AtHBNAFmOMyAvcuREOdo6H6+tWEDynZtEcankcFR9fVv0FU3nM0vlxttRDw38z/QVbgYIoVBtC9FzQBq24REYJgAjLFuWY+5/yKhuCdxAfJ9+M1ALgAA55+6B0pl3KkUReRlYgdByc+1AFK4uGkuo0jkAbPODjFWNPaLLbyGY9DkniqUDMZ0d4iWZvvBcAegzVqz/ANYQRlT7dMUAaw8qFC6DcWwGx6+tVpcrJISj4ZgFbHB4zWxpkQltNuFOMhuM5q/cQobFQu0EHIOOSeaAOe0t2tpLoOHj3MJMc8gj/GqN5fMVl+YkknbkZH1rortkmW4ZflYRqxPbrg1xs5kV2OSTnOT0oAzZ7vcvXGRjbVGWUtGw3AMOckcYqW8Q7wQME9Aa9L+Dfw9stTtLjxp44ZbXwXpoMv77gXzLxtHcoDgf7TfKM80Ae2fs9eEfCsHhfTPEMXhuWx1S5Yrb3GqSrNNKACQ8XACggMRhVJAJ5HNfN/x58RnxR8V9dvUffa2kn9n23ORsi4Yj2L7m/GrnxE+K+teKfGlprmmzSabZ6W+dKtlx+5HTe46FmHXsBxXmpJH3iSfU8k/jQA05z/8AWqRFz0H5imgKe2TWz4b0z+1NVt7d3McDN+8Kj5tvUgf40Adb4K8PxR6dHqF0m+4ZzJGmPlAHQn8atWJNtr83JB/eEH8mB/WuhcKkRhiVYo1UIqL2GOAPasiQH7fEEBJcBMDg9x/hQBvm4WTaM4J/KrFl4mu/CsGvQ2Zf/if2X2BSM/urn7kcvsPLeTP/AFzWqUUTbQG+XjBz/n9atECRwGHT/PSgCSzgjggihtFCW0a7UQDpj29T61uWiLMmckHGDznJrG3KCMLj6U19ZXSJI2vEIsnYBrhedhPQMB296AOilsgybTgOD0x1rNuIgjjaAV7cVrJOSnKnIGVwR0/wqreKGUFRlc8H+dAG58HQR8U4M/8AQGvP/R9pXv8AXgXwg5+Kduc/8wW8/wDR9pXvtABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB4n+1gQPA2hE9P7ZT/wBJrivl6YqznqQa+nv2t1LeAtDC9f7aT/0muK+VGlcPszj1x3oAvJEWVsYwByTSM4jgLMcE/KMHuaigdlXJY4PGM5pk+1gASN2cnHUYHH86AJ4OIN0aEk88nHA6VZt4biQ/6wKD1wvFQPfRwgImGKgKCozSG6mlT92pQHqQeT/SgDRgRUL4k81hxubsPap4LZp2L9FHGSOTWbZjdKsY4z8v0r0TSbVLa0UhiSOEXbksf60AcegEcvlBSrK2QPp1H5USJ5U6yIeBnd6YPQ10eo6RvU7RtYEnIPQ9c/nXNgyW5aOUZfPboR/hQB0GmuPs8MKDAZg4cdiP89Kk1G/hjSJQc7jwY+R/u/WsmENgqDlcblG6qOpTyLd2qxkKgPmcfr+FAF24ufsl4ig5jlAB5zhT7+oNYV7tiLk8Hbn8ckEYrSvwJbQy43fLnnjI7/rWLdNLdwB1GWjwJBjPPQN+I60Adf8ACz4ep401S8u9WuBZ+FNJG/UbpnCbgF3eUD2+Xlm7L7mqfxn+I3/CaXcGlaFELLwdphCWVrGuwTbeBMy4GFx91ew571yjz3Atby0+0zwQ3AVbiGKUqlwFOV3qOGAPIz0NZEoMblX+96+tAFQtg5HBpGCuBjA9qlMfmNiMDPoamh0+RnG4bR1oAqpCSec49RzXpfhCzg0i0VpUkN5KNznyySi9lHv61naZ4ah06GO5vFMlx94RFjtj9M46mtVzESyeSm5Rlic9fzoA7n4a+Ap/F3hO5k0jW3XWtOuHtrm11JC0Uo+9G6sP3kYKEddwyD8orD8V6LrPhvULX/hINLn01FcKLgkPbtlgRiZfl/Btre1bvwQ1oeGviJao+I7HWVGnzAYA80ZaBz3JzuT/AIGK0fiP8Ttd1zWr3StHv0sdBaeS0VreJWluEU7GYyNnALB8BQDgDk5oA5mPdgE/xdGIp7AHg5zj14NZGmaZLp1uqWDYiU8IrnP5NkH86ux3xV/LuYjvB/gXaw+q/wDxOaAL8fKlSRjGOKuxAbSCucgZyMj8qpxMsluJYirx9Mqe/v6GrEJZMjC46c+ntQBpW74UYwMfKO2Pb6VdTE8J2fNnoBx/kVkyMWQAkBWXqB0rUsHAXZgDaMgDrx2oA1fhA3/F2Y4z95dFvCR9Z7X/AAr3+vEfhpaxxfFGzuIyG8/Rr3JBzjE1l8v4ZNe3UAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHiX7WZA8CaEScD+2U/wDSa4r5TmZWlG3knvX1X+1rIIvAehuRkDWU/wDSa4r5Plkw7Efd7YoAl+0hQVC5zUEhLlSwGORuFRE4lbrj0qZiGVeBwR+A6UAW7eEYLsBgdCRVvdhcc8+lV4c/Z4wPvEY59uM1PDCzKWfCoByT+lAFzS7fzLxA2QDzj1xXbW/mK6tcNlBwDjgH0H/165LTC73EckS/u40OSeAFHc+ldXa3kE0aCBkZ9pPlqwOQDyQRwcf5xQBJdTYGFLunOVUcj3zWBeQCVyhAB27lcn17/T1FaV/qqR/JCEMp6v3X/E1Rh2X7/I5WVBnBGd3v7e/rQBSgWdd6EqrA9Tnj/wCtWdqE7tdTfModE3KOeuc/0rY1JhAuJG2ngEY+8K5VrpZfNPPL4LEdgMUAdNFE0kQZWjZCAVAz3HSodOtjb6mrtCXtpVKMq9AfeovC1wZYhHI2dnGMdMVri7it4Emj2CRwTgng+u70A70Ac/4i0mSw4cKUYb4pcYXb/dbuPr3rBW0e5fdIGGehIwT7H0rtbZl1K/Zbn94rHdtAGXOOrDpj0XtWrH4etztJUDP9wfpz6UAefw6SWIQgZyAq56/QdTXY6F4eh09I57lS92wyAfux+wHc+5rVu9M+xaLetpYEN2sLtHKVDtkDPfr06dK0dW0XWNH0LTtZvIReaJfW8dxHqtqh2IjqG/fx9Ym55PK5PUdKAOd1+YxKkath5T09FHes21b5V/2myfXFM1CU3d+ZNwZcZUg5BXtg01Bt4yQPagDYiU3NnJEJZIpGOVkjO1oyCCrKexBAOfUU2KGO3vrGGEYihjAHTJABP58VWtrlYh8pUv6ZqSyuluNTlbaPlXAx64A/mTQB0EbjABGfQAdankiWWHZOgcdSD2+npUNlKgYgNKXU4O0Zx9TWisrFF2IzN1+cgZ+lAGbJZz2zF7ZnY98DL49COjj9atWN6lztRsLI3QDlXx12/wBQeRV1R56fdx8vOeqmqP8AZxvnxAAJ2ILDoH9OezejfnQBpWUTOj8ZVWPPrWpFbSxYkUDA9u3epNAKyW8dlMpS5O5VJGGkbujekg/Uciuiisklh3YxIgwc96AH/C+1jj+IVhdLIWe503UiV7KqzWIH9TXtleMfDpBF8S9PiTiNNJ1AAe/n2ef6V7PQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAeGftff8k90X/sNR/8ApPcV8qeUJEHr2NfVX7YBx8O9FPprUf8A6T3FfKIkO0sh5zytACSxPG394EZJNSW5L5DD5W4AqZczIpkIwRjGKdsWMqsYHPfvQBJFdLbo6SfNIT6d+/8AjToTLdSgyn5QflQdF/8Ar1n3ilZQxbDDk98ehIqW2nEiZPVeig/d98dx70Abt08Uljc2jtiJwFkCnaWAI4J7DIqtZPaWVqbRIp4rfcJivmN8jY5Oeo4A5FZwYsVR23RlgW3n5SR7jpS3EkkKIgBVsl1Lckj3P0oAvsUDgrPJMCCQWOSPx/iH6063kZZ18vG49QpPze/19qxI7gowKAI/I29Vb1xViG4ElyzxkDaAXxng+3pQB1sUZurWM5TaORgnIrn760EUpTPB5Kng81uaPdqINzlVJ5KkclvUCsjV3Hn5kzvkOOOefSgCpF9os3Z4XKI67QBznNRiS5nJld0ZQAMdM49PYfrWjBD9ojeeQbYVQr68+g9/U/hSi0V412DaQoY88dOlAF3QJ3e65RVLNxIrfdOK9HACWyybT8y9D69x+deaeHIwivuc5yHjXPG8Hr7V3ErusYSSaRyRyWbr+VAD7y9MWWIA2DIGOpr0v4O+OtN0P4M6xNrG77N4fuJYfKJDPLFI2+FRng7jJsGfTn1rxfU5wluzbievU1ytzPMDLFDLIlncPHNLCoIEkkYYIxIP8Idhj6egoA6PxvqeiX2sC98KeHp9DikbNxDLOrQP6lI1B8tunQ7T6dzjNLJNnyZIceoB3D86q2koBxv2Mf4Jeh/GtS0tSsqOo8okkYI4bjtQBCsMiIjTNgpz6k89Kj0x3SSU8l5GGQPTrj9RWpextFZyyEOSRsG0c88Y9u9VbFHMSLlIVbLEZyeT3xz6UAdRo+64+RVCso5AHb3962likQfORx2PB/Kq+iWyQQndhn2/KGQhR9e9aiwFtwEcTY7L1z7ZoAiS4CIwGPu8gitTwtaq0Qdxh2PQj+EVny2W5drKA/YbhwKv6Hc/Y5PJnODn5TnHFAHQ6tpoubdrmBWM6KN6Jw0yLyCv/TReqn8KtaXqcV3Ad7q9woXzCowJFI+WQex6EdmFRx3ZLqyMSw6EdqwtWY6dfx3VuuUdmcJ0BPWSPHow+Ye4NAHW+Bnz8VLBMY26PfkfQz2f+Br2GvGvAEiS/FHTnibfG+iXro2OqmazINey0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHhX7YIJ+HWjBRk/2zH/6T3FfJtvE/mnONuM5r64/a3TzPAWhqTjOtR8/9u1xXzAkKYCkcHnPfPrQBEABjAIGKrzXY3bLU5kzs34yAe/1wKXVQ8UTRQMzTYDEAY2oevPYkdKzUeQRYSFUReBjqMdsGgC/wqEFCD6g5yapTwMkglhBK91B5H0ojuSwHmMCM8Z6Voabb3Gp3trZWNvLdXdzKscMEQy8r+g9R654A60AO0m3utSuobPTbS51C6dsiG1hMkmB6qoP59KueJNC1nw3qUVjr9itncz24uVheVWdELFV3BSQpJBwCc8dq+yvA97pvhDQrbRtebw/pWvR2D6jd2emRiJI4UxudgOpGeW7kNjgGvjjxjr114t8V6tr11vSTUJy0agjMcQ+WJCPZQMkdyaAMVcpI/wC7Oc5XvuFMJCTK6HO0g4HTHcfSpnSUocMNw46jB+hqEwtu+ZgSeeeSaAN23mIhZlG8evQA+5rPvEkkvoJZ9+zcFBPyk/Qdh+tXrFhHbxjG5gPvN2/oKbqR+WIOGCE53HrQBpxXWU2sgCYwFAxgfSoPtCRKUBAY9OM5Hr/9aqdlcFo/mzv5B9MirunhXvPn25HUkdKAN+x0pLaS1uB/q22N+fr710V/BIxPlgKME/KehrMeaGGzQNtQR/dbofpU1xdGWJCTncMAjkkd6AOd1VwiFX6k469R7Vzs0RQs7yqoY/e5yfwrbv0wzuvzleMn19KzhJknKpuPGNmTn+lACafLufDSiRcdfLPX611+jmF4CPLAYfODIRkH2XORxXLI13IPlLkDp8gUCrmj38qXiwyKrmQ7N4VdwJHHPWgDQ1xkdI0AeZ3Y4BJ2jjjA+prRgCQ8KqqFwAFUDp+prG1Nnk1W3RnJVP4c8DnsPTitCBSR/rOp4A5zQB0FvqbmULKjeWRxt5J/z6VNHqFsJiAxQk5ClSBWZDGgALZ3A+mMfWlnklU5yCuOPMTd19aAOmgnjnAUYGOflH6Zpl8+ZlxwTwR7VgWkjlee3XZ8o/KtGM7+RkcY554+tAGnbXskA2hiRno3akvrq4u7Z4EWMSE7o2ySVcHKn+n41RViCOeTzViMjaCB82eMUAbfwIumm+JkMTk4TRrx0B6KrT2p2j6MGFfRtfPHwYRYvjFPGqgD+yLuRQOytNaNj8y1fQ9ABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB4l+1nj/hBNCzjH9sp1/wCva4r5hadLaF55AdiDOAOWPQD8a+nv2shu8C6EP+o0n/pNcV8o63MEFpFwNzmVs9MLwP1P6UAMgE++SSQlnlcuSpyTnt746fhVW4YZJAyuex6fT/CpDcIYiQdykY9P/wBdUbi6Vgfmye0g+8v19R+tAFzRNF1LxFrNvpmiWcl5qNydsccfRgOpbPAA7k4xXvV1c6D+z9oxs7E22t/Ei+h/eTNzHYqR055Ve4H3n6nAwK5Tw58TfDnw9+G0EPge1kk8calHjUL+7iB+zHPO09GXj5FHHQtzxXjt3dTXs9xc3c0lxcTu0kssp3PI5OSWJ6k+tAGxd6zqOo6je399qFzNf3jH7TcO3zTZUgqcfw4429AOKiDJtyC27AOPT3z3rIEjLjcxK9N3XFTCdfKIzjjBP9aANN8sQHmbB4PAAqUwMWEvmE7eTzyQP61kNc5GD1Psf0rW01xIwebATGQG6kjpn2+tAGrFbtCoUtyqBsE96zdT84EbnJGcbSeRW7asqM8zkM2cAk5xx1rPuEN3czSFBgjOM98Y/pQBU0iBmkmwWwR8uTxnvWtbpPDNhihUcnk4qhakQ/Njkf5xT5JSADnpjp2oA37SWe9uCsrqETDAD5iT6H2rZij8sEY5P3sVzfh5mBlmA5Z8hT6etdJJMsULyKA21SwBPWgDI1xoUCRMhMwBfaMZC9zj19O9YDToXLG5bd0B8o7se+6odWmE13LI0mS3zEMpyD+Hp2qC3Z5MLuEysPlU8Z/E0AXjKjEmR5SSP4vmxVzR4fO1SARuM8k/LjdgdMiqywQRyDeYkdQCQMjjrg5PWtbR7q1ivUeVERCCqTMfuk/4+vagCZ5Gl1WMqAVjH49D1re06Ty5Fdhx1JPPFZE7INaKKv8ACRwOCdvX9a1rQkM2NrN6E8AUAa1wpKl0+YjnpwRVJ7kjO75scZx0qveTmJSGkO3jCg8D6VBHMRvGQR79fpQBoxKUZdrkqe+elXoztGOg9u3vVCPIUYb0JHpVq3PZlBHagC4nbg4PertqA2D+B5rPVSf89qt2rbSM9BQB1vwpTZ8Zo+ck+Hpyf/Ai3H9K99r58+EMhl+NErDO2PRLiH8RNaE/+hV9B0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHif7WH/Ij6F/2GU/9JrivkbxA6LdxF92+NBgA4DKeevavrb9rbjwHof/AGGU/wDSa4r5E1oj7WwKq5+UgAHK8D2xQBCZoyoKzLGT3yxP5YqpLJGwy1zFJn+7CxP58UycuThpVAHqx/wqrIQvSQsT1wMD9eaAJ0MAJBl47qQV/LqKnt4IrmYLZvIz4ztaPOeOQdp/WqCTMrIWCuEOQrjIP19atpqd75flrKUjJ5WJVjz7ZAzQBaNhdoDutJVypOShIx6g45qxBorPE0zuVSMhWyPU9qWw1m/hRWe7mAyRgNngdODx1rSfVFuLaRpwPMbgn39aAKs0UUEOIS2Qudx6k/5wKitYpJBlJGGOv+0aZNN5zKFPyjoOmTVuOYJGqpjA4B/nj9aAIJJpE+VpGIJwcnofan29xlmAk+YEffP8sVSvJMwkjqzYXH15/wAKgWUK2Djjr9aANmRw2FLncTng8UsNuDJ5ku7ylySobuOmfT6VmvL5YQjhm5IHGBVmK4ZIx8wBPOB6e9AHS6RO0ewuGbc3PfHpW3cSRSWsoedIk8o5LHGBWVoSLc2zPu/0hhvCZ7Dtj2/rTPEKn+zzwrBnGdxxtx0/HNAGdJNZw286lhLuIKSFcBj0Ge4A64rPuLuQOR5o8rHHkLnIHo1Zc6FCNzHk5wDTIZEU/MG3Z4wcZoA2bS43ANHCCAfvtyR+J4FaSBjuJJYnqS24t7f4Vn6feRs4BQgMcBj8xB+npW7Z38kRIaFFTaS5xkH3FAF3Tl8q2txcF18sluf7vuPStZdRtWby4TvJOAV6YrmoLqWTW1kSR5ovLIAJKgBl5yTWnpsKW6LgHeF+8PX3/wAKAG3M9wJkBZXKs2Sf7vQD+tWtOWSYQ7d4UA8HBwfU/hU0Krt2oowvc+tXIBgljgDaBn/GgC0mAMYGKswuQcc57CqyAbdxbOPSrEf3sDAz39KAL6LuXtnrUjzrbRPM5JjiG898nsPxPH41HGSIwBu3E4UDvWdd3JuLmO3txvKPhOch5f7x/wBlBn8aAO2+BPnH4pgyj/mD3m8+spntWf8ALco/Cvo6vAvg5DHb/EixhiOUTRL0ZzncfPtCSfck5r32gAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA8R/a0GfAmhD/qNJ/6TXFfJOu20u9LiJdybCpAYDBHTr14Pb0r65/auOPBGgk5/wCQynT/AK9rivly/hjvLeSJ41cOMqCccjpg9qAOHuHdsHDYx6cfh7VXxjOamuY/KmkRcx4ODG/BFVzQA7vmpIh8wOSOaiFODY/CgCeaUtJxwg4A9BU1vMfJkXGRwQKo55q1b4A+Y4yw7elAFtGAY5OSgC/jTzcYZgvX7o+p60ugaVqXiDVItO0Szmvb6YllhiXJI6kn2Fev+Gv2afG+pbX1aXTtHjzyssnnSYPcBMj8yKAPF5pd2COAOF/qaiRgW56dTWv410Gbw7r17ZCO+azt5TFFc3Nm1v5wHBcKc4BPI56EVghxjgjJoAttIZJCTn3+lHnNvHzcZ71XVvlxQDzmgDp9JvpYmEyOAY+Qw7e39Ks+KZxJdiS2fdDsXZzwvGSPwJ/SuYglO/LMQOnyn+VXLW5MkJjZeRyMUAV7mXzGJbaD6dvwptu0mcJGrj0Jomt1XO9tp/u1HBlZ18p1DdcnvQB1WhkoVnfyNmN+1VyB9Sefyro71kW2jwxIfJ4HPT+Vc/4fnDhvLUkhjuVxwuev4Vq3khiitkZcghipHZv7tADoXDSRqGO4lRjvxWqrOItsZTb1yaxtOO6eMnGR1474rZjfOCF+93x7UAWIgiDGflx1zVqMqUPHH+HeqseWx29eO1WTwigZ2gY9qAJ43OT0BPT3qzD1+cFQPfOKpwZDcGm3l8LbdHAyrKOXc8rED6+regoAs6jqKwBoRIySYHmsvWNewHq57elaOhwGFS0sOyZxt2cHyk7J9T39+K57TLXEryzBgytmNHOSv+2x7uf0qz4i8VReE9IFwVSTUZci0t35Gehdh/dHp3PHrQB6t8Jr60l+L0enwyh7y10O6edB0jDz2uxc+uFJx2BFe+V8Y/sbXU978XtburuVpbibSJpJJGOSzGeAkmvs6gAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA8R/azx/wguhbiBnWkHJxz9muK+XGkCA5wBnpX0l+2rx8LNKP/Uai/wDRE9fJml6wZQIbx/3nRZSevsf8aALOsacbxvNgKmU43Bzjd9D/AENc1LG0TtHICrqcEEdK7JWIPPB/lTmjjcK80UcpAON6g0AcRmlz2rq5dKsJcAQtGxOSY3PT6HIrEutMMTnyZFkXOADwaAKUa7mUdMn8qlJAU7Se+M1N9meAoZdo3DIAOcdue1MZMIhxwwzQAyGaSCaOaCR4pY2Do6MVZCOhBHINfQfww/aQ1bRo4tO8biXVLEjat/EB9qh92B+WQD3wfc9K+eiuAc06Y9PTHFAHttn+0x45s5HinGi6rAGK757RkLrnrhWXGR6jv0q5/wAL70DU+PFHwv0G/Y/elj2AjryA0bHqfUda8BHWlGSCfQUAe56r4s+CGq6ddH/hCdU07U2hYwPbyFYxJt+UHEoGM4/hNeGgkgZ603PNLnigCaMjOWOFHJ+la+l4WUnywC6kYdQcD1Bz+tYgbtWpYzbobl2K/u4wqJ3IzyaAK9zOS0qqEGX5OeuO2O1VVO7qcD1NNlbc+71ppOeT+NAHReHb2RbkW+dok6Me+O1dDq0pXYsbYO0Z749K4vS0a4njSJykincCOo5FdTcs0s0mcsg4Ddj7/nQBp6PueVnZgcJgj+tbSjnnj096y9GVkVyRyAM8Vqqc/eOPbtQBKpPUZB9j1q1CGcjGc49etUmuIrdR5hwW+6FGWf2VaqPLNfStDGgCD70e75VH/TRh1/3RQBfutQCRlbVjtPHmryWPpGO59+gqHSyFmVp0CsrZRA2QhPUn+83v+VWbSBbc73YvKRhpG4wPQD+Ee1ZniDVrPw/B5022SeQfurdThm9z6L79+1AGn4h1e28OW/2u7G9JgTBEh5lYdvYep/rXi+tard6zqEl7fyb5n444VVHRVHYD0o1jVbvWL1rq/lMkhGFHRUXsqjsB6VQoA+gP2Kv+Sp6r/wBgWX/0fBX2pXxX+xT/AMlT1X/sCy/+j4K+1KACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDwD9tb/klmlf9hqL/wBET18VV+qlFAH5gabqrQbYp8vF0B7r/wDWrc+22+ARcwkEZ++B+lfpHRQB+a73luoz58THthxxVA3Ebs372MEdywr9N6KAPzMFzAF+aSMjqRuB/CoPOhcfO0Z9MkDFfp1RQB+ZSCxcku0f/fzGaSWKyKxoJ0Iz94uPlHpX6bUUAfl7LaRiTMFzA68cM4U/4U24iSKIBZYmJYkqrg4GPWv1EooA/LHIz1FG4eor9TqKAPyxDD1FTRT+UuVKnggjPUHqK/UiigD8tCQUYbgSDnOetIgBJyR+Yr9TKKAPzY8PW9lazC5nu7eQlMpEZ1Qc9Q+T+lbL39mJyftNmvH8Eq4HsOa/Q6igD8/NL1PT1iYPe2wJIABmUfzNTT69YrlYL213L96V5AQP91f4j+lfftFAH5+293p8snmXOp2yhuSTcIZHH+0c/KPYVqJrmjW6LGt/aqi/dWNlIH6193UUAfn74m8b21koh0kx3VyBnzesaH/2Y/p9a8zuria6uJJ7mRpZpDlnY5JNfqdRQB+VlJX6qUUAfFf7FP8AyVPVf+wLL/6Pgr7UoooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAP/Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    60-year-old man with connected Roux-en-O misconstruction.",
"    <br>",
"     (A) Representative axial CT scan through upper abdomen shows nonspecific mild dilatation of upper abdominal bowel loops (thick arrows). Ileum (thin arrow) and colon (arrowheads)are unremarkable. Gastrojejunostomy tube placed in excluded gastric segment is partially evident within transverse duodenum.",
"     <br>",
"      (B) Patient was given medium-density barium in serial patient-controlled swallows during fluoroscopic observation. Early spot image of gastric pouch (thick arrow) shows patent proximal anastomosis (paired thin arrows) and normal-caliber alimentary limb (arrowheads). Small collection of contrast material lateral to pouch (single thin arrow) is residual contrast agent from earlier anastomotic leak that had healed.",
"      <br>",
"       (C) Fluoroscopic spot image of alimentary limb during initial filling shows normal bowel caliber. Mild indentation of alimentary limb as it goes through transverse mesocolon (arrow) is evident. Residual enteric contrast material from previous CT examination faintly opacifies colon.",
"       <br>",
"        (D) Fluoroscopic spot image of distal alimentary limb shows mild to moderate dilatation of limb. Antegrade contrast flow is by gravity only with no peristaltic activity observed. Most contrast material has reached distal alimentary limb (arrowheads).",
"        <br>",
"         (E) Fifteen-minute-delayed fluoroscopic spot image of alimentary limb shows retrograde peristalsis (arrows) with return of considerable amount of contrast material into dilated proximal alimentary limb (arrowheads). Fluoroscopy showed contrast material eventually reaching gastric pouch (not shown).",
"         <div class=\"footnotes\">",
"         </div>",
"         <div class=\"reference\">",
"          Reprinted with the permission of the American Journal of Roentgenology. Mitchell MT, Gasparaitis AE, Alverdy JC. Imaging findings in roux-en-o and other misconstructions: Rare but serious complications of roux-en-y gastric bypass surgery. AJR Am J Roentgenol 2008; 190:367. Copyright &copy; 2008 American Roentgen Ray Society.",
"         </div>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_49_26392=[""].join("\n");
var outline_f25_49_26392=null;
var title_f25_49_26393="Inguinal and femoral hernia repair: Laparoscopic techniques";
var content_f25_49_26393=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Inguinal and femoral hernia repair: Laparoscopic techniques",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/49/26393/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/49/26393/contributors\">",
"     George A Sarosi, Jr, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/49/26393/contributors\">",
"     Kfir Ben-David, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/49/26393/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/49/26393/contributors\">",
"     Richard Turnage, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/49/26393/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/49/26393/contributors\">",
"     Kathryn A Collins, MD, PhD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?25/49/26393/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 4, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Minimally invasive surgical approaches have been increasingly offered throughout general surgery over the last several decades, because they offer the potential of less postoperative pain and a faster recovery to full function. Repairs of inguinal hernias are no exception, and laparoscopic approaches have been used to treat inguinal hernias since the first repair was reported in 1992 [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/1\">",
"     1",
"    </a>",
"    ]. There is a steep learning curve for laparoscopic hernia repair. These procedures should only be performed by experienced surgeons or with the assistance of an experienced surgeon.",
"   </p>",
"   <p>",
"    Laparoscopic hernia repair techniques and results are discussed here. The classification and diagnosis of inguinal and femoral hernias and open surgical techniques are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/37/31321?source=see_link\">",
"     \"Classification, clinical features and diagnosis of inguinal and femoral hernias in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/20/29000?source=see_link\">",
"     \"Overview of treatment for inguinal and femoral hernias\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/15/9465?source=see_link\">",
"     \"Inguinal and femoral hernia repair: Open techniques\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TYPES OF LAPAROSCOPIC HERNIA REPAIRS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inguinal hernia repairs are performed through either an anterior or posterior approach, depending on whether they are open or laparoscopic (",
"    <a class=\"graphic graphic_figure graphicRef70359 \" href=\"UTD.htm?11/28/11721\">",
"     figure 1",
"    </a>",
"    ). An anterior approach through the inguinal canal is used for open inguinal hernia repairs, while the posterior approach from underneath the abdominal wall is typically used when performing laparoscopic repairs.",
"   </p>",
"   <p>",
"    One of the primary challenges in learning laparoscopic inguinal hernia repair is the relative unfamiliarity of the anterior abdominal wall anatomy for most surgeons. All currently performed laparoscopic hernia repairs involve placing mesh in the preperitoneal space. A clear understanding of the anatomy of this space and its anatomic approaches is crucial for successful laparoscopic hernia repair (",
"    <a class=\"graphic graphic_figure graphicRef70359 \" href=\"UTD.htm?11/28/11721\">",
"     figure 1",
"    </a>",
"    ) .",
"   </p>",
"   <p>",
"    The anatomic approach to the preperitoneal space depends on the laparoscopic technique used for hernia repair. The two commonly used approaches for laparoscopic repair of groin hernia are the totally extraperitoneal hernia repair (TEP) and the transabdominal preperitoneal hernia repair or (TAPP). The drawback of the TAPP procedure is that it requires entry into the peritoneal cavity and peritoneal closure. The TEP was developed to address and potentially avoid the risks of entering the peritoneal cavity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The laparoscopic approach to inguinal hernia repair is theoretically possible in nearly all inguinal hernias. The precise role of laparoscopy in inguinal hernia repair still remains somewhat controversial given the increased costs, greater technical difficulty, and longer learning curve compared to open mesh repair [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/20/29000?source=see_link&amp;anchor=H8#H8\">",
"     \"Overview of treatment for inguinal and femoral hernias\", section on 'Laparoscopic versus open repair'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In general the open approach is still preferred for unilateral inguinal hernia repair, although the pros and cons should be discussed with each patient [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. The laparoscopic approach is preferred by many surgeons for bilateral, recurrent, and femoral hernias. Each of these indications is discussed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Bilateral hernias",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the case of bilateral hernias, there are strong theoretical arguments in favor of a laparoscopic approach. Both hernias can be accessed through the same incisions, which improves the cosmetic results. A single large piece of mesh can be used with a laparoscopic TEP repair, reducing costs and potentially reducing the risk of medial direct recurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In cases where there is a definite hernia and contralateral groin pain, with uncertainty regarding the presence of a contralateral hernia, a laparoscopic approach allows for easy exploration of the contralateral groin. It has been well documented that laparoscopy is more sensitive than clinical examination in documenting hernias in a patient with groin pain [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite these theoretical arguments in favor of laparoscopic repair for bilateral hernias, there is a relative paucity of clinical trials addressing this issue. Three small, randomized trials have compared laparoscopic with open repairs for bilateral inguinal hernia [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/7-9\">",
"     7-9",
"    </a>",
"    ]. All showed less postoperative pain and a more rapid recovery to normal activities with a laparoscopic approach with a similar recurrence rate for both techniques. The National Institute for Health and Clinical Excellence (NICE) in the UK advocates laparoscopic repair for bilateral hernias [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Recurrent hernias",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many surgeons feel that recurrent hernias, especially those that recur after an anterior mesh repair, are best addressed via a laparoscopic technique. The theoretical argument is that the best repair for a recurrent hernia is one attempted in a previously undissected tissue plane. This allows for more precise identification of anatomy, and should reduce complication rates.",
"   </p>",
"   <p>",
"    Four small, randomized clinical trials comparing laparoscopic to open hernia repair for recurrent hernia demonstrated that a laparoscopic technique is associated with faster recovery, less postoperative pain, and fewer complications [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/9,11-13\">",
"     9,11-13",
"    </a>",
"    ]. A meta-analysis of the four randomized trials showed no significant difference between the laparoscopic and open groups in terms of preventing future recurrence, chronic pain, complications requiring further surgery, or seroma and hematoma formation [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/14\">",
"     14",
"    </a>",
"    ]. There was evidence that laparoscopic surgery significantly shortened the recovery time, reduced short-term postoperative pain and led to fewer superficial wound infections. The National Institute for Health and Clinical Excellence (NICE) in the UK advocates laparoscopic repair for recurrent hernias [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Femoral hernias",
"    </span>",
"    &nbsp;&mdash;&nbsp;Femoral hernias are directly approached by a laparoscopic technique, either TEP or TAPP. In contrast, the floor of the inguinal canal must be opened to gain access to a femoral hernia for an open technique.",
"   </p>",
"   <p>",
"    Femoral hernias are often missed at initial diagnosis. In an audit of recurrent hernia repairs, 10 percent of recurrent hernias after an open repair for presumed inguinal hernia were found to be femoral [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/15\">",
"     15",
"    </a>",
"    ]. This suggests that missed femoral hernia may be a risk with open anterior mesh repair of groin hernia and favors a posterior approach to femoral hernias with laparoscopic repair. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/15/9465?source=see_link\">",
"     \"Inguinal and femoral hernia repair: Open techniques\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     CONTRAINDICATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Age &ndash; With increased experience with laparoscopic approaches to inguinal hernia repair, advanced age, with its associated chronic medical conditions, is not generally a contraindication to laparoscopic repair [",
"      <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Inability to tolerate general anesthesia &ndash; Although several case series report laparoscopic hernia repair under spinal or epidural anesthesia, most surgeons perform these repairs under general anesthesia. Given the safety and ease with which open inguinal hernia repair can be performed under local anesthesia, inability to tolerate general anesthesia secondary to conditions such as severe COPD is a relative contraindication for a laparoscopic inguinal hernia repair. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/8/1162?source=see_link\">",
"       \"Evaluation of preoperative pulmonary risk\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/22/19817?source=see_link\">",
"       \"Overview of anesthesia and anesthetic choices\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Prior surgery &ndash; Prior surgery in the preperitoneal space, such as prior prostatectomy, is a relative contraindication to laparoscopic hernia repair. Although several authors have shown either TAPP or TEP repair can be performed after prostatectomy, laparoscopic repair is associated with higher morbidities and longer operative times [",
"      <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/17,18\">",
"       17,18",
"      </a>",
"      ]. A prior lower midline incision makes TEP repair more difficult, although TAPP repair is a feasible option in the presence of a prior lower midline incision. Prior mesh placement in the preperitoneal space makes laparoscopic repair much more difficult.",
"     </li>",
"     <li>",
"      Infection &ndash; Active infection is a contraindication to mesh placement. Since all laparoscopic hernia repairs utilize mesh, patients must be free of infection in order to reduce the risk of infected prosthetic material. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/0/11268?source=see_link\">",
"       \"Infection in mesh graft following hernia repair: Clinical manifestations, diagnosis, and treatment\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Incarcerated inguinal hernias &ndash; There are several case series documenting successful laparoscopic repairs of acutely incarcerated inguinal hernia by either a TAPP or TEP approach [",
"      <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/19,20\">",
"       19,20",
"      </a>",
"      ]. However, we suggest that an acutely incarcerated hernia should not be repaired laparoscopically because of the risk of bowel perforation when reducing incarcerated bowel with laparoscopic instruments. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/37/31321?source=see_link\">",
"       \"Classification, clinical features and diagnosis of inguinal and femoral hernias in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Large scrotal hernias &ndash; Large scrotal hernias represent a relative contraindication for laparoscopic repair because of the difficulty in managing and reducing a large indirect inguinal hernia sac. Transection and closure of the large hernia sac are difficult with laparoscopic repair, and scrotal hematomas and swelling are common [",
"      <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/21\">",
"       21",
"      </a>",
"      ]. Hence, most studies evaluating laparoscopic hernia repair exclude larger scrotal hernias. The size of inguinal hernias is generally categorized as small (&lt;1.5 cm), medium (1.5 to 3 cm) or large (&gt;3 cm) [",
"      <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Cirrhosis &ndash; Cirrhosis is a contraindication to laparoscopic inguinal hernia repair because of the risk of bleeding secondary to portal hypertension with a TEP approach or the risk of ascites leak with a TAPP approach. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/35/12858?source=see_link\">",
"       \"Assessing surgical risk in patients with liver disease\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     PREOPERATIVE EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laparoscopic hernia repair will almost always be performed under elective circumstances. Therefore, chronic medical conditions, such as coronary heart disease and diabetes mellitus, should be optimally managed prior to surgery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/4/10314?source=see_link\">",
"     \"Preoperative medical evaluation of the healthy patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most of the preoperative evaluation is directed toward insuring that the patient is adequately prepared for anesthesia. As discussed above, most surgeons prefer general anesthesia for laparoscopic hernia repair, even though several large series report the feasibility of laparoscopic hernia repair, especially TEP, under spinal anesthesia [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/23,24\">",
"     23,24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The risks and benefits of surgery versus expectant management, as well as potential surgical complications, should be reviewed with the patient. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/20/29000?source=see_link\">",
"     \"Overview of treatment for inguinal and femoral hernias\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The risks and benefits of laparoscopic versus open repair should be discussed with the patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     SURGEON'S SAFETY CHECKLIST FOR LAPAROSCOPIC HERNIA REPAIR",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Consent includes the possibility of hernia recurrence, mesh infection, neuralgia, and other pain syndromes. For men, the possibility of chronic orchialgia, injury to the vas deferens leading to infertility and testicular ischemia should be documented.",
"     </li>",
"     <li>",
"      Anesthetic concerns specific to the patient have been reviewed.",
"     </li>",
"     <li>",
"      Appropriate mesh is available.",
"     </li>",
"     <li>",
"      Prophylactic antibiotics have been administered. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Antibiotics'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Appropriate deep venous thromboembolism (DVT) prophylaxis has been administered. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Deep venous thrombosis prophylaxis'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Ensure bladder decompression by having the patient void immediately prior to the procedure. This avoids the need for placement of a Foley catheter.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Skin preparation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients are instructed to take a chlorhexidine bath the night before surgery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31290?source=see_link\">",
"     \"Overview of control measures to prevent surgical site infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Equipment",
"    </span>",
"    &nbsp;&mdash;&nbsp;An angled laparoscope, usually a 30&ordm; or a 45&ordm; scope, is used for these procedures, which allows for better visualization than a nonangled laparoscope.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Antibiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;All patients receive an appropriate antibiotic, such as 1 g of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/2/4136?source=see_link\">",
"     cefazolin",
"    </a>",
"    , intravenously after arriving in the operating room and before the incision is made. The efficacy of antibiotic prophylaxis decreases if administered more than one hour before surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/25,26\">",
"     25,26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hernia surgery is considered clean surgery, meaning surgery with no inflammation and no contact with septic material. There are few controlled clinical trials on the use of antibiotic prophylaxis in hernia surgery and the data are conflicting [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/27\">",
"     27",
"    </a>",
"    ]. While antibiotics are not usually recommended for clean procedures, antibiotic prophylaxis is generally accepted as an imperative when prosthetic materials will be used (",
"    <a class=\"graphic graphic_table graphicRef65369 \" href=\"UTD.htm?23/52/24397\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31290?source=see_link\">",
"     \"Overview of control measures to prevent surgical site infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Deep venous thrombosis prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;All patients except those who are healthy, thin, and under 40 years of age receive one dose of 5000 units aqueous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    subcutaneously in the preoperative holding room. Thigh-length sequential compression devices are applied for all patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/52/41802?source=see_link\">",
"     \"Prevention of venous thromboembolic disease in surgical patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     TOTALLY EXTRAPERITONEAL (TEP) HERNIA REPAIR",
"    </span>",
"    &nbsp;&mdash;&nbsp;The anatomic landmarks for entry into the preperitoneal space are the median umbilical ligament and the hernia defect. Direct entry into the rectus sheath just off of midline with blunt dissection to the linea semicircularis provides entry into the preperitoneal space (",
"    <a class=\"graphic graphic_figure graphicRef70359 \" href=\"UTD.htm?11/28/11721\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26374583\">",
"    <span class=\"h2\">",
"     Establishing the preperitoneal space",
"    </span>",
"    &nbsp;&mdash;&nbsp;The preperitoneal space is entered by establishing a plane between the posterior surface of the rectus muscle and the posterior rectus sheath and peritoneum. To accomplish this, an incision is made at the umbilicus, the rectus sheath is incised transversely and the rectus muscle is retracted laterally allowing for blunt instrumentation to dissect the preperitoneal space through the 10 mm trocar. Alternatively, a preperitoneal balloon dissector can be used to dissect this space under direct visualization (",
"    <a class=\"graphic graphic_figure graphicRef77369 \" href=\"UTD.htm?17/26/17824\">",
"     figure 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef56408 \" href=\"UTD.htm?3/0/3072\">",
"     figure 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Initial dissection should identify the epigastric artery and vein, which should be kept on the anterior abdominal wall. Occasionally the balloon dissector will dissect the epigastric vessels from the abdominal wall, which complicates the rest of the procedure.",
"     </li>",
"     <li>",
"      Once the preperitoneal space is dissected below the arcuate line, two additional 5 mm trocars are placed along the midline under direct visualization, using an angled laparoscope. The first 5 mm cannula is often positioned approximately 5 cm from the pubic symphysis. The second 5 mm cannula is placed midway between the umbilicus and the pubic symphysis (",
"      <a class=\"graphic graphic_figure graphicRef54751 \" href=\"UTD.htm?7/8/7298\">",
"       figure 4",
"      </a>",
"      ). Some surgeons prefer to place the working cannulas on either side of initial 10 mm umbilical trocar. Following establishment of the preperitoneal space with either a balloon dissector or direct dissection, pneumopreperitoneum is established. The patient is usually placed in 15 to 20&ordm; of Trendelenburg position to improve visualization of the working area.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26374612\">",
"    <span class=\"h2\">",
"     Dissection and exposure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blunt dissection of the preperitoneal space is completed in an avascular plane between the peritoneum and the transversalis fascia to allow visualization of both inguinal regions. This allows exposure of the inferior epigastric vessels, femoral vessels, pubic tubercle, Cooper's ligament, and spermatic cord. The anatomy of the preperitoneal space and the location of the hernia defects are illustrated in the figure (",
"    <a class=\"graphic graphic_figure graphicRef70359 \" href=\"UTD.htm?11/28/11721\">",
"     figure 1",
"    </a>",
"    ). It is best to avoid the use of cautery during the dissection as this can lead to nerve injury [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Care in dissecting Cooper's ligament is warranted to avoid disrupting the venous circle of Bendavid, which can produce troublesome bleeding. The Bendavid venous circle is a venous network fixed to the abdominal wall in the subinguinal space [",
"      <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/29\">",
"       29",
"      </a>",
"      ]. Tracing Cooper's ligament laterally to the femoral vessels identifies the femoral canal. A packet of lymph nodes is often encountered in the femoral canal and care should be used in this area to avoid excessive dissection, which can produce bleeding and lead to the development of a hernia in the femoral space.",
"     </li>",
"     <li>",
"      The iliopubic tract is less well seen with a laparoscopic approach, but can be felt at the lower border of the internal inguinal ring. During this dissection, direct hernia sacs are often reduced (",
"      <a class=\"graphic graphic_picture graphicRef63005 \" href=\"UTD.htm?27/34/28197\">",
"       picture 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef77859 \" href=\"UTD.htm?11/16/11524\">",
"       picture 2",
"      </a>",
"      ). Indirect sacs are more difficult to deal with and can be quite adherent to the spermatic cord. This dissection requires meticulous skeletonization of the spermatic cord ensuring that the vas deferens and the blood supply to the testicle are not injured (",
"      <a class=\"graphic graphic_picture graphicRef57923 \" href=\"UTD.htm?38/48/39683\">",
"       picture 3",
"      </a>",
"      ). Tracing the epigastric vessels toward their origin is a useful technique to identify the spermatic cord as it enters the internal ring. Often times a cord lipoma will also be removed during this process (",
"      <a class=\"graphic graphic_figure graphicRef77800 \" href=\"UTD.htm?21/50/22305\">",
"       figure 5",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Once a small sac is mobilized, it should be reduced, returned back to the peritoneal cavity, or ligated. Larger indirect sacs that are difficult to dissect and reduce may need to be carefully divided just distal to the internal ring, leaving the distal sac in situ. The size of inguinal hernias is generally categorized as small &lt;1.5 cm, medium 1.5 to 3 cm or large &gt;3 cm (",
"      <a class=\"graphic graphic_figure graphicRef66073 \" href=\"UTD.htm?12/61/13266\">",
"       figure 6",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26374711\">",
"    <span class=\"h2\">",
"     Mesh placement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once the dissection is complete, a 15 X 10 cm prosthetic mesh, either polypropylene or polyester, is introduced into the preperitoneal space through the umbilical cannula. The mesh is placed such that it completely covers the direct, indirect, and femoral hernia defects.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Some surgeons prefer to slit the mesh longitudinally or vertically to accommodate the cord structures, while others prefer to simply place the mesh over them. Additionally, some surgeons feel that preformed meshes conform to the preperitoneal space better than a flat piece of mesh that has to be trimmed to accommodate the patient's anatomy. The particular product or the method used is often a matter of personal preference.",
"     </li>",
"     <li>",
"      Some surgeons maintain that fixation of the mesh is not required, avoiding the costs of the stapler, reducing operative time and complications of nerve entrapment associated with the fixation devices [",
"      <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/30,31\">",
"       30,31",
"      </a>",
"      ]. However, most surgeons continue to utilize staples, tacks, or biological glue to prevent mesh migration or shrinkage [",
"      <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/32\">",
"       32",
"      </a>",
"      ]. Migration of mesh can result in erosion into adjacent organs, causing multiple complications [",
"      <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/33,34\">",
"       33,34",
"      </a>",
"      ]. One randomized trial found no difference in recurrence with or without mesh fixation, however the hernia's defects were small and follow-up was only six months [",
"      <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/35\">",
"       35",
"      </a>",
"      ]. We suggest that mesh fixation be employed for laparoscopic hernia repair to avoid the problem of mesh migration.",
"     </li>",
"     <li>",
"      The landmarks for fixation of the mesh are the pubic tubercle, Cooper's ligament, posterior rectus sheath and the transversalis fascia at least 2 cm superior to the hernia defect. In order to minimize the chance of damaging the lateral cutaneous nerve of the thigh, or the femoral branch of the genitofemoral nerve, the mesh should not be tacked or stapled below the iliopubic tract when lateral to the spermatic cord and the epigastric vessels [",
"      <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/28\">",
"       28",
"      </a>",
"      ]. This area is often referred to as the \"triangle of pain.\" The surgeon also needs to avoid the adjacent \"triangle of doom\" containing the external iliac artery and vein; this is defined medially by the vas deferens and laterally by the spermatic vessels.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26374791\">",
"    <span class=\"h2\">",
"     Wound closure",
"    </span>",
"    &nbsp;&mdash;&nbsp;At the conclusion of the procedure, a long acting local anesthetic is injected into the preperitoneal space. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/57/33689?source=see_link\">",
"     \"Infiltration of local anesthetics\"",
"    </a>",
"    .) The 10 mm umbilical cannula is closed at the fascia level. The pneumopreperitoneum is released and the skin incisions are closed with absorbable suture.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     TRANSABDOMINAL PREPERITONEAL (TAPP) HERNIA REPAIR",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a transabdominal preperitoneal repair (TAPP), the peritoneal cavity is entered as in most laparoscopic procedures. Beginning at the lateral edge of the median umbilical ligament, an incision along the peritoneum is made at least 4 cm above the hernia defect and extends 8 to 10 cm laterally. &nbsp;The key anatomic issue is to make the incision high enough above the hernia defect to be able to cover with mesh (",
"    <a class=\"graphic graphic_figure graphicRef70359 \" href=\"UTD.htm?11/28/11721\">",
"     figure 1",
"    </a>",
"    ). The major advantage of the posterior approach to groin hernias is that all three hernia defects, direct, indirect and femoral, are well-visualized, and in close proximity to each other, allowing easy repair of any type of groin hernia.",
"   </p>",
"   <p>",
"    Similar to the TEP procedure, three laparoscopic cannulas are used in a horizontal plane with the umbilicus. The sizes of the cannulas vary, but typically a 10 mm cannula is placed at the umbilicus to facilitate the introduction of mesh into the peritoneal cavity. Various techniques are described in the literature for the placement of the initial umbilical cannula. The open technique for the placement of the initial cannula is used in patients who have had previous surgeries. Following access to the peritoneal cavity, the abdomen is insufflated and two additional cannulas (usually 5 mm in size) are placed just lateral to the rectus muscles (",
"    <a class=\"graphic graphic_figure graphicRef63523 \" href=\"UTD.htm?7/59/8114\">",
"     figure 7",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The dissection is facilitated by placing the patient in Trendelenburg position to move the small bowel out from the pelvis. The median and medial umbilical ligaments, bladder, inferior epigastric vessels, vas deferens, spermatic cord, iliac vessels, and hernia defects are identified upon initial evaluation. The peritoneum is incised at least 4 cm above the hernia defect, beginning at the lateral edge of the median umbilical ligament and extended 8 to 10 cm laterally. This dissection is accomplished in an avascular plane between the peritoneum and the transversalis fascia extending towards the anterior superior iliac spine. As this peritoneal flap is developed, the inferior epigastric vessels are exposed.",
"   </p>",
"   <p>",
"    Mobilizing the peritoneal flap inferiorly allows for the visualization of the pubic symphysis, Cooper's ligament, iliopubic tract, cord structures, and hernia spaces. Direct hernia is often dealt with during this part of the procedure. This requires reducing the sac and the preperitoneal fat from the hernia orifice by gentle traction. The medial dissection is completed by identifying the iliopubic tract to ensure that the surgeon is cognizant of the femoral branch of the genitofemoral and lateral femoral cutaneous nerves. The lateral dissection proceeds from lateral to medial resulting in the dissection of the cord structures. Indirect sacs should be mobilized from the cord structures and reduced into the peritoneal cavity. A larger hernia sac that is difficult to mobilize from the cord without undue trauma to the vas deferens or vasculature to the testicle can be simply divided just distal to the internal ring leaving the distal sac in situ (",
"    <a class=\"graphic graphic_figure graphicRef71264 \" href=\"UTD.htm?28/17/28945\">",
"     figure 8",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Once the dissection is completed, a 15 X 10 cm piece of mesh is placed to completely cover the direct, indirect, and femoral hernia spaces (",
"    <a class=\"graphic graphic_figure graphicRef50283 \" href=\"UTD.htm?4/0/4099\">",
"     figure 9",
"    </a>",
"    ). The mesh placement is performed in a similar fashion to the totally extraperitoneal procedure. Patients with bilateral hernias can be repaired using one long transverse peritoneal incision extending from one anterior superior iliac spine to another on the opposite side.",
"   </p>",
"   <p>",
"    Following the fixation of the mesh, the inferior peritoneal flap is placed over the prosthesis in order to isolate it from the peritoneal cavity. This is performed by a running suture, staples, tacks, or biological sealants. It is important to avoid gaps when closing the peritoneum because small bowel can potentially find its way through these spaces and lead to a small bowel obstruction. A long acting local anesthetic is injected into the preperitoneal space prior to the closure of the peritoneum. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/57/33689?source=see_link\">",
"     \"Infiltration of local anesthetics\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The 10 mm umbilical cannula site is closed at the fascia level. Finally, the pneumoperitoneum is released and the skin incisions are closed with absorbable suture.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     CHOICE OF PROCEDURE: TEP OR TAPP?",
"    </span>",
"    &nbsp;&mdash;&nbsp;The drawback of the transabdominal preperitoneal (TAPP) procedure is entering the peritoneal cavity and peritoneal closure. Entering the peritoneal cavity can result in an injury to adjacent abdominal organs, adhesions resulting in intestinal obstruction, or incisional herniation. Closure of the peritoneum over the mesh can lead to inadvertent breaches, and has been associated with bowel herniation and obstruction. The totally extraperitoneal procedure (TEP) was developed to address and potentially avoid the risks of entering the peritoneal cavity.",
"   </p>",
"   <p>",
"    A systematic review of eight retrospective studies and one randomized trial that compared TEP with TAPP repair demonstrated a lower risk of visceral injury or incisional hernia formation with TEP repair [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/36\">",
"     36",
"    </a>",
"    ]. &nbsp; However, the risk of conversion to an open procedure is lower with TAPP repair [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/36\">",
"     36",
"    </a>",
"    ]. The TEP is technically more challenging because of the limited working space, which probably explains the higher conversion rate. It is believed that surgeons should master the TAPP repair before attempting the TEP repair. Unrecognized peritoneal holes during a TEP procedure can also lead to intestinal obstruction; however, the rate still appears to be much lower than with TAPP repair [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We prefer the TEP when performing hernia repairs. We will convert to a TAPP in patients with large hernias, previous lower abdominal incisions, inability to develop the preperitoneal space, or any other complicating situation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     HERNIA REPAIRS IN WOMEN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Groin hernias are less common in women than men. Only 8 percent of all groin hernia repairs are performed in women [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. Indirect hernias are the most common groin hernias in women, followed by femoral hernias [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/40\">",
"     40",
"    </a>",
"    ]. Direct hernias are rare in women.",
"   </p>",
"   <p>",
"    Occult hernias are a particular problem because the inguinal canal is difficult to examine in women. The skin of the labium majus does not have enough redundancy to allow the examining finger to directly palpate the inguinal floor. Because hernias are more difficult to detect on routine physical exam in women, they are more likely than men to present with hernia incarceration or strangulation, requiring emergency surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/38\">",
"     38",
"    </a>",
"    ]. Women have frequently had prior lower abdominal surgery that causes adhesions within the preperitoneal space, increasing the risk of unintended organ injury during laparoscopic repairs. Women also have a significantly higher risk of hernia recurrence after repair than men [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Indirect inguinal hernia sacs are frequently much more intimately attached to the round ligament in women than are indirect sacs to the cord structures in males. Compared to men, this makes totally preperitoneal laparoscopic repairs somewhat more technically difficult when inadvertent pneumoperitoneum occurs during dissection of the sac from the ligament. In a large series of hernia repairs in women, the TAPP repair produced the best outcomes, with the lowest recurrence rate [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     POSTOPERATIVE MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients can return to work 48 hours after a laparoscopic hernia repair if they are not required to perform heavy lifting or straining. This recommendation is tempered by the patient's pain tolerance.",
"   </p>",
"   <p>",
"    Patients can return to heavy lifting, straining, or exercise two weeks after hernia repair if they are otherwise doing well and report that they are completely recovered from surgery. There are little high quality data regarding the timing of return to work and the return to strenuous activity following laparoscopic hernia repair.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     OUTCOMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;A meta-analysis of 41 eligible trials of laparoscopic versus open groin hernia repair showed that operating room time for laparoscopic repair was longer and there was a higher risk of intraoperative vascular and visceral injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/2\">",
"     2",
"    </a>",
"    ]. After a laparoscopic inguinal hernia repair, patients are discharged from the hospital sooner, have less postoperative pain, fewer postoperative complications, and a more rapid return to work than with open hernia repair [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/2,41\">",
"     2,41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Both laparoscopic and open repairs have their strengths and weaknesses, and the authors believe that both open and laparoscopic procedures have a place in managing this common surgical problem. We prefer open repair for unilateral primary hernias and TEP repair for bilateral and recurrent hernias.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Hernia recurrence",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of factors contribute to hernia recurrence, including surgeon inexperience, inadequate dissection and mesh size, inappropriate fixation, missed hernias, migration of prosthesis, and insufficient prosthesis overlap of hernia defect. The learning curve for laparoscopic hernia repair is long, with one study estimating it to be as high as 250 cases [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several studies have shown that laparoscopic inguinal hernia repair may be associated with a higher recurrence rate when compared to open mesh repair [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/42-44\">",
"     42-44",
"    </a>",
"    ]. The two largest randomized controlled trials, comparing nearly 3700 patients, report that the recurrence rate after laparoscopic repair may be two times higher than with open mesh repair [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/42,44\">",
"     42,44",
"    </a>",
"    ]. However, careful examination of these studies revealed that a few surgeons or centers were responsible for many of the recurrences, reinforcing the notion that surgeon experience with laparoscopic hernia repair plays an important role in the risk of hernia recurrence. The Swedish Hernia Register contains information on all patients (142,578) who underwent inguinal hernia repair from 1992 to 2006 [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/45\">",
"     45",
"    </a>",
"    ]. This study documented an increased risk for early recurrence in patients who underwent laparoscopic repairs as compared to open mesh repairs [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/45\">",
"     45",
"    </a>",
"    ]. Early recurrences are most likely due to technical failures, which underscores the importance of surgeon experience.",
"   </p>",
"   <p>",
"    In the hands of experienced laparoscopic hernia surgeons, recurrence rates after laparoscopic inguinal hernia repairs are similar to those after open repair and the rates of recurrence seem to be the same with TEP and TAPP repair [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;The overall incidence of short-term complications after laparoscopic hernia repair is between 17 and 25 percent in the two largest randomized controlled trials of laparoscopic hernia repair [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/42,47\">",
"     42,47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Reported complications include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Groin pain &ndash; The incidence of chronic groin pain after laparoscopic hernia repair at two years is up to 8 percent in one study [",
"      <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/48\">",
"       48",
"      </a>",
"      ]. Postoperative groin pain and numbness can be very difficult to treat because of the inability to determine the exact etiology. Patients with obvious immediate neuralgia due to impingement on the femoral branches of the genitofemoral nerve or the lateral cutaneous nerve of the thigh, may benefit from removal of the tack or staple that is compromising the nerve. Patients with chronic postoperative groin pain may require removal of mesh or neurectomy to help manage their pain.",
"     </li>",
"     <li>",
"      Testicular pain &ndash; Interference with blood supply to the testicle, resulting from dissecting an indirect hernia from the cord structures, may lead to testicular pain, ischemic orchitis, and testicular atrophy [",
"      <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/47,49\">",
"       47,49",
"      </a>",
"      ]. The incidence of orchitis after laparoscopic hernia repair is 1.4 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/48\">",
"       48",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Injury to vas deferens &ndash; Transection or obstruction of the vas deferens is of particular concern in young men [",
"      <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/50\">",
"       50",
"      </a>",
"      ]. The incidence ranges from 0.3 to 7.2 percent and can result from direct injury, vascular compromise, extrinsic compression or the fibrotic reaction to polypropylene mesh.",
"     </li>",
"     <li>",
"      Seroma &ndash; A seroma can develop and can be confused with a hernia recurrence since this usually presents with an inguinal bulge and pain. Seromas and hematomas are reported in 5 percent of laparoscopic hernia repairs [",
"      <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/48\">",
"       48",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Bleeding &ndash; Vascular injuries to either the external iliac artery or vein, or more commonly the epigastric artery or vein, can result in significant intraoperative or postoperative bleeding. Care during dissection and placement of mesh fixation tacks is the key to avoiding these complications. Bleeding can result in a scrotal or wound hematoma. Seromas and hematomas are reported in 5 percent of laparoscopic hernia repairs [",
"      <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/48\">",
"       48",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Mesh infection &ndash; The incidence of infection following laparoscopic hernia repair with mesh is reported as lower than with open repairs. In one series of 1182 laparoscopic repairs, the mesh infection rate was 0.17 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/51\">",
"       51",
"      </a>",
"      ]. The risk of infection may be higher when mesh is used to repair large defects",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      in the setting of comorbid conditions such as diabetes, immunosuppression, or obesity. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/0/11268?source=see_link\">",
"       \"Infection in mesh graft following hernia repair: Clinical manifestations, diagnosis, and treatment\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Mesh migration &ndash; Migration of mesh can result in erosion into adjacent organs, causing infection and related complications [",
"      <a class=\"abstract\" href=\"UTD.htm?25/49/26393/abstract/34,52\">",
"       34,52",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?41/62/42977?source=see_link\">",
"       \"Patient information: Inguinal and femoral (groin) hernias (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Inguinal hernia repairs are performed through either an anterior or posterior approach. An anterior approach through the inguinal canal is used for most open inguinal hernia repairs while the posterior approach from underneath the abdominal wall is typically used when performing laparoscopic groin hernia repairs. All currently performed laparoscopic hernia repairs involve placing mesh in the preperitoneal space. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Types of laparoscopic hernia repairs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The two commonly used approaches for laparoscopic repair of groin hernia are the totally extraperitoneal hernia repair (TEP) and the transabdominal preperitoneal hernia repair or (TAPP). The drawback of the transabdominal preperitoneal (TAPP) procedure is entry into the peritoneal cavity. The totally extraperitoneal procedure (TEP), developed to avoid the risks of entering the peritoneal cavity, is technically more challenging. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Types of laparoscopic hernia repairs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The precise role of laparoscopy in inguinal hernia repair remains controversial given the increased costs, greater technical difficulty, and longer learning curve relative to open mesh repair. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Indications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest laparoscopic hernia repair for bilateral hernias, recurrent hernias and femoral hernias (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). We suggest open repair for unilateral primary hernias (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Indications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Laparoscopic hernia repair is not recommended for patients who are unable to tolerate general anesthesia, patients who have had prior surgery in the preperitoneal space, or those with active infection, an incarcerated hernia, large scrotal hernias or cirrhosis. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Contraindications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest the totally extraperitoneal approach (TEP) for laparoscopic hernia repairs in men if the surgeon is experienced with this technique (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      We suggest conversion from a TEP to a transabdominal preperitoneal procedure (TAPP) in patients with large hernias, previous lower abdominal incisions, or inability to develop the preperitoneal space (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Choice of procedure: TEP or TAPP?'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest the TAPP approach for hernia repairs in women (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Hernia repairs in women'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest that mesh fixation be employed for laparoscopic hernia repair (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Totally extraperitoneal (TEP) hernia repair'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H15\">",
"       'Transabdominal preperitoneal (TAPP) hernia repair'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In the hands of experienced laparoscopic hernia surgeons, recurrence rates after laparoscopic inguinal hernia repairs are similar to those after open repair and the rates of recurrence are the same with TEP and TAPP repair. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Outcomes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Complications of laparoscopic hernia repair include groin pain and numbness, testicular pain, injury to the vas deferens, seroma and hematoma formation, vascular injury and mesh infection or migration. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Outcomes'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/1\">",
"      Arregui ME, Davis CJ, Yucel O, Nagan RF. Laparoscopic mesh repair of inguinal hernia using a preperitoneal approach: a preliminary report. Surg Laparosc Endosc 1992; 2:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/2\">",
"      McCormack K, Scott NW, Go PM, et al. Laparoscopic techniques versus open techniques for inguinal hernia repair. Cochrane Database Syst Rev 2003; :CD001785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/3\">",
"      Rattner DW. Physicians' choice for their own hernia repairs. J Laparoendosc Adv Surg Tech A 2000; 10:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/4\">",
"      Winslow ER, Quasebarth M, Brunt LM. Perioperative outcomes and complications of open vs laparoscopic extraperitoneal inguinal hernia repair in a mature surgical practice. Surg Endosc 2004; 18:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/5\">",
"      Ohana G, Powsner E, Melki Y, et al. Simultaneous repair of bilateral inguinal hernias: a prospective, randomized study of single versus double mesh laparoscopic totally extraperitoneal repair. Surg Laparosc Endosc Percutan Tech 2006; 16:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/6\">",
"      O'Rourke A, Zell JA, Varkey-Zell TT, et al. Laparoscopic diagnosis and repair of asymptomatic bilateral inguinal hernias. Am J Surg 2002; 183:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/7\">",
"      Sarli L, Iusco DR, Sansebastiano G, Costi R. Simultaneous repair of bilateral inguinal hernias: a prospective, randomized study of open, tension-free versus laparoscopic approach. Surg Laparosc Endosc Percutan Tech 2001; 11:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/8\">",
"      Kr&auml;henb&uuml;hl L, Sch&auml;fer M, Schilling M, et al. Simultaneous repair of bilateral groin hernias: open or laparoscopic approach? Surg Laparosc Endosc 1998; 8:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/9\">",
"      Mahon D, Decadt B, Rhodes M. Prospective randomized trial of laparoscopic (transabdominal preperitoneal) vs open (mesh) repair for bilateral and recurrent inguinal hernia. Surg Endosc 2003; 17:1386.",
"     </a>",
"    </li>",
"    <li>",
"     National Institute for Health and Clinical Excellence (NICE). Laparoscopic surgery for inguinal hernia repair. NICE; 2004. Available online at www.nice.org.uk/TA083guidance (Accessed on April 22, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/11\">",
"      Dedemadi G, Sgourakis G, Karaliotas C, et al. Comparison of laparoscopic and open tension-free repair of recurrent inguinal hernias: a prospective randomized study. Surg Endosc 2006; 20:1099.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/12\">",
"      Eklund A, Rudberg C, Leijonmarck CE, et al. Recurrent inguinal hernia: randomized multicenter trial comparing laparoscopic and Lichtenstein repair. Surg Endosc 2007; 21:634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/13\">",
"      Kouhia ST, Huttunen R, Silvasti SO, et al. Lichtenstein hernioplasty versus totally extraperitoneal laparoscopic hernioplasty in treatment of recurrent inguinal hernia--a prospective randomized trial. Ann Surg 2009; 249:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/14\">",
"      Karthikesalingam A, Markar SR, Holt PJ, Praseedom RK. Meta-analysis of randomized controlled trials comparing laparoscopic with open mesh repair of recurrent inguinal hernia. Br J Surg 2010; 97:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/15\">",
"      Bisgaard T, Bay-Nielsen M, Kehlet H. Re-recurrence after operation for recurrent inguinal hernia. A nationwide 8-year follow-up study on the role of type of repair. Ann Surg 2008; 247:707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/16\">",
"      Velasco JM, Vallina VL, Esposito DJ, Theodore S. Laparoscopic herniorrhaphy in the geriatric population. Am Surg 1998; 64:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/17\">",
"      Wauschkuhn CA, Schwarz J, Bittner R. Laparoscopic transperitoneal inguinal hernia repair (TAPP) after radical prostatectomy: is it safe? Results of prospectively collected data of more than 200 cases. Surg Endosc 2009; 23:973.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/18\">",
"      Dulucq JL, Wintringer P, Mahajna A. Totally extraperitoneal (TEP) hernia repair after radical prostatectomy or previous lower abdominal surgery: is it safe? A prospective study. Surg Endosc 2006; 20:473.",
"     </a>",
"    </li>",
"    <li>",
"     Hoffman, A, Leshem, E, Zmora, O, et al. The combined laparoscopic approach for the treatment of incarcerated inguinal hernia. Surg Endosc 2010; Epub ahead of print. Available online at: www.ncbi.nlm.nih.gov/pubmed/20063015 (Accessed June 8, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/20\">",
"      Deeba S, Purkayastha S, Paraskevas P, et al. Laparoscopic approach to incarcerated and strangulated inguinal hernias. JSLS 2009; 13:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/21\">",
"      Matthews RD, Anthony T, Kim LT, et al. Factors associated with postoperative complications and hernia recurrence for patients undergoing inguinal hernia repair: a report from the VA Cooperative Hernia Study Group. Am J Surg 2007; 194:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/22\">",
"      Zollinger RM Jr. An updated traditional classification of inguinal hernias. Hernia 2004; 8:318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/23\">",
"      Ismail M, Garg P. Laparoscopic inguinal total extraperitoneal hernia repair under spinal anesthesia without mesh fixation in 1,220 hernia repairs. Hernia 2009; 13:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/24\">",
"      Molinelli BM, Tagliavia A, Bernstein D. Total extraperitoneal preperitoneal laparoscopic hernia repair using spinal anesthesia. JSLS 2006; 10:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/25\">",
"      Fry DE. Surgical site infections and the surgical care improvement project (SCIP): evolution of national quality measures. Surg Infect (Larchmt) 2008; 9:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/26\">",
"      Bratzler DW, Houck PM, Surgical Infection Prevention Guidelines Writers Workgroup, et al. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004; 38:1706.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/27\">",
"      Sanchez-Manuel FJ, Lozano-Garc&iacute;a J, Seco-Gil JL. Antibiotic prophylaxis for hernia repair. Cochrane Database Syst Rev 2007; :CD003769.",
"     </a>",
"    </li>",
"    <li>",
"     Rattner, DW. Commentary regarding Laparoscopic inguinal hernia repair. In: Atlas of minimally invasive surgery, Jones, DB, Maithel, SK, Schneider, BE (Eds), Cine-med, Woodbury 2006. p 545.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/29\">",
"      Bendavid R. The space of Bogros and the deep inguinal venous circulation. Surg Gynecol Obstet 1992; 174:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/30\">",
"      Kapiris S, Mavromatis T, Andrikopoulos S, et al. Laparoscopic transabdominal preperitoneal hernia repair (TAPP): stapling the mesh is not mandatory. J Laparoendosc Adv Surg Tech A 2009; 19:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/31\">",
"      Dulucq JL, Wintringer P, Mahajna A. Laparoscopic totally extraperitoneal inguinal hernia repair: lessons learned from 3,100 hernia repairs over 15 years. Surg Endosc 2009; 23:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/32\">",
"      Balakrishnan S, Singhal T, Samdani T, et al. Laparoscopic inguinal hernia repair: over a thousand convincing reasons to go on. Hernia 2008; 12:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/33\">",
"      Hamouda A, Kennedy J, Grant N, et al. Mesh erosion into the urinary bladder following laparoscopic inguinal hernia repair; is this the tip of the iceberg? Hernia 2010; 14:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/34\">",
"      Goswami R, Babor M, Ojo A. Mesh erosion into caecum following laparoscopic repair of inguinal hernia (TAPP): a case report and literature review. J Laparoendosc Adv Surg Tech A 2007; 17:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/35\">",
"      Taylor C, Layani L, Liew V, et al. Laparoscopic inguinal hernia repair without mesh fixation, early results of a large randomised clinical trial. Surg Endosc 2008; 22:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/36\">",
"      McCormack K, Wake BL, Fraser C, et al. Transabdominal pre-peritoneal (TAPP) versus totally extraperitoneal (TEP) laparoscopic techniques for inguinal hernia repair: a systematic review. Hernia 2005; 9:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/37\">",
"      Bringman S, Blomqvist P. Intestinal obstruction after inguinal and femoral hernia repair: a study of 33,275 operations during 1992-2000 in Sweden. Hernia 2005; 9:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/38\">",
"      Koch A, Edwards A, Haapaniemi S, et al. Prospective evaluation of 6895 groin hernia repairs in women. Br J Surg 2005; 92:1553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/39\">",
"      Nilsson E, Kald A, Anderberg B, et al. Hernia surgery in a defined population: a prospective three year audit. Eur J Surg 1997; 163:823.",
"     </a>",
"    </li>",
"    <li>",
"     Fitzgibbons, RJ, Filipi, CJ, Quinn, TH. Inguinal hernias. In: Schwartz's Principles of Surgery, 8th ed, Brunicardi, FC, et al (Eds), 2005. p1390.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/41\">",
"      Memon MA, Cooper NJ, Memon B, et al. Meta-analysis of randomized clinical trials comparing open and laparoscopic inguinal hernia repair. Br J Surg 2003; 90:1479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/42\">",
"      Neumayer L, Giobbie-Hurder A, Jonasson O, et al. Open mesh versus laparoscopic mesh repair of inguinal hernia. N Engl J Med 2004; 350:1819.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/43\">",
"      McCormack K, Wake B, Perez J, et al. Laparoscopic surgery for inguinal hernia repair: systematic review of effectiveness and economic evaluation. Health Technol Assess 2005; 9:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/44\">",
"      Eklund AS, Montgomery AK, Rasmussen IC, et al. Low recurrence rate after laparoscopic (TEP) and open (Lichtenstein) inguinal hernia repair: a randomized, multicenter trial with 5-year follow-up. Ann Surg 2009; 249:33.",
"     </a>",
"    </li>",
"    <li>",
"     Magnusson N, Nordin P, Hedberg M, et al. The time profile of groin hernia recurrences. Hernia. 2010;. [Epub ahead of print].",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/46\">",
"      Pokorny H, Klingler A, Schmid T, et al. Recurrence and complications after laparoscopic versus open inguinal hernia repair: results of a prospective randomized multicenter trial. Hernia 2008; 12:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/47\">",
"      Eklund A, Rudberg C, Smedberg S, et al. Short-term results of a randomized clinical trial comparing Lichtenstein open repair with totally extraperitoneal laparoscopic inguinal hernia repair. Br J Surg 2006; 93:1060.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/48\">",
"      Hawn MT, Itani KM, Giobbie-Hurder A, et al. Patient-reported outcomes after inguinal herniorrhaphy. Surgery 2006; 140:198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/49\">",
"      Grant AM, Scott NW, O'Dwyer PJ, MRC Laparoscopic Groin Hernia Trial Group. Five-year follow-up of a randomized trial to assess pain and numbness after laparoscopic or open repair of groin hernia. Br J Surg 2004; 91:1570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/50\">",
"      Shin D, Lipshultz LI, Goldstein M, et al. Herniorrhaphy with polypropylene mesh causing inguinal vasal obstruction: a preventable cause of obstructive azoospermia. Ann Surg 2005; 241:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26393/abstract/51\">",
"      Moon V, Chaudry GA, Choy C, Ferzli GS. Mesh infection in the era of laparoscopy. J Laparoendosc Adv Surg Tech A 2004; 14:349.",
"     </a>",
"    </li>",
"    <li>",
"     Hamouda A, Kennedy J, Grant N, et al. Mesh erosion into the urinary bladder following laparoscopic inguinal hernia repair; is this the tip of the iceberg? Hernia. 2009;. [Epub ahead of print].",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3692 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-201.77.166.39-C008A65255-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_49_26393=[""].join("\n");
var outline_f25_49_26393=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TYPES OF LAPAROSCOPIC HERNIA REPAIRS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Bilateral hernias",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Recurrent hernias",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Femoral hernias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      CONTRAINDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      PREOPERATIVE EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      SURGEON'S SAFETY CHECKLIST FOR LAPAROSCOPIC HERNIA REPAIR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Skin preparation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Equipment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Antibiotics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Deep venous thrombosis prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      TOTALLY EXTRAPERITONEAL (TEP) HERNIA REPAIR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26374583\">",
"      Establishing the preperitoneal space",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26374612\">",
"      Dissection and exposure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26374711\">",
"      Mesh placement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26374791\">",
"      Wound closure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      TRANSABDOMINAL PREPERITONEAL (TAPP) HERNIA REPAIR",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      CHOICE OF PROCEDURE: TEP OR TAPP?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      HERNIA REPAIRS IN WOMEN",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      POSTOPERATIVE MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Hernia recurrence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/3692\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/3692|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?11/28/11721\" title=\"figure 1\">",
"      Laparoscopic view of inguinal anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?17/26/17824\" title=\"figure 2\">",
"      TEP access balloon dissector",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?3/0/3072\" title=\"figure 3\">",
"      TEP access direct vision",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?7/8/7298\" title=\"figure 4\">",
"      Port placement for TEP hernia repair",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?21/50/22305\" title=\"figure 5\">",
"      Indirect inguinal hernia sac TEP dissection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?12/61/13266\" title=\"figure 6\">",
"      TEP hernia reduction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?7/59/8114\" title=\"figure 7\">",
"      Port placement for TAPP hernia repair",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/17/28945\" title=\"figure 8\">",
"      TAPP hernia reduction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?4/0/4099\" title=\"figure 9\">",
"      Transabdominal preperitoneal hernia repair",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/3692|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?27/34/28197\" title=\"picture 1\">",
"      Lap hernia still A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?11/16/11524\" title=\"picture 2\">",
"      Lap hernia still B",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?38/48/39683\" title=\"picture 3\">",
"      Lap hernia still C",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/3692|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/52/24397\" title=\"table 1\">",
"      Antimicrobial prophylaxis for gastrointestinal surgery",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/35/12858?source=related_link\">",
"      Assessing surgical risk in patients with liver disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/37/31321?source=related_link\">",
"      Classification, clinical features and diagnosis of inguinal and femoral hernias in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/8/1162?source=related_link\">",
"      Evaluation of preoperative pulmonary risk",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/0/11268?source=related_link\">",
"      Infection in mesh graft following hernia repair: Clinical manifestations, diagnosis, and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/57/33689?source=related_link\">",
"      Infiltration of local anesthetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/15/9465?source=related_link\">",
"      Inguinal and femoral hernia repair: Open techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/22/19817?source=related_link\">",
"      Overview of anesthesia and anesthetic choices",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31290?source=related_link\">",
"      Overview of control measures to prevent surgical site infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/20/29000?source=related_link\">",
"      Overview of treatment for inguinal and femoral hernias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?41/62/42977?source=related_link\">",
"      Patient information: Inguinal and femoral (groin) hernias (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/4/10314?source=related_link\">",
"      Preoperative medical evaluation of the healthy patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/52/41802?source=related_link\">",
"      Prevention of venous thromboembolic disease in surgical patients",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f25_49_26394="Developmental-behavioral surveillance and screening in primary care";
var content_f25_49_26394=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Developmental-behavioral surveillance and screening in primary care",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/49/26394/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/49/26394/contributors\">",
"     Angela LaRosa, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/49/26394/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/49/26394/contributors\">",
"     Carolyn Bridgemohan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/49/26394/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/49/26394/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?25/49/26394/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 20, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;This topic review discusses the rationale for, challenges of, and components of developmental-behavioral screening and surveillance in the primary care setting. Detailed descriptions of developmental-behavioral screening tests and screening for autism spectrum disorders are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/29/19928?source=see_link\">",
"     \"Developmental and behavioral screening tests in primary care\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/17/35097?source=see_link\">",
"     \"Surveillance and screening for autism spectrum disorders in primary care\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/1/14361?source=see_link\">",
"     \"Screening tools for autism spectrum disorders\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19981925\">",
"    <span class=\"h1\">",
"     BACKGROUND",
"    </span>",
"    &nbsp;&mdash;&nbsp;Development is a broad term that encompasses language and motor, as well as behavioral, social-emotional, and mental health domains (",
"    <a class=\"graphic graphic_table graphicRef77685 \" href=\"UTD.htm?4/33/4637\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    It is estimated that 17 percent of children (0 to 18 years) have a developmental",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    behavioral disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/1\">",
"     1",
"    </a>",
"    ]. However, only 30 percent are identified before school entrance [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/2\">",
"     2",
"    </a>",
"    ]. Children who are detected after school entrance miss the opportunity to participate in early developmental",
"    <span class=\"nowrap\">",
"     intervention/early",
"    </span>",
"    childhood services, which are associated with long-term benefits [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/3-10\">",
"     3-10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Milestones checklists within age-specific encounter forms or informal questions to parents about their concerns detect only about 30 percent of children with developmental delays and disabilities [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/2\">",
"     2",
"    </a>",
"    ]. To increase detection, it is necessary to use validated developmental-behavioral surveillance and screening measures [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/11\">",
"     11",
"    </a>",
"    ]. The use of such measures is feasible in busy clinics [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/12,13\">",
"     12,13",
"    </a>",
"    ], aids in decision-making, improves parent-provider satisfaction with clinic services, and is reimbursable. (See",
"    <a class=\"local\" href=\"#H1873091\">",
"     'Coding and billing'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    To improve the early identification of children with developmental and behavioral problems, the American Academy of Pediatrics (AAP) recommends that all infants and young children be screened for developmental delays [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/11\">",
"     11",
"    </a>",
"    ]. The AAP recommends a combination of developmental surveillance",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    screening and surveillance at all well-visits. At a minimum, standardized screening tools should be administered at the 9-month, 18-month, and 24- or 30-month visits, and if developmental concerns are raised by the parent or provider during surveillance. The AAP algorithm is available in the full text of reference [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/11\">",
"     11",
"    </a>",
"    ]. The AAP policy statement does not address developmental screening and surveillance in children older than 30 months. The authors of this topic review recommend developmental-behavioral screening at the three-year well-child visit and annually thereafter.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h2\">",
"     Definitions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Definitions of terms used in developmental-behavioral screening and surveillance are provided in the table (",
"    <a class=\"graphic graphic_table graphicRef56688 \" href=\"UTD.htm?39/8/40077\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33894841\">",
"    <span class=\"h2\">",
"     Subsets of child development",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children seen in primary care can be categorized into three subsets according to their developmental status:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Those with normal development and behavior whose caregivers will face the &ldquo;normal problems of normal children&rdquo; (ie, parents may need advice from time to time on various issues of typical development, such as temper tantrums and toilet training). (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Passed screening test'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Those with developmental delays that may be amenable with appropriate early intervention. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Failed screening test'",
"      </a>",
"      below and",
"      <a class=\"local\" href=\"#H89189211\">",
"       'Early Intervention, special education, and other intervention services'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      A subset that falls in the middle &ndash; Those children who do not appear to be delayed but who may well acquire delays if psychosocial risk factors are not identified and addressed (ie, those who are &ldquo;at risk&rdquo; for developmental challenges). These children may benefit from parental counseling or referral for parenting intervention, referral to Early Intervention (or, if not eligible for Early Intervention, to other prevention programs such as Head Start, quality day care, etc). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Assessment of psychosocial risks and protective factors'",
"      </a>",
"      below and",
"      <a class=\"local\" href=\"#H89189211\">",
"       'Early Intervention, special education, and other intervention services'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Rationale for surveillance and screening",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goal of developmental surveillance and screening is the identification of children who have or are at risk for delays so that services can be provided in a timely manner [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/11,14\">",
"     11,14",
"    </a>",
"    ]. Systematic reviews, prospective observational studies, and a few randomized trials have demonstrated that outcomes for children are substantially better if problems are detected early and services are provided [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/3-10\">",
"     3-10",
"    </a>",
"    ]. For this reason, the Individuals with Disabilities Education Act (IDEA) requires clinicians to refer children with suspected (as well as confirmed) developmental delays to the appropriate early intervention system [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The primary care clinic is the most likely place where families of young children will encounter a professional who can detect developmental or behavioral problems. Primary care providers are in a unique position to provide developmental surveillance and screening because they have routine contact with young children and their families. In addition, because they have an ongoing relationship with the child and family, they are better placed than other providers to understand the strengths and needs of both [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/14\">",
"     14",
"    </a>",
"    ]. Evidence-based surveillance and screening (ie, the use of accurate validated measures) in primary care facilitates timely identification of developmental and behavioral problems and early referral to community resources for treatment and intervention [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/16-19\">",
"     16-19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Examples from several states illustrate the effectiveness of quality tools in enhancing detection. Hawaii and Massachusetts, whose providers are required to use validated developmental-behavioral screening measures for Medicaid reimbursement, had the highest national Early Intervention enrollment rates in 2008 (6.7 and 6.4 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/20\">",
"     20",
"    </a>",
"    ]. Although these rates are slightly below the Centers for Disease Control and Prevention&rsquo;s estimated prevalence of developmental delay in this age group (7 to 8 percent), they are more than twice the rates in states without mandates to use quality screening measures (the national average is 2.7 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/16,20,21\">",
"     16,20,21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Benefits of early intervention",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary goal of developmental surveillance and screening is early identification of developmental delays [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/11,14\">",
"     11,14",
"    </a>",
"    ]. Early identification of developmental delays by primary care providers results in early referral for diagnostic evaluation and early treatment, providing children with the medical and ancillary support that is necessary to meet their full developmental potential.",
"   </p>",
"   <p>",
"    In systematic reviews, prospective observational studies, and a few randomized trials, early developmental intervention was associated with improved health outcomes for children, improved school performance, decreased need for special education services during the school years, and fewer secondary problems [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/3-10\">",
"     3-10",
"    </a>",
"    ]. Early",
"    <span class=\"nowrap\">",
"     developmental/childhood",
"    </span>",
"    intervention services for children with disabilities have been associated with higher graduation rates, reduced teen pregnancy rates, higher employment rates, and a decrease in criminal behavior and violence [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/8\">",
"     8",
"    </a>",
"    ]. Early intervention services are estimated to save society $30,000 to $100,000 per participant through decreased need for special education services during the school years and increased income during adulthood [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/22,23\">",
"     22,23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Early identification permits parents to better match their expectations to their child's abilities, to provide developmentally appropriate activities and stimulation, and to feel that they are doing all that they can to assist their child [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/7,24\">",
"     7,24",
"    </a>",
"    ]. In addition, practices that provide developmental surveillance and screening have documented increased attendance at health supervision visits, perhaps because parents have a greater opportunity to discuss issues of interest and need [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9015185\">",
"    <span class=\"h2\">",
"     Challenges in early detection",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Potential harms",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several potential harms of efforts to identify children with developmental problems: (1) Failure to detect children with developmental problems, usually because of problematic identification methods (eg, informal measures) or due to false-negative tests, either of which results in under-referral to needed services",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    less of time to benefit from early intervention; (2) False-positive tests, resulting in over-referral and potentially introducing unwarranted concerns for parents of children with false-positive screening tests.",
"   </p>",
"   <p>",
"    Although providers often worry about false-positive results and their impact on families [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/26\">",
"     26",
"    </a>",
"    ], a false-positive developmental screen actually may be beneficial for some children. In a report of children who participated in validation studies of various developmental screening tests, those who failed the screening test and were not found to have a developmental disability on diagnostic testing (false positives) had more psychosocial risk factors than children with true negative screening results, and 70 percent performed lower on the better predictors of future school success (intelligence, language, and academic achievement) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/27\">",
"     27",
"    </a>",
"    ]. Diagnostic testing of children who fail developmental screening tests provides an opportunity to focus intervention efforts. Although only children who are diagnosed with developmental disability through the diagnostic evaluation qualify for early intervention or special education services, those with a false-positive screening test may benefit from other programs known to improve language, cognitive, and academic skills (eg, Head Start, tutoring). (See",
"    <a class=\"local\" href=\"#H89189211\">",
"     'Early Intervention, special education, and other intervention services'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The likelihood of false-positive and false-negative developmental and behavioral screening test results can be minimized by choosing screening instruments that have been validated in the general population and shown to have a sensitivity and specificity of 70 to 80 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/14\">",
"     14",
"    </a>",
"    ]. Underdetection cannot be eliminated but can be minimized by using systematic, validated measures rather than relying entirely on clinical judgment, informal checklists, or nonvalidated measures, and by repeated screening [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/28\">",
"     28",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Problems with informal methods'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Barriers to early detection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most pediatric health care providers agree that monitoring children's development is an important aspect of health maintenance and support early intervention services [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. Despite this belief, in the 2007 National Survey of Children&rsquo;s Health only 19.5 percent of children received a parent-completed developmental screening in the previous 12 months [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/31\">",
"     31",
"    </a>",
"    ] and only 48 percent of respondents to the 2009 American Academy of Pediatrics Periodic Survey of Fellows reported that they always or almost always used one or more formal screening tools [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/32\">",
"     32",
"    </a>",
"    ]. As a result, enrollment rates for Early Intervention programs for 0 to 3 year olds (2.7 percent) remain below the Centers for Disease Control and Prevention&rsquo;s estimated prevalence of developmental delay (8 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/16,20,21\">",
"     16,20,21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Barriers to routine use of accurate approaches to developmental surveillance and screening in primary care include [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/24,26,28,29,33,34\">",
"     24,26,28,29,33,34",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Concerns about time",
"     </li>",
"     <li>",
"      Concerns about reimbursement",
"     </li>",
"     <li>",
"      Concerns about providing developmental",
"      <span class=\"nowrap\">",
"       surveillance/screening",
"      </span>",
"      at a visit focused on an acute illness or other immediate parental concern",
"     </li>",
"     <li>",
"      Belief that clinical judgment is adequate",
"     </li>",
"     <li>",
"      Language and literacy barriers to use of screens in writing or by interview",
"     </li>",
"     <li>",
"      Incomplete administration of screens (eg, selected items from longer measures that thus lack scoring criteria)",
"     </li>",
"     <li>",
"      Inconsistent health supervision attendance, particularly for children with psychosocial risk factors",
"     </li>",
"     <li>",
"      Lack of confidence in the validity of screening measures",
"     </li>",
"     <li>",
"      Insufficient knowledge or training in how to explain results",
"     </li>",
"     <li>",
"      Lack of knowledge about appropriate interventions or referral sources",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The most striking barrier is the widespread use of informal measures such as using milestones checklists extracted from longer screens",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    asking parents non-validated questions. Both approaches lack evidence and leave providers without critical decision support. Other barriers are rooted in misconceptions (ie, that clinical judgment is adequate, that effective screening is time-consuming and not reimbursable). In the US, developmental-behavioral screening is reimbursable under Medicaid and most private payers; it averages about $10.00 per screen. Brief, accurate screens often take less than five minutes to administer and score. Reimbursement for such screens should adequately cover the expenses of the tool, provider time, etc. (See",
"    <a class=\"local\" href=\"#H1873091\">",
"     'Coding and billing'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/29/19928?source=see_link&amp;anchor=H4#H4\">",
"     \"Developmental and behavioral screening tests in primary care\", section on 'Developmental screening tests'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Problems with informal methods",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many pediatricians assess development with informal methods (eg, clinical assessment, informal checklists, screening instruments that have not been validated, or informal elicitation of parental concerns) or tests that have suboptimal sensitivity and specificity [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/29\">",
"     29",
"    </a>",
"    ]. The use of such methods is problematic, as illustrated below:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pediatric health care providers are inaccurate in their overall assessment of developmental, behavioral, and emotional status when they do not use specific criteria [",
"      <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/17,35-38\">",
"       17,35-38",
"      </a>",
"      ]. A systematic review indicated that pediatric clinicians are accurate in identifying children who clearly do not have a developmental or behavioral concern (specificity ranged from 69 to 100 percent) but much less accurate in identifying children with a true developmental behavioral problem (sensitivity ranged from 14 to 54 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/38\">",
"       38",
"      </a>",
"      ]. Waiting until the problem is obvious by clinical judgment alone results in the detection of 30 percent fewer children with developmental disabilities than reliance on formal developmental screening [",
"      <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/2\">",
"       2",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Reviewing the age of achievement of developmental milestones is problematic because developmental status in the past does not necessarily predict current developmental status.",
"     </li>",
"     <li>",
"      There is no evidence that informal checklists of milestones (including selected items from longer tools) predict developmental status. Such instruments have not been validated or standardized; there is no proof that the items are optimally chosen, nor do they have scoring criteria that indicate when referral for diagnostic evaluation is necessary [",
"      <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The use of screening tests with limited accuracy usually results in underdetection (and, less likely, in over-referrals). In addition, the performance characteristics of a validated screening instrument no longer apply if the test is not used in the way that it was standardized and validated (eg, changing the wording of questions,",
"      <span class=\"nowrap\">",
"       asking/eliciting",
"      </span>",
"      only certain items, or using a screening test in symptomatic, rather than asymptomatic, children) [",
"      <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Unless parents are asked systematically about mental health,",
"      <span class=\"nowrap\">",
"       housing/food",
"      </span>",
"      instability, domestic violence, parent-child interactions, etc, psychosocial risk and protective factors are not likely to be identified [",
"      <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/39\">",
"       39",
"      </a>",
"      ]. Quality measurement of these risk factors is critical.",
"     </li>",
"     <li>",
"      Informal elicitation of parents&rsquo; concerns is problematic for several reasons:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Many of the routine questions asked of parents may not effectively elicit concerns [",
"      <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/40\">",
"       40",
"      </a>",
"      ]. As an example, the question, \"Do you have worries about your child's development?\" does not work well because parents may not be certain that they are \"worried\" and because the word \"development\" is understood by only 50 percent of parents [",
"      <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/40,41\">",
"       40,41",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Many parents, particularly those with limited education, do not raise developmental concerns spontaneously. Actively eliciting parents&rsquo; concerns with questions proven to work is essential and helps parents realize that health care providers are interested in child development and behavior, which many low-income parents do not know [",
"      <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/42,43\">",
"       42,43",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In most states, informal approaches, such as clinical judgment, informal milestones checklists, or asking parents nonvalidated questions, do not qualify for reimbursement. (See",
"      <a class=\"local\" href=\"#H1873091\">",
"       'Coding and billing'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     HOW TO PROVIDE EVIDENCE-BASED SURVEILLANCE AND SCREENING",
"    </span>",
"    &nbsp;&mdash;&nbsp;The remainder of this topic review will discuss how surveillance and screening can work efficiently in primary care and provide the information that providers need to know to effectively screen children for developmental problems. Screening and surveillance can often be accomplished with the same tools. The use of standardized, validated, accurate measures is essential for early detection.",
"   </p>",
"   <p>",
"    The use of validated measures does not preclude the use of informed clinical opinion but enhances and optimizes clinical opinion by using measurement to strengthen the index of suspicion and to inform decision making. The ideal screening test should have established psychometric qualities (ie, precision, reliability, accuracy) and be easy to perform and interpret, inexpensive, and acceptable to the child and parents [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/14\">",
"     14",
"    </a>",
"    ]. These characteristics are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/13/43225?source=see_link&amp;anchor=H2#H2\">",
"     \"Screening tests in children and adolescents\", section on 'Overview'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/29/19928?source=see_link\">",
"     \"Developmental and behavioral screening tests in primary care\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/18/22823?source=see_link\">",
"     \"Glossary of common biostatistical and epidemiological terms\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Components",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evidence-based developmental surveillance and screening includes several components [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/11\">",
"     11",
"    </a>",
"    ], described in greater detail below:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Objective, validated measurement of psychosocial risks and protective factors",
"     </li>",
"     <li>",
"      Objective, validated measurement to elicit and address parents' concerns",
"     </li>",
"     <li>",
"      Screening all areas of development (",
"      <a class=\"graphic graphic_table graphicRef77685 \" href=\"UTD.htm?4/33/4637\">",
"       table 1",
"      </a>",
"      ) with an accurate, validated screening instrument (",
"      <a class=\"graphic graphic_table graphicRef57703 \" href=\"UTD.htm?33/61/34780\">",
"       table 3",
"      </a>",
"      ) at periodic intervals, and occasional use of an accurate disability-focused screen (ie, for autism spectrum disorders or",
"      <span class=\"nowrap\">",
"       behavioral/mental",
"      </span>",
"      health if such issues are not captured with the developmental screening test that is used)",
"     </li>",
"     <li>",
"      Monitoring milestones (which is best accomplished with accurate screening tools because many of these also offer longitudinal progress tracking)",
"     </li>",
"     <li>",
"      A quality medical evaluation including a physical examination and family and child medical history",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Assessment of psychosocial risks and protective factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Psychosocial risk factors often are better predictors of developmental delays and disabilities than are medical issues [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. Psychosocial risk factors focus on the parents&rsquo; challenges, including:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Having less than a high school education",
"     </li>",
"     <li>",
"      Being single",
"     </li>",
"     <li>",
"      Being unemployed",
"     </li>",
"     <li>",
"      Mental health problems (of which depression or anxiety are particularly common)",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Housing/food",
"      </span>",
"      instability",
"     </li>",
"     <li>",
"      Three or more children in the home",
"     </li>",
"     <li>",
"      Limited facility with the English language",
"     </li>",
"     <li>",
"      Limited literacy in any language",
"     </li>",
"     <li>",
"      Belonging to an ethnic minority",
"     </li>",
"     <li>",
"      Having a problematic parenting style (eg, not interested in teaching or conversing with their children)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Psychosocial risks can be objectively evaluated using a measure such as the Family Psychosocial Screen (FPS, available online through Bright Futures at",
"    <a class=\"external\" href=\"file://www.brightfutures.org/mentalhealth/pdf/professionals/ped_intake_form.pdf\">",
"     www.brightfutures.org/mentalhealth/pdf/professionals/ped_intake_form.pdf",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/46\">",
"     46",
"    </a>",
"    ]. The FPS takes approximately 15 minutes to administer and interpret (if an interview is required) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/47\">",
"     47",
"    </a>",
"    ]. It can be used as a clinic intake form so that each patient receives only a single administration, although repeat administrations (often of selected items, such as the two-item parental depression screen) are needed when family circumstances change and to check on family well-being, especially in the first two years of life. The FPS identifies risk factors for developmental and behavioral problems related to parents' educational status, income, marital status, number of children in the home, parental mental health problems, parents' history of abuse as a child, domestic violence, frequency of household moves, etc. The presence of four or more such risk factors is associated with developmental delay [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/45\">",
"     45",
"    </a>",
"    ]. The FPS also screens for maternal depression and substance abuse. Recommendations for additional evaluation or referral (to early stimulation programs, such as Head Start, family training, social work, or mental health services) are based upon the number of positive responses in the various sections. Using larger inventories as the gold standard, the FPS has a sensitivity and specificity of 90 percent in the detection of various psychosocial risk factors [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/47-49\">",
"     47-49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Protective (sometimes called resilience) factors also tend to focus on parents, particularly on positive parenting styles. Resilience is likely when parents actively (and age-appropriately) teach children new things, label objects of interest, talk with children at meals, share books with their children, perceive their child as able to be soothed, and are interested in conversing with their children (including back-and-forth sound play in infancy, playing peek-a-boo, etc) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/9,10\">",
"     9,10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Critical protective factors can be objectively assessed using a measure such as the Brigance Parent-Child Interaction Scale (BPCIS) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/50\">",
"     50",
"    </a>",
"    ]. The eight critical items of the BPCIS (which takes about two minutes to complete) address parenting behaviors and perceptions strongly associated with developmental status.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Eliciting and addressing parents' concerns",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is essential to use proven methods to elicit and address parents&rsquo; concerns about children&rsquo;s development and behavior. Proven methods combine both screening and surveillance. Some measures encourage providers to add clinical observations to parents&rsquo; concerns (eg, when clinicians are concerned but the parent is not).",
"   </p>",
"   <p>",
"    The Parents' Evaluation of Developmental Status (PEDS) is a measure that uses parents&rsquo; concerns for developmental and behavioral surveillance and screening [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/51,52\">",
"     51,52",
"    </a>",
"    ]. The PEDS scoring system indicates whether children are at high, moderate, or low risk of developmental disability and provides guidelines for referral, counseling, or additional evaluation; the guidelines are complemented by clinical judgment. The PEDS is described in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/29/19928?source=see_link&amp;anchor=H5#H5\">",
"     \"Developmental and behavioral screening tests in primary care\", section on 'Parent report screens'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9015915\">",
"    <span class=\"h3\">",
"     Milestones-focused developmental-behavioral screening tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Validated developmental-behavioral screening tests (",
"    <a class=\"graphic graphic_table graphicRef57703 \" href=\"UTD.htm?33/61/34780\">",
"     table 3",
"    </a>",
"    ) provide information about a child's skill attainment and risk for developmental, and in some cases",
"    <span class=\"nowrap\">",
"     behavioral/mental",
"    </span>",
"    health disabilities. The periodic administration of such screens can increase the accuracy of clinical impressions formulated through developmental surveillance [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/19,53-55\">",
"     19,53-55",
"    </a>",
"    ]. Individual screening tests are described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/29/19928?source=see_link&amp;anchor=H4#H4\">",
"     \"Developmental and behavioral screening tests in primary care\", section on 'Developmental screening tests'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18501566\">",
"    <span class=\"h4\">",
"     When to perform developmental-behavioral screening",
"    </span>",
"    &nbsp;&mdash;&nbsp;The American Academy of Pediatrics (AAP) recommends that all infants and young children be formally screened for developmental delay at periodic intervals and if developmental concerns are raised by the parent or provider during routine developmental surveillance [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/11\">",
"     11",
"    </a>",
"    ]. Appropriate measures are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef57703 \" href=\"UTD.htm?33/61/34780\">",
"     table 3",
"    </a>",
"    ). The AAP recommends that infants and young children undergo formal developmental screening at the following ages [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/11\">",
"     11",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      9 months &ndash; Developmental screening at nine months provides an opportunity to evaluate the child's vision and hearing, motor skills, and early communication skills, to educate parents about developmental screening, and to encourage parents to pay particular attention to communication and language skills",
"     </li>",
"     <li>",
"      18 months &ndash; Developmental screening at 18 months of age provides an opportunity to evaluate motor, communication, and language skills",
"     </li>",
"     <li>",
"      24 or 30 months &ndash; Developmental screening at 24 or 30 months provides an opportunity to evaluate motor, language, and cognitive skills",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There is a lack of agreement regarding whether and for how long clinicians should &ldquo;correct&rdquo; for prematurity when assessing developmental status of children who were born prematurely [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/56,57\">",
"     56,57",
"    </a>",
"    ]. Correction is most important during the first year of life. We suggest correction for prematurity (by subtracting the number of weeks or months the infant was premature from his or her chronologic age) until the child has a chronologic age of 24 months.",
"   </p>",
"   <p>",
"    The AAP also recommends that developmental monitoring continue at all well-visits after 30 months",
"    <strong>",
"    </strong>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/11,58\">",
"     11,58",
"    </a>",
"    ] and is urging third-party payers to reimburse for screening.",
"   </p>",
"   <p>",
"    In addition to general developmental screening, the AAP recommends autism-specific screening at 18 and 24 months screen [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/59\">",
"     59",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/17/35097?source=see_link&amp;anchor=H13#H13\">",
"     \"Surveillance and screening for autism spectrum disorders in primary care\", section on 'Guidelines for surveillance and screening'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/1/14361?source=see_link&amp;anchor=H7#H7\">",
"     \"Screening tools for autism spectrum disorders\", section on 'Tools for children &lt;3 years'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Repeated screening is necessary because developmental challenges manifest with age; a child whose skills appear normal at one year of age may demonstrate problems later on [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/60\">",
"     60",
"    </a>",
"    ]. The risk of developmental disability increases as the scope of the developmental skills expands. It is impossible to determine that a child has a language delay, for example, until vocabulary or word combinations fail to emerge [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/28\">",
"     28",
"    </a>",
"    ]. Development develops, and developmental problems do, too. Many problems are not visible until later in life (eg, language disorders, reading disabilities, etc). Repeated screening is essential.",
"   </p>",
"   <p>",
"    Behavioral and mental health screening should be provided when indicated [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/11\">",
"     11",
"    </a>",
"    ]. Children with undetected developmental problems often present with behavioral issues [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/61-63\">",
"     61-63",
"    </a>",
"    ]. Temper tantrums or disruptive behavior may be the manifestation of frustration in communication for a child with language delay. Behavioral problems should be evaluated in concert with and in context of developmental issues. Some developmental screening tests also identify behavioral and mental health problems, but some do not. When using a developmental screen that does not identify behavioral and mental health problems, the AAP&rsquo;s Mental Health Task Force recommends using a separate behavioral screen, particularly when clinicians&rsquo; or parents&rsquo; concerns persist despite developmental promotion or early intervention. Several validated behavioral screening instruments that are easily and briefly administered are available (",
"    <a class=\"graphic graphic_table graphicRef57703 \" href=\"UTD.htm?33/61/34780\">",
"     table 3",
"    </a>",
"    ). These tests are described in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/29/19928?source=see_link&amp;anchor=H7#H7\">",
"     \"Developmental and behavioral screening tests in primary care\", section on 'Behavioral screening tests'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H307347\">",
"    <span class=\"h3\">",
"     Monitoring milestones",
"    </span>",
"    &nbsp;&mdash;&nbsp;Monitoring milestones is an important component of developmental surveillance [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/11\">",
"     11",
"    </a>",
"    ]. Normal developmental-behavioral milestones for children are provided in the following tables. Such milestone checklists are helpful for pediatric and parent education. When assessing developmental milestones, we suggest that the age of premature infants younger than 24 months (chronologic age) be &ldquo;corrected&rdquo; for prematurity by subtracting the number of weeks or months the infant was premature from his or her chronologic age.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For 0 to 12 months (",
"      <a class=\"graphic graphic_table graphicRef66383 \" href=\"UTD.htm?16/49/17183\">",
"       table 4",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      For 12 to 24 months (",
"      <a class=\"graphic graphic_table graphicRef75336 graphicRef55365 \" href=\"UTD.htm?14/41/15002\">",
"       table 5A-B",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      For 24 to 42 months (",
"      <a class=\"graphic graphic_table graphicRef68086 graphicRef79265 \" href=\"UTD.htm?9/0/9224\">",
"       table 6A-B",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      For 4 to 8 years (",
"      <a class=\"graphic graphic_table graphicRef60900 graphicRef69590 \" href=\"UTD.htm?33/59/34745\">",
"       table 7A-B",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is critical to note that the lists provided above are not screens; they provide information about skill attainment at roughly the 50",
"    <sup>",
"     th",
"    </sup>",
"    percentile&mdash;meaning that roughly 50 percent of children are not able to perform the stated tasks. The use of milestones focused screens (eg, Battelle Developmental Inventory Screening Test, PEDS: Developmental Milestones) is more helpful in decision making.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H94392219\">",
"    <span class=\"h3\">",
"     Medical evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The medical evaluation, which generally is part of the health supervision visit, includes review of the history and the performance of a physical examination. The focus of the medical evaluation in children with suspected developmental delay is to discern the presence of biologic risks (eg, prenatal or perinatal insults) or medical problems associated with developmental disabilities (eg, hypothyroidism, neurocutaneous disorders, lead poisoning, congenital heart disease, etc) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The aspects of the history that particularly relate to development and behavior are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef63435 \" href=\"UTD.htm?8/38/8812\">",
"     table 8A",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/65,66\">",
"     65,66",
"    </a>",
"    ]. The effects of chronic illness on development and school attendance should not be underestimated.",
"   </p>",
"   <p>",
"    Aspects of the examination that particularly relate to developmental and behavioral disabilities are highlighted below (",
"    <a class=\"graphic graphic_table graphicRef68449 \" href=\"UTD.htm?1/11/1212\">",
"     table 8B",
"    </a>",
"    ). The University of Utah provides a video for guidance in conducting a pediatric neurodevelopmental examination (available at:",
"    <a class=\"external\" href=\"file://library.med.utah.edu/pedineurologicexam/html/home_exam.html\">",
"     library.med.utah.edu/pedineurologicexam/html/home_exam.html",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Head circumference should be monitored for microcephaly, macrocephaly, and increased or decreased growth velocity (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/54/3946?source=see_link\">",
"       \"Etiology and evaluation of macrocephaly in infants and children\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/51/36665?source=see_link&amp;anchor=H5#H5\">",
"       \"Etiology and evaluation of microcephaly in infants and children\", section on 'Definitions'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Weight and height should be monitored for growth deficiency (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/40/42633?source=see_link\">",
"       \"Normal growth patterns in infants and prepubertal children\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/12/14538?source=see_link&amp;anchor=H2#H2\">",
"       \"Etiology and evaluation of failure to thrive (undernutrition) in children younger than two years\", section on 'Measurement of growth'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      The child should be assessed for dysmorphology, including both minor (eg, hypertelorism, micrognathia) and major congenital anomalies (eg, spina bifida, midline defects) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/45/19161?source=see_link\">",
"       \"Approach to congenital malformations\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      The eyes should be examined for acuity, poor tracking, strabismus, or cataracts (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/59/24505?source=see_link\">",
"       \"Visual development and vision assessment in infants and children\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/8/34951?source=see_link&amp;anchor=H8#H8\">",
"       \"Evaluation and management of strabismus in children\", section on 'Evaluation'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      The ears should be evaluated for unusual shape or placement, recurrent acute otitis media, or chronic otitis media with effusion; hearing acuity should also be assessed (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/19/44344?source=see_link\">",
"       \"Evaluation of hearing impairment in children\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29642?source=see_link&amp;anchor=H21#H21\">",
"       \"Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications\", section on 'Clinical manifestations'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/40/22153?source=see_link&amp;anchor=H5#H5\">",
"       \"Otitis media with effusion (serous otitis media) in children\", section on 'Clinical features'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      The abdomen should be examined for hepatosplenomegaly, which may be a sign of metabolic disease (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/55/13177?source=see_link&amp;anchor=H25935258#H25935258\">",
"       \"Inborn errors of metabolism: Identifying the specific disorder\", section on 'Hepatosplenomegaly'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      The skin should be evaluated for neurocutaneous lesions (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/50/36650?source=see_link\">",
"       \"Neurofibromatosis type 1 (von Recklinghausen's disease)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/39/4727?source=see_link\">",
"       \"Sturge-Weber syndrome\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/38/34410?source=see_link\">",
"       \"Tuberous sclerosis complex: Genetics, clinical features, and diagnosis\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      The neurologic examination should include assessment of primitive and protective reflexes, symmetry, tone, muscle strength, and deep tendon reflexes (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/17/14618?source=see_link&amp;anchor=H10928992#H10928992\">",
"       \"Detailed neurologic assessment of infants and children\", section on 'Neurologic examination'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Laboratory evaluation should include evaluation for iron deficiency and lead poisoning if these tests have not recently been performed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/18/22826?source=see_link\">",
"     \"Iron deficiency in infants and young children: Screening, prevention, clinical manifestations, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/24/394?source=see_link\">",
"     \"Childhood lead poisoning: Clinical manifestations and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Guidelines for implementation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Implementation of validated developmental screening in primary care can be challenging. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Barriers to early detection'",
"    </a>",
"    above.) A",
"    <a class=\"external\" href=\"file://www.developmentalscreening.org/\">",
"     Developmental Screening Tool Kit",
"    </a>",
"    toolkit has been developed to help providers and practices that are planning to start using a validated tool to screen children for developmental needs. Additional suggestions for organizing offices to maximize detection of children with developmental needs and",
"    <span class=\"nowrap\">",
"     developmental/behavioral",
"    </span>",
"    promotion are provided in the table (",
"    <a class=\"graphic graphic_table graphicRef79718 \" href=\"UTD.htm?11/45/11997\">",
"     table 9",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Anticipating and preparing for the outcomes of early detection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anticipating and preparing for the outcomes of developmental screening are important components of implementing developmental screening in primary care. It is critical that providers follow up when results are abnormal; it is estimated that 50 to 80 percent of children who fail developmental screening are not referred for services [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/13,67\">",
"     13,67",
"    </a>",
"    ]. Failure to follow up on abnormal screening results or using a \"wait and see\" approach in children who have failed a screening instrument delays initiation of early intervention services.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h4\">",
"     Passed screening test",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children in a primary care practice who pass a screening test typically can be categorized into one of two groups on the basis of the psychosocial risks and screening test results:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Those with typical development and few psychosocial risk factors; these children and their families need continued",
"      <span class=\"nowrap\">",
"       monitoring/screening",
"      </span>",
"      at well-child visits with anticipatory",
"      <span class=\"nowrap\">",
"       guidance/developmental",
"      </span>",
"      promotion in regard to acquisition of milestones, age-appropriate behavior, and child-rearing challenges [",
"      <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/68\">",
"       68",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H307347\">",
"       'Monitoring milestones'",
"      </a>",
"      above.) Several Web sites that provide parenting tips and information about developmental promotion are provided in the table (",
"      <a class=\"graphic graphic_table graphicRef56742 \" href=\"UTD.htm?18/7/18557\">",
"       table 10",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Those for whom providers have concerns despite a passed screen. This may include children who have psychosocial risk factors and a dearth of protective factors (see",
"      <a class=\"local\" href=\"#H11\">",
"       'Assessment of psychosocial risks and protective factors'",
"      </a>",
"      above), or children for whom substantial health problems (eg, prematurity, hearing loss, lead poisoning) are apparent. In these cases, referrals to Early Intervention (EI) or special education (SE) are recommended. If the child does not qualify for EI or SE, referral to an early prevention program (eg, Head Start) is a reasonable alternative. (See",
"      <a class=\"local\" href=\"#H89189211\">",
"       'Early Intervention, special education, and other intervention services'",
"      </a>",
"      below.)",
"      <br/>",
"      <br/>",
"      Mediation of psychosocial risk factors may require parent training in how to promote development; early prevention programs for children (eg, Head Start); efforts to reduce stressors such as income, housing, and food instability;",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      intervention in parental depression or other mental illness.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h4\">",
"     Failed screening test",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most children who fail a screening should be promptly referred for additional assessment and evaluation, starting with Early Intervention or special education. These services are provided without cost to families. (See",
"    <a class=\"local\" href=\"#H89189211\">",
"     'Early Intervention, special education, and other intervention services'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h5\">",
"     Disclosure of results",
"    </span>",
"    &nbsp;&mdash;&nbsp;The discussion of failed screening test results with families can be difficult for health care providers. It can be made easier when parents' concerns have already been elicited, because affirmation is the logical next step. In any case, disclosure of screening test results should be sensitive and complete; the health care provider should provide as much information as he or she can, using colloquial terms (eg, \"developmental delay,\" \"is behind other children,\" \"has difficulty with\") for provisional diagnoses [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/60\">",
"     60",
"    </a>",
"    ]. Additional information about explaining results is available through the training module at pedstest.com.",
"   </p>",
"   <p>",
"    The child's areas of strength should be presented along with his or her weaknesses and the need for referral for comprehensive diagnostic evaluation, if one is indicated. The family's questions should be answered, and the need for follow-through with Early Intervention services",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    additional evaluations emphasized. A second meeting should be offered so other family members can hear the results and recommendations [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H89189211\">",
"    <span class=\"h5\">",
"     Early Intervention, special education, and other intervention services",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Individuals with Disabilities Education Act (IDEA) mandates early identification and intervention for developmental disabilities and requires clinicians to refer children with suspected (as well as confirmed) developmental delays in a timely manner to the appropriate early intervention system [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/15\">",
"     15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/38/37480?source=see_link&amp;anchor=H13#H13\">",
"     \"Definitions of specific learning disability and laws pertaining to learning disabilities\", section on 'Individuals with Disabilities Education Act'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The appropriate system varies depending on the age of the child and whether or not he or she qualifies for services in his or her community (",
"    <a class=\"graphic graphic_table graphicRef70428 \" href=\"UTD.htm?42/13/43228\">",
"     table 11",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Children 0 to 36 months &ndash; For children ages 0 to 36 months with suspected or confirmed developmental disabilities, Early Intervention (EI) is provided through state agencies (with state-to-state variations in eligibility criteria). An established diagnosis of developmental disability is not necessary for the provision of EI services [",
"      <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/69\">",
"       69",
"      </a>",
"      ]. The agencies take referrals from primary care providers and then perform further evaluations to determine whether the child qualifies for services. The typical focus of the Early Intervention evaluation is establishment of the need for services, rather than a specific diagnosis. For each child who qualifies, an Individualized Family Service Plan (IFSP) is developed. Evaluations and treatment by speech and language pathologists and occupational and physical therapists are available.",
"      <br/>",
"      <br/>",
"      When referring children for EI services, it is helpful to provide families with telephone numbers, contact information, a description of the services that EI provides, and data on the positive outcomes for children who have received EI [",
"      <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/3-10\">",
"       3-10",
"      </a>",
"      ]. Although all children with delays or disabilities benefit from EI, children with mild to moderate delays typically make the most gains [",
"      <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/70\">",
"       70",
"      </a>",
"      ]. A parents&rsquo; guide for EI is available through the",
"      <a class=\"external\" href=\"file://nichcy.org/\">",
"       National Dissemination Center for Children with Disabilities",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      Children three to five years &ndash; For children ages three to five years old with developmental disabilities, preschool special education (SE) services are available through state-run agencies, often through the department of education and the local public school system (with state-to-state variations in eligibility criteria). Services offered may include preschool services (exclusive or inclusive classroom settings) and speech, language, occupational, and physical therapy.",
"     </li>",
"     <li>",
"      Children older than five years &ndash; For children older than five years of age with developmental disabilities, referrals should be made to the public school system, usually through the department of special education. The",
"      <a class=\"external\" href=\"file://www.nectac.org/contact/contact.asp\">",
"       National Early Childhood Technical Assistance Center",
"      </a>",
"      provides local contact information. Eligibility requirements for public school SE services vary from state to state.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition to the above public services provided through the IDEA, private evaluations and services also are available within local communities. However, waiting times and commercial insurance reimbursement for private services vary. It is advisable to make the initial referral IDEA programs (ie, EI or SE) and reserve private services for second opinions or highly focused evaluations (eg, autism-focused, neuropsychology, etc).",
"   </p>",
"   <p>",
"    Although referrals to EI or SE are the best initial step when a child fails a developmental screening test, not all children qualify. If the child does not qualify for EI or SE services, other approaches to intervention may be necessary. These approaches often are called &ldquo;prevention services&rdquo; and include Head Start, Early Head Start, parent training, social services, quality day care and preschool programs, private speech-language and other therapies, and, to a less intensive extent, developmental promotion in primary care (with careful monitoring as to its effectiveness).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1871984\">",
"    <span class=\"h5\">",
"     Additional referrals",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to being referred to EI or SE, children who fail developmental screening tests also may require referrals to a speech-language therapist, physical therapist, occupational therapist, developmental behavioral pediatrician, or mental health provider.",
"   </p>",
"   <p>",
"    Referral to a developmental-behavioral pediatrician may be necessary if there are",
"    <span class=\"nowrap\">",
"     behavioral/mental",
"    </span>",
"    health concerns, the child&rsquo;s management is complicated by a medical diagnosis or medication issues, or a second opinion is necessary.",
"   </p>",
"   <p>",
"    Referral for psychologic evaluation and counseling may be warranted for concerns regarding behavioral and mental health issues. This is particularly true when brief in-office counseling and patient education has not been successful or when",
"    <span class=\"nowrap\">",
"     behavioral/mental",
"    </span>",
"    health screens indicate potential behavioral or mental health problems. Community mental health centers often offer behavior management techniques and family counseling for parents of younger children. Individualized cognitive-behavioral therapy with a trained mental health professional may be necessary for older children.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h5\">",
"     Follow-up medical evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children who are confirmed to have developmental disability after diagnostic evaluation may require additional medical evaluation to determine the primary etiology of the disability, if possible (eg, metabolic disease, fragile X syndrome) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/11\">",
"     11",
"    </a>",
"    ]. Establishment of a specific diagnosis may require referral to a",
"    <span class=\"nowrap\">",
"     developmental/behavioral",
"    </span>",
"    pediatrician or other pediatric specialist. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/4/34889?source=see_link\">",
"     \"Clinical features and diagnosis of fragile X syndrome in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/30/17896?source=see_link\">",
"     \"Management of children and adolescents with fragile X syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The following evaluations should be performed if they have not already been performed in the routine course of health supervision [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/24\">",
"     24",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Evaluation for iron deficiency anemia (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/18/22826?source=see_link\">",
"       \"Iron deficiency in infants and young children: Screening, prevention, clinical manifestations, and diagnosis\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Evaluation for lead poisoning (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/24/394?source=see_link\">",
"       \"Childhood lead poisoning: Clinical manifestations and diagnosis\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Vision screening (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/59/24505?source=see_link\">",
"       \"Visual development and vision assessment in infants and children\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Hearing screening (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/19/44344?source=see_link\">",
"       \"Evaluation of hearing impairment in children\"",
"      </a>",
"      ) &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The additional evaluation should be tailored to clinical findings [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/71\">",
"     71",
"    </a>",
"    ] and may include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Review of the medical history and results of recent physical examination (for clues to possible etiology of the delay) (",
"      <a class=\"graphic graphic_table graphicRef63435 graphicRef68449 \" href=\"UTD.htm?15/5/15453\">",
"       table 8A-B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H94392219\">",
"       'Medical evaluation'",
"      </a>",
"      above.) &nbsp;",
"     </li>",
"     <li>",
"      Thyroid function testing if signs or symptoms of hypothyroidism are present. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/22/21865?source=see_link\">",
"       \"Acquired hypothyroidism in childhood and adolescence\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/39/2682?source=see_link\">",
"       \"Clinical features and detection of congenital hypothyroidism\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Neuroimaging or electroencephalography if the child has microcephaly or clinical suspicion of seizures or encephalopathy, in which case neurologic",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      neurodevelopmental evaluation also may be necessary. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/51/36665?source=see_link&amp;anchor=H16#H16\">",
"       \"Etiology and evaluation of microcephaly in infants and children\", section on 'Evaluation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Metabolic screening. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/0/10250?source=see_link&amp;anchor=H366024#H366024\">",
"       \"Inborn errors of metabolism: Metabolic emergencies\", section on 'Initial evaluation'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/55/13177?source=see_link&amp;anchor=H12033830#H12033830\">",
"       \"Inborn errors of metabolism: Identifying the specific disorder\", section on 'Laboratory evaluation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Genetic testing, particularly if there is a family history of developmental delay (to detect conditions such as fragile X syndrome and genetic deletions and duplications). Karyotype, fragile X testing, and genomic hybridization microarray analysis may be warranted even in the absence of dysmorphic features. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/4/34889?source=see_link\">",
"       \"Clinical features and diagnosis of fragile X syndrome in children and adolescents\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/29/32218?source=see_link\">",
"       \"Rett syndrome\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/8/5257?source=see_link\">",
"       \"Intellectual disability (mental retardation) in children: Evaluation\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Creatine phosphokinase or aldolase in children with abnormal muscle tone (for possible muscular dystrophy). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/16/1290?source=see_link\">",
"       \"Clinical features and diagnosis of Duchenne and Becker muscular dystrophy\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1873091\">",
"    <span class=\"h3\">",
"     Coding and billing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Developmental surveillance and screening is a reimbursable service [",
"    <a class=\"abstract\" href=\"UTD.htm?25/49/26394/abstract/72\">",
"     72",
"    </a>",
"    ]. In the United States, CPT (Current Procedural Terminology) 96110 has been established to document and bill for limited developmental testing with interpretation and report. Examples of screening instruments that are included under 96110 include the Parents&rsquo; Evaluation of Developmental Status, Ages and Stages Questionnaire, and Vanderbilt Rating Scale (for attention deficit hyperactivity disorder), among others. If more than one screen is administered, 96110 can be followed (in most states) by multipliers to represent the number of screens administered, (eg, x 2, x 3, etc). When a limited screen is performed along with any evaluation and management",
"    <span class=\"nowrap\">",
"     (E/M)",
"    </span>",
"    service, such as a preventive medicine visit or an office outpatient visit, both services should be reported and a modifier (&ndash;25) added to the",
"    <span class=\"nowrap\">",
"     E/M",
"    </span>",
"    code to show the",
"    <span class=\"nowrap\">",
"     E/M",
"    </span>",
"    service was distinct and necessary. Private payers (and some states) sometimes use different modifiers. Clinic coordinators should investigate the required procedures for each payer to make sure available reimbursement is rendered appropriately.",
"   </p>",
"   <p>",
"    Denied claims should be appealed. If denied a second time, the American Academy of Pediatrics (AAP) has a coding",
"    <span class=\"nowrap\">",
"     section/hotline",
"    </span>",
"    to assist (phone: 800-433-9016, ext. 4022, or e-mail: aapcodinghotline@aap.org).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     ROLE OF PRIMARY CARE PROVIDER",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary care provider is instrumental in providing a medical home for the child with developmental challenges. In addition to his or her fundamental role in early identification, the primary care provider also provides follow-up to monitor developmental status and the effectiveness of advice or interventions, and coordinates referrals (eg, to Early Intervention [EI], special education [SE], and subspecialists). Primary care providers should receive copies of all evaluations, test results, information, and recommendations from outside resources so that they can manage the &ldquo;big picture&rdquo; and optimally coordinate care.",
"   </p>",
"   <p>",
"    Primary care providers should work with",
"    <span class=\"nowrap\">",
"     EI/SE",
"    </span>",
"    and all other services to establish two-way consent forms so that results are consistently shared across relevant services. An Early Intervention referral form that includes consent for release of information is available through the",
"    <a class=\"external\" href=\"file://www.medicalhomeinfo.org/how/clinical_care/developmental_screening/\">",
"     National Center for Medical Home Implementation",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/5/27737?source=see_link&amp;anchor=H16#H16\">",
"     \"Children with special health care needs\", section on 'Medical home'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Nonmedical providers may need encouragement to respond to referrals in the manner that medical providers expect (eg, by sending copies of reports and collaborating in decision making about needed services). Medical providers should communicate with nonmedical providers about what types of information the medical providers would like to receive (eg, results of evaluations, individual education plans), the preferred type of communication (eg, e-mail, fax, phone), and when they are available for in-person discussion or consultation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     RESOURCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Resources for health care providers and parents of children with confirmed or suspected developmental or behavioral disabilities are provided in the tables:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Educational and informational resources (",
"      <a class=\"graphic graphic_table graphicRef56742 \" href=\"UTD.htm?18/7/18557\">",
"       table 10",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Service resources (",
"      <a class=\"graphic graphic_table graphicRef70428 \" href=\"UTD.htm?42/13/43228\">",
"       table 11",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Professional development resources (",
"      <a class=\"graphic graphic_table graphicRef79755 \" href=\"UTD.htm?29/56/30605\">",
"       table 12",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Development is a broad term that encompasses cognitive, language, and motor, as well as behavioral, social-emotional, and mental health domains (",
"      <a class=\"graphic graphic_table graphicRef77685 \" href=\"UTD.htm?4/33/4637\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H19981925\">",
"       'Background'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      It is estimated that 17 percent of children in the birth to 18-year age range have a developmental",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      behavioral disability. However, only 30 percent of such children are identified before school entrance. Those who are identified after school entrance miss the opportunity to participate in early intervention and early childhood programs. (See",
"      <a class=\"local\" href=\"#H19981925\">",
"       'Background'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The goal of developmental surveillance and screening (",
"      <a class=\"graphic graphic_table graphicRef56688 \" href=\"UTD.htm?39/8/40077\">",
"       table 2",
"      </a>",
"      ) is the identification of children who have or are at risk for delays so that services can be provided in a timely manner. Early intervention is associated with improved outcomes. Primary care providers are in a unique position to provide developmental surveillance and screening because they have routine contact with young children and their families. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Rationale for surveillance and screening'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Methods of developmental surveillance and screening that rely on informal clinical observation, ad hoc checklists, and screening instruments that have not been validated result in substantial underdetection of children with developmental and behavioral problems. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Problems with informal methods'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Detection of children with developmental and behavioral problems is increased by using validated surveillance and screening measures and by ensuring referrals and follow-up when results are abnormal. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'How to provide evidence-based surveillance and screening'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Components of developmental surveillance and screening include assessment of psychosocial risks and protective factors, assessment of parents&rsquo; concerns, validated developmental screening tests (",
"      <a class=\"graphic graphic_table graphicRef57703 \" href=\"UTD.htm?33/61/34780\">",
"       table 3",
"      </a>",
"      ), monitoring milestones (",
"      <a class=\"graphic graphic_table graphicRef66383 \" href=\"UTD.htm?16/49/17183\">",
"       table 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef75336 graphicRef55365 graphicRef68086 graphicRef79265 graphicRef60900 graphicRef69590 \" href=\"UTD.htm?43/33/44570\">",
"       table 5A-B, 6A-B, 7A-B",
"      </a>",
"      ), and a medical evaluation for biologic risks (eg, prenatal or perinatal insults) or medical problems associated with developmental disabilities (",
"      <a class=\"graphic graphic_table graphicRef63435 graphicRef68449 \" href=\"UTD.htm?15/5/15453\">",
"       table 8A-B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Components'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Implementation of validated developmental screening in primary care can be challenging. Suggestions for organizing offices to maximize detection of children with developmental needs and",
"      <span class=\"nowrap\">",
"       developmental/behavioral",
"      </span>",
"      promotion are provided in the table (",
"      <a class=\"graphic graphic_table graphicRef79718 \" href=\"UTD.htm?11/45/11997\">",
"       table 9",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Guidelines for implementation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Anticipating and preparing for the outcomes of developmental screening are important components of implementing developmental screening in primary care. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Anticipating and preparing for the outcomes of early detection'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Children who pass developmental screening may require continued",
"      <span class=\"nowrap\">",
"       monitoring/surveillance",
"      </span>",
"      and anticipatory guidance (including developmental promotion) or referral for preventive, Early Intervention (EI), or special education (SE) services depending upon health problems, psychosocial risk and protective factors, and the level of clinician and parent concern (",
"      <a class=\"graphic graphic_table graphicRef70428 \" href=\"UTD.htm?42/13/43228\">",
"       table 11",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Passed screening test'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most children who fail developmental screening should be referred for EI or SE services. Failure to follow up on abnormal screening results or using a \"wait and see\" approach in children who have failed a screening instrument delays initiation of early intervention services. Additional referrals (eg, to a developmental-behavioral pediatrician or a specialist) may be warranted depending upon the clinical circumstances. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Failed screening test'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H89189211\">",
"       'Early Intervention, special education, and other intervention services'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Interventions that may be beneficial for children with psychosocial risk factors or children who do not qualify for EI or SE services include Early Head Start, Head Start, parent training, social services, quality day care and preschool programs, private speech-language and other therapies, and, to a less intensive extent, developmental promotion in primary care (",
"      <a class=\"graphic graphic_table graphicRef70428 \" href=\"UTD.htm?42/13/43228\">",
"       table 11",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H89189211\">",
"       'Early Intervention, special education, and other intervention services'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In addition to his or her fundamental role in early identification, the primary care provider also provides follow-up to monitor developmental status and the effectiveness of advice or interventions, and coordinates referrals to Early Intervention, special education, and other specialists. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Role of primary care provider'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Centers for Disease Control and Prevention. Developmental Screening. file://www.cdc.gov/ncbddd/child/devtool.htm (Accessed on April 11, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/2\">",
"      Palfrey JS, Singer JD, Walker DK, Butler JA. Early identification of children's special needs: a study in five metropolitan communities. J Pediatr 1987; 111:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/3\">",
"      Anderson LM, Shinn C, Fullilove MT, et al. The effectiveness of early childhood development programs. A systematic review. Am J Prev Med 2003; 24:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/4\">",
"      Barnett WS. Long-term cognitive and academic effects of early childhood education on children in poverty. Prev Med 1998; 27:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/5\">",
"      Palfrey JS, Hauser-Cram P, Bronson MB, et al. The Brookline Early Education Project: a 25-year follow-up study of a family-centered early health and development intervention. Pediatrics 2005; 116:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/6\">",
"      Campbell FA, Pungello EP, Miller-Johnson S, et al. The development of cognitive and academic abilities: growth curves from an early childhood educational experiment. Dev Psychol 2001; 37:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/7\">",
"      Shonkoff JP, Hauser-Cram P. Early intervention for disabled infants and their families: a quantitative analysis. Pediatrics 1987; 80:650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/8\">",
"      Reynolds AJ, Temple JA, Robertson DL, Mann EA. Long-term effects of an early childhood intervention on educational achievement and juvenile arrest: A 15-year follow-up of low-income children in public schools. JAMA 2001; 285:2339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/9\">",
"      van Agt HM, van der Stege HA, de Ridder-Sluiter H, et al. A cluster-randomized trial of screening for language delay in toddlers: effects on school performance and language development at age 8. Pediatrics 2007; 120:1317.",
"     </a>",
"    </li>",
"    <li>",
"     McNulty B, Smith DB, Soper EW. Effectiveness of early special education for handicapped children. Colorado Department of Education, 1983.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/11\">",
"      Council on Children With Disabilities, Section on Developmental Behavioral Pediatrics, Bright Futures Steering Committee, Medical Home Initiatives for Children With Special Needs Project Advisory Committee. Identifying infants and young children with developmental disorders in the medical home: an algorithm for developmental surveillance and screening. Pediatrics 2006; 118:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/12\">",
"      Schonwald A, Huntington N, Chan E, et al. Routine developmental screening implemented in urban primary care settings: more evidence of feasibility and effectiveness. Pediatrics 2009; 123:660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/13\">",
"      King TM, Tandon SD, Macias MM, et al. Implementing developmental screening and referrals: lessons learned from a national project. Pediatrics 2010; 125:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/14\">",
"      Squires J, Nickel RE, Eisert D. Early detection of developmental problems: strategies for monitoring young children in the practice setting. J Dev Behav Pediatr 1996; 17:420.",
"     </a>",
"    </li>",
"    <li>",
"     Individuals with Disabilities Education Act Amendments of 1997. Pub L No. 105-17.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/16\">",
"      Pinto-Martin JA, Dunkle M, Earls M, et al. Developmental stages of developmental screening: steps to implementation of a successful program. Am J Public Health 2005; 95:1928.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/17\">",
"      Hix-Small H, Marks K, Squires J, Nickel R. Impact of implementing developmental screening at 12 and 24 months in a pediatric practice. Pediatrics 2007; 120:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/18\">",
"      Jee SH, Szilagyi M, Ovenshire C, et al. Improved detection of developmental delays among young children in foster care. Pediatrics 2010; 125:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/19\">",
"      Guevara JP, Gerdes M, Localio R, et al. Effectiveness of developmental screening in an urban setting. Pediatrics 2013; 131:30.",
"     </a>",
"    </li>",
"    <li>",
"     Number and percentage of infants and toddlers receiving early intervention services under IDEA. https://www.ideadata.org/PopulationData.asp (Accessed on January 24, 2011).",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention. Child development. Available at: www.cdc.gov/ncbddd/child/devtool.htm (Accessed on February 08, 2008).",
"    </li>",
"    <li>",
"     Barnett WS, Escobar CM. Economic costs and benefits of early intervention. In: Handbook of Early Childhood Intervention, Meisels SJ, Shonkoff JP (Eds), Cambridge University Press, New York 1990. p.560.",
"    </li>",
"    <li>",
"     Instutute of Medicine. Committee on Integrating the Science of Early Childhood Development. From Neurons to Neighborhoods: The Science of Early Childhood Development, Shonkoff, JP, Phillips, DA (Eds), The National Academies Press, Washington, DC 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/24\">",
"      First LR, Palfrey JS. The infant or young child with developmental delay. N Engl J Med 1994; 330:478.",
"     </a>",
"    </li>",
"    <li>",
"     Center for Health Care Strategies, Inc. Improving developmental screening: one child at a time. file://www.chcs.org/publications3960/publications_show.htm?doc_id=623283 (Accessed on January 26, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/26\">",
"      King TM, Glascoe FP. Developmental surveillance of infants and young children in pediatric primary care. Curr Opin Pediatr 2003; 15:624.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/27\">",
"      Glascoe FP. Are overreferrals on developmental screening tests really a problem? Arch Pediatr Adolesc Med 2001; 155:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/28\">",
"      Glascoe FP. Early detection of developmental and behavioral problems. Pediatr Rev 2000; 21:272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/29\">",
"      Sand N, Silverstein M, Glascoe FP, et al. Pediatricians' reported practices regarding developmental screening: do guidelines work? Do they help? Pediatrics 2005; 116:174.",
"     </a>",
"    </li>",
"    <li>",
"     American Academy of Pediatrics. Periodic Survey of Fellows 2002. Executive Summary file://www.aap.org/research/periodicsurvey/ps53exs.htm.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/31\">",
"      Bethell C, Reuland C, Schor E, et al. Rates of parent-centered developmental screening: disparities and links to services access. Pediatrics 2011; 128:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/32\">",
"      Radecki L, Sand-Loud N, O'Connor KG, et al. Trends in the use of standardized tools for developmental screening in early childhood: 2002-2009. Pediatrics 2011; 128:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/33\">",
"      Glascoe FP, Dworkin PH. Obstacles to effective developmental surveillance: errors in clinical reasoning. J Dev Behav Pediatr 1993; 14:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/34\">",
"      Schonwald A, Horan K, Huntington N. Developmental screening: is there enough time? Clin Pediatr (Phila) 2009; 48:648.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/35\">",
"      BIERMAN JM, CONNOR A, VAAGE M, HONZIK MP. PEDIATRICIANS' ASSESSMENTS OF THE INTELLIGENCE OF TWO-YEAR-OLDS AND THEIR MENTAL TEST SCORES. Pediatrics 1964; 34:680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/36\">",
"      KORSCH B, COBB K, ASHE B. Pediatricians' appraisals of patients' intelligence. Pediatrics 1961; 27:990.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/37\">",
"      Lavigne JV, Binns HJ, Christoffel KK, et al. Behavioral and emotional problems among preschool children in pediatric primary care: prevalence and pediatricians' recognition. Pediatric Practice Research Group. Pediatrics 1993; 91:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/38\">",
"      Sheldrick RC, Merchant S, Perrin EC. Identification of developmental-behavioral problems in primary care: a systematic review. Pediatrics 2011; 128:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/39\">",
"      Glascoe FP. If you don't ask, parents may not tell: noticing problems vs expressing concerns. Arch Pediatr Adolesc Med 2006; 160:220; author reply 220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/40\">",
"      Glascoe FP, Dworkin PH. The role of parents in the detection of developmental and behavioral problems. Pediatrics 1995; 95:829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/41\">",
"      Glascoe FP, Altemeier WA, MacLean WE. The importance of parents' concerns about their child's development. Am J Dis Child 1989; 143:955.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/42\">",
"      Glascoe FP. Do parents discuss concerns about children's development with health care providers? Ambul Child Health 1997; 2:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/43\">",
"      Barlow M, Wildman B, Stancin T. Mothers' help-seeking for pediatric psychosocial problems. Clin Pediatr (Phila) 2005; 44:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/44\">",
"      McPhillips M, Jordan-Black JA. The effect of social disadvantage on motor development in young children: a comparative study. J Child Psychol Psychiatry 2007; 48:1214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/45\">",
"      Sameroff AJ, Seifer R, Barocas R, et al. Intelligence quotient scores of 4-year-old children: social-environmental risk factors. Pediatrics 1987; 79:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/46\">",
"      Kemper KJ, Kellerher KJ. Family psychosocial screening: instruments and techniques. Ambulatory Child Health 1996; 4:325.",
"     </a>",
"    </li>",
"    <li>",
"     Glascoe FP. Collaborating with parents: Using parents' evaluations of developmental status to detect and address developmental and behavioral problems. PEDSTest.com, LLC, Nolensville, TN 2002.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/48\">",
"      Kemper KJ. Self-administered questionnaire for structured psychosocial screening in pediatrics. Pediatrics 1992; 89:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/49\">",
"      Kemper KJ, Babonis TR. Screening for maternal depression in pediatric clinics. Am J Dis Child 1992; 146:876.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/50\">",
"      Glascoe FP, Leew S. Parenting behaviors, perceptions, and psychosocial risk: impacts on young children's development. Pediatrics 2010; 125:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/51\">",
"      Glascoe FP. Parents' concerns about children's development: prescreening technique or screening test? Pediatrics 1997; 99:522.",
"     </a>",
"    </li>",
"    <li>",
"     Glascoe FP. Parents' evaluations of developmental status: a method for detecting and addressing developmental and behavioral problems in children. PEDSTest.com, LLC. Nolensville, TN, 2010.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/53\">",
"      Dworkin PH. Detection of behavioral, developmental, and psychosocial problems in pediatric primary care practice. Curr Opin Pediatr 1993; 5:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/54\">",
"      Dworkin PH. Developmental screening: (still) expecting the impossible? Pediatrics 1992; 89:1253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/55\">",
"      Thomas SA, Cotton W, Pan X, Ratliff-Schaub K. Comparison of systematic developmental surveillance with standardized developmental screening in primary care. Clin Pediatr (Phila) 2012; 51:154.",
"     </a>",
"    </li>",
"    <li>",
"     Leppert M, Allen MC. Neurodevelopmental consequences of preterm birth: Causes, assessment, and management. In: Developmental-Behavioral Pediatrics, Carey WB, Crocker AC, Coleman WL, et al.  (Eds), Saunders Elsevier, Philadelphia 2009. p.259.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/57\">",
"      Allen MC. Preterm outcomes research: a critical component of neonatal intensive care. Ment Retard Dev Disabil Res Rev 2002; 8:221.",
"     </a>",
"    </li>",
"    <li>",
"     Recommendations for preventive pediatric health care. In: Bright Futures Guidelines for Health Supervision, 3rd ed, Hagan JF, Shaw JS, Duncan PM.  (Eds), American Academy of Pediatrics, Elk Grove Village, IL 2008. p.591.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/59\">",
"      Johnson CP, Myers SM, American Academy of Pediatrics Council on Children With Disabilities. Identification and evaluation of children with autism spectrum disorders. Pediatrics 2007; 120:1183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/60\">",
"      Glascoe FP. Screening for developmental and behavioral problems. Ment Retard Dev Disabil Res Rev 2005; 11:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/61\">",
"      Glascoe FP. It's not what it seems. The relationship between parents' concerns and children with global delays. Clin Pediatr (Phila) 1994; 33:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/62\">",
"      Blackman JA, Cobb LS. A comparison of parents' perceptions of common behavior problems in developmentally at-risk and normal children. Child Health Care 1989; 18:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/63\">",
"      Oberklaid F, Dworkin PH, Levine MD. Developmental-behavioral dysfunction in preschool children. Descriptive analysis of a pediatric consultative model. Am J Dis Child 1979; 133:1126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/64\">",
"      Marino BS, Lipkin PH, Newburger JW, et al. Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association. Circulation 2012; 126:1143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/65\">",
"      Bear LM. Early identification of infants at risk for developmental disabilities. Pediatr Clin North Am 2004; 51:685.",
"     </a>",
"    </li>",
"    <li>",
"     Blackman JA. Developmental screening: Infants, toddlers, and preschoolers. In: Developmental-Behavioral Pediatrics, 3rd ed, Levine MD, Carey WB, Crocker AC (Eds), WB Saunders, Philadelphia 1999. p.689.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/67\">",
"      Rushton J, Bruckman D, Kelleher K. Primary care referral of children with psychosocial problems. Arch Pediatr Adolesc Med 2002; 156:592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/68\">",
"      Olson LM, Inkelas M, Halfon N, et al. Overview of the content of health supervision for young children: reports from parents and pediatricians. Pediatrics 2004; 113:1907.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/69\">",
"      Silverstein M, Sand N, Glascoe FP, et al. Pediatrician practices regarding referral to early intervention services: is an established diagnosis important? Ambul Pediatr 2006; 6:105.",
"     </a>",
"    </li>",
"    <li>",
"     Meisels SJ, Shonkoff JP. Handbook of Early Childhood Intervention, 2nd ed, Cambridge University Press, New York 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/49/26394/abstract/71\">",
"      Srour M, Mazer B, Shevell MI. Analysis of clinical features predicting etiologic yield in the assessment of global developmental delay. Pediatrics 2006; 118:139.",
"     </a>",
"    </li>",
"    <li>",
"     American Academy of Pediatrics. Coding for developmental and behavioral disorders. file://coding.aap.org/content.aspx?aid=10423.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 615 Version 15.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-93.125.6.160-7DBF348CA4-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_49_26394=[""].join("\n");
var outline_f25_49_26394=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H28\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19981925\">",
"      BACKGROUND",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      Definitions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33894841\">",
"      Subsets of child development",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Rationale for surveillance and screening",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Benefits of early intervention",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9015185\">",
"      Challenges in early detection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Potential harms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Barriers to early detection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Problems with informal methods",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      HOW TO PROVIDE EVIDENCE-BASED SURVEILLANCE AND SCREENING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Components",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Assessment of psychosocial risks and protective factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Eliciting and addressing parents' concerns",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9015915\">",
"      - Milestones-focused developmental-behavioral screening tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H18501566\">",
"      When to perform developmental-behavioral screening",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H307347\">",
"      - Monitoring milestones",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H94392219\">",
"      - Medical evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Guidelines for implementation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Anticipating and preparing for the outcomes of early detection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Passed screening test",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Failed screening test",
"     </a>",
"    </li>",
"    <li class=\"dashItem2\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Disclosure of results",
"     </a>",
"    </li>",
"    <li class=\"dashItem2\">",
"     <a class=\"outlineLink\" href=\"#H89189211\">",
"      - Early Intervention, special education, and other intervention services",
"     </a>",
"    </li>",
"    <li class=\"dashItem2\">",
"     <a class=\"outlineLink\" href=\"#H1871984\">",
"      - Additional referrals",
"     </a>",
"    </li>",
"    <li class=\"dashItem2\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Follow-up medical evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1873091\">",
"      - Coding and billing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      ROLE OF PRIMARY CARE PROVIDER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      RESOURCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/615\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/615|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?4/33/4637\" title=\"table 1\">",
"      Domains of development",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?39/8/40077\" title=\"table 2\">",
"      Developmental screening glossary",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?33/61/34780\" title=\"table 3\">",
"      Developmental and behavioral screening tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/49/17183\" title=\"table 4\">",
"      Developmental milestones 0 through 12 mos",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?39/2/39974\" title=\"table 5A\">",
"      Developmental milestones 12 through 24 mos A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?11/31/11766\" title=\"table 5B\">",
"      Developmental milestones 12 through 24 mos B",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?18/45/19157\" title=\"table 6A\">",
"      Developmental milestones 24 through 42 mos A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/2/23584\" title=\"table 6B\">",
"      Developmental milestones 24 through 42 mos B",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?10/46/10982\" title=\"table 7A\">",
"      Developmental milestones 4 through 8 yrs A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?21/26/21924\" title=\"table 7B\">",
"      Developmental milestones 4 through 8 yrs B",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?8/38/8812\" title=\"table 8A\">",
"      Development history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?1/11/1212\" title=\"table 8B\">",
"      Developmental screening medical evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?11/45/11997\" title=\"table 9\">",
"      Guidelines for implementation of developmental screening",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?18/7/18557\" title=\"table 10\">",
"      Educational resources for developmental-behavioral concerns",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?42/13/43228\" title=\"table 11\">",
"      Service resources for children with developmental-behavioral con",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?29/56/30605\" title=\"table 12\">",
"      Developmental-behavioral pediatrics professional development",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/22/21865?source=related_link\">",
"      Acquired hypothyroidism in childhood and adolescence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29642?source=related_link\">",
"      Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/45/19161?source=related_link\">",
"      Approach to congenital malformations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/24/394?source=related_link\">",
"      Childhood lead poisoning: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/5/27737?source=related_link\">",
"      Children with special health care needs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/39/2682?source=related_link\">",
"      Clinical features and detection of congenital hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/16/1290?source=related_link\">",
"      Clinical features and diagnosis of Duchenne and Becker muscular dystrophy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/4/34889?source=related_link\">",
"      Clinical features and diagnosis of fragile X syndrome in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/38/37480?source=related_link\">",
"      Definitions of specific learning disability and laws pertaining to learning disabilities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/17/14618?source=related_link\">",
"      Detailed neurologic assessment of infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/29/19928?source=related_link\">",
"      Developmental and behavioral screening tests in primary care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/12/14538?source=related_link\">",
"      Etiology and evaluation of failure to thrive (undernutrition) in children younger than two years",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/54/3946?source=related_link\">",
"      Etiology and evaluation of macrocephaly in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/51/36665?source=related_link\">",
"      Etiology and evaluation of microcephaly in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/8/34951?source=related_link\">",
"      Evaluation and management of strabismus in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/19/44344?source=related_link\">",
"      Evaluation of hearing impairment in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/18/22823?source=related_link\">",
"      Glossary of common biostatistical and epidemiological terms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/55/13177?source=related_link\">",
"      Inborn errors of metabolism: Identifying the specific disorder",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/0/10250?source=related_link\">",
"      Inborn errors of metabolism: Metabolic emergencies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/8/5257?source=related_link\">",
"      Intellectual disability (mental retardation) in children: Evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/18/22826?source=related_link\">",
"      Iron deficiency in infants and young children: Screening, prevention, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/30/17896?source=related_link\">",
"      Management of children and adolescents with fragile X syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/50/36650?source=related_link\">",
"      Neurofibromatosis type 1 (von Recklinghausen's disease)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/40/42633?source=related_link\">",
"      Normal growth patterns in infants and prepubertal children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/40/22153?source=related_link\">",
"      Otitis media with effusion (serous otitis media) in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/29/32218?source=related_link\">",
"      Rett syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/13/43225?source=related_link\">",
"      Screening tests in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/1/14361?source=related_link\">",
"      Screening tools for autism spectrum disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/39/4727?source=related_link\">",
"      Sturge-Weber syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/17/35097?source=related_link\">",
"      Surveillance and screening for autism spectrum disorders in primary care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/38/34410?source=related_link\">",
"      Tuberous sclerosis complex: Genetics, clinical features, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/59/24505?source=related_link\">",
"      Visual development and vision assessment in infants and children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f25_49_26395="Describing a fracture";
var content_f25_49_26395=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F61020&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F61020&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Describing a fracture",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tr>",
"          <td class=\"subtitle1_single\">",
"           Clinical descriptors",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Age",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Gender",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Mechanism of injury",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Anatomic location",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Soft tissue involvement",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Key physical exam findings",
"          </td>",
"         </tr>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tr>",
"          <td class=\"subtitle1_single\">",
"           Radiologic descriptors",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Type of imaging",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Anatomic location",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Fracture pattern",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Relationship of fragments",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Physeal involvement",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Apophyseal disruption",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Joint involvement",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Soft tissue involvement",
"          </td>",
"         </tr>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_49_26395=[""].join("\n");
var outline_f25_49_26395=null;
var title_f25_49_26396="Endocytosis of water channels";
var content_f25_49_26396=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F52911&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F52911&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Water channel recycling",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 423px; height: 185px; background-image: url(data:image/gif;base64,R0lGODlhpwG5AIAAAP///wAAACH5BAAAAAAALAAAAACnAbkAAAL/hI+py+0Po5y02ouz3rz7D4biSJbmiabqyrbuC8fyTNf2jef6zvf+DwwKh8Si8YhMKpfMpvMJjUqn1Kr1is1qt9yu9wsOi8fksvmMTqvX7Lb7DY/L5/S6/Y7P6/f8vv8PGCg4SFhoeIiYqLjI2Oj4CBkpOUlZaXmJWRmwGTCx+fAJ2gkQmsnHiZqqusraipoTWio66zlq+uUq68DZ0kqjS1rKGxwrPHzwSkxsezuVm7y6yxzj2jv9KVtsgN3JneAdvD2N81ye2xhtAYywfpOMogsOPZoaHt9Nn0/uG3IMYf6uTD0N7cQBUWVCmzd5+pDh+/YwnERq6VIUdPhq3DJ+/1gqcrhIaggrEe+OlcxnK+Ayhyw9aGTHcQW9BiovPHtS8yNIZUUGQvSx84M/cUOpbaNpJ6g6pUV/oOTlU4dSndX2FUQp6SVNrTyYPW16ZdzIqRaJhlSAkFFaClF7eIUJtsrQeuB+rV1wN1Hef3uBer0bV4k5iVxZ9IUbeJBHvm17Qn1MVmS6eVbbpmx8aLEozJKLHZaMli6+yIY/fyakWVpOIsM8k648GqE2WNyg4R2Y+M/qrbl7YrT8unRa3Adrs90tKLhBKJd9cS7NQDTRwlJTfjvLjuci5UflzqyN3CKwydTdanx5rTwg7titYEMslr0En/zkv8D8vn12tb1Dq/9fkt90ojXVDnpFVbVSd6ylhsx1p+n23G39OfGXa40RuE5NwxkDYDT/MbjegxCF591sFV14IEBmMZfXTNqBCGGE/pGYhYUI/gafMAIe9d+CaOk344R5iDgijR399hVAHDVXI15OFmnfG0RC2aNcOHaHG3k7KgikFP6cd5aLE233148tufHWRsuVhNF+WnBWnpEhAgajGsZctiKXUXZIIJdIOuLRlHNUScZw8xGaXEAyNhNFizN2ic5gjNYoYkyRljMppYrquJGYgGooZKZJeKiSoIZctaeoQoyUo6qudvFVm3K+SisSrbGaJ61VhlqrYYiF2Wt0TEUUrHkLFXtbBan/IpuQn8xqR8uz0h4h47LTHnetTbxmKxO3S+1krbfSiIttuOR+e6626cqA6LrbrrvBu/C2Cy8G5k57b73X6ZtBvvrKy++YAQs1MEEAF9wmwv3Sq7DADS/1MMSmLIrtoeNGbPEt4aZ68LwMZ1YmYXca5FqeGZVcJMYSTnqSQg8thKc9xJJcWMfc+tvHeHjWJXNLDMWcmLk4h6jqPS73XNfRPoe876wROM1FczHD8yWj0onM5HQwrXhSgowpq7PNVEh95glDa/yxvb2peMatajpMEoaBKTfV2ZrOEPRapoYFGa4lXBQU3Wk/O3dUfodB6mMJC1VzhWS/qPQ8ZN9qd2ab/0lunNgiCRhrp/aRSBnMSL9M7NH3wJ1ui+lBLRjni3dKVS1biy46Sxz2DHmuqcfWILB1Nuq3dXtL3WM2pI+O/O08z7acu09KyHqHK3k6/GhqK46ySXeGTPnOmlsNZtMUeymW+JQzVnnGKvPmdnarf+8XnP69LWz0CaUfrGZxDh7E4WX/pJrxrY82hmJLtATjP6Sg7n8DpFYCsdS7+ChpghS0H5Ji8STH4a+B1sAgYf4RJJBEpIIkvAn0eoc++HGQNqBwFnJUCD2w7A1SLpKgBVfolDTRkHP8u562qCNABf0Oh7ZCj7N42EOwGUyER6wFDIloAyCO6YH3GxzooLIfT/9tDYpj24sOh8i4JDbxggrUkxi56A7ApFAmQpMb656IRqqdx1T4G5oN2QQp220wjgarX6m+Yx0XnFFYVJKiGvnYvwIV8H1wrB8bqaS7ViGyM5frniQfaQ32yTCIk6QIonA1w4VtcC5jaVkjOxk7UWqPk/36BVxglyVWolIFB1OSeFwZw9iM8JSzVBdVYpmvhuAtbCZcYC9hECVZduCG/XjUlgZ5zGX2kJmiZCEAnwnNaC4MeHsso2q02ZVserI64ByVOO/DS7U5g4vd/Ns5P+KMD50vWcasJ5ns6ZiDdPFpDVFk80RFzTu00538DA3X+rYjhEIioAJ9ZyYLek2R0Qz/WrX7VDrXMFAQ0OePBk2Q6dKDO4tOIqP9IB4AP7qm481uZvfEyahYNKITppRDFZ0oSWF1U5fQEygwHaBDe9FRp5Szg2B0IAr/6Zeh0jJDOS0pE5rKzsbFc1++odBP+QPEi1Ltn1CFKJ/2t8WgbjOMHXlLgNz01Kx19YBFXBvTIqpOjV4VmdmwxxTX6kueaNE8aV0lMUfmUQvNz2uWJOzt9plXCnlTqF81KSS3+NE5Ik+Pydule8oXnbA2gaV4fR4C6/al9l1NrD87HszaNzYUfsdJnf0WIOdqBjl1zURvXWllb3s6K5lxF2M0wghHCjbjKY95gy3tbXOH2AjaFq2f/52aUsXAHthC57ljyBAEM0vd3TWvhsrNYzm7ca3g7HWoBmotG5TnM/1Il1+l+yNkCMlAuCYFhEf1rjbnSEr5wncre2CYeYsFXvXZ1Hpe05phH6fV4uxXvR5sKMecSz6aWpZnx50oZQWiwx9BGA8U7uObQMqQkA4Ya1ihX6E+hNQh9ROwkHuKMkyJwJ+EmMK0U6mF02C8+uJTDiitMWS9N9kinlS0pIycQqEVW/UkmG80U9yFKTPiDkN3vR/mypLLKlHK+ngiPv7vdAvhXipfVriL8+vScMdQVFrqZmLOLsu87OY4s1XO64MznZOiN8H+bEt3/rJs0rxZG8sMwaRrc6VPRwrSlKKhdid7ZUINfehIbOrMLS6xd3DrOK5CGidl2p7J5nkiO7szx3y+sYjJh2YnWxi1p+i0MIOM6VPjtGspllyp+3yxG7vNM1EutKjjtl0IL4+luD4gjQXdZUEjTpiHxVHLis3Pwj77wCNGMrQx8etrz0nb3O62t78N7nCLe9zkLre5z43udKt73exut7vfDe94y3ve9K63ve+N73zre9/iLgAAOw==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Proposed pathways of recycling of luminal membrane water channels in principal cells in the collecting tubule. Water channels are concentrated in clathrin-coated pits at the cell surface and are endocytosed in coated vesicles. These vesicles are rapidly decoated; the water channels may escape degradation and be recycled to the luminal membrane in the presence of ADH.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Brown, D, Kidney Int 1989; 256:F1.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_49_26396=[""].join("\n");
var outline_f25_49_26396=null;
var title_f25_49_26397="CT and osteoporotic bone pain";
var content_f25_49_26397=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F68237&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F68237&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Nasal calcitonin improves bone pain",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 401px; height: 272px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Effect of intranasal salmon calcitonin (sCT) or placebo on the intensity of spontaneous bone pain (score from 0 to 20) in women with recent osteoporotic spinal fractures. Salmon calcitonin led to a more rapid reduction in pain.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Gennari, C, Agnusdei, D, Camporeale, A, Calcif Tissue Int 1991; 49 Suppl 2:S9.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_49_26397=[""].join("\n");
var outline_f25_49_26397=null;
var title_f25_49_26398="Beta blocker ACEI HF mort";
var content_f25_49_26398=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F56213&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F56213&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Beta blockers and ACE inhibitors have synergistic effects in asymptomatic LV dysfunction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 431px; height: 225px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In the SOLVD-prevention trial of 4223 patients with mostly asymptomatic left ventricular (LV) dysfunction, those receiving a beta blocker and enalapril had a significantly lower all cause mortality compared to those receiving beta blocker or enalapril alone (relative risk 0.7); this was due to a significant reduction in death from arrhythmia or pump failure.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Exner DV, Dries DL, Waclawiw MA, et al. J Am Coll Cardiol 1999; 33:916.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_49_26398=[""].join("\n");
var outline_f25_49_26398=null;
var title_f25_49_26399="Proper knee position squat";
var content_f25_49_26399=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F54894&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F54894&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Proper knee position during a squat",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 284px; height: 353px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The knee should not pass over the toes when squatting. This helps prevent placing excessive stress on the knee joint.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Sharon Alzner, MPT.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_49_26399=[""].join("\n");
var outline_f25_49_26399=null;
